: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Bladder Cancer, January 2022
Free Subscription

Abstracts
Retrieve all available abstracts of the following 3331 articles:
HTML format

Single Articles

PAVLOV VN, Urmantsev MF, Yudina YB, Bakeev MP, et al
[A place of robot-assisted cystectomy in treatment of muscle-invasive bladder cancer].
Urologiia. 2021;:141-144.
Abstract Related articles

PEMOV A, Wegman-Ostrosky T, Kim J, Koutros S, et al
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study.
JCO Precis Oncol. 2021;5.
Abstract Related articles

FU M, Klose C, Sparks A, Whalen M, et al
Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database.
Clin Genitourin Cancer. 2021 Dec 1. pii: S1558-7673(21)00226.
Abstract Related articles

REN W, Hu J, Li H, Chen J, et al
miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression.
Front Oncol. 2021;11:762946.
Abstract Related articles

TANABE S, Sugino S, Niiya K, Ichida K, et al
A Case of Incidental Detection of Asymptomatic Bladder Cancer by Transvaginal Ultrasound.
Cureus. 2021;13:e20451.
Abstract Related articles

TANG W, Niu H, Yang Y, Li H, et al
Efficacy and safety of transurethral resection of bladder tumor for superficial bladder cancer.
Am J Transl Res. 2021;13:12860-12867.
Abstract Related articles

MA X, Wen Y, Wang Y, Zhang M, et al
Linc00662 plays an oncogenic role in bladder cancer by sponging miR-199a-5p.
Am J Transl Res. 2021;13:12673-12683.
Abstract Related articles

FABIANO E, Riou O, Pointreau Y, Perichon N, et al
Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology.
Cancer Radiother. 2021 Dec 23. pii: S1278-3218(21)00295.
Abstract Related articles

ZHANG X, Ma X, Wang Q, Kong Z, et al
EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells.
Transl Oncol. 2021;16:101316.
Abstract Related articles

HAN C, Wang Z, Chen S, Li L, et al
Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-kappaB Axis".
Oxid Med Cell Longev. 2021;2021:9857803.
Abstract Related articles

ADAMCZYK P, Kadlubowski M, Poblocki P, Adamowicz J, et al
Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer.
Wideochir Inne Tech Maloinwazyjne. 2021;16:722-727.
Abstract Related articles

LU M, Zhan H, Liu B, Li D, et al
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
EPMA J. 2021;12:589-604.
Abstract Related articles

FLETCHER SA, Bivalacqua TJ, Brawley OW, Kates M, et al
Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer.
Urol Oncol. 2021 Dec 20. pii: S1078-1439(21)00514.
Abstract Related articles

LIU T, Jiang G
A systematic review and meta-analysis of neoadjuvant chemotherapy for bladder cancer between ddMVAC and GC regimen.
Urol Oncol. 2021 Dec 20. pii: S1078-1439(21)00515.
Abstract Related articles

LEMINSKI A, Kaczmarek K, Bancarz A, Zakrzewska A, et al
Educational and Psychological Support Combined with Minimally Invasive Surgical Technique Reduces Perioperative Depression and Anxiety in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Int J Environ Res Public Health. 2021;18.
Abstract Related articles

NEDJADI T, Albarakati N, Benabdelkamel H, Masood A, et al
Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation.
Life (Basel). 2021;11.
Abstract Related articles

D'ALOIA A, Arrigoni E, Costa B, Berruti G, et al
RalGPS2 Interacts with Akt and PDK1 Promoting Tunneling Nanotubes Formation in Bladder Cancer and Kidney Cells Microenvironment.
Cancers (Basel). 2021;13.
Abstract Related articles

THAM SM, Rahmat JN, Chiong E, Wu Q, et al
Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN alpha Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model.
Biomedicines. 2021;9.
Abstract Related articles

CONSTANTIN T, Pavalean M, Bucur S, Constantin MM, et al
Animal Models in Bladder Cancer.
Biomedicines. 2021;9.
Abstract Related articles

RANA V, Parama D, Khatoon E, Girisa S, et al
Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer.
Biomolecules. 2021;11.
Abstract Related articles

YAMASHITA S, Iwahashi Y, Miyai H, Matsumura N, et al
Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis.
Diagnostics (Basel). 2021;11.
Abstract Related articles

LAUKHTINA E, Schuettfort VM, D'Andrea D, Pradere B, et al
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Mol Carcinog. 2022;61:5-18.
Abstract Related articles

NA L, Wang Z, Bai Y, Sun Y, et al
WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma.
Biochim Biophys Acta Mol Basis Dis. 2022;1868:166271.
Abstract Related articles

SHEU ZL, Huang CP, Chang CH, Chen CH, et al
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.
Sci Rep. 2021;11:19059.
Abstract Related articles

GHASEMI H, Mousavibahar SH, Hashemnia M, Karimi J, et al
Transitional cell carcinoma matrix stiffness regulates the osteopontin and YAP expression in recurrent patients.
Mol Biol Rep. 2021;48:4253-4262.
Abstract Related articles

MINERVINI A, Di Maida F, Tasso G, Mari A, et al
Robot assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): Analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework.
Eur J Surg Oncol. 2021;47:2651-2657.
Abstract Related articles

MICHEL KF, Spaulding A, Jemal A, Yabroff KR, et al
Associations of Medicaid Expansion With Insurance Coverage, Stage at Diagnosis, and Treatment Among Patients With Genitourinary Malignant Neoplasms.
JAMA Netw Open. 2021;4:e217051.
Abstract Related articles

LOPEZ-BELTRAN A, Cimadamore A, Montironi R, Cheng L, et al
Molecular pathology of urothelial carcinoma.
Hum Pathol. 2021;113:67-83.
Abstract Related articles

ZANCHETTIN C, Zanella L, Zoffoli G, Venturini A, et al
Ultra-rapid regrowth of urothelial cardiac metastasis after debulking surgery.
Cardiovasc Pathol. 2021;53:107334.
Abstract Related articles

WANG Y, Ju L, Guo Z, Qian K, et al
Pedigree analysis of a POLD1 germline mutation in urothelial carcinoma shows a close association between different mutation burdens and overall survival.
Cell Mol Immunol. 2021;18:767-769.
Abstract Related articles

KATAYAMA S, Schuettfort VM, Pradere B, Mori K, et al
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer.
J Cancer Res Clin Oncol. 2022 Jan 8. pii: 10.1007/s00432-021-03887.
Abstract Related articles

TSE RT, Zhao H, Wong CY, Kong AW, et al
In vitro assessment of intra-operative and post-operative environment in reducing bladder cancer recurrence.
Sci Rep. 2022;12:22.
Abstract Related articles

BOUCHELOUCHE K
PET/CT in Bladder Cancer: An Update.
Semin Nucl Med. 2022 Jan 4. pii: S0001-2998(21)00105.
Abstract Related articles

YU XY, Ma CQ, Sheng YH
circRNA CRIM1 regulates the migration and invasion of bladder cancer by targeting miR182/Foxo3a axis.
Clin Transl Oncol. 2022 Jan 7. pii: 10.1007/s12094-021-02768.
Abstract Related articles

MASTRI M, Ramakrishnan S, Shah SD, Karasik E, et al
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment.
Am J Clin Exp Urol. 2021;9:416-434.
Abstract Related articles

DAVIS L, Isali I, Prunty M, Calaway A, et al
Female Sexual Function Following Radical Cystectomy in Bladder Cancer.
Sex Med Rev. 2022 Jan 3. pii: S2050-0521(21)00090.
Abstract Related articles

LI P, Li L, Li Z, Wang S, et al
Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway.
Cancer Cell Int. 2022;22:7.
Abstract Related articles

ALAM SM, Chollet-Hinton L, Thompson J, Holzbeierlein JM, et al
Effect of prior radiation on stage, differentiation, and survival in bladder cancer.
World J Urol. 2022 Jan 6. pii: 10.1007/s00345-021-03901.
Abstract Related articles

CHEN K, Xing J, Yu W, Xia Y, et al
Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays.
Front Oncol. 2021;11:782981.
Abstract Related articles

LIU X, Xu A, Huang J, Shen H, et al
Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment.
J Int Med Res. 2022;50:3000605211067688.
Abstract Related articles

MA J, Vaishnani DK, Lin R, Lyu J, et al
Artificial intelligence in bladder cancer: current trends and future possibilities.
Chin Med J (Engl). 2022 Jan 4. pii: 00029330-900000000-98223.
Abstract Related articles

OKUNEYE K, Bergman D, Bloodworth JC, Pearson AT, et al
A validated mathematical model of FGFR3-mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer.
Comput Syst Oncol. 2021;1.
Abstract Related articles

WAN P, Chen Z, Huang M, Jiang H, et al
miR-200a-3p facilitates bladder cancer cell proliferation by targeting the A20 gene.
Transl Androl Urol. 2021;10:4262-4274.
Abstract Related articles

TENG X, Liu Y, Wang L, Wang G, et al
Lidocaine exerts anticancer activity in bladder cancer by targeting isoprenylcysteine carboxylmethyltransferase (ICMT).
Transl Androl Urol. 2021;10:4219-4230.
Abstract Related articles

CHEN C, Huang Z, Huang P, Li K, et al
Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer.
BMC Microbiol. 2022;22:7.
Abstract Related articles

FATTAHI MJ, Haghshenas MR, Ghaderi A
Immunometabolism in bladder cancer microenvironment.
Endocr Metab Immune Disord Drug Targets. 2022 Jan 4. pii: EMIDDT-EPUB-119930.
Abstract Related articles

REIS LO, Dal Col LSB, Capibaribe DM, de Mendonca GB, et al
Presence and predominance of histological grade 3 define cT1HG bladder cancer prognostic groups.
Investig Clin Urol. 2022;63:21-26.
Abstract Related articles

LEE S, Oh YT, Kim HM, Jung DC, et al
Imaging Patterns of Bacillus Calmette-Guerin-Related Granulomatous Prostatitis Based on Multiparametric MRI.
Korean J Radiol. 2022;23:60-67.
Abstract Related articles

FAVARO WJ, Socca EAR, Bockelmann PK, Reis IB, et al
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model.
Med Oncol. 2022;39:24.
Abstract Related articles

LIU Q
The emerging roles of exosomal long non-coding RNAs in bladder cancer.
J Cell Mol Med. 2022 Jan 3. doi: 10.1111/jcmm.17152.
Abstract Related articles

DA Z, Huo Z, Luo HH, Liao RQ, et al
[Clinicopathological Analysis of Brain Metastatic Carcinoma in Tibet].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43:869-874.
Abstract Related articles

ZHUANG J, Hao J, Bu F, Yin H, et al
MicroRNA-582-5p regulates cell invasion in bladder cancer through targeting Forkhead Box G1.
Pathol Res Pract. 2021;230:153752.
Abstract Related articles

YACOUBA A, Alou MT, Lagier JC, Dubourg G, et al
Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens.
Semin Cancer Biol. 2021 Dec 31. pii: S1044-579X(21)00303.
Abstract Related articles

GHASSEMI H, Hashemnia M, Mousavibahar SH, Mahmoodzadeh Hosseini H, et al
Positive Association of Matrix Proteins Alteration with TAZ and The Progression of High-Grade Bladder Cancer.
Cell J. 2021;23:742-749.
Abstract Related articles

HEMISSI I, Boussetta S, Dallali H, Hellal F, et al
Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Mol Biol Rep. 2022 Jan 2. pii: 10.1007/s11033-021-07052.
Abstract Related articles

HUANG Z, Liu J, Yang J, Yan Y, et al
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7.
Front Cell Dev Biol. 2021;9:783050.
Abstract Related articles

SZYMANKIEWICZ M, Kamecki K, Jarzynka S, Koryszewska-Baginska A, et al
Case Report: Echinocandin-Resistance Candida glabrata FKS Mutants From Patient Following Radical Cystoprostatectomy Due to Muscle-Invasive Bladder Cancer.
Front Oncol. 2021;11:794235.
Abstract Related articles

XU Y, Chen D, Shen L, Huang X, et al
Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.
Front Genet. 2021;12:736158.
Abstract Related articles

LIU Z, Qi T, Li X, Yao Y, et al
A Novel TGF-beta Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.
Front Immunol. 2021;12:791924.
Abstract Related articles

LI B, Xiao Q, Shan L, Song Y, et al
NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
Cell Cycle. 2022 Jan 2:1-12. doi: 10.1080/15384101.2021.2021050.
Abstract Related articles

NAUMAN M, Hasan AS, Sultan G, Kumar P, et al
Inflammatory myofibroblastic tumour of genitourinary system.
J Pak Med Assoc. 2021;71:2467-2469.
Abstract Related articles

RAVINDRANATHAN D, Alhalabi O, Rafei H, Shah AY, et al
Landscape of Immunotherapy in Genitourinary Malignancies.
Adv Exp Med Biol. 2021;1342:143-192.
Abstract Related articles

ISHIYAMA Y, Kondo T, Tachibana H, Ishihara H, et al
Association Between Anesthetic Technique and Survival After Radical Nephroureterectomy: A Propensity Score-matching Study.
In Vivo. 2022;36:458-464.
Abstract Related articles

XIANG P, Du Z, Hao Y, Guan D, et al
Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.
Front Oncol. 2021;11:784627.
Abstract Related articles

TALWAR HS, Panwar VK, Mittal A, Ghorai RP, et al
Successful management of a high-output urinary fistula following radical cystectomy and ileal conduit: a conservative approach.
BMJ Case Rep. 2021;14.
Abstract Related articles

SCHULE J, Kraus F, Veil C, Kunkel S, et al
Multi-Physical Tissue Modeling of a Human Urinary Bladder.
Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:4297-4302.
Abstract Related articles

YANAGISAWA T, Mori K, Katayama S, Mostafaei H, et al
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
Int J Clin Oncol. 2022;27:59-71.
Abstract Related articles

ISOBE T, Naiki T, Sugiyama Y, Naiki-Ito A, et al
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.
Int J Clin Oncol. 2022;27:165-174.
Abstract Related articles

SHIMIZU R, Honda M, Teraoka S, Yumioka T, et al
Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.
Int J Clin Oncol. 2022;27:175-183.
Abstract Related articles

SHIGIHARA K, Shimonohara N, Stanley BJ
Outcome of a dog with urinary bladder osteosarcoma treated with a total cystectomy and ureterocutaneostomy.
Can Vet J. 2021;62:1089-1094.
Abstract Related articles

LI X, Wei Z, Yu H, Xu Y, et al
Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis.
Cancer Lett. 2021;523:10-28.
Abstract Related articles

GAO H, Chen J, Li G, Cui X, et al
Pediatric laparoscopic partial cystectomy for the treatment of benign bladder tumors and urachal cysts.
BMC Urol. 2021;21:128.
Abstract Related articles

OSHINA T, Taguchi S, Miyakawa J, Akiyama Y, et al
Clinicopathological features and oncological outcomes of urothelial carcinoma involving the ureterovesical junction.
Jpn J Clin Oncol. 2022;52:65-72.
Abstract Related articles

DURANTE J, Manassero F, Fidecicchi T, Tognarelli A, et al
Autologous fascial slings remain viable at long-term follow-up: a post cystectomy case report.
BMC Urol. 2021;21:122.
Abstract Related articles

HO SR, Lee YC, Ittmann MM, Lin FT, et al
RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis.
Cancer Lett. 2021;520:344-360.
Abstract Related articles

MIYASAKA Y, Kawamura H, Sato H, Kubo N, et al
Carbon ion radiotherapy for prostate cancer with bladder invasion.
BMC Urol. 2021;21:106.
Abstract Related articles

TU X, Zhang N, Zhuang X, Chen S, et al
Incidental diagnosis of nonfunctional bladder paraganglioma: a case report and literature review.
BMC Urol. 2021;21:98.
Abstract Related articles

PRUITT SL, Gerber DE, Zhu H, Heitjan DF, et al
Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Cancer Med. 2021;10:4752-4767.
Abstract Related articles

SHIMOHAMA S, Oki K, Narita H, Mashima K, et al
Trousseau's Syndrome Presenting as Multiple Cerebral Infarctions Caused by Mucin-producing Bladder Micropapillary Urothelial Cancer.
Intern Med. 2022;61:97-101.
Abstract Related articles

MOHANTY SK, Mishra SK, Tiwari A, Sharma S, et al
Reappraisal of HER2 Amplification in High-Grade Urothelial Carcinoma Based on 2018 ASCO/CAP Clinical Practice Guidelines.
Am J Clin Pathol. 2021;156:1130-1141.
Abstract Related articles

STERN ES, Siddiqui MT
Nuclear hypochromasia: Shedding light on the "lightness" of high-grade urothelial carcinoma.
Diagn Cytopathol. 2021;49:1032-1035.
Abstract Related articles

TODENHOFER T, Gibb EA, Seiler R, Kamyabi A, et al
Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Urol Oncol. 2021;39:498.
Abstract Related articles

BELLAMRI M, Brandt K, Brown CV, Wu MT, et al
Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells.
Arch Toxicol. 2021;95:2189-2199.
Abstract Related articles

LAUKHTINA E, Pradere B, Mori K, Schuettfort VM, et al
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review.
Urol Oncol. 2021;39:471-479.
Abstract Related articles

GOTO T, Miyamoto H
The Role of Estrogen Receptors in Urothelial Cancer.
Front Endocrinol (Lausanne). 2021;12:643870.
Abstract Related articles

NAYYAR R, Saini S, Sharma A, Kurra S, et al
Systemic dissemination of tumor cells during transurethral resection in patients with bladder tumor and its clinical relevance: A follow up study.
Urol Oncol. 2021;39:497.
Abstract Related articles

KERROUMI S, Neuzillet Y, Soorojebally Y, Radulescu C, et al
The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study.
Urol Oncol. 2021;39:497.
Abstract Related articles

DIAMANTOPOULOS LN, Sekar RR, Holt SK, Khaki AR, et al
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
Urol Oncol. 2021;39:496.
Abstract Related articles

SWAMI U, Grivas P, Pal SK, Agarwal N, et al
Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience.
Cancer Treat Res Commun. 2021;27:100325.
Abstract Related articles

SU X, Lu X, Bazai SK, Comperat E, et al
Comprehensive integrative profiling of upper tract urothelial carcinomas.
Genome Biol. 2021;22:7.
Abstract Related articles

CHEN CH, Grollman AP, Huang CY, Shun CT, et al
Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.
Cancer Epidemiol Biomarkers Prev. 2021;30:317-325.
Abstract Related articles

ASSADI A, Alzubaidi A, Lesmana H, Brennan RC, et al
Pure Bladder Malignant Rhabdoid Tumor Successfully Treated With Partial Cystectomy, Radiation, and Chemotherapy: A Case Report and Review of the Literature.
J Pediatr Hematol Oncol. 2021;43:e1214-e1216.
Abstract Related articles

LIPETSKAIA L, Lee TG, Li D, Meyer H, et al
Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma.
Female Pelvic Med Reconstr Surg. 2021;27:e501-e504.
Abstract Related articles

QIU Y, Gao Y, Chen C, Xie M, et al
Deciphering the influence of urinary microbiota on FoxP3+ regulatory T cell infiltration and prognosis in Chinese patients with non-muscle-invasive bladder cancer.
Hum Cell. 2022 Jan 15. pii: 10.1007/s13577-021-00659.
Abstract Related articles

MAO M, Yang L, Hu J, Liu B, et al
Oncogenic E3 ubiquitin ligase NEDD4 binds to KLF8 and regulates the microRNA-132/NRF2 axis in bladder cancer.
Exp Mol Med. 2022 Jan 14. pii: 10.1038/s12276-021-00663.
Abstract Related articles

YAMASHITA S, Mashima N, Higuchi M, Matsumura N, et al
Modified 5-Item Frailty Index Score as Prognostic Marker After Radical Cystectomy in Bladder Cancer.
Clin Genitourin Cancer. 2021 Dec 27. pii: S1558-7673(21)00250.
Abstract Related articles

QIU F, Liu Q, Xia Y, Jin H, et al
Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.
J Exp Clin Cancer Res. 2022;41:22.
Abstract Related articles

DING H, Huang Y, Shi J, Wang L, et al
Correction to: Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation.
Cancer Cell Int. 2022;22:20.
Abstract Related articles

PENG G, Guan J, Leng P, Peng L, et al
Circular RNA circ_0000515 adsorbs miR-542-3p to accelerate bladder cancer progression via up-regulating ILK expression.
Aging (Albany NY). 2022;14.
Abstract Related articles

HAMADA K, Yoshimura K, Oshinomi K, Hirasawa Y, et al
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report.
Medicine (Baltimore). 2022;101:e28339.
Abstract Related articles

WEN Z, Huang G, Lai Y, Xiao L, et al
Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
Clin Transl Oncol. 2022 Jan 14. pii: 10.1007/s12094-021-02741.
Abstract Related articles

HURST CD, Cheng G, Platt FM, Castro MAA, et al
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.
Cell Rep Med. 2021;2:100472.
Abstract Related articles

BILIM V, Hoshi S
Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC).
Clin Case Rep. 2022;10:e05256.
Abstract Related articles

ZHU K, Deng W, Deng H, Liu X, et al
Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.
PPAR Res. 2021;2021:7056506.
Abstract Related articles

YU EY, Stern MC, Jiang X, Tang L, et al
Family history and risk of bladder cancer: an analysis accounting for first- and second-degree relatives.
Cancer Prev Res (Phila). 2022 Jan 13. pii: 1940-6207.CAPR-21-0490.
Abstract Related articles

Correction: Bladder cancer incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant.
Occup Environ Med. 2022;79:e1.
Abstract Related articles

LIA T, Shao Y, Regmi P, Li X, et al
Development and validation of Pyroptosisrelated lncRNAs prediction model for bladder cancer.
Biosci Rep. 2022 Jan 13. pii: 230650. doi: 10.1042/BSR20212253.
Abstract Related articles

SCHMIDT B, Velaer KN, Thomas IC, Ganesan C, et al
Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer.
Eur Urol Open Sci. 2022;35:29-36.
Abstract Related articles

HORIBE Y, Nakata W, Tsujimura G, Tsujimoto Y, et al
A case of long-term complete remission of locally advanced T4 bladder cancer treated with pembrolizumab.
Urol Case Rep. 2021;41:101959.
Abstract Related articles

KONG N, Chen X, Feng J, Duan T, et al
Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1.
Acta Pharm Sin B. 2021;11:4045-4054.
Abstract Related articles

YU J, Mao W, Sun S, Hu Q, et al
Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
Cancer Manag Res. 2022;14:67-88.
Abstract Related articles

MOHSENZADEGAN M, Razmi M, Vafaei S, Abolhasani M, et al
Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer.
Sci Rep. 2022;12:599.
Abstract Related articles

SHAH AA, Sun Z, Eom KY, Grajales V, et al
Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry.
Urol Oncol. 2022 Jan 9. pii: S1078-1439(21)00552.
Abstract Related articles

ZHAO H, Wu W, Li X, Chen W, et al
Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression.
Transl Oncol. 2022;17:101340.
Abstract Related articles

XU J, Wei L, Liu H, Lei Y, et al
CD274 (PD-L1) Methylation is an Independent Predictor for Bladder Cancer Patients' Survival.
Cancer Invest. 2022 Jan 12:1-11. doi: 10.1080/07357907.2022.2028805.
Abstract Related articles

LIEDBERG F, Hagberg O, Baseckas G, Brandstedt J, et al
Anorectal dysfunction after radical cystectomy for bladder cancer.
Scand J Urol. 2022 Jan 12:1-7. doi: 10.1080/21681805.2021.2025423.
Abstract Related articles

HAJJAR M, Rezazadeh A, Naja F, Kardoust Parizi M, et al
Association of Recommended and Non-Recommended Food Score and Risk of Bladder Cancer: A Case-Control Study.
Nutr Cancer. 2022 Jan 12:1-8. doi: 10.1080/01635581.2021.2004172.
Abstract Related articles

DIANATINASAB M, Forozani E, Akbari A, Azmi N, et al
Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis.
BMC Public Health. 2022;22:73.
Abstract Related articles

LIU H, Zhang M, Jin H, Tao K, et al
Fe(III)-Doped Polyaminopyrrole Nanoparticle for Imaging-Guided Photothermal Therapy of Bladder Cancer.
ACS Biomater Sci Eng. 2022 Jan 11. doi: 10.1021/acsbiomaterials.1c01217.
Abstract Related articles

YIN H, Zhang C, Wei Z, He W, et al
EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
Cell Death Dis. 2022;13:39.
Abstract Related articles

DYUGAY IA, Lukyanov DK, Turchaninova MA, Serebrovskaya EO, et al
Accounting for B-cell behavior and sampling bias predicts anti-PD-L1 response in bladder cancer.
Cancer Immunol Res. 2022 Jan 10. pii: 2326-6066.CIR-21-0489.
Abstract Related articles

RENTSCH CA, Thalmann GN, Lucca I, Kwiatkowski M, et al
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guerin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.
Eur Urol Oncol. 2022 Jan 7. pii: S2588-9311(21)00222.
Abstract Related articles

RACIOPPI M
Advances in Management of Bladder Cancer.
J Clin Med. 2021;11.
Abstract Related articles

WRONSKI P, Wronski S, Kurant M, Malinowski B, et al
Curcumin May Prevent Basement Membrane Disassembly by Matrix Metalloproteinases and Progression of the Bladder Cancer.
Nutrients. 2021;14.
Abstract Related articles

JIMENEZ-GUERRERO R, Belmonte-Fernandez A, Flores ML, Gonzalez-Moreno M, et al
Wnt/beta-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties.
Int J Mol Sci. 2021;23.
Abstract Related articles

JAGUSIAK A, Gosiewski T, Romaniszyn D, Lasota M, et al
Antibacterial Therapy by Ag(+) Ions Complexed with Titan Yellow/Congo Red and Albumin during Anticancer Therapy of Urinary Bladder Cancer.
Int J Mol Sci. 2021;23.
Abstract Related articles

VAN HATTUM JW, de Ruiter BM, Oddens JR, Hulshof MCCM, et al
Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer-A Review.
Cancers (Basel). 2021;14.
Abstract Related articles

MAZZA C, Gaydou V, Eymard JC, Birembaut P, et al
Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging.
Cancers (Basel). 2021;14.
Abstract Related articles

YANG X, Wei X, Yi C, Yang Y, et al
Long Noncoding RNA HAND2-AS1 Suppresses Cell Proliferation, Migration, and Invasion of Bladder Cancer via miR-17-5p/KLF9 Axis.
DNA Cell Biol. 2022 Jan 10. doi: 10.1089/dna.2021.0637.
Abstract Related articles

CHEN WH, Yu KJ, Jhou JW, Pang HH, et al
Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer.
ACS Appl Bio Mater. 2021;4:7485-7496.
Abstract Related articles

CHEN D, Ye Y, Guo S, Yao K, et al
Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer.
Front Mol Biosci. 2021;8:800945.
Abstract Related articles

ZHANG F, Feng D, Wang X, Gu Y, et al
An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.
Front Mol Biosci. 2021;8:780329.
Abstract Related articles

LIU J, Wang J, Wu M, Zhang W, et al
Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
Front Med (Lausanne). 2021;8:757432.
Abstract Related articles

ZHENG X, Liao X, Nie L, Lin T, et al
LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients.
Front Cell Dev Biol. 2021;9:748280.
Abstract Related articles

WANG J, Peng X, Li R, Liu K, et al
Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis.
Front Oncol. 2021;11:795837.
Abstract Related articles

TAN S, Fu L, Dong Q
AATF is Overexpressed in Human Bladder Cancer and Regulates Chemo-Sensitivity Through Survivin.
Onco Targets Ther. 2021;14:5493-5505.
Abstract Related articles

SANTOS HJSP, Matheus LHG, Silva A, Dalmazzo SV, et al
Indoleamine 2,3-Dioxygenase-1 Expression is Changed During Bladder Cancer Cell Invasion.
Int J Tryptophan Res. 2022;15:11786469211065612.
Abstract Related articles

JIN S, Zeng H, Liu Z, Jin K, et al
Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients.
Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11155.
Abstract Related articles

SUN Y, Guan Z, Sheng Q, Duan W, et al
N-myristoyltransferase-1 deficiency blocks myristoylation of LAMTOR1 and inhibits bladder cancer progression.
Cancer Lett. 2022;529:126-138.
Abstract Related articles

CROCETTO F, Barone B, Ferro M, Busetto GM, et al
Liquid biopsy in bladder cancer: State of the art and future perspectives.
Crit Rev Oncol Hematol. 2022;170:103577.
Abstract Related articles

WILKINS A, Hall E, Lewis R, Gribble H, et al
RE-ARMing the Immune Response to Bladder Cancer with Radiotherapy.
Clin Oncol (R Coll Radiol). 2022 Jan 5. pii: S0936-6555(21)00518.
Abstract Related articles

FUJIZUKA Y, Suzuki K, Sawada T, Suto Y, et al
[Malignant Central Nervous System Lymphoma after Radical Total Cystectomy : A Diagnostic Challenge].
Hinyokika Kiyo. 2021;67:539-542.
Abstract Related articles

SUZUKI R, Kohei N, Kiyozuka K
[A Case of Advanced Bladder Carcinoma Treated by Third-Line Gemcitabine and Paclitaxel Chemotherapy].
Hinyokika Kiyo. 2021;67:533-537.
Abstract Related articles

COHEN S, Gal J, Freifeld Y, Khoury S, et al
Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications.
Nutrients. 2021;13.
Abstract Related articles

HAGHSHENAS MR, Hosseini SR, Fattahi MJ, Malekzadeh M, et al
Elevated IL-37 Serum Levels in Patients with Transitional Cell Carcinoma of Bladder.
Iran J Immunol. 2021;18:346-353.
Abstract Related articles

XU G, Li J, Yu L
miR-19a-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma via Targeting THBS1.
Comput Math Methods Med. 2021;2021:2710231.
Abstract Related articles

TAPAK L, Kosorok MR, Sadeghifar M, Hamidi O, et al
Regularized Weighted Nonparametric Likelihood Approach for High-Dimension Sparse Subdistribution Hazards Model for Competing Risk Data.
Comput Math Methods Med. 2021;2021:5169052.
Abstract Related articles

KHRIGUIAN J, Patrocinio H, Andonian S, Aprikian A, et al
Stereotactic Ablative Radiation Therapy for the Treatment of Upper Urinary Tract Urothelial Carcinoma.
Pract Radiat Oncol. 2022;12:e34-e39.
Abstract Related articles

SINGH PK, Bhatt MLB, Singh P, Rath SK, et al
Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1 (hMps1/TTK) in human urinary bladder transitional cell carcinoma.
Drug Discov Ther. 2021;15:204-209.
Abstract Related articles

CHEN TJ, Dehghanian SZ, Chan TC, He HL, et al
High G protein subunit beta 4 protein level is correlated to poor prognosis of urothelial carcinoma.
Med Mol Morphol. 2021;54:356-367.
Abstract Related articles

KAPETANAKIS V, Prawitz T, Schlichting M, Ishak KJ, et al
How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
Value Health. 2021;24:1137-1144.
Abstract Related articles

GALSKY MD, Balar AV, Black PC, Campbell MT, et al
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer.
J Immunother Cancer. 2021;9.
Abstract Related articles

ANAMI T, Komohara Y, Miura Y, Yamanaka K, et al
High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer.
Med Mol Morphol. 2021;54:316-323.
Abstract Related articles

WU B, Jiang X, Huang Y, Ying X, et al
Integrated analysis of mRNA-m(6)A-protein profiles reveals novel insights into the mechanisms for cadmium-induced urothelial transformation.
Biomarkers. 2021;26:499-507.
Abstract Related articles

TAN WS, Kelly JD
Is delay to radical cystectomy following BCG failure oncologically safe?
Nat Rev Urol. 2021;18:323-324.
Abstract Related articles

TODENHOFER T, Maas M, Ketz M, Kossack N, et al
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB.
World J Urol. 2021;39:2953-2960.
Abstract Related articles

SANCHEZ DJ, Missiaen R, Skuli N, Steger DJ, et al
Cell-Intrinsic Tumorigenic Functions of PPARgamma in Bladder Urothelial Carcinoma.
Mol Cancer Res. 2021;19:598-611.
Abstract Related articles

BERRIDGE C, Kailavasan M, Athanasiadis G, Gkentzis A, et al
Endoscopic surgical simulation using low-fidelity and virtual reality transurethral resection simulators in urology simulation boot camp course: trainees feedback assessment study.
World J Urol. 2021;39:3103-3107.
Abstract Related articles

SURCEL C, Mirvald C, Tsaur I, Borgmann H, et al
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
World J Urol. 2021;39:2483-2490.
Abstract Related articles

RODLER S, Buchner A, Ledderose ST, Eismann L, et al
Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
World J Urol. 2021;39:2537-2543.
Abstract Related articles

MITRA S, Purkait S, Das MK
Unilateral axillary lymph node metastasis from small cell neuroendocrine carcinoma of the urinary bladder.
Cytopathology. 2021;32:371-373.
Abstract Related articles

HACEK J, Brisuda A, Babjuk M, Zamecnik J, et al
Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165:316-321.
Abstract Related articles

FREUDENBURG E, Shan Y, Martinez A, Srinivasan A, et al
Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement.
Cancer Causes Control. 2022 Jan 20. pii: 10.1007/s10552-022-01553.
Abstract Related articles

AMINOLTEJARI K, Kulkarni G, Mason R
Practice-changing publications: Muscle-invasive bladder cancer.
Can Urol Assoc J. 2021 Aug 26. pii: cuaj.7733. doi: 10.5489/cuaj.7733.
Abstract Related articles

SHIH HJ, Lin KH, Wen YC, Fan YC, et al
Increased risk of bladder cancer in young adult men with hyperlipidemia: A population-based cohort study.
Medicine (Baltimore). 2021;100:e28125.
Abstract Related articles

MENG X, Hu H, Wang Y, Feng C, et al
Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer.
J Magn Reson Imaging. 2022 Jan 20. doi: 10.1002/jmri.28064.
Abstract Related articles

ZHANG Z, Zhao H, Zhou G, Han R, et al
Circ_0002623 promotes bladder cancer progression by regulating the miR-1276/SMAD2 axis.
Cancer Sci. 2022 Jan 20. doi: 10.1111/cas.15274.
Abstract Related articles

XUAN L, Hu JH, Bi R, Liu SQ, et al
Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF-kappaB and PI3K/AKT Signaling In Vitro and In Vivo.
Chin J Integr Med. 2022 Jan 19. pii: 10.1007/s11655-022-3464.
Abstract Related articles

MUSAT MG, Kwon CS, Masters E, Sikirica S, et al
Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR).
Clinicoecon Outcomes Res. 2022;14:35-48.
Abstract Related articles

MATSUI Y
[. The Development Status of the Novel Therapeutic Strategies against Non-Muscle Invasive Bladder Cancer -The Introduction of On-Going or Completed Clinical Trials].
Gan To Kagaku Ryoho. 2022;49:39-42.
Abstract Related articles

MIYAKE M
[. Clinical Evidence and Biological Mechanism of BCG Failure in Patients with Non-Muscle Invasive Bladder Cancer].
Gan To Kagaku Ryoho. 2022;49:33-38.
Abstract Related articles

FUKUHARA H, Inoue K
[. Diagnosis and Therapy for Non-Muscle Invasive Bladder Cancer Using Photodynamic Technique].
Gan To Kagaku Ryoho. 2022;49:29-32.
Abstract Related articles

NISHIYAMA H
[Urological Cancer Non-Muscle Invasive Bladder Cancer- Update of Diagnosis and Treatment].
Gan To Kagaku Ryoho. 2022;49:28.
Abstract Related articles

KALAYARASAN R, Narayanan S, James M
Robotic fluorescence-guided anatomical segment IVb and V liver resection with radical lymphadenectomy for gall bladder cancer.
J Minim Access Surg. 2022 Jan 6. pii: 335071. doi: 10.4103.
Abstract Related articles

GABRIELSON AT, Daniels MJ, Rowe J, Alam R, et al
Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials.
Urol Oncol. 2022 Jan 16. pii: S1078-1439(21)00536.
Abstract Related articles

ZHANG Z, Liang Z, Li D, Wang L, et al
Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.
Hum Cell. 2022 Jan 19. pii: 10.1007/s13577-022-00673.
Abstract Related articles

YU Y, Zeng H, Jin K, You R, et al
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.
Cancer Immunol Immunother. 2022 Jan 18. pii: 10.1007/s00262-022-03153.
Abstract Related articles

NISHIMURA K, Nishio K, Hirosuna K, Komura K, et al
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer.
J Immunother Cancer. 2022;10.
Abstract Related articles

VENKAT S, Lewicki PJ, Khan AI, Gaffney C, et al
Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer.
Clin Genitourin Cancer. 2021 Dec 24. pii: S1558-7673(21)00248.
Abstract Related articles

ISALI I, McClellan P, Calaway A, Prunty M, et al
Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis.
Urol Oncol. 2022 Jan 15. pii: S1078-1439(21)00484.
Abstract Related articles

YANG C, Wu S, Mou Z, Zhou Q, et al
Exosome derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironment through modulating reactive oxygen species equilibrium via GLS1 mediated glutamine metabolism alteration.
Mol Ther. 2022 Jan 13. pii: S1525-0016(22)00022.
Abstract Related articles

LEONI C, Paradiso FV, Foschi N, Tedesco M, et al
Prevalence of bladder cancer in Costello syndrome: new insights to drive clinical decision-making.
Clin Genet. 2022 Jan 17. doi: 10.1111/cge.14111.
Abstract Related articles

GUERRERO-RAMOS F, Gonzalez-Padilla DA, Gonzalez-Diaz A, de la Rosa-Kehrmann F, et al
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.
World J Urol. 2022 Jan 17. pii: 10.1007/s00345-022-03928.
Abstract Related articles

THOMAS PB, Perera MPJ, Alinezhad S, Joshi A, et al
Culture of Bladder Cancer Organoids as Precision Medicine Tools.
J Vis Exp. 2021;.
Abstract Related articles

ADEYELU TT, Moya-Garcia AA, Orengo C
Exploiting protein family and protein network data to identify novel drug targets for bladder cancer.
Oncotarget. 2022;13:105-117.
Abstract Related articles

BAN D, Lu W, Lu Z, Li B, et al
Effects of radical cystectomy combined with GC chemotherapy in the treatment of invasive bladder cancer and its influence on the incidence of adverse reactions.
Am J Transl Res. 2021;13:13845-13853.
Abstract Related articles

XU Y, Lou J, Gao Z, Zhan M, et al
Computed Tomography Image Features under Deep Learning Algorithm Applied in Staging Diagnosis of Bladder Cancer and Detection on Ceramide Glycosylation.
Comput Math Methods Med. 2022;2022:7979523.
Abstract Related articles

SINGH PK, Bhatt MLB, Singh P, Rath SK, et al
CASC5 is a potential cancer-testis gene in human urinary bladder transitional cell carcinoma.
Drug Discov Ther. 2021;15:331-336.
Abstract Related articles

MUHLBAUER J, Klotz D, Buttner S, Stein R, et al
Bladder cancer in patients with neurogenic bladder disorder: a comparative study of different etiologies.
World J Urol. 2022 Jan 15. pii: 10.1007/s00345-021-03922.
Abstract Related articles

WANG SC, Yu CY, Wu YC, Chang YC, et al
Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model.
Cancer Lett. 2022;530:8-15.
Abstract Related articles

OSWALD D, Pallauf M, Herrmann TRW, Netsch C, et al
[Transurethral resection of bladder tumors (TURBT)].
Urologe A. 2022;61:71-82.
Abstract Related articles

LAUKHTINA E, Sari Motlagh R, Mori K, Katayama S, et al
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.
Crit Rev Oncol Hematol. 2022;169:103570.
Abstract Related articles

KOLLI RT, Xu Z, Panduri V, Taylor JA, et al
Differential Gene Expression in Bladder Tumors from Workers Occupationally Exposed to Arylamines.
Biomed Res Int. 2021;2021:2624433.
Abstract Related articles

MORRISS S, Zargar H, Dias BH
Management of the Distal Ureter During Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Comprehensive Review of Literature.
Urol J. 2021;18:585-599.
Abstract Related articles

ALSYOUF M, Djaladat H, Daneshmand S
An emerging role for immuno-nutrition in patients undergoing radical cystectomy.
Nat Rev Urol. 2022;19:1-2.
Abstract Related articles

AGARWAL PK, Sfakianos JP, Feldman A, Tagawa ST, et al
A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer.
Urol Oncol. 2021;39:528-547.
Abstract Related articles

FELDMAN AS, Lokeshwar V, Lin DW
A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers.
Urol Oncol. 2021;39:602-617.
Abstract Related articles

TAYEH GA, Alkassis M, Semaan A, Khalil N, et al
Neoadjuvant PARPi for urothelial carcinoma: between lifeline and desperation.
Future Oncol. 2021;17:3281-3283.
Abstract Related articles

BASIRI A, Soltani MH, Shakhssalim N, Shemshaki HR, et al
Single Umbilical Stoma for Bilateral Ureterostomy after Radical Cystectomy.
Urol J. 2021;18:646-651.
Abstract Related articles

OGUNBONA OB, Matoso A, Cheng L, Shen S, et al
Metastatic urothelial carcinoma to the brain, spinal cord and spine: A contemporary multi-institutional clinicopathologic analysis of 24 cases.
Pathol Res Pract. 2021;224:153537.
Abstract Related articles

VARELA DOS SANTOS M, Pacheco J, Barroca H
Guar cells in urine cytology: Two case reports and literature review.
Cytopathology. 2021;32:671-673.
Abstract Related articles

TREGUNNA R
Combination treatment in advanced urothelial carcinoma.
Nat Rev Urol. 2021;18:383.
Abstract Related articles

FUKUOKAYA W, Kimura T, Yanagisawa T, Kimura S, et al
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.
Cancer Immunol Immunother. 2022;71:229-236.
Abstract Related articles

OKUDA C, Kyotake A, Nakamura A, Itoh T, et al
Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
Cytopathology. 2021;32:654-659.
Abstract Related articles

ABDULLGAFFAR B, Hotait H
The value of intercluster single cell streaks, triplet signet ring cells, and a two-cell population in urine small cell neuroendocrine carcinoma.
Cytopathology. 2021;32:700-704.
Abstract Related articles

ZEUSCHNER P, Vollmer SG, Linxweiler J, Wagenpfeil G, et al
Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
Surg Oncol. 2021;38:101607.
Abstract Related articles

GIERTH M, Breyer J, Zeman F, Fritsche HM, et al
The HELENA study: Hexvix((R))-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study.
World J Urol. 2021;39:3799-3805.
Abstract Related articles

UYSAL D, Egen L, Grilli M, Wessels F, et al
Impact of perioperative blood transfusions on oncologic outcomes after radical cystectomy: A systematic review and meta-analysis of comparative studies.
Surg Oncol. 2021;38:101592.
Abstract Related articles

XIAO CX, Zhang W, Lin BX
The Effect of Action Research on Neobladder Function Training in Patients with Orthotopic Ileal Neobladders: A Prospective Cohort Study.
Urol J. 2021;18:525-529.
Abstract Related articles

WU YR, Lee YC, Li WM, Hsu WC, et al
High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma.
Pathol Int. 2021;71:463-470.
Abstract Related articles

XU H, Genega EM, Zhuang L, Zhou M, et al
High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
Int J Surg Pathol. 2021;29:794-797.
Abstract Related articles

MARIAPPAN P
Attention to detail and a permissive set-up: crucial for an effective TURBT.
Nat Rev Urol. 2021;18:253-254.
Abstract Related articles

BANSAL P, Dwivedi DK, Hatwal D, Sharma P, et al
Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma.
Anticancer Agents Med Chem. 2021;21:2478-2486.
Abstract Related articles

WU J, Chen S, Wu X, Mao W, et al
Trends of incidence and prognosis of upper tract urothelial carcinoma.
Bosn J Basic Med Sci. 2021;21:607-619.
Abstract Related articles

EL-GEDAMY M, El-Khayat Z, Abol-Enein H, El-Said A, et al
Rs-1884444 G/T variant in IL-23 receptor is likely to modify risk of bladder urothelial carcinoma by regulating IL-23/IL-17 inflammatory pathway.
Cytokine. 2021;138:155355.
Abstract Related articles

BRUNELLI M, Tafuri A, Cima L, Cerruto MA, et al
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
J Clin Pathol. 2022;75:39-44.
Abstract Related articles

TAMBARO R, Napoli MD, Pisano C, Cecere SC, et al
From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer.
Immunotherapy. 2021;13:67-77.
Abstract Related articles

POSIELSKI N MD, Koenig H MPH, Ho O PhD, Porter C MD, et al
Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017.
Oncology (Williston Park). 2022;36:21-33.
Abstract Related articles

GONG J
Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer.
Oncology (Williston Park). 2022;36:30-31.
Abstract Related articles

ZARGAR P, Koochakkhani S, Hassanzadeh M, Ashouri Taziani Y, et al
Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy.
Mol Biol Rep. 2022 Jan 28. pii: 10.1007/s11033-021-07087.
Abstract Related articles

LIU Q
Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
Front Genet. 2022;12:825109.
Abstract Related articles

LEE YC, Tsai KW, Liao JB, Kuo WT, et al
High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging.
Sci Rep. 2022;12:1496.
Abstract Related articles

KOKOROVIC A, Ory J, Saad F
Emerging treatment options for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
Curr Opin Support Palliat Care. 2022;16:48-53.
Abstract Related articles

WEI W, Rong Y, Sanhe L, Chunxiu Y, et al
Single-cell sequencing and its applications in bladder cancer.
Expert Rev Mol Med. 2022;24:e6.
Abstract Related articles

YU X, Wu T, Liao B, Du Z, et al
Anticancer potential of corilagin on T24 and TSGH 8301 bladder cancer cells via the activation of apoptosis by the suppression of NF-kappaB-induced P13K/Akt signaling pathway.
Environ Toxicol. 2022 Jan 27. doi: 10.1002/tox.23472.
Abstract Related articles

BALASUBRAMANIAN A, Gunjur A, Weickhardt A, Papa N, et al
Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.
World J Urol. 2022 Jan 27. pii: 10.1007/s00345-021-03908.
Abstract Related articles

KOSTYEV F, Bondar O, Chystiakov R, Lysenko V, et al
The impact of different adjuvant intravesical therapy methods on tumor biology in patients with high-risk non-muscle-invasive bladder cancer.
Cent European J Urol. 2021;74:496-502.
Abstract Related articles

Erratum: The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy: Erratum.
Curr Urol. 2021;15:253.
Abstract Related articles

Erratum: In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer: Erratum.
Curr Urol. 2021;15:246.
Abstract Related articles

WU G, Liang H, Nan H, Shao Z, et al
One-Step In Situ Self-Assembly of Biodegradable Films for Long-Term Intravesical Bladder Cancer Therapy.
ACS Appl Bio Mater. 2022 Jan 26. doi: 10.1021/acsabm.1c01186.
Abstract Related articles

MOCHIZUKI Y, Tsuchiya M, Oyama J, Wada A, et al
Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series.
J Med Case Rep. 2022;16:33.
Abstract Related articles

STERNSCHUSS M, Sarfaty M
[ANTIBODY-DRUG CONJUGATES - A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC UROTHELIAL CARCINOMA].
Harefuah. 2022;161:49-54.
Abstract Related articles

WU Y, Zhang Z, Liu Y, Shi G, et al
The Application Effect of Traditional Chinese Medicine Nursing on General Anesthesia Combined with Epidural Anesthesia and Electric Resection for the Treatment of Bladder Cancer and Its Influence on Tumor Markers.
Evid Based Complement Alternat Med. 2022;2022:7178711.
Abstract Related articles

SYMEONIDIS A, Tsikopoulos I, Symeonidis EN, Tsifountoudis I, et al
More than meets the eye: A case of synchronous ipsilateral clear cell renal cell carcinoma and urothelial carcinoma of the pelvicalyceal system and literature review.
Acta Biomed. 2022;92:e2021380.
Abstract Related articles

CHIANG CH, Chiang CH, Chiang CH
Re: Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol 2021;4:927-42: Considerations for
Eur Urol Oncol. 2022 Jan 21. pii: S2588-9311(22)00002.
Abstract Related articles

DOWNES MR, Lajkosz K, Kuk C, Gao B, et al
The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes.
Pathology. 2022 Jan 21. pii: S0031-3025(21)00545.
Abstract Related articles

RISTIC PETROVIC A, Stokanovic D, Stojnev S, Potic Floranovic M, et al
The Association between NOTCH3 expression and the clinical outcome in the urothelial bladder cancer patients.
Bosn J Basic Med Sci. 2022 Jan 24. doi: 10.17305/bjbms.2021.6767.
Abstract Related articles

YANG R, Zhu D, Howard LE, De Hoedt A, et al
Context-Based Identification of Muscle Invasion Status in Patients With Bladder Cancer Using Natural Language Processing.
JCO Clin Cancer Inform. 2022;6:e2100097.
Abstract Related articles

JIN S, Zeng H, Liu Z, Jin K, et al
ASO Visual Abstract: Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients.
Ann Surg Oncol. 2022 Jan 24. pii: 10.1245/s10434-021-11262.
Abstract Related articles

SZYMANSKA B, Sawicka E, Jurkowska K, Matuszewski M, et al
The relationship between interleukin-13 and angiogenin in patients with bladder cancer.
J Physiol Pharmacol. 2021;72.
Abstract Related articles

KOTHA NV, Kumar A, Nelson TJ, Qiao EM, et al
Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation.
Adv Radiat Oncol. 2021;7:100836.
Abstract Related articles

XIE C, Yuan X, Chen SH, Liu ZY, et al
Successful response to camrelizumab in metastatic bladder cancer: A case report.
World J Clin Cases. 2022;10:254-259.
Abstract Related articles

ZENG S, Ying Y, Yu X, Wang L, et al
Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study.
Transl Androl Urol. 2021;10:4365-4375.
Abstract Related articles

ZHANG Z, Li Q, Li A, Wang F, et al
Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.
Transl Androl Urol. 2021;10:4353-4364.
Abstract Related articles

WANG H, Zuo Y, Ding M, Ke C, et al
Erratum: LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.
Oncol Lett. 2022;23:69.
Abstract Related articles

WU K, Zeng J, Shi X, Xie J, et al
Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32.
Front Pharmacol. 2022;12:801493.
Abstract Related articles

ANWAR I, Pandith AA, Wani MS, Mir H, et al
Analysis of MNS16A VNTR polymorphic sequence variations of the TERT gene and associated risk for development of bladder cancer.
Curr Urol. 2021;15:225-230.
Abstract Related articles

ERAY A, Erkek-Ozhan S
Classification of bladder cancer cell lines according to regulon activity.
Turk J Biol. 2021;45:656-666.
Abstract Related articles

VAN HAUEN MB, Maibom SL, Thind PO, Martin Poulsen A, et al
Risk of recurrence and long-term mortality following radical cystectomy for bladder cancer.
Scand J Urol. 2022 Jan 24:1-6. doi: 10.1080/21681805.2022.2028897.
Abstract Related articles

ZHANG Z, Wang C, Liu T, Tang Z, et al
miRNA-182-5p promotes human bladder cancer proliferation and migration through the FOXF2/SHH axis.
Neoplasma. 2022 Jan 25. pii: 210903N1266. doi: 10.4149/neo_2021_210903N1266.
Abstract Related articles

WIECZOREK E, Jablonowski Z, Lesicka M, Jablonska E, et al
Genetic contributions of MHC class I antigen processing and presentation pathway to bladder cancer risk and recurrence.
Neoplasma. 2022 Jan 25. pii: 210805N1113. doi: 10.4149/neo_2021_210805N1113.
Abstract Related articles

SZUCS E, Lukacs N, Budai A, Seres E, et al
Actinomycosis mimicking urachal cancer
Orv Hetil. 2022;163:157-160.
Abstract Related articles

BORHANI S, Borhani R, Kajdacsy-Balla A
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction.
Crit Rev Oncol Hematol. 2022 Jan 19:103601.
Abstract Related articles

MARTINS-LIMA C, Miranda-Goncalves V, Lobo J, Constancio V, et al
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Cell Oncol (Dordr). 2022 Jan 22. pii: 10.1007/s13402-021-00657.
Abstract Related articles

ZHANG G, Wu Z, Zhang X, Xu L, et al
CT-based radiomics to predict muscle invasion in bladder cancer.
Eur Radiol. 2022 Jan 22. pii: 10.1007/s00330-021-08426.
Abstract Related articles

WU Z, Xia C, Zhang C, Tang D, et al
Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway.
Cancer Gene Ther. 2022 Jan 21. pii: 10.1038/s41417-022-00425.
Abstract Related articles

ARAFA A, Ewis A, Eshak E
Chronic exposure to nitrate in drinking water and the risk of bladder cancer: a meta-analysis of epidemiological evidence.
Public Health. 2022;203:123-129.
Abstract Related articles

LIU D, Wang S, Wang J
The effect of CT high-resolution imaging diagnosis based on deep residual network on the pathology of bladder cancer classification and staging.
Comput Methods Programs Biomed. 2022;215:106635.
Abstract Related articles

LAUKHTINA E, Shim SR, Mori K, D'Andrea D, et al
Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42].
Eur Urol Oncol. 2022 Jan 19. pii: S2588-9311(22)00004.
Abstract Related articles

CHEN JQ, Salas LA, Wiencke JK, Koestler DC, et al
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes.
Clin Epigenetics. 2022;14:14.
Abstract Related articles

KHATAMI A, Salavatiha Z, Razizadeh MH
Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.
Infect Agent Cancer. 2022;17:3.
Abstract Related articles

CHOI SY, Ha MS, Chi BH, Kim JW, et al
Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study.
J Cancer Res Clin Oncol. 2022 Jan 21. pii: 10.1007/s00432-022-03926.
Abstract Related articles

XIA W, Zhang S, Duan H, Wang C, et al
The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8(+) T cells in bladder cancer.
Med Oncol. 2022;39:37.
Abstract Related articles

CHEN W, Wang W, Zhang J, Liao G, et al
Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression.
J Oncol. 2022;2022:7985468.
Abstract Related articles

WEN L, Zhong G, Ren M
Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer.
Sci Rep. 2022;12:1032.
Abstract Related articles

XIAO L, Xu C, Lin P, Mu L, et al
Novel dihydroartemisinin derivative Mito-DHA5 induces apoptosis associated with mitochondrial pathway in bladder cancer cells.
BMC Pharmacol Toxicol. 2022;23:10.
Abstract Related articles

RUTZ J, Maxeiner S, Juengel E, Chun FK, et al
Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.
Nutrients. 2022;14.
Abstract Related articles

MANTICA G, Chierigo F, Malinaric R, Smelzo S, et al
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?
Medicina (Kaunas). 2022;58.
Abstract Related articles

TSAI IJ, Shen WC, Lee CL, Wang HD, et al
Machine Learning in Prediction of Bladder Cancer on Clinical Laboratory Data.
Diagnostics (Basel). 2022;12.
Abstract Related articles

MURAKAMI K, Pagano I, Furuya H, Daskivich T, et al
Clinical Utility of Oncuria, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer-A Pilot Study.
Diagnostics (Basel). 2022;12.
Abstract Related articles

RUBIO C, Avendano-Ortiz J, Ruiz-Palomares R, Karaivanova V, et al
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

CONSTANTIN T, Pavalean M, Bucur S, Constantin MM, et al
Retraction: Constantin et al. Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762.
Biomedicines. 2022;10.
Abstract Related articles

ASANO A, Nishikimi T, Morikami H, Ohashi T, et al
[A PRIMARY BLADDER ALVEOLAR SOFT PART SARCOMA: A CASE REPORT].
Nihon Hinyokika Gakkai Zasshi. 2021;112:45-48.
Abstract Related articles

TABEI T, Iwai T, Noguchi G, Horiguchi A, et al
[ARTIFICIAL URINARY SPHINCTER IMPLANTATION AFTER ILEAL NEOBLADDER RECONSTRUCTION: A CASE REPORT].
Nihon Hinyokika Gakkai Zasshi. 2021;112:34-37.
Abstract Related articles

SCHLARBAUM JP, Fenyk J, Miller D, O'Neill LB, et al
Paraneoplastic Signs in Bladder Transitional Cell Carcinoma: An Unusual Presentation.
Cutis. 2021;108:E29-E32.
Abstract Related articles

AFIFY H, Ghoneum A, Almousa S, Abdulfattah AY, et al
Metabolomic credentialing of murine carcinogen-induced urothelial cancer.
Sci Rep. 2021;11:22085.
Abstract Related articles

DUBOIS J, Sczakiel G
The human TRAM1 locus expresses circular RNAs.
Sci Rep. 2021;11:22114.
Abstract Related articles

ZHENG S, Carugo D, Mosayyebi A, Turney B, et al
Fluid mechanical modeling of the upper urinary tract.
WIREs Mech Dis. 2021;13:e1523.
Abstract Related articles

KAWASHIMA A, Yamamoto Y, Sato M, Nakata W, et al
FAN score comprising fibrosis-4 index, albumin-bilirubin score and neutrophil-lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab.
Sci Rep. 2021;11:21199.
Abstract Related articles

YANG WS
Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases.
Sci Rep. 2021;11:20981.
Abstract Related articles

LIU Q, Gong H, Zhu H, Yuan C, et al
Contrast-Enhanced Ultrasound in the Bladder: Critical Features to Differentiate Occupied Lesions.
Comput Math Methods Med. 2021;2021:1047948.
Abstract Related articles

BRUNETTI B, Foglia A, Savini F, Dondi F, et al
Inverted urothelial papilloma in a cat.
Vet Pathol. 2022;59:138-142.
Abstract Related articles

HE W, Jin L, Lin FF, Qi XL, et al
Cavernous lymphangioma of the urinary bladder in an adult woman: an additional case report of a rare lesion and literature review.
BMC Urol. 2021;21:145.
Abstract Related articles

INANAGA S, Igase M, Sakai Y, Tanabe M, et al
Mismatch repair deficiency in canine neoplasms.
Vet Pathol. 2021;58:1058-1063.
Abstract Related articles

SHUKLA SK, Chandra S, Chauhan N, Sarpal R, et al
Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients.
J Cancer Res Ther. 2021;17:887-892.
Abstract Related articles

XIE Y, Olkhov-Mitsel E, Alminawi S, Slodkowska E, et al
Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
Pathol Res Pract. 2021;226:153607.
Abstract Related articles

FENG Z, Vuky J
Combination Therapy With Immune Checkpoint Inhibitors in Urothelial Carcinoma: Current Data and Future Outlook.
Oncology (Williston Park). 2021;35:410-420.
Abstract Related articles

FENNER A
Using ctDNA to guide immunotherapy for urothelial cancer.
Nat Rev Urol. 2021;18:443.
Abstract Related articles

CHILDS DS, Quevedo JF, Costello BA, Pagliaro LC, et al
Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: a case series.
Anticancer Drugs. 2021;32:986-990.
Abstract Related articles

SEKER NS, Tekin E, Ozen A, Can C, et al
Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the urinary bladder.
Ann Diagn Pathol. 2021;54:151786.
Abstract Related articles

ZHANG X, Chen Y, Yan D, Han J, et al
TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.
Biochem Genet. 2022;60:241-266.
Abstract Related articles

FENNER A
Adjuvant nivolumab improves survival after radical cystectomy.
Nat Rev Urol. 2021;18:444.
Abstract Related articles

CHOI E, Waldbillig F, Jeong M, Li D, et al
Soft Urinary Bladder Phantom for Endoscopic Training.
Ann Biomed Eng. 2021;49:2412-2420.
Abstract Related articles

CHANDLER JB, Colunga M, Celli R, Lithgow MY, et al
Applicability of the Paris System for veterans: high rates of undiagnosed low-grade urothelial neoplasia.
J Am Soc Cytopathol. 2021;10:357-365.
Abstract Related articles

CHENG L, Lopez-Beltran A, Wang M, Montironi R, et al
Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
Mod Pathol. 2021;34:1384-1391.
Abstract Related articles

MCALONEY CA, Evans SJM, Hokamp JA, Wellman ML, et al
Comparison of pathologist review protocols for cytologic detection of prostatic and urothelial carcinomas in canines: A bi-institutional retrospective study of 298 cases.
Vet Comp Oncol. 2021;19:374-380.
Abstract Related articles

SEN A, Kaul A, Kaul R
Estrogen receptors in human bladder cells regulate innate cytokine responses to differentially modulate uropathogenic E. coli colonization.
Immunobiology. 2021;226:152020.
Abstract Related articles

WOO S, Ghafoor S, Becker AS, Hricak H, et al
Prognostic Utility of MRI Features in Intradiverticular Bladder Tumor.
Acad Radiol. 2022;29:219-228.
Abstract Related articles

SBIZZERA M, Descotes F, Arber T, Neuville P, et al
Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review.
World J Urol. 2022 Feb 4. pii: 10.1007/s00345-022-03943.
Abstract Related articles

DEB AA, Agag A, Naushad N, Krishnamoorthy R, et al
Chemoresection by mitomycin C compared to transurethral resection of bladder tumor in patients with recurrent nonmuscle-invasive bladder cancer: A systematic review and meta-analysis.
Turk J Urol. 2021;47:260-269.
Abstract Related articles

YANG Y, Yan X, Li J, Liu C, et al
CD47-targeted optical molecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder cancer.
Mol Ther Oncolytics. 2022;24:319-330.
Abstract Related articles

ZHOU Q, Zhang Z, Ang X, Zhang H, et al
A nomogram combined with radiomics features, albuminuria, and metabolic syndrome to predict the risk of myometrial invasion of bladder cancer.
Transl Cancer Res. 2021;10:3177-3191.
Abstract Related articles

LU JL, Xia QD, Liu CQ, Sun JX, et al
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis.
Transl Cancer Res. 2021;10:2849-2858.
Abstract Related articles

FENG D, Song P, Yang Y, Wei W, et al
Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis.
Transl Cancer Res. 2021;10:2188-2198.
Abstract Related articles

LI X, Wu Y, Yuan Y
Gene network screening of bladder cancer via modular analysis.
Transl Cancer Res. 2021;10:1043-1052.
Abstract Related articles

ONG K, Dyer J, Wilson M, Hayne D, et al
Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer - A rare complication.
Urol Case Rep. 2022;42:102003.
Abstract Related articles

LI ZJ, Wang DY, Liu ZH
Clinical Efficacy and Quality of Life Assessment of Partial Cystectomy and Plasmakinetic Transurethral Resection of Tumor in Bladder Cancer Patients.
Cancer Manag Res. 2022;14:389-398.
Abstract Related articles

ZHU RJ, Zhou J, Liang PQ, Xiang XX, et al
Accuracy of cytokeratin 19 fragment in the diagnosis of bladder cancer.
Biomark Med. 2022 Feb 3. doi: 10.2217/bmm-2021-0754.
Abstract Related articles

ALGHAFEES MA, Alqahtani MA, Musalli ZF, Alasker A, et al
Bladder cancer in Saudi Arabia: a registry-based nationwide descriptive epidemiological and survival analysis.
Ann Saudi Med. 2022;42:17-28.
Abstract Related articles

MALIK K, Raja A, Ravishankar LS, Narayanaswamy K, et al
Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule.
Indian J Surg Oncol. 2021;12:796-801.
Abstract Related articles

ATHER MH
What after BCG Fails in Non-muscle Invasive Bladder Cancer?
J Coll Physicians Surg Pak. 2022;32:139-140.
Abstract Related articles

OMURA M, Kikuchi E, Shigeta K, Ogihara K, et al
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.
Jpn J Clin Oncol. 2022 Feb 1. pii: 6518269. doi: 10.1093.
Abstract Related articles

MARTINI A, Lonati C, Montorsi F, Briganti A, et al
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
Clin Genitourin Cancer. 2021 Dec 11. pii: S1558-7673(21)00236.
Abstract Related articles

LUO Y, He Z, Liu W, Zhou F, et al
DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.
Oxid Med Cell Longev. 2022;2022:3369858.
Abstract Related articles

BERTOLASO P, Brouste V, Cazeau AL, de Clermont-Gallerande H, et al
Impact of (18) FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2022 Jan 14. pii: S1558-7673(22)00020.
Abstract Related articles

ZHANG LH, Zhang WY, Xiong JM, Duan XM, et al
Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
Chin J Nat Med. 2022;20:43-53.
Abstract Related articles

CHEN H, Hong Y, Yu B, Ruiqian L, et al
Retrospective analysis of bladder cancer morphology and depth of invasion under cystoscopy.
BMC Urol. 2022;22:12.
Abstract Related articles

KOOL R, Yanev I, Hijal T, Vanhuyse M, et al
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Canadian cost-effectiveness analysis.
Can Urol Assoc J. 2022 Jan 27. pii: cuaj.7430. doi: 10.5489/cuaj.7430.
Abstract Related articles

BHINDI B, Kool R, Kulkarni GS, Siemens DR, et al
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.
Can Urol Assoc J. 2021;15:230-239.
Abstract Related articles

KOOL R, Marcq G, Shinde-Jadhav S, Mansure JJ, et al
Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy.
Eur Urol Open Sci. 2021;36:26-33.
Abstract Related articles

WU JH, Sun KN, Chen ZH, He YJ, et al
Exosome-Mediated miR-4792 Transfer Promotes Bladder Cancer Cell Proliferation via Enhanced FOXC1/c-Myc Signaling and Warburg Effect.
J Oncol. 2022;2022:5680353.
Abstract Related articles

SELL V, Ettala O, Perez IM, Jarvinen R, et al
Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.
Eur Urol Focus. 2022 Jan 27. pii: S2405-4569(22)00035.
Abstract Related articles

KIDA N, Morishima T, Tsubakihara Y, Miyashiro I, et al
Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative Data.
Nephron. 2022 Jan 28:1-10. doi: 10.1159/000521603.
Abstract Related articles

KANMALAR M, Abdul Sani SF, Kamri NINB, Said NABM, et al
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review.
Cell Mol Biol Lett. 2022;27:9.
Abstract Related articles

BOTHIG R, Rosenbaum C, Bohme H, Kowald B, et al
Special surgical aspects of radical cystectomy in spinal cord injury patients with bladder cancer.
World J Urol. 2022 Jan 29. pii: 10.1007/s00345-022-03939.
Abstract Related articles

MAMDOUH S, Khorshed F, Hammad G, Elesaily K, et al
Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients.
Asian Pac J Cancer Prev. 2022;23:221-232.
Abstract Related articles

TANG F, Li Z, Lai Y, Lu Z, et al
A 7-gene signature predicts the prognosis of patients with bladder cancer.
BMC Urol. 2022;22:8.
Abstract Related articles

SHIGA M, Nishiyama H
[. Current Understanding of Mechanism of BCG Failure, and the Status of Drug Development Using BCG Cell Wall Components].
Gan To Kagaku Ryoho. 2022;49:43-46.
Abstract Related articles

ALLAMEH F, Sangian A, Razaghi M, Razzaghi Z, et al
Comparison of various types of lasers and transurethral resection in the treatment of bladder tumors: a systematic review and meta-analysis.
Lasers Med Sci. 2022;37:95-101.
Abstract Related articles

PALACKA P, Gvozdjakova A, Rausova Z, Kucharska J, et al
Platelet Mitochondrial Bioenergetics Reprogramming in Patients with Urothelial Carcinoma.
Int J Mol Sci. 2021;23.
Abstract Related articles

BELL CJ, Potts KG, Hitt MM, Pink D, et al
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma.
Cancer Lett. 2022;526:168-179.
Abstract Related articles

OU L, Luo J, Wei Z, Zheng A, et al
Urachal tuberculosis with invasion of the bladder wall: A case report and literature review.
Actas Urol Esp (Engl Ed). 2022;46:1-3.
Abstract Related articles

KAWADA T
Sex difference in survival in patients with radical cystectomy.
Urol Oncol. 2022;40:67.
Abstract Related articles

WESTERDAHL JS, Grant J, Sontheimer R, Zussman J, et al
Darier disease, radiation therapy, and herpesvirus -- an unfortunate triad.
Dermatol Online J. 2021;27.
Abstract Related articles

PARMAR KM, Thummala Y, Kumar S, Singh P, et al
Utility of FDG-PET CT scan to detect an incidental rare recurrence of carcinoma urinary bladder following radical cystectomy.
BMJ Case Rep. 2021;14.
Abstract Related articles

MADHUMITHA B, Joseph LD, Archana B, Chandru T, et al
Urothelial carcinoma with divergent differentiation in a horseshoe kidney.
Indian J Pathol Microbiol. 2021;64:866-867.
Abstract Related articles

KRISHNAMURTHY S, Menon M, Parameswaran A, Sivaraman A, et al
A case of solitary fibrous tumor of urinary bladder.
Indian J Pathol Microbiol. 2021;64:847-849.
Abstract Related articles

YAO X, Liu H, Xu H
The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
Biomed Res Int. 2021;2021:5311828.
Abstract Related articles

MOLLICA V, Rizzo A, Massari F
Re: Thomas Powles, Tibor Csoszi, Mustafa Ozguroglu, et al. Pembrolizumab Alone or Combined with Chemotherapy Versus Chemotherapy as First-line Therapy for Advanced Urothelial Carcinoma (KEYNOTE-361): A Randomised, Open-label, Phase 3 Trial. Lancet Onc
Eur Urol Oncol. 2021;4:854.
Abstract Related articles

LI F, Wang Y, Xie K, Fang Y, et al
The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials.
Aging (Albany NY). 2021;13:20468-20480.
Abstract Related articles

BURATIN A, Gaffo E, Dal Molin A, Bortoluzzi S, et al
CircIMPACT: An R Package to Explore Circular RNA Impact on Gene Expression and Pathways.
Genes (Basel). 2021;12.
Abstract Related articles

REDDY AG, Sparks AD, Darwish C, Whalen MJ, et al
Oncologic Outcomes for Robotic Vs. Open Radical Cystectomy Among Locally Advanced and Node-Positive Patients: Analysis of The National Cancer Database.
Clin Genitourin Cancer. 2021;19:547-553.
Abstract Related articles

FENG C, Wang Y, Dan G, Zhong Z, et al
Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
Eur Radiol. 2022;32:890-900.
Abstract Related articles

KHALIFE N, Chahine C, Kordahi M, Felefly T, et al
Urothelial carcinoma in the era of immune checkpoint inhibitors.
Immunotherapy. 2021;13:953-964.
Abstract Related articles

LAUKHTINA E, Mori K, Mostafaei H, Merseburger AS, et al
Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis.
Immunotherapy. 2021;13:917-929.
Abstract Related articles

WONG JL, Rosenberg JE
Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma.
Expert Opin Biol Ther. 2021;21:863-873.
Abstract Related articles

JAIN RK, Skelton Iv WP, Pond GR, Naqvi M, et al
Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma.
Clin Genitourin Cancer. 2021;19:540-546.
Abstract Related articles

RIZZO A, Mollica V, Massari F
Re: Thomas Powles, Jonathan E. Rosenberg, Guru P. Sonpavde, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med 2021;384:1125-35.
Eur Urol Oncol. 2021;4:670.
Abstract Related articles

HOFFMAN-CENSITS JH, Lombardo KA, Parimi V, Kamanda S, et al
Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.
Appl Immunohistochem Mol Morphol. 2021;29:619-625.
Abstract Related articles

PATEL SY, Trona N, Alford B, Laborde JM, et al
Preoperative immunonutrition and carbohydrate loading associated with improved bowel function after radical cystectomy.
Nutr Clin Pract. 2022;37:176-182.
Abstract Related articles

BOREA R, Damassi A, Rebuzzi SE, Banna GL, et al
Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios.
Immunotherapy. 2021;13:645-652.
Abstract Related articles

SZABADOS B, Prendergast A, Jackson-Spence F, Choy J, et al
Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer.
Eur Urol Oncol. 2021;4:943-947.
Abstract Related articles

KHAKI AR, Li A, Diamantopoulos LN, Miller NJ, et al
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol. 2021;4:464-472.
Abstract Related articles

MAAS M, Stuhler V, Walz S, Stenzl A, et al
Enfortumab vedotin - next game-changer in urothelial cancer.
Expert Opin Biol Ther. 2021;21:801-809.
Abstract Related articles

COLLA RUVOLO C, Nocera L, Stolzenbach LF, Wenzel M, et al
Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
Eur Urol Oncol. 2021;4:792-801.
Abstract Related articles

RAVI P, McGregor BA
Antibody-drug conjugates for the treatment of urothelial carcinoma.
Expert Opin Biol Ther. 2021;21:915-922.
Abstract Related articles

BROOKS N, Nagaraju S, Matulay J, Han XY, et al
Bacillus Calmette-Guerin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage.
Eur Urol Oncol. 2021;4:826-828.
Abstract Related articles

SHARIAT S, Gontero P, Catto JWF
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?
Eur Urol Oncol. 2021;4:663-669.
Abstract Related articles

BURGER M, Kamat AM, McConkey D
Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?
Eur Urol Oncol. 2021;4:510-514.
Abstract Related articles

STENZL A, McConkey D, Bellmunt J
Does it matter whether a T1 high-grade tumor is molecularly classified?
Eur Urol Oncol. 2021;4:837-842.
Abstract Related articles

LAM JM, Liu WK, Powles T, Tang YZ, et al
Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition.
Eur Urol Oncol. 2021;4:659-662.
Abstract Related articles

TAMAI M, Tatarano S, Okamura S, Fukumoto W, et al
microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
Mol Oncol. 2022 Feb 11. doi: 10.1002/1878-0261.13192.
Abstract Related articles

LIU J, Zhang Z, Zhang W, Meng L, et al
Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer.
Front Cell Dev Biol. 2022;10:791630.
Abstract Related articles

PAGLIARULO F, Cheng PF, Brugger L, van Dijk N, et al
Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
Front Immunol. 2022;12:793992.
Abstract Related articles

TOMIDA R, Miyake M, Minato R, Sawada Y, et al
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
Int J Clin Oncol. 2022 Feb 10. pii: 10.1007/s10147-022-02127.
Abstract Related articles

AFFERI L, Lonati C, Montorsi F, Briganti A, et al
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
World J Urol. 2022 Feb 10. pii: 10.1007/s00345-022-03948.
Abstract Related articles

CHEN K, Zhu S, Yu W, Xia Y, et al
Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
Front Oncol. 2022;12:774307.
Abstract Related articles

PENG S, Ma S, Yang F, Xu C, et al
Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer.
Sci Rep. 2022;12:2219.
Abstract Related articles

MICHEL F, Cancrini F, Cancel-Tassin G, Game X, et al
A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology.
World J Urol. 2022 Feb 9. pii: 10.1007/s00345-022-03942.
Abstract Related articles

SCHIERZ JH, McLeod A, Ali F
Rare osteoarticular complications on [18F]FDG-PET/CT - following intravesical BCG immunotherapy for bladder cancer.
Nucl Med Rev Cent East Eur. 2022;25:68-69.
Abstract Related articles

NERLI RB, Ghagane SC, Rangrez SS, Chandra S, et al
Author Reply Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9.
Indian J Urol. 2022;38:78-79.
Abstract Related articles

PATTNAIK SS
Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9.
Indian J Urol. 2022;38:77-78.
Abstract Related articles

WETTSTEIN MS, Baxter NN, Sutradhar R, Mamdani M, et al
Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeons.
Urol Oncol. 2022 Feb 5. pii: S1078-1439(21)00553.
Abstract Related articles

OKAMOTO T, Yamamoto K, Kanomata N
Metastatic Rectal Linitis Plastic From Bladder Cancer.
Am J Gastroenterol. 2021;116:2324.
Abstract Related articles

MOHSENZADEGAN M, Razmi M, Vafaei S, Abolhasani M, et al
Publisher Correction: Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer.
Sci Rep. 2022;12:2330.
Abstract Related articles

AL-ZUBAIDI M, McCombie S, Swarbrick N, Hayne D, et al
Unique case of IgG4-related disease of the renal pelvis involving the inferior vena cava masquerading as locally advanced urothelial cancer.
BMJ Case Rep. 2022;15.
Abstract Related articles

SHI ZD, Hao L, Han XX, Wu ZX, et al
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
Mol Cancer. 2022;21:37.
Abstract Related articles

BOOT IWA, Wesselius A, Yu EYW, Brinkman M, et al
Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies.
Eur J Nutr. 2022 Feb 7. pii: 10.1007/s00394-022-02805.
Abstract Related articles

PRESS RH, Shelton JW, Zhang C, Dang Q, et al
Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy-Phase 2 Trial Secondary Analysis.
Int J Part Ther. 2021;8:1-10.
Abstract Related articles

ZHANG S, Wang Q, Li W, Chen J, et al
MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing.
Front Mol Biosci. 2022;8:793493.
Abstract Related articles

LU X, Jiang H, Wang D, Wang Y, et al
Early Warning Models to Predict the 90-Day Urinary Tract Infection Risk After Radical Cystectomy and Urinary Diversion for Patients With Bladder Cancer.
Front Surg. 2022;8:782029.
Abstract Related articles

SONG Y, Du Y, Qin C, Liang H, et al
Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment.
Front Cell Dev Biol. 2022;9:809620.
Abstract Related articles

HU J, Zheng Z, Zheng J, Xie W, et al
A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer.
Front Oncol. 2022;11:809664.
Abstract Related articles

WANG DQ, Shuai J, Zheng H, Guo ZQ, et al
Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case-Control Study.
Front Oncol. 2022;11:796975.
Abstract Related articles

ZHANG Y, Lin Y, Lv D, Wu X, et al
Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.
PeerJ. 2022;10:e12843.
Abstract Related articles

XU C, Zhou G, Sun Z, Zhang Z, et al
miR-148a-3p inhibits the proliferation and migration of bladder cancer via regulating the expression of ROCK-1.
PeerJ. 2022;10:e12724.
Abstract Related articles

ZHANG C, Wang YQ, Jin G, Wu S, et al
Erratum: Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction.
Oncol Lett. 2022;23:85.
Abstract Related articles

HUANG L, Zhang X, Li F, Wang X, et al
MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer.
Comput Math Methods Med. 2022;2022:2880087.
Abstract Related articles

ZHU K, Liu X, Deng W, Wang G, et al
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer.
Hereditas. 2022;159:13.
Abstract Related articles

BANGASH M, Faruqui N, Muhammad AU, Uddin Z, et al
Leiomyoma Urinary Bladder, Mimicking Urothelial Cancer.
J Ayub Med Coll Abbottabad. 2021;33:685-689.
Abstract Related articles

JORDAN SR, Geiger CL, Fischer SM, Kessler ER, et al
Care planning priorities of older patients with advanced bladder cancer.
J Geriatr Oncol. 2022 Feb 2. pii: S1879-4068(22)00011.
Abstract Related articles

YU C, Zhang Y, Wang N, Wei W, et al
Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA.
Biomater Res. 2022;26:6.
Abstract Related articles

HENTSCHEL AE, Beijert IJ, Bosschieter J, Kauer PC, et al
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
Clin Epigenetics. 2022;14:19.
Abstract Related articles

ASGHARIAZAR V, Kadkhodayi M, Mansoori B, Mohammadi A, et al
Restoration of miR-143 reduces migration and proliferation of bladder cancer cells by regulating signaling pathways involved in EMT.
Mol Cell Probes. 2022;61:101794.
Abstract Related articles

MOSCHINI M, Gandaglia G, Deho F, Salonia A, et al
Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up.
Ann Oncol. 2022 Feb 1. pii: S0923-7534(22)00102.
Abstract Related articles

TOMITA Y, Yamamoto Y, Tsuchiya N, Kanayama H, et al
Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.
Int J Clin Oncol. 2022;27:383-395.
Abstract Related articles

PINARD CJ, Hocker SE, Poon AC, Inkol JM, et al
Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines.
Vet Immunol Immunopathol. 2022;243:110367.
Abstract Related articles

SCHNEIDER AK, Teuschler T, Wolko S
[Care after radical cystectomy].
Urologe A. 2022;61:83-86.
Abstract Related articles

ZENGIN ZB, Chehrazi-Raffle A, Salgia NJ, Muddasani R, et al
Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.
Urol Oncol. 2022;40:25-36.
Abstract Related articles

LI L, Na R, Mi T, Cheng H, et al
Medical Image Diagnostic Value of Computed Tomography for Bladder Tumors.
Comput Math Methods Med. 2021;2021:3781028.
Abstract Related articles

LI S, Liu X, Chen X
Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
BMC Urol. 2021;21:162.
Abstract Related articles

TUO Z, Zhang Y, Wang J, Zhou H, et al
Three-port approach vs standard laparoscopic radical cystectomy with an ileal conduit: a single-centre retrospective study.
BMC Urol. 2021;21:159.
Abstract Related articles

TURNER LD, Trinh CH, Hubball RA, Orritt KM, et al
From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
J Med Chem. 2022;65:1481-1504.
Abstract Related articles

INOUE K, Fukuhara H, Yamamoto S, Karashima T, et al
Current status of photodynamic technology for urothelial cancer.
Cancer Sci. 2022;113:392-398.
Abstract Related articles

CACCIAMANI GE, Matulewicz RS, Kumar R, Teoh JY, et al
Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer.
Urol Oncol. 2021;39:793-796.
Abstract Related articles

GRUNEWALD CM, Niegisch G
[Circulating tumor DNA (ctDNA) in urothelial carcinoma-the long-desired biomarker?]
Urologe A. 2021;60:1466-1467.
Abstract Related articles

BETANCOURT RL, Samulski DT
Endometrial adenocarcinoma presenting in a voided urine cytology specimen: Case report.
Diagn Cytopathol. 2021 Aug 19. doi: 10.1002/dc.24838.
Abstract Related articles

DURSUN F, Mackay A, Guzman JCA, Wenker E, et al
Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database.
Urol Oncol. 2022;40:61.
Abstract Related articles

SOOD A, Keeley J, Palma-Zamora I, Novara G, et al
High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival.
Urol Oncol. 2022;40:62.
Abstract Related articles

LI CF, Chan TC, Pan CT, Vejvisithsakul PP, et al
EMP2 induces cytostasis and apoptosis via the TGFbeta/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
Cell Oncol (Dordr). 2021;44:1133-1150.
Abstract Related articles

NGUYEN A, Fassas S, Freidberg N, Sullo E, et al
Recurrence and treatment of adult primary nonmetastatic bladder rhabdomyosarcoma: A systematic review.
Urol Oncol. 2021;39:774-780.
Abstract Related articles

LE BRUN IC, Benderra MA
[New approval: Avelumab - maintenance therapy for advanced or metastatic urothelial carcinoma].
Bull Cancer. 2021;108:784-786.
Abstract Related articles

GHANDOUR RA, Freifeld Y, Cheaib J, Singla N, et al
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
Urol Oncol. 2021;39:788.
Abstract Related articles

CHEN H, Wang M, Weng T, Wei Y, et al
The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma.
Urol Oncol. 2021;39:743-753.
Abstract Related articles

COLLA RUVOLO C, Wenzel M, Nocera L, Wurnschimmel C, et al
The effect of race on stage at presentation and survival in upper tract urothelial carcinoma.
Urol Oncol. 2021;39:788.
Abstract Related articles

ISHIYAMA Y, Kondo T, Nemoto Y, Kobari Y, et al
Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma.
Urol Oncol. 2021;39:834.
Abstract Related articles

TACHIBANA I, Calaway AC, Abedali Z, Szymanski KM, et al
Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach.
Urol Oncol. 2021;39:789.
Abstract Related articles

KOBAYASHI T, Ito K, Kojima T, Maruyama S, et al
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
Cancer Immunol Immunother. 2022;71:461-471.
Abstract Related articles

MATSUMOTO A, Matsui I, Mano K, Mizuno H, et al
Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
BMC Nephrol. 2021;22:253.
Abstract Related articles

AJIB K, Berjaoui MB, Herrera-Caceres J, Nason G, et al
Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis.
Urol Oncol. 2021;39:835.
Abstract Related articles

RUVOLO CC, Nocera L, Stolzenbach FL, Wenzel M, et al
Contemporary analysis of the effect of marital status on survival in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: A population-based study.
Urol Oncol. 2021;39:789.
Abstract Related articles

HUBERT P, Selmani Z, Loriot Y, Thiery-Vuillemin A, et al
FGFR alterations in urothelial carcinoma: Picking the right target.
Bull Cancer. 2021;108:566-570.
Abstract Related articles

MILOJEVIC B, Dzamic Z, Grozdic Milojevic I, Bumbasirevic U, et al
Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study.
Urol Oncol. 2021;39:786.
Abstract Related articles

NICHOLS MM, Reynolds JP, McKenney JK, Nicolas MM, et al
Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
Cancer Cytopathol. 2021;129:798-804.
Abstract Related articles

OKITA K, Hatakeyama S, Hagiwara K, Suzuki Y, et al
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.
Urol Oncol. 2021;39:832.
Abstract Related articles

RODRIGUES PESSOA R, Morrison JC, Konety B, Gershman B, et al
National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
Urol Oncol. 2021;39:832.
Abstract Related articles

KIM HD, Im HS, Kim JH, Jeong H, et al
Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.
Cancer Res Treat. 2021;53:1166-1173.
Abstract Related articles

MOREIRA I, Coelho S, Rodrigues A, Patrao AS, et al
Urachal carcinoma: A case of a rare neoplasm.
Curr Probl Cancer. 2021;45:100711.
Abstract Related articles

LIU L, Zhu J, Tian Y
Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based study.
Cancer Med. 2022 Feb 18. doi: 10.1002/cam4.4611.
Abstract Related articles

KACHANOV M, Vetterlein MW, Soave A, Karakiewicz PI, et al
Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis.
Aging Male. 2022;25:54-61.
Abstract Related articles

HAGIMOTO H, Makita N, Mine Y, Kokubun H, et al
Correction to: Comparison between 5-aminolevulinic acid photodynamic diagnosis and narrow-band imaging for bladder cancer detection.
BMC Urol. 2022;22:23.
Abstract Related articles

ZHANG S, Zhang J, Zhang Q, Liang Y, et al
Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile.
Front Cell Dev Biol. 2022;9:817086.
Abstract Related articles

XU J, Zeng S, Li J, Gao L, et al
Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles.
Front Cell Dev Biol. 2022;9:813420.
Abstract Related articles

CHEN X, Wang P, Ou T, Li J, et al
KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration.
Cancer Manag Res. 2022;14:465-477.
Abstract Related articles

GAKIS G
[Adjuvant instillation therapy for non-muscle invasive bladder cancer - beyond BCG und mitomycin C].
Aktuelle Urol. 2022 Feb 16. doi: 10.1055/a-1677-0952.
Abstract Related articles

LONG Y, Wu Z, Yang X, Chen L, et al
[Retracted] MicroRNA101 inhibits the proliferation and invasion of bladder cancer cells via targeting cFOS.
Mol Med Rep. 2022;25.
Abstract Related articles

WANG Z, Zhu L, Li L, Stebbing J, et al
Identification of an immune gene-associated prognostic signature in patients with bladder cancer.
Cancer Gene Ther. 2022 Feb 15. pii: 10.1038/s41417-022-00438.
Abstract Related articles

SINGH AK, Praharaj M, Lombardo KA, Yoshida T, et al
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.
Nat Commun. 2022;13:878.
Abstract Related articles

GOLLA V, Shan Y, Farran EJ, Stewart CA, et al
Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
Urol Oncol. 2022 Feb 12. pii: S1078-1439(22)00025.
Abstract Related articles

PEKALA KR, Yabes JG, Bandari J, Yu M, et al
Corrigendum to 'The centralization of bladder cancer care and its implications for patient travel distance' [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9-834.e.20/9680].
Urol Oncol. 2022 Feb 12. pii: S1078-1439(21)00567.
Abstract Related articles

LIU T, Zhang Z, Wang C, Huang H, et al
BRD4 promotes the migration and invasion of bladder cancer through the Sonic hedgehog signaling pathway and enhances cisplatin resistance.
Biochem Cell Biol. 2022 Feb 15. doi: 10.1139/bcb-2021-0552.
Abstract Related articles

YEARY KHK, Clark N, Saad-Harfouche F, Erwin D, et al
Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process.
JMIR Cancer. 2022;8:e32291.
Abstract Related articles

KORKES F, Timoteo F, Soledade LCB, Bugalho LS, et al
Stage-Related Cost of Treatment of Bladder Cancer in Brazil.
Pharmacoecon Open. 2022 Feb 14. pii: 10.1007/s41669-022-00325.
Abstract Related articles

LIU CQ, Xia QD, Sun JX, Xu JZ, et al
Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer.
Aging (Albany NY). 2022;14.
Abstract Related articles

KUBRAK T, Karakula M, Czop M, Kawczyk-Krupka A, et al
Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy.
Molecules. 2022;27.
Abstract Related articles

ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
A Comprehensive Approach to Clinical Staging of Bladder Cancer.
J Clin Med. 2022;11.
Abstract Related articles

LA CROCE G, Naspro R, Finati M, Pellucchi F, et al
The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy.
J Clin Med. 2022;11.
Abstract Related articles

PARDO JC, Sanhueza T, Ruiz de Porras V, Etxaniz O, et al
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy.
J Clin Med. 2022;11.
Abstract Related articles

AUDISIO A, Buttigliero C, Delcuratolo MD, Parlagreco E, et al
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond.
Cells. 2022;11.
Abstract Related articles

SHISHIDO SN, Sayeed S, Courcoubetis G, Djaladat H, et al
Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

DEININGER S, Torzsok P, Mitterberger M, Pallauf M, et al
From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guerin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).
Cancers (Basel). 2022;14.
Abstract Related articles

SINGER G, Ramakrishnan VM, Rogel U, Schotzau A, et al
The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT(c) Bladder Cancer Monitor and Narrow Band Imaging(c) Cystoscopy.
Cancers (Basel). 2022;14.
Abstract Related articles

BOSKOVIC M, Roje B, Chung FF, Gelemanovic A, et al
DNA Methylome Changes of Muscle- and Neuronal-Related Processes Precede Bladder Cancer Invasiveness.
Cancers (Basel). 2022;14.
Abstract Related articles

FASULO V, Paciotti M, Lazzeri M, Contieri R, et al
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.
Front Oncol. 2022;12:832835.
Abstract Related articles

LI Y, Cheng X, Yan J, Jiang S, et al
CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathway.
Arch Med Sci. 2019;18:183-194.
Abstract Related articles

WEI B, Wang Z, Lian Q, Chi B, et al
hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling.
Dis Markers. 2022;2022:9899548.
Abstract Related articles

LU Z, Tang F, Li Z, Lai Y, et al
Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
Dis Markers. 2022;2022:7931393.
Abstract Related articles

SHIMIZU R, Ohira T, Yagyu T, Yumioka T, et al
Activation of PPARgamma in bladder cancer via introduction of the long arm of human chromosome 9.
Oncol Lett. 2022;23:92.
Abstract Related articles

KAYID M
Applications of Bladder Cancer Data Using a Modified Log-Logistic Model.
Appl Bionics Biomech. 2022;2022:6600278.
Abstract Related articles

LU H, Wu J, Liang L, Wang X, et al
Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Front Immunol. 2022;13:803355.
Abstract Related articles

LI T, Tang Z, Li C, Liu X, et al
Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/beta-Catenin Signaling Pathway.
Front Pharmacol. 2022;12:804615.
Abstract Related articles

PATTOU M, Baboudjian M, Pinar U, Parra J, et al
Continent cutaneous urinary diversion with an ileal pouch with the Mitrofanoff principle versus a Miami pouch in patients undergoing cystectomy for bladder cancer: results of a comparative study.
World J Urol. 2022 Feb 12. pii: 10.1007/s00345-022-03954.
Abstract Related articles

FUKUHARA H, Yamamoto S, Lai HW, Karashima T, et al
Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2(nd) report): reduced bladder recurrence after PDD-TURBT.
Photodiagnosis Photodyn Ther. 2022 Feb 10:102757.
Abstract Related articles

D'SOUZA AA, Tulpule V, Zang PD, Quinn DI, et al
Bladder cancer: from a therapeutic wilderness to so many options; a guide to practice in a changing landscape.
Ann Oncol. 2022;33:242-243.
Abstract Related articles

SHEN Y, Ye H, Zhang D, Yang M, et al
The role of exosomal CDC6 in the hirudin-mediated suppression of the malignant phenotype of bladder cancer cells.
Gene. 2022 Feb 9:146269. doi: 10.1016/j.gene.2022.146269.
Abstract Related articles

ZHANG J, Dong Y, Shi Z, He H, et al
P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer.
Clin Transl Oncol. 2022 Feb 11. pii: 10.1007/s12094-022-02791.
Abstract Related articles

LI F, Xu M, Zhuang J
Dual biomineralized metal-organic frameworks-mediated conversion of chemical energy to electricity enabling portable PEC sensing of telomerase activity in bladder cancer tissues.
Biosens Bioelectron. 2022;204:114070.
Abstract Related articles

TACHIBANA I, Mahmoud M, Abedali ZA, Flack C, et al
Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?
Urol Oncol. 2022 Feb 8. pii: S1078-1439(21)00556.
Abstract Related articles

CUI J, Zhu Y, Liu X, Wang W, et al
Comprehensive analysis of N(6)-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer.
Cancer Cell Int. 2022;22:72.
Abstract Related articles

GALLIOLI A, Pradere B, Albisinni S, Moschini M, et al
Robot-assisted radical cystectomy: towards a future of sexual-sparing surgery?
Minerva Urol Nephrol. 2021;73:697-699.
Abstract Related articles

BANI-HANI M, Abdel Majid A, Al-Zubi MT, Al Demour S, et al
Continuous Saline Bladder Irrigation in Reducing Recurrence and Progression When Compared to Immediate Mitomycin- C Instillation Post- Resection of Bladder Tumor: A Short Communication.
Asian Pac J Cancer Prev. 2022;23:171-175.
Abstract Related articles

MASONE MC
NMIBC risk factors in patients treated with BCG.
Nat Rev Urol. 2022;19:67.
Abstract Related articles

YIN H, Yongkang M, Bao G, Shiming Z, et al
PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma: A case report.
Medicine (Baltimore). 2022;101:e28591.
Abstract Related articles

THOMAS T
Bladder EpiCheck for NMIBC.
Nat Rev Urol. 2022;19:67.
Abstract Related articles

MAEDA S, Sakai K, Kaji K, Iio A, et al
Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.
Sci Rep. 2022;12:4.
Abstract Related articles

DOSNE AG, Valade E, Goeyvaerts N, De Porre P, et al
Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.
Cancer Chemother Pharmacol. 2022;89:151-164.
Abstract Related articles

ZOU X, Wei Y, Qi T, Wang X, et al
A novel 6-gene signature derived from tumor-infiltrating T cells and neutrophils predicts survival of bladder urothelial carcinoma.
Aging (Albany NY). 2021;13:25496-25517.
Abstract Related articles

LIN S, Wang L, Shi Z, Zhu A, et al
Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
Bioengineered. 2021;12:11376-11389.
Abstract Related articles

HARVEY M, Chislett B, Perera M, Lawrentschuk N, et al
Critical shortage in BCG immunotherapy: How did we get here and where will it take us?
Urol Oncol. 2022;40:1-3.
Abstract Related articles

YAMADA S, Abe T, Sazawa A, Katano H, et al
Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities.
Urol Oncol. 2022;40:11.
Abstract Related articles

HURLE R, Guazzoni G, Colombo P, Santoro A, et al
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start.
Urol Oncol. 2022;40:11.
Abstract Related articles

AHN AR, Noh SJ, Hussein UK, Park HS, et al
FAM83H and Nectin1 expression are related with survival and relapse of bladder urothelial carcinoma patients.
BMC Urol. 2021;21:143.
Abstract Related articles

COMPERAT E, Oszwald A, Wasinger G, Wacquet J, et al
PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers.
World J Urol. 2021;39:4067-4071.
Abstract Related articles

KOSSAI M, Radulescu C, Adam J, Dziegielewski A, et al
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC.
Urol Oncol. 2022;40:12.
Abstract Related articles

MURTHY PB, Lone Z, Corrigan D, Campbell R, et al
Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: A matched cohort analysis.
Urol Oncol. 2022;40:10.
Abstract Related articles

NECCHI A, Raggi D, Gallina A, Bandini M, et al
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition.
Urol Oncol. 2021;39:734.
Abstract Related articles

GOUTAS D, Savvidou K, Vrettou K, Meletis E, et al
Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
Cytopathology. 2021;32:795-801.
Abstract Related articles

ZHOU YW, Long YX, Song K, Liang LB, et al
Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
Cancer Med. 2021;10:5415-5428.
Abstract Related articles

MORGANS AK, Hepp Z, Shah SN, Shah A, et al
Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis.
Urol Oncol. 2021;39:733.
Abstract Related articles

MUSANGILE FY, Matsuzaki I, Okodo M, Shirasaki A, et al
Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization.
Cancer Med. 2021;10:5534-5544.
Abstract Related articles

BEBANE S, Denize J, Goujon A, Meria P, et al
Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria.
World J Urol. 2021;39:4159-4165.
Abstract Related articles

SUBIELA JD, Faba OR, Aumatell J, Krajewski W, et al
Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: Lessons learned from long-term follow-up of a series of CIS patients treated with BCG.
Urol Oncol. 2022;40:9.
Abstract Related articles

JANA S, Deo R, Hough RP, Liu Y, et al
mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformation.
JCI Insight. 2021;6.
Abstract Related articles

MAAS M, Mischinger J, Comperat E, Scharpf M, et al
Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
World J Urol. 2021;39:4021-4027.
Abstract Related articles

AUMATELL J, Huguet J, Subiela JD, Gaya JM, et al
Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy.
Urol Oncol. 2021;39:732.
Abstract Related articles

BATEN E, Van der Aa F, Goethuys H, Slabbert K, et al
A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB).
World J Urol. 2021;39:3839-3844.
Abstract Related articles

CALO B, Sanguedolce F, Falagario UG, Chirico M, et al
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary?
World J Urol. 2021;39:3815-3821.
Abstract Related articles

KATAYAMA S, Kobayashi Y, Takamoto A, Edamura K, et al
Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma.
Urol Oncol. 2021;39:731.
Abstract Related articles

CHENG HL, Chou LP, Tsai HW, Lee CT, et al
Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features.
Urol Oncol. 2021;39:732.
Abstract Related articles

OSZWALD A, Wasinger G, Larnaudie L, Varinot J, et al
Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris.
World J Urol. 2021;39:4029-4035.
Abstract Related articles

MORMILE R
Letter to the editor: What about cholesterol as a novel biomarker for bladder and kidney cancer diagnosis and surveillance? In memory of my dad Sossio Mormile.
Investig Clin Urol. 2021;62:239-240.
Abstract Related articles

DE VLAMING A, Mathews KG, Hash JA, Keenihan EK, et al
Creation of a Continent Urinary Bladder Reservoir Vascularized by Omentum as a Possible Surgical Option for Canine Trigonal/Urethral Urothelial Carcinoma.
J Invest Surg. 2022;35:481-495.
Abstract Related articles

ERCOLINO A, Droghetti M, Schiavina R, Bianchi L, et al
Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal.
Minerva Urol Nephrol. 2021;73:763-772.
Abstract Related articles

TUDERTI G, Mastroianni R, Brassetti A, Bove AM, et al
Robot-assisted radical cystectomy with intracorporeal neobladder: impact of learning curve and long-term assessment of functional outcomes.
Minerva Urol Nephrol. 2021;73:754-762.
Abstract Related articles

ROUMIGUIE M, Comperat E, Chaltiel L, Nouhaud FX, et al
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment.
World J Urol. 2021;39:4055-4065.
Abstract Related articles

SMELSER WW, Jones CP
Management of anticoagulation and antiplatelet agents in the radical cystectomy patient.
Urol Oncol. 2021;39:691-697.
Abstract Related articles

GUO CC, Al-Ahmadie HA, Flaig TW, Kamat AM, et al
Contribution of bladder cancer pathology assessment in planning clinical trials.
Urol Oncol. 2021;39:713-719.
Abstract Related articles

JIANG X, Li H, Fang Y, Xu C, et al
LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
Environ Toxicol. 2022 Feb 25. doi: 10.1002/tox.23501.
Abstract Related articles

LOBO N, Martini A, Kamat AM
Evolution of immunotherapy in the treatment of non-muscle-invasive bladder cancer.
Expert Rev Anticancer Ther. 2022 Feb 25. doi: 10.1080/14737140.2022.2046466.
Abstract Related articles

LIU J, Zhang Z, Liu X, Zhang W, et al
Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
World J Surg Oncol. 2022;20:47.
Abstract Related articles

LEE SW, Tae BS, Choi YJ, Yoon SM, et al
A Comparison of the Anesthetic Methods for Recurrence Rates of Bladder Cancer after Transurethral Resection of Bladder Tumors Using National Health Insurance Claims Data of South Korea.
J Clin Med. 2022;11.
Abstract Related articles

SARRIO-SANZ P, Martinez-Cayuelas L, Gil-Guillen VF, Quesada JA, et al
Mortality Trends Related to Bladder Cancer in Spain, 1999-2018.
J Clin Med. 2022;11.
Abstract Related articles

IBRAHIM NK, Eraky A, Eggers J, Steiert TA, et al
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients.
Cancers (Basel). 2022;14.
Abstract Related articles

HUANG CS, Tsai CH, Yu CP, Wu YS, et al
Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

BEEREN I, Goeij L, Dandis R, Vidra N, et al
Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis.
Cancers (Basel). 2022;14.
Abstract Related articles

DEL GIUDICE F, Flammia RS, Chung BI, Moschini M, et al
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis.
Cancers (Basel). 2022;14.
Abstract Related articles

YAO X, Qi X, Wang Y, Zhang B, et al
Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis.
Biology (Basel). 2022;11.
Abstract Related articles

CROCETTO F, Pandolfo SD, Aveta A, Martino R, et al
A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer.
Diagnostics (Basel). 2022;12.
Abstract Related articles

SHAHAB U, Habib S, Alsulimani A, Alshammari QT, et al
N-OH-AABP Modifications in Human DNA May Lead to Auto-Antibodies in Bladder Cancer Subjects.
Diagnostics (Basel). 2022;12.
Abstract Related articles

MAIORANO BA, De Giorgi U, Ciardiello D, Schinzari G, et al
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day.
Biomedicines. 2022;10.
Abstract Related articles

NOWAK L, Krajewski W, Malkiewicz B, Szydelko T, et al
Characteristics and Applications of Canine In Vitro Models of Bladder Cancer in Veterinary Medicine: An Up-to-Date Mini Review.
Animals (Basel). 2022;12.
Abstract Related articles

ABUDUREXITI M, Ma J, Li Y, Hu C, et al
Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients.
Curr Oncol. 2022;29:578-588.
Abstract Related articles

ZUO L, Zhu Y, Han J, Liu H, et al
Circular RNA circSHPRH inhibits the malignant behaviors of bladder cancer by regulating the miR-942/BARX2 pathway.
Aging (Albany NY). 2022;14.
Abstract Related articles

SAH AK, Maharjan B, Adhikari MB, Rana R, et al
Radical Cystectomy for Intradiverticular Bladder Carcinoma: A Case Report.
JNMA J Nepal Med Assoc. 2021;59:1069-1071.
Abstract Related articles

GUNERI-SOZERI PY, Erkek-Ozhan S
Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer.
Mol Biol Rep. 2022 Feb 24. pii: 10.1007/s11033-022-07145.
Abstract Related articles

PARRA-GRANDE M, Ore-Arce M, Martinez-Priego L, D'Auria G, et al
Profiling the Bladder Microbiota in Patients With Bladder Cancer.
Front Microbiol. 2022;12:718776.
Abstract Related articles

RIGHETTO M, Modonutti D, Celso FG, Fulcoli V, et al
Metabolic syndrome and bladder cancer.
Panminerva Med. 2022 Feb 22. pii: S0031-0808.22.04641.
Abstract Related articles

SHANG W, Peng L, He K, Guo P, et al
A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer.
Eur J Nucl Med Mol Imaging. 2022 Feb 21. pii: 10.1007/s00259-022-05701.
Abstract Related articles

ZHAN X, Jiang M, Deng W, Liu X, et al
Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database.
Front Oncol. 2022;12:789028.
Abstract Related articles

YANG X, Lv J, Zhou Z, Feng D, et al
Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity.
Front Oncol. 2022;11:802188.
Abstract Related articles

WESTHOFEN T, Eismann L, Buchner A, Schlenker B, et al
Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
Eur Urol Focus. 2022 Feb 17. pii: S2405-4569(22)00045.
Abstract Related articles

CHEN CW
Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'".
Transl Oncol. 2022;18:101372.
Abstract Related articles

MICHEL F, Cancrini F, Bensadoun H, Cussenot O, et al
Incidence of bladder cancer in neuro-urological patients in France: a nationwide study.
World J Urol. 2022 Feb 19. pii: 10.1007/s00345-022-03955.
Abstract Related articles

HOU DY, Zhang NY, Wang MD, Xu SX, et al
In Situ Constructed Nano-drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer.
Angew Chem Int Ed Engl. 2022 Feb 18. doi: 10.1002/anie.202116893.
Abstract Related articles

FENG Y, Zhong K, Chen R, Zhou W, et al
Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.
Abdom Radiol (NY). 2022 Feb 18. pii: 10.1007/s00261-022-03449.
Abstract Related articles

LI M, Zhang N, Shan W, Guan B, et al
ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer.
Ann Clin Lab Sci. 2022;52:117-125.
Abstract Related articles

MIR MC, Marchioni M, Zargar H, Zargar-Shoshtari K, et al
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].
Eur Urol Focus. 2022 Feb 15. pii: S2405-4569(22)00016.
Abstract Related articles

KAWASAKI M, Nagase K, Aoki S, Udo K, et al
Bystander effects induced by the interaction between urothelial cancer cells and irradiated adipose tissue-derived stromal cells in urothelial carcinoma.
Hum Cell. 2022;35:613-627.
Abstract Related articles

SIEFKER-RADTKE AO, Necchi A, Park SH, Garcia-Donas J, et al
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Lancet Oncol. 2022;23:248-258.
Abstract Related articles

HONG T, Piao S, Sun L, Tao Y, et al
Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-small ka, CyrillicB/cyclooxygenase-2/prostaglandin E2 axis.
Bosn J Basic Med Sci. 2022;22:100-109.
Abstract Related articles

POWLES T, Sridhar SS, Loriot Y, Bellmunt J, et al
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.
Nat Med. 2021;27:2200-2211.
Abstract Related articles

YANAGI M, Hamasaki T, Akatsuka J, Endo Y, et al
Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
BMC Urol. 2021;21:167.
Abstract Related articles

LOMBARDO KA, Obradovic A, Singh AK, Liu JL, et al
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.
J Pathol. 2022;256:223-234.
Abstract Related articles

ZAZA SI, Ghasemzadeh A, Bennett KM
Mycobacterium Bovis Causing Mycotic Aneurysm Secondary to Intravesical Treatment with Bacillus Calmette-Guerin: A Case Report.
Ann Vasc Surg. 2022;79:437.
Abstract Related articles

ZHOU X, Wang F, Wu H, Chen X, et al
Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells.
Int J Biol Sci. 2021;17:3456-3475.
Abstract Related articles

TANIGUCHI Y, Nishikawa H, Kimata T, Yoshinaga Y, et al
Reactive Arthritis After Intravesical Bacillus Calmette-Guerin Therapy.
J Clin Rheumatol. 2022;28:e583-e588.
Abstract Related articles

WHELAN P, Kim C, Tabib C, Preminger GM, et al
Evolution of Single-Use Urologic Endoscopy: Benchtop and Initial Clinical Assessment of a New Single-Use Flexible Cystoscope.
J Endourol. 2022;36:13-21.
Abstract Related articles

VRANIC S, Gatalica Z
Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers.
Bosn J Basic Med Sci. 2022;22:14-21.
Abstract Related articles

PIZZIGHELLA M, Bruyere F, Peyronnet B, Graffeille V, et al
The Management of Distal Ureter During Radical Nephroureterectomy Does Not Influence Bladder Recurrence.
J Endourol. 2022;36:77-82.
Abstract Related articles

SUN T, Hutchinson L, Tomaszewicz K, Caporelli ML, et al
Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Cancer Cytopathol. 2021;129:537-547.
Abstract Related articles

FARRAG MA, Ezz MK, Ibrahim NK, Ahmed EK, et al
Chemopreventive Potential of Myrtenal against Nitrosamine-Initiated, Radiation-Promoted Rat Bladder Carcinogenesis.
Nutr Cancer. 2022;74:288-298.
Abstract Related articles

HUI J, Wang C, Miao Y, Liu R, et al
The pancancer landscape of Wnt family expression reveals potential biomarkers in urinary system tumors.
Cancer Gene Ther. 2021;28:1035-1045.
Abstract Related articles

REIS IB, Tibo LHS, Socca EAR, de Souza BR, et al
OncoTherad(R) (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway.
Tissue Cell. 2022;76:101762.
Abstract Related articles

KIM JH, Choi J, Kim M, Kang SJ, et al
Immunotherapeutic effects of recombinant Bacillus Calmette-Guerin containing sic gene in ex vivo and in vivo bladder cancer models.
Investig Clin Urol. 2022;63:228-237.
Abstract Related articles

CHOI SY, Ha MS, Kim JH, Chi BH, et al
Low-dose versus standard-dose bacille Calmette-Guerin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials.
Investig Clin Urol. 2022;63:140-150.
Abstract Related articles

HADJI M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, et al
Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran.
Int J Epidemiol. 2022 Mar 4. pii: 6542534. doi: 10.1093.
Abstract Related articles

HENTSCHEL AE, Blankvoort CJ, Bosschieter J, Vis AN, et al
Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non-muscle-invasive Bladder Cancer.
Eur Urol Open Sci. 2022;37:7-13.
Abstract Related articles

LI X, Yang L, Huang W, Jia B, et al
Immunological significance of alternative splicing prognostic signatures for bladder cancer.
Heliyon. 2022;8:e08994.
Abstract Related articles

ZHU J, Lu Z, Chen W, Ke M, et al
Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer.
Transl Androl Urol. 2022;11:67-78.
Abstract Related articles

FAN X, Zou X, Liu C, Peng S, et al
Global analysis of miRNA-mRNA regulation pair in bladder cancer.
World J Surg Oncol. 2022;20:66.
Abstract Related articles

HAN Z, Gu J, Xin J, Liu H, et al
Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population.
Arch Toxicol. 2022 Mar 3. pii: 10.1007/s00204-022-03258.
Abstract Related articles

REN W, Zuo S, Yang L, Tu R, et al
Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer.
Sci Rep. 2022;12:3444.
Abstract Related articles

LONATI C, Mordasini L, Afferi L, De Cobelli O, et al
Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.
Urol Oncol. 2022 Feb 27. pii: S1078-1439(22)00003.
Abstract Related articles

ZHAN X, Chen L, Jiang M, Fu B, et al
Trends in the cause of death among patients with bladder cancer in the US SEER population, 1992-2018.
World J Urol. 2022 Mar 2. pii: 10.1007/s00345-022-03971.
Abstract Related articles

STOMP-AGENANT M, van Dijk T, Onur AR, Grimbergen MCM, et al
In vivo Raman spectroscopy for bladder cancer detection using a superficial Raman probe compared to a non-superficial Raman probe.
J Biophotonics. 2022 Mar 1:e202100354. doi: 10.1002/jbio.202100354.
Abstract Related articles

CAZENAVE L, Faucher M, Tourret M, Marques M, et al
Intravenous lidocaine and cancer outcomes after radical cystectomy.
Eur J Anaesthesiol. 2022;39:396-399.
Abstract Related articles

DUTTA EK, Lewis MG, Albert S
Risk factors associated with gall bladder cancer in high incidence areas in India: a systematic review protocol.
BMJ Open. 2022;12:e056849.
Abstract Related articles

GARCIA-PERDOMO HA, Sanchez AL, Spiess PE
Immune checkpoints inhibitors in the management of high-risk non-muscle-invasive bladder cancer. A scoping review.
Urol Oncol. 2022 Feb 26. pii: S1078-1439(22)00038.
Abstract Related articles

REBHAN K, Gust KM
[Erratum to: Locally advanced or oligometastatic bladder cancer-role of local treatment of the primary tumor and metastases].
Urologe A. 2022 Mar 1. pii: 10.1007/s00120-022-01789.
Abstract Related articles

RANGSITRATKUL C, Lawson C, Bernier-Godon F, Niavarani SR, et al
Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer.
Mol Ther Oncolytics. 2022;24:507-521.
Abstract Related articles

JAHANGIRIAN E, Jamal GA, Nouroozi M, Mohammadpour A, et al
A Novel Multiepitope Vaccine Against Bladder Cancer Based on CTL and HTL Epitopes for Induction of Strong Immune Using Immunoinformatics Approaches.
Int J Pept Res Ther. 2022;28:71.
Abstract Related articles

TABER A, Prip F, Lamy P, Agerbaek M, et al
Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer.
Eur Urol Oncol. 2022 Feb 25. pii: S2588-9311(22)00009.
Abstract Related articles

LIEDBERG F, Kjellstrom S, Lind AK, Sherif A, et al
Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma.
Scand J Urol. 2022 Feb 28:1-10. doi: 10.1080/21681805.2022.2041086.
Abstract Related articles

YANG F, Liu XQ, He JZ, Xian SP, et al
Occludin facilitates tumour angiogenesis in bladder cancer by regulating IL8/STAT3 through STAT4.
J Cell Mol Med. 2022 Feb 27. doi: 10.1111/jcmm.17257.
Abstract Related articles

HU R, Tao T, Yu L, Ding Q, et al
Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.
Front Cell Dev Biol. 2022;9:809588.
Abstract Related articles

YI R, Hong S, Zhang Y, Lin A, et al
MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.
Front Cell Dev Biol. 2022;10:757137.
Abstract Related articles

EL AHANIDI H, El Azzouzi M, Hafidi Alaoui C, Tetou M, et al
Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer.
Front Oncol. 2022;11:795242.
Abstract Related articles

ALVAREZ-MAESTRO M, Chierigo F, Mantica G, Quesada-Olarte JM, et al
The effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic review.
Arab J Urol. 2021;20:1-13.
Abstract Related articles

SU G, Yao L, Han X, Liao X, et al
A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression.
Clin Transl Med. 2022;12:e734.
Abstract Related articles

HELTE E, Save-Soderbergh M, Ugge H, Fall K, et al
Chlorination by-products in drinking water and risk of bladder cancer - A population-based cohort study.
Water Res. 2022;214:118202.
Abstract Related articles

LI G, Tao T, Deng D, Zhang S, et al
Collagen-targeted tumor-specific transepithelial penetration enhancer mediated intravesical chemoimmunotherapy for non-muscle-invasive bladder cancer.
Biomaterials. 2022;283:121422.
Abstract Related articles

BROUGHTON EI, Gooden KM, Mycock KL, Rajkovic I, et al
Multi-country clinical practice patterns, including use of biomarkers, among physicians' treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).
BMC Urol. 2022;22:27.
Abstract Related articles

LONATI C, Afferi L, Mari A, Minervini A, et al
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
World J Urol. 2022 Feb 26. pii: 10.1007/s00345-022-03958.
Abstract Related articles

HOU J, Liang S, Xie Z, Qu G, et al
An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer.
Sci Rep. 2022;12:3225.
Abstract Related articles

KOTHA NV, Kumar A, Nelson TJ, Qiao EM, et al
Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer.
Urol Oncol. 2022 Feb 22. pii: S1078-1439(22)00028.
Abstract Related articles

CIMADAMORE A, Lonati C, Di Trapani E, De Cobelli O, et al
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
Urol Oncol. 2022 Feb 22. pii: S1078-1439(22)00026.
Abstract Related articles

LIN CH, Chang HH, Lai CR, Wang HH, et al
Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers.
Int J Mol Sci. 2022;23.
Abstract Related articles

VENKATRAMANI V, Reis IM, Gonzalgo ML, Castle EP, et al
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open. 2022;5:e2148329.
Abstract Related articles

SINGHAL S, Ruprecht NA, Sens D, Tavakolian K, et al
Association between Arsenic Level, Gene Expression in Asian Population, and In Vitro Carcinogenic Bladder Tumor.
Oxid Med Cell Longev. 2022;2022:3459855.
Abstract Related articles

OLKHOV-MITSEL E, Hodgson A, Liu SK, Vesprini D, et al
Upregulation of IFN-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.
Sci Rep. 2022;12:716.
Abstract Related articles

MA C, Wang J, Zhao N, Pan Z, et al
Network Pharmacology-Based Study on the Active Component and Mechanism of the Anti-Non-Invasive and Invasive Bladder Urothelial Carcinoma Effects of Zhuling Jisheng Decoction.
Comput Math Methods Med. 2021;2021:7667707.
Abstract Related articles

JIN HJ, Shim JS, Kwon TG, Kim TH, et al
Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study.
Investig Clin Urol. 2022;63:53-62.
Abstract Related articles

LEE K, Jeong SH, Yoo SH, Ku JH, et al
Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Investig Clin Urol. 2022;63:14-20.
Abstract Related articles

CHAN TC, Chen YT, Tan KT, Wu CL, et al
Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
Clin Transl Med. 2021;11:e674.
Abstract Related articles

PEHALOVA L, Krejci D, Buchler T, Janosek J, et al
Incidence, mortality and survival of bladder neoplasms in the Czech Republic in the period 1977-2017: a time trend analysis.
Klin Onkol. 2021;34:467-476.
Abstract Related articles

KOBAYASHI S, Ito M, Takemura K, Suzuki H, et al
Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.
Int J Clin Oncol. 2022;27:574-584.
Abstract Related articles

MATSUMURA T, Inoue K, Toyooka K, Inoue M, et al
Clinical trajectory of a patient with filaminopathy who developed arrhythmogenic cardiomyopathy, myofibrillar myopathy, and multiorgan tumors.
Neuromuscul Disord. 2021;31:1282-1286.
Abstract Related articles

ZAKI SA, Hazeem AA, Rashid A
Bacillus Calmette-Guerin scar reactivation in multisystem inflammatory syndrome in children.
Trop Doct. 2022;52:222-223.
Abstract Related articles

TURAL D, Selcukbiricik F, Olmez OF, Sumbul AT, et al
Response to first-line chemotherapy regimen is associated with efficacy of immune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.
Int J Clin Oncol. 2022;27:585-591.
Abstract Related articles

DA SILVA GOMES PR, Candido P, Ghazarian V, Camargo JA, et al
Can increased expression of miR-Let-7c reduce the transition potential of high-grade urothelial carcinoma?
Mol Biol Rep. 2021;48:7947-7952.
Abstract Related articles

GUPTA P, Kumar N, Garg M
Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladder.
Expert Opin Ther Targets. 2021;25:787-797.
Abstract Related articles

LIEDBERG F
Adjuvant checkpoint inhibition after cystectomy - why, when, and for whom?
Scand J Urol. 2022;56:73-74.
Abstract Related articles

ALI D, Sawhney R, Billah M, Harrison R, et al
Single-Port Robotic Radical Cystectomy with Intracorporeal Bowel Diversion: Initial Experience and Review of Surgical Outcomes.
J Endourol. 2022;36:216-223.
Abstract Related articles

NIELSEN MO, Elversang J, Martin Poulsen A, Persson Theilgaard Z, et al
A case of visible diffuse peritoneal Bacillus Calmette-Guerin infection at the time of planned radical cystectomy.
Scand J Urol. 2021;55:505-506.
Abstract Related articles

NISHIYAMA N, Kobayashi T, Narita S, Hidaka Y, et al
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.
J Geriatr Oncol. 2022;13:88-93.
Abstract Related articles

SERAG ELDIEN MM, Abdou AG, Elghrabawy GRA, Alhanafy AM, et al
Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6.
J Immunoassay Immunochem. 2021;42:662-678.
Abstract Related articles

VENKATRAMANI V, Parekh DJ
Surgery for Bladder and Upper Tract Urothelial Cancer.
Hematol Oncol Clin North Am. 2021;35:543-566.
Abstract Related articles

NADAL R, Clara JA, Valderrama BP, Bellmunt J, et al
Current Therapy for Metastatic Urothelial Carcinoma.
Hematol Oncol Clin North Am. 2021;35:469-493.
Abstract Related articles

JENSEN JB
Patients with NMIBC with the highest risk of progression are correctly selected for cystectomy in Sweden.
Scand J Urol. 2021;55:54-55.
Abstract Related articles

HEMDAN T, Einarsson R, Malmstrom PU
The new classification of urinary cytology - is it an improvement?
Scand J Urol. 2021;55:98-99.
Abstract Related articles

ZHANG X, Wei X, Qi J, Shen J, et al
Simultaneous Detection of Bladder Cancer Exosomal MicroRNAs Based on Inorganic Nanoflare and DNAzyme Walker.
Anal Chem. 2022 Mar 11. doi: 10.1021/acs.analchem.1c05588.
Abstract Related articles

TEODOROVICH OV, Shatokhin MN, Kholimenko IM, Abdullaev MI, et al
[Application of laser technologies in the treatment of non-muscle-invasive bladder cancer].
Urologiia. 2022;:89-95.
Abstract Related articles

NIK AB KADIR MN, Hairon SM, Yaacob NM, Ab Manan A, et al
Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study.
Int J Environ Res Public Health. 2022;19.
Abstract Related articles

HOEH B, Flammia RS, Hohenhorst L, Sorce G, et al
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy.
Cancers (Basel). 2022;14.
Abstract Related articles

JACYNA J, Kordalewska M, Artymowicz M, Markuszewski M, et al
Pre- and Post-Resection Urine Metabolic Profiles of Bladder Cancer Patients: Results of Preliminary Studies on Time Series Metabolomics Analysis.
Cancers (Basel). 2022;14.
Abstract Related articles

GONZALEZ-DEL-ALBA A, Conde-Moreno AJ, Garcia Vicente AM, Gonzalez-Peramato P, et al
Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
Cancers (Basel). 2022;14.
Abstract Related articles

OZLER S, Pazarci P
Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways.
Anticancer Drugs. 2022;33:384-388.
Abstract Related articles

MULAWKAR PM, Sharma G, Tamhankar A, Shah U, et al
Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.
Front Surg. 2022;9:762027.
Abstract Related articles

SONG X, Xin S, Zhang Y, Mao J, et al
Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer.
Front Cell Dev Biol. 2022;10:810272.
Abstract Related articles

LUO Y, Tao T, Tao R, Huang G, et al
Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem.
Front Oncol. 2022;12:818147.
Abstract Related articles

ALANEE S, El-Zawahry A
Robotic-Assisted Partial Cystectomy for Muscle Invasive Bladder Cancer: Contemporary Experience.
Int J Med Robot. 2022 Mar 8:e2390. doi: 10.1002/rcs.2390.
Abstract Related articles

NERONI B, Zingaropoli MA, Radocchia G, Ciardi MR, et al
Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines.
Oncol Lett. 2022;23:132.
Abstract Related articles

NISHIHARA K, Ueda K, Kurose H, Ogasawara N, et al
Survival outcomes of non-definitive therapy for muscle-invasive bladder cancer.
Oncol Lett. 2022;23:126.
Abstract Related articles

IYA AM, Beyer K, Kotecha P, Kibaru J, et al
Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research?
BMJ Open. 2022;12:e049241.
Abstract Related articles

KANO K, Ishiyama R, Yagisawa T, Odani K, et al
[Primary Carcinoid Tumor of the Urinary Bladder : A Case Report].
Hinyokika Kiyo. 2022;68:53-57.
Abstract Related articles

BELLUT L, Kunath F
[Blue versus white light for transurethral resection of non-muscle invasive bladder cancer (Review)].
Urologe A. 2022 Mar 8. pii: 10.1007/s00120-022-01790.
Abstract Related articles

POURKERMAN M, Rashidkhani B, Moslehi N
Correlating Dietary Pattern and Bladder Cancer Risk Using Principal Component and Reduced Rank Regression Analyses.
Nutr Cancer. 2022 Mar 7:1-9. doi: 10.1080/01635581.2022.2047739.
Abstract Related articles

NAKASATO T, Inoue T, Kato R, Nakagami Y, et al
A case of complete response following the administration of pembrolizumab and metastasectomy for lung and bone metastases of bladder cancer.
IJU Case Rep. 2021;5:92-94.
Abstract Related articles

DU H, Tao T, Xu S, Xu C, et al
4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway.
Front Mol Biosci. 2022;8:789658.
Abstract Related articles

ZHAO J, Huang S, Tan D, Yang K, et al
PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration.
J Oncol. 2022;2022:8581805.
Abstract Related articles

PAPAETIS GS
Pioglitazone, Bladder Cancer and the Presumption of Innocence.
Curr Drug Saf. 2022 Mar 4. pii: CDS-EPUB-121335.
Abstract Related articles

TONYALI S
Combining Clinical Parameters and Immunohistochemical Markers Might Strengthen Prediction of Recurrence of Non-Muscle Invasive Bladder Cancer.
J Invest Surg. 2022 Mar 6:1-2. doi: 10.1080/08941939.2022.2047244.
Abstract Related articles

BEIJE N, de Kruijff IE, de Jong JJ, Klaver SO, et al
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
ESMO Open. 2022;7:100416.
Abstract Related articles

LIU KL, Yin YW, Lu BS, Niu YL, et al
E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter.
Cancer Cell Int. 2022;22:109.
Abstract Related articles

XU D, Cao Q, Wang L, Wang J, et al
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
Mol Cancer Ther. 2022 Feb 28. pii: 681956. doi: 10.1158/1535-7163.MCT-21-0613.
Abstract Related articles

WANG L, Hu C, Zhao Y, Hu X, et al
Novel smac mimetic ASTX660 (Tolinapant) and TNF-alpha synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition.
Biochem Biophys Res Commun. 2022;602:8-14.
Abstract Related articles

MOFID B, Razzaghdoust A, Ghajari M, Basiri A, et al
The Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis.
Urol J. 2022 Mar 5. pii: 6841. doi: 10.22037/uj.v19i.6841.
Abstract Related articles

PARAMANANTHAM Y, Chung I, Bm Said NA
The role of tumour microenvironment-driven miRNAs in the chemoresistance of muscle-invasive bladder cancer-a review.
Urol Oncol. 2022 Mar 1. pii: S1078-1439(22)00031.
Abstract Related articles

HAO J, Zhang W, Huang Z
Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway.
Bioengineered. 2022;13:6794-6806.
Abstract Related articles

KAO CC, Chang YL, Liu HY, Wu ST, et al
DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.
Int J Mol Sci. 2022;23.
Abstract Related articles

PATELLI G, Zeppellini A, Spina F, Righetti E, et al
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives.
Cancer Treat Rev. 2022;104:102351.
Abstract Related articles

MARTINI A, Raggi D, Fallara G, Nocera L, et al
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis.
Cancer Treat Rev. 2022;104:102360.
Abstract Related articles

IACOVINO ML, Miceli CC, De Felice M, Barone B, et al
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.
Int J Mol Sci. 2022;23.
Abstract Related articles

OKAMATSU Y, Tsubouchi K, Iwasaki T, Nakamura T, et al
Recurrent Massive Hemothorax of Unknown Etiology in an 85-Year-Old Man.
Chest. 2022;161:e103-e110.
Abstract Related articles

ALTAHA MA, Tarulli M, Bajwa J, Mafeld S, et al
Endovascular coil embolization of inferior mesenteric artery to ileal-conduit fistula: a case report.
BMC Urol. 2022;22:11.
Abstract Related articles

ALLEN G
A Systematic Review and Meta-Analysis of Enhanced Recovery After Surgery Protocols for Radical Cystectomy.
AORN J. 2022;115:186-189.
Abstract Related articles

ZHONG W, Yang M, Cheng S, Hou W, et al
Identification of an IDO1-based immune classifier for survival prediction of upper tract urothelial carcinoma.
Cancer Sci. 2022;113:852-863.
Abstract Related articles

YU J, Zheng J
Comparative efficacy and safety of transurethral laser surgery with holmium laser, KTP laser, 2-micron laser or thulium laser for the treatment of non-muscle invasive bladder carcinoma: a protocol of network meta-analysis.
BMJ Open. 2021;11:e055840.
Abstract Related articles

BAECKER D, Sagasser J, Karaman S, Hormann AA, et al
Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.
Arch Pharm (Weinheim). 2022;355:e2100408.
Abstract Related articles

MEZA L, Malhotra J, Favorito C, Pal SK, et al
Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma.
Future Oncol. 2022;18:21-33.
Abstract Related articles

NORGAARD M, Andersen IT, Heide-Jorgensen U, Erichsen R, et al
Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort Study.
Cancer Epidemiol Biomarkers Prev. 2022;31:45-50.
Abstract Related articles

QUAQUARINI E, Saltalamacchia G, Tresoldi MM, Schmid M, et al
Primary melanoma of the bladder: a case report and review of the literature.
Eur Rev Med Pharmacol Sci. 2021;25:5122-5128.
Abstract Related articles

PAL SK, Frankel PH, Mortazavi A, Milowsky M, et al
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol. 2021;7:1536-1543.
Abstract Related articles

COLLINS K, Alkashash AM, Hwang M, Kaimakliotis HZ, et al
Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Int J Surg Pathol. 2022;30:207-213.
Abstract Related articles

GUPTA M, Sancheti S, Sali AP, Somal PK, et al
Ectopic Prostate Tissue Presenting as Urinary Bladder Tumor: The Imitation Game!
Int J Surg Pathol. 2022;30:160-162.
Abstract Related articles

ZHENG G, Sundquist K, Sundquist J, Forsti A, et al
Bladder and upper urinary tract cancers as first and second primary cancers.
Cancer Rep (Hoboken). 2021;4:e1406.
Abstract Related articles

SHASH LS, Ibrahim RA, Elgohary SA
E-cadherin and N-cadherin Immunohistochemical Expression in Proliferating Urothelial Lesions: Potential Novel Cancer Predictive EMT Profiles.
Appl Immunohistochem Mol Morphol. 2021;29:657-666.
Abstract Related articles

FUJIWARA M, Yuasa T, Urasaki T, Komai Y, et al
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan.
Cancer Rep (Hoboken). 2021;4:e1398.
Abstract Related articles

KYRIAZOGLOU A, Beuselinck B
Equivocal evaluation of progressive disease in patients treated with immune checkpoint inhibitors: a challenge for clinical trials and biomarker research.
Acta Clin Belg. 2022;77:406-409.
Abstract Related articles

DELLI PIZZI A, Mastrodicasa D, Taraschi A, Civitareale N, et al
Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging.
Abdom Radiol (NY). 2022 Mar 18. pii: 10.1007/s00261-022-03490.
Abstract Related articles

COOK GS, Howard JM
Patterns in the Management of Low-Grade Non-Muscle-Invasive Bladder Cancer-the Human and Economic Costs of Excessive Surveillance.
JAMA Netw Open. 2022;5:e223055.
Abstract Related articles

BREE KK, Shan Y, Hensley PJ, Lobo N, et al
Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013.
JAMA Netw Open. 2022;5:e223050.
Abstract Related articles

SHANGGUAN W, Hu J, Xie Y, Chen Z, et al
Conditional survival of trimodal therapy for nonmetastatic muscle-invasive bladder cancer: A SEER database analysis.
Cancer Med. 2022 Mar 18. doi: 10.1002/cam4.4625.
Abstract Related articles

ROUPRET M, Gontero P, McCracken SRC, Dudderidge T, et al
Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker.
Eur Urol Focus. 2022 Mar 14. pii: S2405-4569(22)00051.
Abstract Related articles

ZHONG Z, Huang M, Lv M, He Y, et al
Corrigendum to "Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway" [Cancer Letter 403(2017) 305-317].
Cancer Lett. 2022 Mar 14:215631. doi: 10.1016/j.canlet.2022.215631.
Abstract Related articles

ZHANG M, Du G, Li Z, Li D, et al
An Oxidative Stress-Related Genes Signature for Predicting Survival in Bladder Cancer: Based on TCGA Database and Bioinformatics.
Int J Gen Med. 2022;15:2645-2667.
Abstract Related articles

LEMINSKI A, Kaczmarek K, Golab A, Kotfis K, et al
Increased One-Year Mortality Among Elderly Patients After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective, Observational Comparative Study.
Clin Interv Aging. 2022;17:255-263.
Abstract Related articles

GHAFOURI-FARD S, Najafi S, Hussen BM, Basiri A, et al
The Role of Circular RNAs in the Carcinogenesis of Bladder Cancer.
Front Oncol. 2022;12:801842.
Abstract Related articles

YUAN Z, Guo G, Sun G, Li Q, et al
Magnesium isoglycyrrhizinate suppresses bladder cancer progression by modulating the miR-26b/Nox4 axis.
Bioengineered. 2022;13:7986-7999.
Abstract Related articles

MIAO L, Liu HY, Zhou C, He X, et al
Correction to: LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
J Exp Clin Cancer Res. 2022;41:103.
Abstract Related articles

LI D, Zhen F, Le J, Chen G, et al
Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.
Am J Clin Exp Urol. 2022;10:13-24.
Abstract Related articles

DALLA E, Picco R, Novara G, Moro FD, et al
Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer.
Mol Biomed. 2022;3:9.
Abstract Related articles

PAWAR D, Arif D, Raghunath A, Rehman S, et al
Urothelial carcinoma with mandibular metastasis and synchronous prostate cancer.
BMJ Case Rep. 2022;15.
Abstract Related articles

TELEKA S, Jochems SHJ, Jirstrom K, Stocks T, et al
The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness.
Cancer Med. 2022 Mar 13. doi: 10.1002/cam4.4654.
Abstract Related articles

WIECZOREK E, Farooqi AA, Reszka E
Androgen receptor modulation and bladder cancer prevention - a short review.
Med Pr. 2022 Mar 14. pii: 146548. doi: 10.13075/mp.5893.01229.
Abstract Related articles

MARTINI A, Raggi D, Marandino L, Montorsi F, et al
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy.
Eur Urol Oncol. 2022 Mar 10. pii: S2588-9311(22)00030.
Abstract Related articles

ELUMALAI T, Croxford W, Buijtenhuijs B, Conroy R, et al
Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy.
Clin Oncol (R Coll Radiol). 2022 Mar 10. pii: S0936-6555(22)00106.
Abstract Related articles

WANG W, Liu X, Zhang C, Sheng F, et al
Identification of two-dimensional copper signatures in human blood for bladder cancer with machine learning.
Chem Sci. 2022;13:1648-1656.
Abstract Related articles

SOIPI S, Vucic M, Spajic B, Kruslin B, et al
REVIEW OF THE BLADDER CANCER MOLECULAR CLASSIFICATION PROPOSED: A NEW ERA - NEW TAXONOMY.
Acta Clin Croat. 2022;60:519-524.
Abstract Related articles

CHEN W, Jiang T, Mao H, Gao R, et al
Erratum: Nodal Promotes the Migration and Invasion of Bladder Cancer Cells via Regulation of Snail: Erratum.
J Cancer. 2022;13:1385.
Abstract Related articles

TONG S, Yin H, Fu J, Li Y, et al
Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.
J Cancer. 2022;13:1103-1118.
Abstract Related articles

ZHAN X, Chen T, Jiang M, Deng W, et al
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy.
J Oncol. 2022;2022:2665711.
Abstract Related articles

DONG Y, Hao L, Shi ZD, Fang K, et al
Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression.
J Oncol. 2022;2022:7261486.
Abstract Related articles

YE L, Chen Y, Xu H, Wang Z, et al
Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.
Front Cell Dev Biol. 2022;10:814388.
Abstract Related articles

HU J, Lai C, Shen Z, Yu H, et al
A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
Front Oncol. 2022;12:833763.
Abstract Related articles

ZHONG Z, Wang Z, Li Y, Zhong Y, et al
Sintilimab treatment for ureteral carcinoma following bladder cancer leads to leukopenia: a case report.
Transl Androl Urol. 2022;11:277-284.
Abstract Related articles

LIU S, Yao Y, Guan F, Sun L, et al
Neoadjuvant Chemotherapy for Different Stages of Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Dis Markers. 2022;2022:8493519.
Abstract Related articles

ZHOU R, Liang J, Tian H, Chen Q, et al
An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer.
Dis Markers. 2022;2022:2143892.
Abstract Related articles

YAN R, Dai W, Wu R, Huang H, et al
Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer.
Cancer Lett. 2022;534:215615.
Abstract Related articles

KULCHAVENYA EV, Kholtobin DP, Telina EV, Neymark AI, et al
[Practice of urological departments during the COVID-19 pandemic].
Urologiia. 2022;:35-40.
Abstract Related articles

CAMPOBASSO D, Puliatti S, Micali S, Maestroni UV, et al
Conservative treatment of upper urinary tract urothelial carcinoma (UTUC) in patients with imperative indications: not only an option.
Minerva Urol Nephrol. 2022;74:129-130.
Abstract Related articles

DEL GIUDICE F, Chung BI, Moschini M, Mari A, et al
Comment on: Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal.
Minerva Urol Nephrol. 2022;74:119-121.
Abstract Related articles

KIM MS, Koom WS, Cho JH, Kim SY, et al
Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
Radiat Oncol. 2022;17:51.
Abstract Related articles

XIONG S, Huang W, Liu X, Chen Q, et al
Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma.
Cell Transplant. 2022;31:9636897221077921.
Abstract Related articles

WANG Z, Zhao Y, Shen X, Zhao Y, et al
Single-Cell Genomics-Based Molecular Algorithm for Early Cancer Detection.
Anal Chem. 2022;94:2607-2614.
Abstract Related articles

PHRUTTINARAKORN B, Plumworasawat S, Kayankarnnavee J, Lualon J, et al
Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
Acta Cytol. 2022;66:134-141.
Abstract Related articles

LI P, Qiao G, Lu J, Ji W, et al
PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma.
Math Biosci Eng. 2022;19:169-190.
Abstract Related articles

ROPERTO S
Role of BAG3 in bovine Deltapapillomavirus-mediated autophagy.
J Cell Biochem. 2022;123:59-64.
Abstract Related articles

STRUCK JP, Schnoor M, Schulze A, Hupe MC, et al
Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals.
World J Urol. 2022;40:409-418.
Abstract Related articles

OSUMO B, Radzevich J, Nashed N, Ustwani O, et al
Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder.
Am Surg. 2021 Nov 8:31348211054526. doi: 10.1177/00031348211054526.
Abstract Related articles

LI M, Xu X, Bechmann N, Pamporaki C, et al
Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review.
World J Urol. 2022;40:385-390.
Abstract Related articles

TARANTINO P, Modi S, Tolaney SM, Cortes J, et al
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review.
JAMA Oncol. 2021;7:1873-1881.
Abstract Related articles

SUN K, Wang D, Wu G, Ma J, et al
Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors.
Cancer Med. 2021;10:7534-7541.
Abstract Related articles

WARD M, Albertson D, Furtado LV, Deftereos G, et al
PD-L1 Tumor Cell Expression in Upper Tract Urothelial Carcinomas is Associated With Higher Pathologic Stage.
Appl Immunohistochem Mol Morphol. 2022;30:56-61.
Abstract Related articles

AFFERI L, Abufaraj M, Soria F, D'Andrea D, et al
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis.
Minerva Urol Nephrol. 2022;74:49-56.
Abstract Related articles

CEYLAN OM, Durukan AH, Uysal Y, Ozge G, et al
Ocular Complications of Intravesicular BCG Treatment for Bladder Carcinoma.
Ocul Immunol Inflamm. 2022;30:111-114.
Abstract Related articles

FENG F, Yang J, Chen A, Cui M, et al
Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis.
J Tissue Eng Regen Med. 2022 Mar 26. doi: 10.1002/term.3291.
Abstract Related articles

XU Y, Zeng H, Jin K, Liu Z, et al
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer.
J Immunother Cancer. 2022;10.
Abstract Related articles

ROBERTS ME, Contreras-Sanz A, Black PC
Establishing a Foundation for Studying the Immune Contexture Across the Spectrum of Bladder Cancer.
Eur Urol Oncol. 2022 Mar 22. pii: S2588-9311(22)00032.
Abstract Related articles

WILSON F, Joseph N, Choudhury A
Biomarkers in muscle invasive bladder cancer.
Adv Clin Chem. 2022;107:265-297.
Abstract Related articles

WIGNER P, Bijak M, Saluk-Bijak J
Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment.
Nutrients. 2022;14.
Abstract Related articles

CLAPS F, Mir C, Rubio-Briones J
Optimization of the different therapeutic strategies in muscle invasive bladder cancer using biomarkers.
Arch Esp Urol. 2022;75:144-155.
Abstract Related articles

LOZANO F, Raventos CX, Carrion A, Trilla E, et al
[Optimization biomarkers in the surveillance of non muscle invasive bladder cancer.]
Arch Esp Urol. 2022;75:133-143.
Abstract Related articles

DOMINGUEZ ESCRIG JL, Rubio Briones J
Urinary biomarkers for the optimization of bladder cancer screening.
Arch Esp Urol. 2022;75:126-132.
Abstract Related articles

TAN Z, Fu S, Huang Y, Duan X, et al
HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.
Front Genet. 2022;13:804858.
Abstract Related articles

AHN JH, Kang CK, Kim EM, Kim AR, et al
Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers.
Life (Basel). 2022;12.
Abstract Related articles

ORTIZ-BONILLA CJ, Uccello TP, Gerber SA, Lord EM, et al
Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity.
Int J Mol Sci. 2022;23.
Abstract Related articles

FERRO M, Tataru OS, Musi G, Lucarelli G, et al
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
Diagnostics (Basel). 2022;12.
Abstract Related articles

TAKEUCHI T, Hattori-Kato M, Okuno Y, Zaitsu M, et al
Genome-Wide Association Study Adjusted for Occupational and Environmental Factors for Bladder Cancer Susceptibility.
Genes (Basel). 2022;13.
Abstract Related articles

WESSOLLY M, Mairinger FD, Herold T, Hadaschik B, et al
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer.
Genes (Basel). 2022;13.
Abstract Related articles

LAMY L, Thomas J, Leroux A, Bisson JF, et al
Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer.
Biomedicines. 2022;10.
Abstract Related articles

MORI K, Matsumoto K, Amano N, Koguchi D, et al
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

HUAN J, Grivas P, Birch J, Hansel DE, et al
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy.
Cancers (Basel). 2022;14.
Abstract Related articles

BOROWCZAK J, Szczerbowski K, Maniewski M, Zdrenka M, et al
The Prognostic Role of CDK9 in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

SZKLENER K, Chmiel P, Michalski A, Mandziuk S, et al
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors.
Cancers (Basel). 2022;14.
Abstract Related articles

RASTEIRO AM, Sa E Lemos E, Oliveira PA, Gil da Costa RM, et al
Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.
Vet Sci. 2022;9.
Abstract Related articles

SINHA A, West A, Hayes J, Teoh J, et al
Methods of Sentinel Lymph Node Detection and Management in Urinary Bladder Cancer-A Narrative Review.
Curr Oncol. 2022;29:1335-1348.
Abstract Related articles

WANG J, Zhao X, Jiang XL, Lu D, et al
Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta-analysis.
Diagn Cytopathol. 2022 Mar 24. doi: 10.1002/dc.24954.
Abstract Related articles

NOTGHI AAA, Hosseini F, Tsogas N
Severe diffuse proliferative bronchiolitis complicating culture-proven disseminated BCG infection after intravesical instillation for bladder cancer.
BMJ Case Rep. 2022;15.
Abstract Related articles

ROBLES VEGA J, Yankovic Barcelo F
[Inverted urothelial papilloma of the bladder in an adolescent].
Andes Pediatr. 2021;92:777-780.
Abstract Related articles

WU S, Xu H, Zhang R, Wang X, et al
Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA.
Mol Ther Oncolytics. 2022;24:742-754.
Abstract Related articles

EL AHANIDI H, El Azzouzi M, Arrouchi H, Alaoui CH, et al
AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients biopsies and matched urine.
Pan Afr Med J. 2022;41:59.
Abstract Related articles

[Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China].
Zhonghua Zhong Liu Za Zhi. 2022;44:209-218.
Abstract Related articles

SUN D, Hadjiiski L, Alva A, Zakharia Y, et al
Computerized Decision Support for Bladder Cancer Treatment Response Assessment in CT Urography: Effect on Diagnostic Accuracy in Multi-Institution Multi-Specialty Study.
Tomography. 2022;8:644-656.
Abstract Related articles

MASUDA T, Tanaka N, Takamatsu K, Hakozaki K, et al
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
J Immunother Cancer. 2022;10.
Abstract Related articles

MOTTERLE G, Morlacco A, Giovannini G, Vecchiato E, et al
Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer.
Clin Genitourin Cancer. 2022 Feb 24. pii: S1558-7673(22)00044.
Abstract Related articles

GAKIS G, Schmid MA, Hassan F, Stenzl A, et al
The Predictive and Prognostic Value of Precystectomy Serum Gamma-Glutamyltransferase Levels in Patients With Invasive Bladder Cancer.
Clin Genitourin Cancer. 2022 Feb 24. pii: S1558-7673(22)00041.
Abstract Related articles

CHEN YH, Tseng JS
Concurrent urachal abscess and florid cystitis glandularis masquerading as malignancy: a case report and literature review.
BMC Surg. 2022;22:105.
Abstract Related articles

HUANG KC, Chanda D, McGrath S, Dixit V, et al
Pharmacological Activation of STING in Bladder Induces Potent Anti-tumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.
Mol Cancer Ther. 2022 Mar 21. pii: 682323. doi: 10.1158/1535-7163.MCT-21-0780.
Abstract Related articles

HONG JH, Tong ZJ, Wei TE, Lu YC, et al
Cigarette smoke containing acrolein contributes to cisplatin resistance in human bladder cancers through the regulation of HER2 pathway or FGFR3 pathway.
Mol Cancer Ther. 2022 Mar 21. pii: 682320. doi: 10.1158/1535-7163.MCT-21-0725.
Abstract Related articles

CHEN Y, Ji S, Ying J, Sun Y, et al
KRT6A expedites bladder cancer progression, regulated by miR-31-5p.
Cell Cycle. 2022 Mar 20:1-12. doi: 10.1080/15384101.2022.2054095.
Abstract Related articles

DENG H, Tang F, Zhou M, Shan D, et al
Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy.
Front Oncol. 2022;12:820242.
Abstract Related articles

SU F, Liu M, Zhang W, Tang M, et al
Bacillus Calmette-Guerin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.
Front Oncol. 2022;12:842182.
Abstract Related articles

DU Y, Sui Y, Cao J, Jiang X, et al
Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling.
Front Cell Dev Biol. 2022;10:833578.
Abstract Related articles

ZHENG H, Luo W, Li Y, Peng G, et al
Identification and Development of Inflammatory Response-Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer.
Front Cell Dev Biol. 2022;10:837849.
Abstract Related articles

BEARDO P, Pinto R, Ayerra H, Aguera J, et al
Optimizing treatment for non muscle-invasive bladder cancer with an app.
Actas Urol Esp (Engl Ed). 2022 Mar 17. pii: S2173-5786(22)00026.
Abstract Related articles

MAIORANO S, Gulden-Sala W, Gerber B, Ghilardi G, et al
Anti-PD-L1 monoclonal antibody for the management of chronic disseminated intravascular coagulation secondary to a urothelial carcinoma: a case report.
J Med Case Rep. 2022;16:113.
Abstract Related articles

ZHANG X, Wang Y, Zhang J, Xu X, et al
Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.
Abdom Radiol (NY). 2022 Mar 20. pii: 10.1007/s00261-022-03455.
Abstract Related articles

HU C, Shang X, Zheng T, Hu X, et al
Ipatasertib (GDC-0068) and erdafitinib co-treatment for inducing mitochondrial apoptosis through Bim upregulation in bladder cancer cells.
Biochem Biophys Res Commun. 2022;604:165-171.
Abstract Related articles

RAMMANT E, Leung TM, Gore JL, Berry D, et al
Associations of self-efficacy, social support and coping strategies with health-related quality of life after radical cystectomy for bladder cancer: A cross-sectional study.
Eur J Cancer Care (Engl). 2022 Mar 18. doi: 10.1111/ecc.13571.
Abstract Related articles

DANG E, Vallee A, Lepage-Seydoux C, Sejean K, et al
Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study.
Curr Oncol. 2022;29:945-955.
Abstract Related articles

CALIFANO G, Ouzaid I, Laine-Caroff P, Peyrottes A, et al
Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art.
Curr Oncol. 2022;29:687-697.
Abstract Related articles

LI X, Wan Z, Liu X, Ou K, et al
A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.
Med Oncol. 2022;39:43.
Abstract Related articles

NIEGISCH G, von Amsberg G, Rehlinghaus M, Grunewald CM, et al
[Metastatic urothelial carcinoma-guideline-based therapy and new options].
Urologe A. 2022;61:265-272.
Abstract Related articles

CHEN S, Cui J, Sun H, Wang W, et al
"Two-zone and Three-segment" Laparoscopic Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Male Patients With Bladder Urothelial Carcinoma: A Retrospective Analysis.
Urol J. 2022;19:34-40.
Abstract Related articles

LU J, Zhao M, Wu C, Chu C, et al
Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues.
Diagn Pathol. 2022;17:10.
Abstract Related articles

SAMAL V, Jirasek T, Paldus V, Richter I, et al
Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literature.
Diagn Pathol. 2022;17:8.
Abstract Related articles

ZHANG J, Bai X, Yuan J, Zhang X, et al
Bladder paraganglioma: CT and MR imaging characteristics in 16 patients.
Radiol Oncol. 2021;56:46-53.
Abstract Related articles

LUO S, Wang W, Feng J, Li R, et al
TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6.
J Immunol Res. 2021;2021:5975893.
Abstract Related articles

HAUDEBERT C, Hascoet J, Freton L, Khene ZE, et al
Cystectomy and ileal conduit for neurogenic bladder: Comparison of the open, laparoscopic and robotic approaches.
Neurourol Urodyn. 2022;41:601-608.
Abstract Related articles

KERIOUI M, Desmee S, Mercier F, Lin A, et al
Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy.
ESMO Open. 2022;7:100346.
Abstract Related articles

ISHIYAMA Y, Kondo T, Ishihara H, Yoshida K, et al
Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy.
Curr Oncol. 2021;28:4986-4997.
Abstract Related articles

SINGH A, Gupta N, Khandakar H, Kaushal S, et al
Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder.
Mol Cell Biochem. 2022;477:493-505.
Abstract Related articles

DONG Y, Zhu GY, Hao L, Liang Q, et al
High S100A7 expression is associated with early muscle invasion and poor survival in bladder carcinoma.
Ann Diagn Pathol. 2022;56:151847.
Abstract Related articles

WEI H, Wang M, Wasilijiang W, Zhou X, et al
Propensity score-matched analysis for ileal conduit and orthotopic neobladder intracorporeally accomplished following laparoscopic radical cystectomy.
Asian J Surg. 2022;45:987-992.
Abstract Related articles

LENIS AT, Litwin MS
Does Artificial Intelligence Meaningfully Enhance Cystoscopy?
J Natl Cancer Inst. 2022;114:174-175.
Abstract Related articles

SARIER M, Usta SS, Turgut H, Ozturk SA, et al
Prognostic value of HPV DNA in Urothelial Carcinoma of the Bladder: A Preliminary Report of 2-Year Follow-up Results.
Urol J. 2021;19:45-49.
Abstract Related articles

KRIMPHOVE MJ, Szymaniak J, Marchese M, Tully KH, et al
Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.
Eur Urol Focus. 2021;7:124-131.
Abstract Related articles

LAMBERT E, D'Hondt F, Mazzone E, Vollemaere J, et al
Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.
Eur Urol Focus. 2021;7:139-141.
Abstract Related articles

MINNELLA EM, Awasthi R, Bousquet-Dion G, Ferreira V, et al
Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial.
Eur Urol Focus. 2021;7:132-138.
Abstract Related articles

WU SC, Kwon D, Jue JS, Chen FV, et al
Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer.
Eur Urol Focus. 2021;7:142-147.
Abstract Related articles

JUBBER I, Pang KH, Groves R, Reed O, et al
Impact of Anaesthetist Volume on Radical Cystectomy Outcomes.
Eur Urol Focus. 2021;7:117-123.
Abstract Related articles

XU T, Junge JA, Delfarah A, Lu YT, et al
Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time.
Sci Rep. 2022;12:5518.
Abstract Related articles

MOISOIU T, Dragomir MP, Iancu SD, Schallenberg S, et al
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
Mol Med. 2022;28:39.
Abstract Related articles

WU X, Cao W, Lu C, Zuo L, et al
circ3323 Motivates Host Gene to Promote the Aggressiveness of Bladder Cancer.
Biochem Genet. 2022 Apr 1. pii: 10.1007/s10528-022-10210.
Abstract Related articles

YE L, Chen Y, Xu H, Xie H, et al
Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
Eur Radiol. 2022 Apr 1. pii: 10.1007/s00330-022-08696.
Abstract Related articles

TEOH JY, Kamat AM, Black PC, Grivas P, et al
Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective.
Nat Rev Urol. 2022 Mar 31. pii: 10.1038/s41585-022-00578.
Abstract Related articles

ZHANG Y, Huo F, Cao Q, Jia R, et al
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer.
J Immunother Cancer. 2022;10.
Abstract Related articles

YUAN S, Zhai Y, Tao T, Zhang X, et al
Conflicting Roles of ZFP36L1 in Regulating the Progression of Muscle Invasive Bladder Cancer.
Front Mol Biosci. 2022;9:687786.
Abstract Related articles

ASTROM LM, Behrens CP, Calmels L, Sjostrom D, et al
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: initial experience and dosimetric benefits.
Radiother Oncol. 2022 Mar 28. pii: S0167-8140(22)00152.
Abstract Related articles

ZHANG X, Xiong H, Zhao Y, Lin S, et al
Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p.
Bioengineered. 2022;13:8823-8835.
Abstract Related articles

GRUNEWALD CM, Feldmeier V, Supprian T, Albers P, et al
Cognitive function in patients undergoing cystectomy for bladder cancer - results from a prospective observational study.
Ther Adv Urol. 2022;14:17562872221087660.
Abstract Related articles

GUALLAR-GARRIDO S, Campo-Perez V, Perez-Trujillo M, Cabrera C, et al
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-gamma/IL-17 release in bladder cancer treatment.
Oncoimmunology. 2022;11:2051845.
Abstract Related articles

KITAMURA K, Isotani S, Muto S, Horie S, et al
Efficacy of pembrolizumab in a rare type of bladder cancer arising 25 years after augmentation cystoplasty.
BMJ Case Rep. 2022;15.
Abstract Related articles

THANGAVELU M, Ismail A, Zakaria A, Elmansy H, et al
Aristolochic acid: What urologists should know.
Arch Ital Urol Androl. 2022;94:123-125.
Abstract Related articles

MEHRNOUSH V, Keramati S, Ismail A, Shabana W, et al
Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario.
Arch Ital Urol Androl. 2022;94:41-45.
Abstract Related articles

DURSUN F, Elshabrawy A, Wang H, Wu S, et al
Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy.
Urol Oncol. 2022 Mar 26. pii: S1078-1439(22)00039.
Abstract Related articles

LIU J, Zhu X, Yu L, Mao M, et al
Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells.
J Enzyme Inhib Med Chem. 2022;37:866-875.
Abstract Related articles

ZHOU W, He L, Dai Y, Zhang Y, et al
MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer.
Exp Ther Med. 2022;23:312.
Abstract Related articles

TRAN TML, Abdelrahman H, Tran C, Abraham R, et al
A Curious Case of Hypercalcemia.
R I Med J (2013). 2022;105:39-41.
Abstract Related articles

NOVRUZOV E, Dendl K, Ndlovu H, Choyke PL, et al
Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer.
Mol Imaging Biol. 2022 Mar 29. pii: 10.1007/s11307-022-01715.
Abstract Related articles

VALDERRAMA BP, Gonzalez-Del-Alba A, Morales-Barrera R, Pelaez Fernandez I, et al
SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021).
Clin Transl Oncol. 2022 Mar 26. pii: 10.1007/s12094-022-02815.
Abstract Related articles

YU K, Du Z, Xuan H, Chen Q, et al
Comprehensive analysis based in silico study of organophosphate flame retardants - environmental explanation of bladder cancer progression.
Environ Toxicol Pharmacol. 2022;92:103851.
Abstract Related articles

TAGUCHI S, Watanabe M, Tambo M, Machida H, et al
Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.
Clin Genitourin Cancer. 2022 Mar 4. pii: S1558-7673(22)00047.
Abstract Related articles

FREITAS NR, Vieira PM, Cordeiro A, Tinoco C, et al
Detection of bladder cancer with feature fusion, transfer learning and CapsNets.
Artif Intell Med. 2022;126:102275.
Abstract Related articles

MALLY D, Pfister D, Heidenreich A, Albers P, et al
[Does robotic radical cystectomy affect oncological outcomes in bladder cancer patients?]
Aktuelle Urol. 2022;53:153-158.
Abstract Related articles

FAN W, Xiong Q, Ge Y, Liu T, et al
Identifying the grade of bladder cancer cells using microfluidic chips based on impedance.
Analyst. 2022 Mar 28. doi: 10.1039/d2an00026.
Abstract Related articles

ZHANG L, Shao G, Shao J, Zhao J, et al
PRMT5-activated c-Myc promote bladder cancer proliferation and invasion through up-regulating NF-kappaB pathway.
Tissue Cell. 2022;76:101788.
Abstract Related articles

DANCIK GM, Theodorescu D
Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314.
Eur Urol Focus. 2022 Mar 23. pii: S2405-4569(22)00067.
Abstract Related articles

BUAC NP, Khusid JA, Sturgis MR, Gupta M, et al
Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer.
Urol Oncol. 2022 Mar 23. pii: S1078-1439(22)00060.
Abstract Related articles

OKA T, Matsuzaki K, Izumi H, Nonomura D, et al
Osteosarcoma of the bladder: a case report.
J Med Case Rep. 2022;16:118.
Abstract Related articles

LI K, Yang X, Zhuang J, Cai L, et al
External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center.
BMC Urol. 2022;22:41.
Abstract Related articles

KAWAI T, Taguchi S, Nakagawa T, Kamei J, et al
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis.
J Immunother Cancer. 2022;10.
Abstract Related articles

CHEN C, Shang A, Sun Z, Gao Y, et al
Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
J Immunol Res. 2022;2022:9038808.
Abstract Related articles

KADKHODA S, Ghafouri-Fard S
Function of miRNA-145-5p in the pathogenesis of human disorders.
Pathol Res Pract. 2022;231:153780.
Abstract Related articles

RIZZO A, Mollica V, Santoni M, Ricci AD, et al
Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis.
Future Oncol. 2022;18:739-748.
Abstract Related articles

SAMADDAR S, Mazur J, Sargent J, Thompson DH, et al
Immunostimulatory Response of RWFV Peptide-Targeted Lipid Nanoparticles on Bladder Tumor Associated Cells.
ACS Appl Bio Mater. 2021;4:3178-3188.
Abstract Related articles

HENG HG, Ramos-Vara JA, Fulkerson CM, Fourez LM, et al
Ultrasonographic detection of apex nodules in the urinary bladder of Scottish Terriers.
Vet Radiol Ultrasound. 2022;63:234-239.
Abstract Related articles

LOUAR M, Morel-Journel N, Ruffion A, Carnicelli D, et al
Female Sexual Function and Body Image After Urinary Diversion for Benign Conditions.
J Sex Med. 2022;19:263-269.
Abstract Related articles

BROSE A, Krombach GA, Roller FC

Rofo. 2022;194:205-207.
Abstract Related articles

SASAKI Y, Takahashi M, Fukuta K, Shiozaki K, et al
The patient-side surgeon plays a key role in facilitating robot-assisted intracorporeal ileal conduit urinary diversion in men.
J Robot Surg. 2022;16:437-444.
Abstract Related articles

NIELENS N, Marot L, Baeck M
Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guerin (BCG) immunotherapy.
Int J Infect Dis. 2022;117:247-250.
Abstract Related articles

DE BROT S, Lothion-Roy J, Grau-Roma L, White E, et al
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
Vet Comp Oncol. 2022;20:38-49.
Abstract Related articles

VECCIA A, Carbonara U, Derweesh I, Mehrazin R, et al
Single-stage Xi(R) robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes.
Minerva Urol Nephrol. 2022;74:233-241.
Abstract Related articles

HIROTSU KE, Rana J, Wang JY, Raghavan SS, et al
Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma.
J Am Acad Dermatol. 2021;85:1610-1611.
Abstract Related articles

DELL'OGLIO P, Mazzone E, Lambert E, Vollemaere J, et al
The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery.
Eur Urol Focus. 2021;7:352-358.
Abstract Related articles

OURFALI S, Ohannessian R, Fassi-Fehri H, Pages A, et al
Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guerin Connaught Strain for Bladder Cancer Patients.
Eur Urol Focus. 2021;7:111-116.
Abstract Related articles

YANG J, Qi M, Fei X, Wang X, et al
Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p.
Cell Death Dis. 2022;13:322.
Abstract Related articles

STONE L
Urinary VOCs as bladder cancer biomarkers.
Nat Rev Urol. 2022 Apr 8. pii: 10.1038/s41585-022-00595.
Abstract Related articles

SUN B, Bte Rahmat JN, Kim HJ, Mahendran R, et al
Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic-Chemotherapy of Orthotopic Bladder Cancer.
Adv Sci (Weinh). 2022 Apr 7:e2200731. doi: 10.1002/advs.202200731.
Abstract Related articles

LAI LY, Tafuri SM, Ginier EC, Herrel LA, et al
Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer.
Cochrane Database Syst Rev. 2022;4:CD014887.
Abstract Related articles

ABEDI Z, MotieGhader H, Hosseini SS, Sheikh Beig Goharrizi MA, et al
mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.
Sci Rep. 2022;12:5885.
Abstract Related articles

MCLOUGHLIN LC, O'Halloran S, Tjong M, Ajib K, et al
The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.
Urol Oncol. 2022 Apr 4. pii: S1078-1439(22)00072.
Abstract Related articles

XIONG Q, Feng D, Wang Z, Ying Y, et al
Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer.
Front Immunol. 2022;13:836939.
Abstract Related articles

MAEYAMA R, Ikeda M, Shimura S, Amano N, et al
Patients with Non-Muscle Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guerin Intravesical Instillation Therapy.
Chemotherapy. 2022 Apr 7. pii: 000524449. doi: 10.1159/000524449.
Abstract Related articles

YU J, Cai L, Chen C, Fu X, et al
Cascade Path Augmentation Unet for Bladder Cancer Segmentation in MRI.
Med Phys. 2022 Apr 7. doi: 10.1002/mp.15646.
Abstract Related articles

ABUHASANEIN S, Jahnson S, Aljabery F, Gardmark T, et al
Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience.
Scand J Urol. 2022 Apr 7:1-6. doi: 10.1080/21681805.2022.2058605.
Abstract Related articles

JIANG Y, Zhang Z, Wang X, Feng Z, et al
A Novel Prognostic Factor TIPE2 in Bladder Cancer.
Pathol Oncol Res. 2022;28:1610282.
Abstract Related articles

LI M, Che N, Jin Y, Li J, et al
CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming.
Onco Targets Ther. 2022;15:299-311.
Abstract Related articles

VAN DER HEIJDEN MS, Powles T, Petrylak D, de Wit R, et al
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
Nat Commun. 2022;13:1878.
Abstract Related articles

PATTENDEN T, Samaranayake D, Morton A, Thangasamy I, et al
Bladder cancer in Aboriginal and Torres Strait Islander people living in Australia: a scoping review protocol.
BMJ Open. 2022;12:e059144.
Abstract Related articles

ZEMLICKOVA B, Brisuda A
Prognostic factors of early second transurethral resection of non-muscle invasive bladder cancer 10 years of experience of a referral center.
Rozhl Chir. 2022;101:119-128.
Abstract Related articles

HORNAK J, Brisuda A, Babjuk M
Management of BCG failure in non-muscle-invasive bladder cancer the present and the future.
Rozhl Chir. 2022;101:108-113.
Abstract Related articles

GREER MD, Schaub SK, Bowen SR, Liao JJ, et al
A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.
Adv Radiat Oncol. 2021;7:100858.
Abstract Related articles

YANG M, Wang B, Hou W, Yu H, et al
Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder.
Front Immunol. 2022;13:827457.
Abstract Related articles

XIA QD, Sun JX, Liu CQ, Xu JZ, et al
Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
Front Cell Dev Biol. 2022;10:832892.
Abstract Related articles

LU D, Yang T, Tang N, Li C, et al
A pH-Dependent rhodamine fluorophore with antiproliferative activity of bladder cancer in Vitro/Vivo and apoptosis mechanism.
Eur J Med Chem. 2022;236:114293.
Abstract Related articles

ZABOR EC, Kaizer AM, Garrett-Mayer E, Hobbs BP, et al
Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts.
JCO Precis Oncol. 2022;6:e2100390.
Abstract Related articles

MONTEIRO CRA, Korkes F, Krutman-Zveibil D, Glina S, et al
Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence.
Einstein (Sao Paulo). 2022;20:eAO6450.
Abstract Related articles

KE HL, Lee YC, Li WM, Wang CS, et al
High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.
Appl Immunohistochem Mol Morphol. 2022;30:304-310.
Abstract Related articles

HAROLD JA, Casilla-Lennon M, Kenney PA, Ratner ES, et al
Vesical clear cell adenocarcinoma of Mullerian origin treated conservatively with partial cystectomy.
BMJ Case Rep. 2022;15.
Abstract Related articles

PIAO XM, Kim YU, Byun YJ, Zheng CM, et al
Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy.
Urol Oncol. 2022 Apr 2. pii: S1078-1439(21)00557.
Abstract Related articles

YAMASAKI M, Taoka R, Katakura K, Matsunaga T, et al
The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
BMC Urol. 2022;22:51.
Abstract Related articles

LIU L, Qiu M, Tan G, Liang Z, et al
Correction to: miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
J Transl Med. 2022;20:153.
Abstract Related articles

ADNAN S, Abu Bakar M, Khalil MAI, Fiaz S, et al
Outcomes of Uretero-ileal Anastomosis in Bladder Cancer Cystectomies: Bricker vs. Wallace 1.
Cureus. 2022;14:e22782.
Abstract Related articles

ZRAIK I, Krege S
[Follow-up in superficial and metastatic bladder cancer].
Urologe A. 2022 Apr 5. pii: 10.1007/s00120-022-01813.
Abstract Related articles

GURAL Z, Yucel S, Oskeroglu S, Agaoglu F, et al
Urachal adenocarcinoma: A case report and review of the literature.
J Cancer Res Ther. 2022;18:291-293.
Abstract Related articles

LI K, Wang F, Wang J, Fan C, et al
Marital status independently predicts survival of patients with upper urinary tract urothelial carcinoma: A population-based study.
J Cancer Res Ther. 2021;17:1709-1717.
Abstract Related articles

ELSHETRY ASF, El-Fawakry RM, Hamed EM, Metwally MI, et al
Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
Eur J Radiol. 2022;151:110282.
Abstract Related articles

TAOKA R, Matsuoka Y, Yamasaki M, Kani N, et al
Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
Photodiagnosis Photodyn Ther. 2022 Apr 2:102838.
Abstract Related articles

THEODORESCU D, Li Z, Li X
Sex differences in bladder cancer: emerging data and call to action.
Nat Rev Urol. 2022 Apr 4. pii: 10.1038/s41585-022-00591.
Abstract Related articles

ALHALABI O, Chen J, Zhang Y, Lu Y, et al
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
Nat Commun. 2022;13:1797.
Abstract Related articles

TABER A, Christensen E, Lamy P, Nordentoft I, et al
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.
Nat Commun. 2022;13:1916.
Abstract Related articles

TALWAR HS, Kumar S, Mittal A, Narain TA, et al
Incidental encounter of intraperitoneal tuberculosis during renal surgeries: A surgeon's dilemma.
Indian J Tuberc. 2022;69:246-249.
Abstract Related articles

FAVORITO LA
Upper tract urothelial carcinoma and bladder cancer in review in this number of International Brazilian Journal of Urology.
Int Braz J Urol. 2022;48:386-388.
Abstract Related articles

LI Z, Wang S, Chen Y, Huang Y, et al
5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer.
Dis Markers. 2022;2022:3117359.
Abstract Related articles

SHAO C, Sun A, Xue H, Di X, et al
Three-Dimensional Ultrasound Images in the Assessment of Bladder Tumor Health Monitoring under Deep Learning Algorithms.
Comput Math Methods Med. 2022;2022:9170274.
Abstract Related articles

YANG X, Lv H, Jiang W, Zhang J, et al
Clinical Value Analysis of Xiaozheng Decoction Combined with Bladder Perfusion for Postoperative Treatment of Bladder Cancer and Its Effect on Serum miR-143 and miR-92a.
J Healthc Eng. 2022;2022:8177674.
Abstract Related articles

CUI Y, Sun Z, Liu X, Zhang X, et al
CT-based radiomics for the preoperative prediction of the muscle-invasive status of bladder cancer and comparison to radiologists' assessment.
Clin Radiol. 2022 Mar 30. pii: S0009-9260(22)00130.
Abstract Related articles

YANISHI M, Kinoshita H
Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.
BMC Nephrol. 2022;23:125.
Abstract Related articles

TAUBER R, von Amsberg G, De Santis M
[Update on systemic treatment of urothelial cancer: therapy in transition].
Aktuelle Urol. 2022;53:167-179.
Abstract Related articles

Aktuelle Urol. 2022;53:119-121.
Abstract Related articles

Aktuelle Urol. 2022;53:116.
Abstract Related articles

Aktuelle Urol. 2022;53:114-116.
Abstract Related articles

Aktuelle Urol. 2022;53:112-114.
Abstract Related articles

Aktuelle Urol. 2022;53:110-112.
Abstract Related articles

NIEGISCH G

Aktuelle Urol. 2022;53:135-136.
Abstract Related articles

ZHAO C, Xiong K, Ji Z, Liu F, et al
The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.
Oxid Med Cell Longev. 2022;2022:8297011.
Abstract Related articles

HURST CD, Cheng G, Platt FM, Alder O, et al
Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling.
J Pathol Clin Res. 2022;8:279-293.
Abstract Related articles

CASARIN M, Fortunato TM, Imran S, Todesco M, et al
Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches.
Int J Mol Sci. 2022;23.
Abstract Related articles

CINQUE A, Capasso A, Vago R, Floris M, et al
MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
Int J Mol Sci. 2022;23.
Abstract Related articles

LIU E, Guan X, Wei R, Jiang Z, et al
Association Between Radiotherapy and Death From Cardiovascular Disease Among Patients With Cancer: A Large Population-Based Cohort Study.
J Am Heart Assoc. 2022;11:e023802.
Abstract Related articles

CHAN TC, Hsing CH, Shiue YL, Huang SK, et al
Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
Cells. 2022;11.
Abstract Related articles

DENG M, Wang N, Li Z, Chen R, et al
FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.
Cell Death Dis. 2022;13:170.
Abstract Related articles

BOLENZ C, Ohlmann CH, Gschwend J
[Do's and Dont's for radical cystectomy and urinary diversion - how to minimise postoperative complications].
Aktuelle Urol. 2022;53:159-166.
Abstract Related articles

YIN Y, Song L, Shi D, Liu B, et al
Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer Types.
JCO Precis Oncol. 2022;6:e2100325.
Abstract Related articles

BOULEFTOUR W, Guillot A, Magne N
The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review.
Mol Cancer Ther. 2022;21:493-501.
Abstract Related articles

BERNARDO C, Eriksson P, Marzouka NA, Liedberg F, et al
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis.
Hum Pathol. 2022;122:11-24.
Abstract Related articles

WOJCIK EM, Kurtycz DFI, Rosenthal DL
We'll always have Paris The Paris System for Reporting Urinary Cytology 2022.
J Am Soc Cytopathol. 2022;11:62-66.
Abstract Related articles

XIAO JF, Kua LF, Ding LW, Sun QY, et al
KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFbeta Activity.
Mol Cancer Res. 2022;20:637-649.
Abstract Related articles

GAO X, Lin B, Lin Q, Ye T, et al
A HALP score-based prediction model for survival of patients with the upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Bosn J Basic Med Sci. 2022;22:280-290.
Abstract Related articles

ZHANG H, Lu X, Huang G, Hua M, et al
A genomic mutation spectrum of collecting duct carcinoma in the Chinese population.
BMC Med Genomics. 2022;15:1.
Abstract Related articles

KOBAYASHI G, Uraoka N, Sentani K, Shibata J, et al
Cytological and histological findings of upper tract mucinous urothelial carcinoma with clear cell component: A case report and review of literature.
Diagn Cytopathol. 2022;50:E129-E135.
Abstract Related articles

ALGER J, Mallahan C, Deng T, Marshall J, et al
Neuroendocrine tumor causing ureteral obstruction in a patient with prior ileal conduit.
Can J Urol. 2021;28:10953-10955.
Abstract Related articles

O'CONNOR A, Sabri S, Muhammad K
The use of methylene blue to aid identification of ileal conduit anatomy during subsequent surgery.
Ann R Coll Surg Engl. 2022;104:1.
Abstract Related articles

SHANG D, Li G, Zhang C, Liu Y, et al
Synergistic inhibitory effects of 5-aza-2'-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways.
Biochem Cell Biol. 2022;100:115-124.
Abstract Related articles

ALLISON DB, Kates M, VandenBussche CJ
Indeterminate atypia in urinary tract cytology: Does it really matter?
Diagn Cytopathol. 2022;50:176-183.
Abstract Related articles

LOGHIN A, Nechifor-Boila A, Borda A, Nechifor-Boila IA, et al
Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263.
Virchows Arch. 2022;480:303-313.
Abstract Related articles

Bicyclic Peptide Makes Targeting EphA2 Possible.
Cancer Discov. 2021;11:2951-2952.
Abstract Related articles

KAMEI J, Fujisaki A, Saito K, Sugihara T, et al
Less invasive and equivalent short-term outcomes with simultaneous en bloc robot-assisted radical cystectomy and laparoscopic nephroureterectomy: Comparison with conventional open radical cystectomy and nephroureterectomy.
Asian J Endosc Surg. 2022;15:255-260.
Abstract Related articles

VOLKEL C, De Wispelaere N, Weidemann S, Gorbokon N, et al
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
Virchows Arch. 2022;480:433-447.
Abstract Related articles

MURAKAMI K, Kamat AM, Dai Y, Pagano I, et al
Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study.
Cancer Biomark. 2022;33:151-157.
Abstract Related articles

PATEL SH
Clinician's commentary: Atypia in urinary tract cytology specimens.
Diagn Cytopathol. 2022;50:184-185.
Abstract Related articles

TATJANA A, Tjota MY, O'Donnell PH, Eggener SE, et al
EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.
Virchows Arch. 2022;480:487-492.
Abstract Related articles

SHARMA G, Yadav AK, Pareek T, Kaundal P, et al
Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.
Int Braz J Urol. 2022;48:406-455.
Abstract Related articles

LUNA-VELEZ MV, Dijkstra JJ, Heuschkel MA, Smit FP, et al
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.
Mol Oncol. 2021;15:1882-1900.
Abstract Related articles

HUSSAIN SA, Lester JF, Jackson R, Gornall M, et al
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol. 2022 Apr 11. pii: S1470-2045(22)00158.
Abstract Related articles

LI X, Zhou L, Lu T, Zhang L, et al
Constructing an immune- and ferroptosis-related lncRNA signature to predict the immune landscape of human bladder cancer.
J Clin Lab Anal. 2022 Apr 14:e24389. doi: 10.1002/jcla.24389.
Abstract Related articles

MAO C, Gao Y, Wan M, Xu N, et al
Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.
Funct Integr Genomics. 2022 Apr 14. pii: 10.1007/s10142-022-00845.
Abstract Related articles

WANG F, Dong X, Yang F, Xing N, et al
Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
Front Genet. 2022;13:831146.
Abstract Related articles

XIA QD, Sun JX, Xun Y, Xiao J, et al
SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
Front Immunol. 2022;13:864156.
Abstract Related articles

SUN J, Ma X, Ying Y, Wang W, et al
SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer.
Cell Death Discov. 2022;8:199.
Abstract Related articles

OU L, Wei Z, Xu J, Li W, et al
FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.
Ann Clin Lab Sci. 2022;52:260-268.
Abstract Related articles

SHARMA G, Sharma A, Krishna M, Ahluwalia P, et al
Diagnostic performance of minichromosome maintenance 5 (MCM5) in bladder cancer: A systematic review and meta-analysis.
Urol Oncol. 2022 Apr 9. pii: S1078-1439(22)00075.
Abstract Related articles

YAMAMOTO A, Kawashima A, Uemura T, Yamamichi G, et al
Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study.
BMC Urol. 2022;22:59.
Abstract Related articles

ABUHASANEIN S, Hansen C, Vojinovic D, Jahnson S, et al
Computed tomography urography with corticomedullary phase can exclude urinary bladder cancer with high accuracy.
BMC Urol. 2022;22:60.
Abstract Related articles

AL-ZALABANI AH, Wesselius A, Yi-Wen Yu E, van den Brandt P, et al
Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international cohort studies.
Clin Nutr. 2022;41:1122-1130.
Abstract Related articles

DING K, Wang L, Zhu J, He D, et al
Photo-Enhanced Chemotherapy Performance in Bladder Cancer Treatment via Albumin Coated AIE Aggregates.
ACS Nano. 2022 Apr 12. doi: 10.1021/acsnano.1c10770.
Abstract Related articles

LI G, Wang Y, Guo XB, Zhao B, et al
CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the IQGAP3-Mediated Ras/ERK Pathway.
Biochem Genet. 2022 Apr 12. pii: 10.1007/s10528-022-10223.
Abstract Related articles

ABDULLAH O, Parashar D, Mustafa IJ, Young AM, et al
Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type of Treatment: A Systematic Review.
Cureus. 2022;14:e22945.
Abstract Related articles

LIN MH, Islam A, Liu YH, Weng CW, et al
Antibiotic heliomycin and its water-soluble 4-aminomethylated derivative provoke cell death in T24 bladder cancer cells by targeting sirtuin 1 (SIRT1).
Am J Cancer Res. 2022;12:1042-1055.
Abstract Related articles

QIAN H, Wang Y, Ma Z, Qian L, et al
Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy.
Int J Nanomedicine. 2022;17:1635-1646.
Abstract Related articles

WARD DG, Baxter L, Ott S, Gordon NS, et al
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA.
Eur Urol Oncol. 2022 Apr 8. pii: S2588-9311(22)00036.
Abstract Related articles

HOLM JS, Funt SA, Borch A, Munk KK, et al
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
Nat Commun. 2022;13:1935.
Abstract Related articles

XU L, Su B, Mo L, Zhao C, et al
Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through Promoting Autophagy in Acidic Culture.
Int J Mol Sci. 2022;23.
Abstract Related articles

THOMAS J, Sonpavde G
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

LU YT, Xu T, Iqbal M, Hsieh TC, et al
FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

SJODAHL G, Abrahamsson J, Bernardo C, Eriksson P, et al
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review.
Cancers (Basel). 2022;14.
Abstract Related articles

WEIDLE UH, Birzele F
Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.
Cancer Diagn Progn. 2021;1:245-263.
Abstract Related articles

LI X, Liu H, Lv C, Du J, et al
Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.
Biomed Res Int. 2022;2022:9304552.
Abstract Related articles

MA Q, Xu C, Han X, Wang X, et al
The effects of modified RNA-binding proteins HuR on the biological behavior of the bladder cancer T24 cell line.
Transl Androl Urol. 2022;11:348-357.
Abstract Related articles

LIU F, Liu X, Deng W, Yang X, et al
Overexpression of F-box and WD repeat domain containing 7 prevents tumor growth of bladder cancer cells through regulating SREBP1a.
Transl Androl Urol. 2022;11:367-376.
Abstract Related articles

LI YD, Gao L, Gou YQ, Tan W, et al
Age of menarche and primary bladder cancer risk: A meta-analysis and systematic review.
Urol Oncol. 2022 Apr 7. pii: S1078-1439(22)00074.
Abstract Related articles

WATANABE K, Tamura K, Matsushita Y, Watanabe H, et al
Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
Cancer Diagn Progn. 2021;1:201-205.
Abstract Related articles

LIN N, Chen L, Zhang Y, Yang Y, et al
KIF4A promotes tumor progression of bladder cancer via CXCL5 dependent myeloid-derived suppressor cells recruitment.
Sci Rep. 2022;12:6015.
Abstract Related articles

SHINWARI K, Chen Z, Liu G, Chen L, et al
Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets.
Acta Med Indones. 2022;54:62-71.
Abstract Related articles

REESINK DJ, van de Garde EMW, van der Nat P, Somford DM, et al
Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands.
World J Urol. 2022 Apr 10. pii: 10.1007/s00345-022-03987.
Abstract Related articles

YE JB, Chen Q, Zeng K, Li XB, et al
Eosinophilic cystitis complicated with cystitis glandularis: a case report.
BMC Urol. 2022;22:55.
Abstract Related articles

YILDIRIM S, Ozkan EI, Sadioglu A, Gonul II, et al
Bone in bladder.
J Nephrol. 2022;35:1043-1044.
Abstract Related articles

NIKOLOS F, Hayashi K, Hoi XP, Alonzo ME, et al
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors.
Nat Commun. 2022;13:1487.
Abstract Related articles

RUSSELL BM, Boussi L, Bellmunt J
Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care?
Drugs Aging. 2022;39:271-284.
Abstract Related articles

VOUTSADAKIS IA
Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies.
Curr Oncol. 2022;29:1390-1407.
Abstract Related articles

HASHIMOTO H, Tanaka Y, Murata M, Ito T, et al
Nectin-4: a Novel Therapeutic Target for Skin Cancers.
Curr Treat Options Oncol. 2022;23:578-593.
Abstract Related articles

DAUBISSE-MARLIAC L, Grosclaude P, Carulla M, Parada D, et al
Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?
Int J Environ Res Public Health. 2022;19.
Abstract Related articles

UNGARO A, Tucci M, Audisio A, Di Prima L, et al
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside.
Cells. 2022;11.
Abstract Related articles

MATHEW THOMAS V, Tripathi N, Agarwal N, Swami U, et al
Current and emerging role of sacituzumab govitecan in the management of urothelial carcinoma.
Expert Rev Anticancer Ther. 2022;22:335-341.
Abstract Related articles

DIAMANTOPOULOS LN, Korentzelos D, Alevizakos M, Wright JL, et al
Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes.
Clin Genitourin Cancer. 2022;20:139-147.
Abstract Related articles

TALUKDER R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, et al
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer. 2022;20:165-175.
Abstract Related articles

WILSON J, Drach D, Zanghi J, Siegert J, et al
Improving practice patterns in patients with newly diagnosed bladder masses treated with transurethral resection.
J Osteopath Med. 2022;122:169-173.
Abstract Related articles

LIN TW, Lee HY, Yang SF, Li CC, et al
ASO Visual Abstract: Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Ann Surg Oncol. 2022;29:3320-3321.
Abstract Related articles

ADIBI M, McCormick B, Economides MP, Petros F, et al
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:176-182.
Abstract Related articles

SPARWASSER P, Epple S, Thomas A, Dotzauer R, et al
First completely robot-assisted retroperitoneal nephroureterectomy with bladder cuff: a step-by-step technique.
World J Urol. 2022;40:1019-1026.
Abstract Related articles

FERRO M, Chiujdea S, Musi G, Lucarelli G, et al
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis.
Clin Genitourin Cancer. 2022;20:e166-e172.
Abstract Related articles

DEL GIUDICE F, van Uem S, Li S, Vilson FL, et al
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and
Clin Genitourin Cancer. 2022;20:198.
Abstract Related articles

RAGGI D, Giannatempo P, Marandino L, Pierantoni F, et al
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study.
Clin Genitourin Cancer. 2022;20:155-164.
Abstract Related articles

JINDAL T, Chou J, Friedlander T, Barata PC, et al
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series.
Clin Genitourin Cancer. 2022;20:189-194.
Abstract Related articles

LAYMON M, Mosbah A, Hashem A, Mahmoud O, et al
Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma.
Clin Genitourin Cancer. 2022;20:148-154.
Abstract Related articles

KARAM A, Mjaess G, Albisinni S, El Daccache Y, et al
Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature.
World J Urol. 2022;40:951-964.
Abstract Related articles

LIN TW, Lee HY, Yang SF, Li CC, et al
Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy.
Ann Surg Oncol. 2022;29:3306-3317.
Abstract Related articles

LIN TW, Yeh HC
ASO Author Reflections: Prognostic Significance of Perineural Invasion in Upper Tract Urothelial Carcinoma.
Ann Surg Oncol. 2022;29:3318-3319.
Abstract Related articles

TANG CH, Chen YC, Hsieh WT, Sue YM, et al
Gender and Age Differences of Genitourinary Cancers Among Chronic Dialysis Patients in Taiwan.
Clin Genitourin Cancer. 2022;20:e126-e134.
Abstract Related articles

ABUHELWA AY, Bellmunt J, Kichenadasse G, McKinnon RA, et al
Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy.
Clin Genitourin Cancer. 2022;20:132-138.
Abstract Related articles

MIYAKE M, Shimizu T, Nishimura N, Kiba K, et al
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:196.
Abstract Related articles

KOSIBA M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
Clin Genitourin Cancer. 2022;20:195.
Abstract Related articles

GRIVAS P, Huber C, Pawar V, Roach M, et al
Management of Patients With Advanced Urothelial Carcinoma in an Evolving Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line Therapies.
Clin Genitourin Cancer. 2022;20:114-122.
Abstract Related articles

KOBAYASHI G, Hayashi T, Sentani K, Babasaki T, et al
Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
Virchows Arch. 2022;480:621-633.
Abstract Related articles

MONTOYA-CERRILLO D, Briski LM, Jorda M, Kryvenko ON, et al
Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
Int J Surg Pathol. 2022;30:260-264.
Abstract Related articles

MALDE S, Grover S, Raj S, Yuan C, et al
A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation.
Eur Urol Focus. 2022;8:141-151.
Abstract Related articles

SEISEN T, Mari A, Campi R, Peyronnet B, et al
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
Eur Urol Focus. 2021;7:1075-1083.
Abstract Related articles

DELL'OGLIO P, Turri F, Larcher A, D'Hondt F, et al
Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board.
Eur Urol Focus. 2022;8:160-164.
Abstract Related articles

TURAL D, Olmez OF, Sumbul AT, Artac M, et al
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Eur Urol Focus. 2021;7:1061-1066.
Abstract Related articles

DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study.
Eur Urol Focus. 2021;7:1332-1338.
Abstract Related articles

MASTROIANNI R, Brassetti A, Krajewski W, Zdrojowy R, et al
Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Eur Urol Focus. 2021;7:1324-1331.
Abstract Related articles

NECCHI A, Madison R, Pal SK, Ross JS, et al
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Eur Urol Focus. 2021;7:1339-1346.
Abstract Related articles

FURRER MA, Kiss B, Wuthrich PY, Thomas BC, et al
Long-term Outcomes of Cystectomy and Crossfolded Ileal Reservoir Combined with an Afferent Tubular Segment for Heterotopic Continent Urinary Diversion: A Longitudinal Single-centre Study.
Eur Urol Focus. 2021;7:629-637.
Abstract Related articles

PANG KH, Thomas F, Novara G, Din OS, et al
The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.
Eur Urol Focus. 2021;7:554-565.
Abstract Related articles

CONG Z, Tang S, Xie L, Yang M, et al
Magnetic-Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer.
Adv Mater. 2022 Apr 22:e2201042. doi: 10.1002/adma.202201042.
Abstract Related articles

GRUNEWALD CM, Niegisch G, Albers P
Using Circulating Tumor DNA To Guide Adjuvant Therapy in Bladder Cancer: IMvigor010 and IMvigor011.
Eur Urol Focus. 2022 Apr 18. pii: S2405-4569(22)00078.
Abstract Related articles

ZHAO H, Chen Z, Fang Y, Su M, et al
Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes.
J Immunol Res. 2022;2022:1793005.
Abstract Related articles

D'ELIA C, Trenti E, Krause P, Pycha A, et al
Xpert(R) bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results.
Ther Adv Urol. 2022;14:17562872221090320.
Abstract Related articles

HWANG TI, Chen PC, Tsai TF, Lin JF, et al
Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion.
Cell Death Dis. 2022;13:390.
Abstract Related articles

XU H, Shi HL, Hao JW, Shu KP, et al
[Casticin inhibits the proliferation, migration and invasion of bladder cancer cells by inhibition of TM7SF4 expression].
Zhonghua Zhong Liu Za Zhi. 2022;44:334-340.
Abstract Related articles

SU Z, Monshaugen I, Wilson B, Wang F, et al
TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer.
Nat Commun. 2022;13:2165.
Abstract Related articles

UEMURA T, Ishibashi T, Pae S, Shirakawa N, et al
[CLINICAL STUDY OF OPEN RADICAL CYSTECTOMY AND ILEAL CONDUIT CONSTRUCTION FOR BLADDER CANCER: RESULTS OF 15-YEAR SINGLE CENTER EXPERIENCE].
Nihon Hinyokika Gakkai Zasshi. 2021;112:89-95.
Abstract Related articles

MATSUMURA S, Yoshida T, Imanaka T, Yamanaka K, et al
[OUTCOMES OF BLADDER CANCER IN NONAGENARIANS].
Nihon Hinyokika Gakkai Zasshi. 2021;112:58-64.
Abstract Related articles

MAEDA K, Mori Y, Nakamura M, Harada Y, et al
[SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION AS A SIDE EFFECT OF CHEMOTHERAPY FOR URACHAL CARCINOMA: A CASE REPORT].
Nihon Hinyokika Gakkai Zasshi. 2021;112:100-104.
Abstract Related articles

XIA Y, Ge M, Xia L, Shan G, et al
CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-kappaB activity.
Bioengineered. 2022;13:10180-10190.
Abstract Related articles

LIU T, Li T, Zheng Y, Xu X, et al
Evaluating adipose-derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer.
Cancer Med. 2022 Apr 20. doi: 10.1002/cam4.4745.
Abstract Related articles

TAE BS, Oh JJ, Jeong BC, Ku JH, et al
Catheter-associated urinary tract infections in patients who have undergone radical cystectomy for bladder cancer: A prospective randomized clinical study of two silicone catheters (clinical benefit of antibiotic silicone material).
Investig Clin Urol. 2022 Mar 28. pii: 63.e32. doi: 10.4111/icu.20210436.
Abstract Related articles

JUNG A, Crandell JL, Nielsen ME, Smith SK, et al
Relationships among uncertainty, post-traumatic stress disorder symptoms, and quality of life in non-muscle-invasive bladder cancer survivors.
Support Care Cancer. 2022 Apr 18. pii: 10.1007/s00520-022-07034.
Abstract Related articles

BIERI U, Scharl M, Sigg S, Szczerba BM, et al
Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol.
BMJ Open. 2022;12:e061421.
Abstract Related articles

HARDY CSC, Ghaedi H, Slotman A, Sjodahl G, et al
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers.
J Histochem Cytochem. 2022 Apr 19:221554221095530.
Abstract Related articles

YAMUC E, Barisik NO, Sensu S, Tarhan F, et al
Correlation of REG1A, Claudin 7 and Ki67 expressions with tumor recurrence and prognostic factors in superficial urothelial urinary bladder carcinomas.
Indian J Pathol Microbiol. 2022;65:355-361.
Abstract Related articles

ELIZALDE BENITO FX, Sieso Gracia MR, Dolezal P, Martin Anoro LF, et al
Abdominal mass as the first manifestation of bladder tumor.
Arch Esp Urol. 2022;75:306-307.
Abstract Related articles

RUIBAL GAGO L
[Altered urinary pH as an aetiology of granulomas in urostomised patients.]
Arch Esp Urol. 2022;75:296-299.
Abstract Related articles

SALAS E, Enguita L, Espilez R, Santander C, et al
[Lymphoepithelioma-like bladder tumor. A rare variant.]
Arch Esp Urol. 2022;75:300-305.
Abstract Related articles

LEI Y, Jiao D, Yao Z, Wang L, et al
Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy.
Arch Esp Urol. 2022;75:287-294.
Abstract Related articles

WANG F, Yang J
Correlations between forkhead box D1 expression and clinicopathological characteristics of patients with bladder cancer and influence on biological behaviors of bladder cancer cells.
Arch Esp Urol. 2022;75:274-281.
Abstract Related articles

CHENG J, Yang Q, Han X, Wang H, et al
Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway.
Bioengineered. 2022;13:10244-10257.
Abstract Related articles

HUANG M, Dong W, Xie R, Wu J, et al
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
Cancer Commun (Lond). 2022 Apr 18. doi: 10.1002/cac2.12284.
Abstract Related articles

GU H, Liang C
Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients.
Front Cell Dev Biol. 2022;10:725024.
Abstract Related articles

HUANG Z, Gao H, Qing L, Wang B, et al
A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/betacatenin signaling pathway.
PeerJ. 2022;10:e13220.
Abstract Related articles

RAZZAGHDOUST A, Muhammadnejad S, Parvin M, Mofid B, et al
Development and immunohistochemical characterization of patient-derived xenograft models for muscle invasive bladder cancer.
Iran J Basic Med Sci. 2021;24:1650-1655.
Abstract Related articles

SORCE G, Chierigo F, Flammia RS, Hoeh B, et al
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity.
Urol Oncol. 2022 Apr 14. pii: S1078-1439(22)00105.
Abstract Related articles

DANESHMAND S, Brummelhuis ISG, Pohar KS, Steinberg GD, et al
The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial.
Urol Oncol. 2022 Apr 14. pii: S1078-1439(22)00059.
Abstract Related articles

WANG SS, Zhai GQ, Chen G, Huang ZG, et al
Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder cancer.
Pathol Res Pract. 2022;233:153847.
Abstract Related articles

MUZAAIL HH, El-Assmy A, Harraz AM, Awadalla A, et al
Prediction of recurrence of non-muscle invasive bladder cancer: The role of androgen receptor and miRNA-2909.
Urol Oncol. 2022 Apr 13. pii: S1078-1439(22)00078.
Abstract Related articles

GONZALEZ-PADILLA DA, Subiela JD, Gonzalez-Diaz A, Hernandez-Arroyo M, et al
Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center.
Urol Oncol. 2022 Apr 14. pii: S1078-1439(22)00067.
Abstract Related articles

TEPLITSKY SL, Hensley PJ, Bettis A, James A, et al
Operative duration and short term morbidity and mortality following radical cystectomy with urinary diversion.
Can J Urol. 2022;29:11087-11094.
Abstract Related articles

DIETRICH F, Cappellari AR, Filippi-Chiela EC, de Paula PB, et al
High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.
Mol Cell Biochem. 2022 Apr 16. pii: 10.1007/s11010-022-04425.
Abstract Related articles

AL-ZUBAIDI M, Viswambaram P, McCombie S, Liow E, et al
(89)Zirconium-labelled girentuximab ((89)Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.
BMJ Open. 2022;12:e060478.
Abstract Related articles

FISHER L
Retraction: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis.
RSC Adv. 2021;11:6254.
Abstract Related articles

MIYAKE M, Nishimura N, Ohnishi S, Oda Y, et al
Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.
Support Care Cancer. 2022 Apr 14. pii: 10.1007/s00520-022-07043.
Abstract Related articles

LIU Q, Wang Y, Gao H, Sun F, et al
An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer.
Front Genet. 2022;13:837301.
Abstract Related articles

ZHAO Y, Che J, Tian A, Zhang G, et al
PBX1 Participates in Estrogen-Mediated Bladder Cancer Progression and Chemo-Resistance Affecting Estrogen Receptors.
Curr Cancer Drug Targets. 2022 Apr 13. pii: CCDT-EPUB-122508.
Abstract Related articles

ZHANG Y, Liu Z, Wang X, Jian H, et al
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells.
Cancer Gene Ther. 2022 Apr 14. pii: 10.1038/s41417-022-00470.
Abstract Related articles

SINGH YP, Roy D, Jois B, Shetti M, et al
Reactive arthritis following treatment with intravesical Bacillus Calmette-Guerin for papillary carcinoma of bladder.
BMJ Case Rep. 2022;15.
Abstract Related articles

FUKATA S, Mizutani K, Yamamoto S, Kuno T, et al
Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma.
Anticancer Drugs. 2022;33:459-466.
Abstract Related articles

LEWICKI P, Basourakos SP, Arenas-Gallo C, Qiu Y, et al
Use of Intravesical Chemotherapy in the US Following Publication of a Randomized Clinical Trial.
JAMA Netw Open. 2022;5:e220602.
Abstract Related articles

SHVERO A, Hubosky SG
Management of Upper Tract Urothelial Carcinoma.
Curr Oncol Rep. 2022;24:611-619.
Abstract Related articles

KUMAR D, Adeniran AJ
Clinicopathological Review of Micropapillary Urothelial Carcinoma.
Curr Oncol Rep. 2022;24:603-610.
Abstract Related articles

MASTERS JC, Khandelwal A, di Pietro A, Dai H, et al
Model-informed drug development supporting the approval of the avelumab flat-dose regimen in patients with advanced renal cell carcinoma.
CPT Pharmacometrics Syst Pharmacol. 2022;11:458-468.
Abstract Related articles

HE L, Wang X, Li C, Wan Y, et al
Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer.
Hum Vaccin Immunother. 2022;18:2035552.
Abstract Related articles

CALDERON CORTEZ JF, Territo A, Fontana M, Gaya JM, et al
Primary urethral carcinoma: Results from a single center experience.
Actas Urol Esp (Engl Ed). 2022;46:70-77.
Abstract Related articles

NISHIMORI T, Hanazono K, Matsuda K, Kawamura Y, et al
Prognostic role of DeltaNp63 expression in canine transitional cell carcinoma of the urinary bladder.
Open Vet J. 2021;11:700-706.
Abstract Related articles

GOVONI VM, Pigoli C, Sueiro FAR, Zuliani F, et al
Lymphatic invasion is a significant indicator of poor patient outcome in canine bladder urothelial carcinoma.
Open Vet J. 2021;11:535-543.
Abstract Related articles

CARRIL-AJURIA L, Martin-Soberon MC, de Velasco G, Agarwal N, et al
Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review.
J Cancer Res Clin Oncol. 2022;148:1097-1105.
Abstract Related articles

RANTI D, Pfail J, Garcia M, Razdan S, et al
Neobladder creation in patients with chronic kidney disease: A viable diversion strategy.
Urol Oncol. 2022;40:168.
Abstract Related articles

VENKAT S, Khan AI, Lewicki PJ, Borregales L, et al
Novel nomograms to predict muscle invasion and lymph node metastasis in upper tract urothelial carcinoma.
Urol Oncol. 2022;40:108.
Abstract Related articles

LI Z, Zhang Z, Ma H, Yao K, et al
Extraperitonealization of ileal conduit reduces parastomal hernia after cystectomy and ileal conduit diversion.
Urol Oncol. 2022;40:162.
Abstract Related articles

PIERCONTI F, Martini M, Cenci T, Fiorentino V, et al
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma.
Urol Oncol. 2022;40:108.
Abstract Related articles

CLAIBORNE RT, Tsan GL
Case Report: Erdafitinib-induced Central Serous Chorioretinopathy.
Optom Vis Sci. 2022;99:88-92.
Abstract Related articles

WOO S, Ghafoor S, Das JP, Gangai N, et al
Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.
Urol Oncol. 2022;40:108.
Abstract Related articles

YANG CH, Weng WC, Ou YC, Lin YS, et al
Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside.
Urol Oncol. 2022;40:109.
Abstract Related articles

BUBE SH, Kingo PS, Madsen MG, Vasquez JL, et al
Validation of a Novel Assessment Tool Identifying Proficiency in Transurethral Bladder Tumor Resection: The OSATURBS Assessment Tool.
J Endourol. 2022;36:572-579.
Abstract Related articles

CHEN X, Ou Z, Wang L, Zhang Z, et al
Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma.
Mol Carcinog. 2022;61:311-321.
Abstract Related articles

LYON TD, Faraj KS, Brennan E, Tyson MD 2nd, et al
Defining radical cystectomy using the ICD-10 procedure coding system.
Urol Oncol. 2022;40:165.
Abstract Related articles

SARI MOTLAGH R, Rajwa P, Mori K, Laukhtina E, et al
Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis, and Network Meta-Analysis with Focus on Different Energy So
J Endourol. 2022;36:535-547.
Abstract Related articles

FLAMMIA RS, Chierigo F, Wurnschimmel C, Horlemann B, et al
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
Urol Oncol. 2022;40:165.
Abstract Related articles

PARK CK, Cho NH
Differences in genomic profile of high-grade urothelial carcinoma according to tumor location.
Urol Oncol. 2022;40:109.
Abstract Related articles

KEENAN RA, Haroon U, Ryan P, Harrington B, et al
Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study.
Exp Clin Transplant. 2021;19:1069-1075.
Abstract Related articles

AYDIN AM, Reich RR, Cao B, Cheriyan SK, et al
Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy.
Urol Oncol. 2022;40:164.
Abstract Related articles

YU A, Wang Y, Mossanen M, Preston M, et al
Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians.
Urol Oncol. 2022;40:163.
Abstract Related articles

ALBISINNI S, Diamand R, Mjaess G, Assenmacher G, et al
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.
Urol Oncol. 2022;40:163.
Abstract Related articles

IAKYMENKO OA, Briski LM, Delma KS, Jorda M, et al
Utility of D2-40, Cytokeratin 5/6, and High-Molecular-weight Cytokeratin (Clone 34betaE12) in Distinguishing Intraductal Spread of Urothelial Carcinoma From Prostatic Stromal Invasion.
Am J Surg Pathol. 2022;46:454-463.
Abstract Related articles

ALKAN S, Evlice O, Agin A
The Evaluation of Cases with Ocular Complications due to Bacillus Calmette-Guerin (BCG) Treatment using the Pool Analysis Method.
Semin Ophthalmol. 2022;37:373-378.
Abstract Related articles

TAOKA R, Kobayashi T, Hidaka Y, Abe H, et al
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma.
Urol Oncol. 2022;40:107.
Abstract Related articles

SHIGETA K, Matsumoto K, Ogihara K, Murakami T, et al
Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.
Urol Oncol. 2022;40:105.
Abstract Related articles

CHAKIRYAN NH, Jiang DD, Gillis KA, Green E, et al
Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder.
Urol Oncol. 2022;40:107.
Abstract Related articles

BHAMIDIPATY M, Rickard MJFX
An ileal conduit retroperitoneal-pexy: An novel operative technique to treat the rare colonic internal hernia.
ANZ J Surg. 2022;92:586-587.
Abstract Related articles

NOJIMA S, Terayama K, Shimoura S, Hijiki S, et al
A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens.
Cancer Cytopathol. 2021;129:984-995.
Abstract Related articles

COLLA RUVOLO C, Wurnschimmel C, Wenzel M, Nocera L, et al
Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder.
J Clin Pathol. 2022;75:333-337.
Abstract Related articles

GUO B, Liu M
The role of chemotherapy in patients with pure squamous cell bladder carcinoma.
World J Urol. 2022;40:865-866.
Abstract Related articles

MITCHELL KA, Williams H
Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
Urol Oncol. 2022;40:126-132.
Abstract Related articles

LI Q, Cao B, Liu K, Sun H, et al
Detecting the muscle invasiveness of bladder cancer: An application of diffusion kurtosis imaging and tumor contact length.
Eur J Radiol. 2022;151:110329.
Abstract Related articles

FLEGAR L, Kraywinkel K, Zacharis A, Aksoy C, et al
Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019.
World J Urol. 2022 Apr 29. pii: 10.1007/s00345-022-04017.
Abstract Related articles

Addition of Nintedanib to Neoadjuvant Chemotherapy Is Safe in Bladder Cancer.
Cancer Discov. 2022 Apr 29:OF1. doi: 10.1158/2159-8290.CD-RW2022.
Abstract Related articles

GARCZYK S, Degener S, Bischoff F, Schnitzler T, et al
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.
Virchows Arch. 2022 Apr 28. pii: 10.1007/s00428-022-03328.
Abstract Related articles

MORTEZAVI A, Crippa A, Kotopouli MI, Akre O, et al
Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden.
JAMA Netw Open. 2022;5:e228959.
Abstract Related articles

DE ROJAS LEAL C, Lage-Sanchez JM, Pinel-Rios J, Leon Plaza O, et al
Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.
Neurol Sci. 2022 Apr 28. pii: 10.1007/s10072-022-06075.
Abstract Related articles

CIOCAN C, Godono A, Franco N, La Vecchia C, et al
Mortality from bladder cancer in dyestuff workers exposed to aromatic amines: A 73-year follow-up.
Med Lav. 2022;113:e2022017.
Abstract Related articles

SUN X, Zhang Y, Chen Y, Xin S, et al
In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer.
Oxid Med Cell Longev. 2022;2022:3170950.
Abstract Related articles

ZUPPONE S, Assalini C, Minici C, Botrugno OA, et al
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer.
Front Oncol. 2022;12:846958.
Abstract Related articles

ZHANG Q, Tan Y, Zhang J, Shi Y, et al
Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer.
Front Immunol. 2022;13:782982.
Abstract Related articles

ZLOWOCKA-PERLOWSKA E, van de Wetering T, Toloczko-Grabarek A, Scott RJ, et al
Bladder cancer survival in patients with NOD2 or CDKN2A variants.
Oncotarget. 2022;13:628-640.
Abstract Related articles

NIE S, Huili Y, He Y, Hu J, et al
Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model.
Front Surg. 2022;9:860857.
Abstract Related articles

EVANS H, O'Sullivan B, Hughes F, Charles K, et al
PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays.
Pathol Oncol Res. 2022;28:1610260.
Abstract Related articles

FU Y, Zhao Z, Shi Y, Xu K, et al
Hybridization chain reaction-mediated Fe2MoO4 bimetallic nanozyme for colorimetric risk prediction of bladder cancer.
Biosens Bioelectron. 2022;210:114272.
Abstract Related articles

GU Q, Hou W, Shi L, Zhu Z, et al
CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of bladder carcinoma through modulating the miR-498/murine double minute-2 axis.
Bioengineered. 2022;13:10734-10748.
Abstract Related articles

RUSSELL B, Haggstrom C, Holmberg L, Liedberg F, et al
Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators.
BJUI Compass. 2021;2:140-158.
Abstract Related articles

GROVER S, Raj S, Russell B, Mensah E, et al
Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: A retrospective cohort study.
BJUI Compass. 2021;3:124-129.
Abstract Related articles

RODRIGUEZ-HOMS M, Baack Kukreja J
Bladder cancer biomarkers: Past and future directions.
BJUI Compass. 2021;2:7-8.
Abstract Related articles

AL KHADER A, Fararjeh AFS, Kaddumi EG, Al-Saghbini M, et al
Significance of fibulin-3 expression in bladder cancer: a tissue microarray-based immunohistochemical study.
World J Surg Oncol. 2022;20:133.
Abstract Related articles

GUO Q, Zhang T, Gong Y, Tao Y, et al
Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer.
Mol Carcinog. 2022 Apr 26. doi: 10.1002/mc.23411.
Abstract Related articles

ERASLAN A, Ekenci BY, Dogan AE, Kaymak S, et al
Parastomal skin metastasis in a patient with history of urinary bladder cancer.
Urol Case Rep. 2022;43:102088.
Abstract Related articles

KUROKAWA G, Sasaki H, Shimada H, Kasai K, et al
[Laparoscopic Radical Cystectomy with Ileal Neobladder for Metachronous Bladder Cancer Following Laparoscopic Radical Prostatectomy : A Case Report].
Hinyokika Kiyo. 2022;68:87-90.
Abstract Related articles

SYMEONIDIS EN, Baniotis P, Langas G, Stefanidis P, et al
En bloc resection, is this the future of non-muscle invasive bladder cancer management? Presentation of our technique and brief review of the literature.
Urologia. 2022 Apr 25:3915603221093739. doi: 10.1177/03915603221093739.
Abstract Related articles

FADALLAH M, Zahran MH, El-Assmy AM, Barakat NM, et al
Omega-3 polyunsaturated fatty acids: a modified approach for chemo-prevention of bladder cancer in a rat model and molecular studies of antineoplastic mechanisms.
Mol Biol Rep. 2022 Apr 25. pii: 10.1007/s11033-022-07445.
Abstract Related articles

MERTENS LS, Claps F, Mayr R, Hodgson A, et al
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.
Int J Surg Pathol. 2022 Apr 24:10668969221095173. doi: 10.1177/10668969221095173
Abstract Related articles

PAN X, Chen G, Hu W
Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS.
J Clin Lab Anal. 2022 Apr 25:e24452. doi: 10.1002/jcla.24452.
Abstract Related articles

LI J, Liu M, Sun P, Zhao W, et al
Three-Dimensional Conformal Radiotherapy Combined with Gemcitabine and Docetaxel in the Treatment of Advanced Bladder Cancer and Its Effects on Inflammatory Factors and Immune Function.
J Oncol. 2022;2022:9347218.
Abstract Related articles

EL-KARAMANY TM, Al-Adl AM, Hosny MM, A Eldeep H, et al
Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.
Urol Oncol. 2022 Apr 21. pii: S1078-1439(22)00099.
Abstract Related articles

BURGESS EF, Livasy C, Trufan S, Zhu J, et al
Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer.
Mol Clin Oncol. 2022;16:102.
Abstract Related articles

TIAN YH, He YF, Tan JS, Jiang Y, et al
The DeltaN p63 Promotes EMT and Metastasis in Bladder Cancer by the PTEN/AKT Signalling Pathway.
Evid Based Complement Alternat Med. 2022;2022:9566055.
Abstract Related articles

LIU CQ, Sun JX, Xu JZ, Qian XY, et al
Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis.
Front Pharmacol. 2022;13:865988.
Abstract Related articles

CHEN Q, Cai L, Liang J
Construction of prognosis model of bladder cancer based on transcriptome.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50:1-9.
Abstract Related articles

MATSUSHITA Y, Kawakami A, Sato R, Watanabe K, et al
Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Jpn J Clin Oncol. 2022 Apr 23. pii: 6573315. doi: 10.1093.
Abstract Related articles

OZAWA Y, Yagi Y, Nakamura K, Hattori S, et al
Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer.
Brachytherapy. 2022 Apr 20. pii: S1538-4721(22)00037.
Abstract Related articles

RODLER S, Solyanik O, Ingenerf M, Fabritius M, et al
Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer.
World J Urol. 2022 Apr 23. pii: 10.1007/s00345-022-04010.
Abstract Related articles

ZHANG Y, Zhou H, Tuo ZT, Wang J, et al
Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach.
World J Surg Oncol. 2022;20:130.
Abstract Related articles

DI MEO NA, Loizzo D, Pandolfo SD, Autorino R, et al
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer.
Int J Mol Sci. 2022;23.
Abstract Related articles

DUAN L, Liu X, Luo Z, Zhang C, et al
G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer.
Genes (Basel). 2022;13.
Abstract Related articles

QIN C, Chen ZH, Cao R, Shi MJ, et al
Differential Expression Profiles and Bioinformatics Analysis of tRNA-Derived Small RNAs in Muscle-Invasive Bladder Cancer in a Chinese Population.
Genes (Basel). 2022;13.
Abstract Related articles

MAJ M, Kazmierski L, Balik K, Kowalska K, et al
Bladder Cancer Cells Exert Pleiotropic Effects on Human Adipose-Derived Stem Cells.
Life (Basel). 2022;12.
Abstract Related articles

LEWANDOWSKA K, Lewandowska A, Baranska I, Klatt M, et al
Severe Respiratory Failure Due to Pulmonary BCGosis in a Patient Treated for Superficial Bladder Cancer.
Diagnostics (Basel). 2022;12.
Abstract Related articles

GONTERO P, Babjuk M
Swedish national guidelines on urothelial cancer echo the EAU guidelines but with some regional dialect.
Scand J Urol. 2022;56:147-148.
Abstract Related articles

METZEN M, Kowar M, Solleder G, Wilhelm K, et al
[BCG-therapy as a rare reason for postrenal failure].
Dtsch Med Wochenschr. 2022;147:403-406.
Abstract Related articles

GAKIS G, Perner S, Stenzl A, Renninger M, et al
The role of single-nucleotide polymorphisms of the 8q24 chromosome region in patients with concomitant bladder and prostate cancer.
Scand J Urol. 2022;56:126-130.
Abstract Related articles

YERUKALA SATHIPATI S, Tsai MJ, Shukla SK, Ho SY, et al
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
Sci Rep. 2022;12:4141.
Abstract Related articles

GUNNARSSON U
Anorectal side-effects of radical cystectomy.
Scand J Urol. 2022;56:162-163.
Abstract Related articles

CHENG M, Wang Q, Chen L, Zhao D, et al
LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
Hum Pathol. 2022;123:59-73.
Abstract Related articles

SUBBIAH V, Iannotti NO, Gutierrez M, Smith DC, et al
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies.
Ann Oncol. 2022;33:522-533.
Abstract Related articles

ALEVIZAKOS M, Bellmunt J
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder.
Expert Rev Anticancer Ther. 2022;22:259-267.
Abstract Related articles

LOPEZ-BELTRAN A, Blanca A, Cimadamore A, Montironi R, et al
T1 bladder carcinoma with variant histology: pathological features and clinical significance.
Virchows Arch. 2022;480:989-998.
Abstract Related articles

NELSON D, Kodsi M, Cockrell D, Morgan J, et al
Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab.
J Oncol Pharm Pract. 2022;28:979-982.
Abstract Related articles

JACKSON-SPENCE F, Szabados B, Toms C, Yang YH, et al
Avelumab in locally advanced or metastatic urothelial carcinoma.
Expert Rev Anticancer Ther. 2022;22:135-140.
Abstract Related articles

PI J, Xiong Y, Liu C, Liao J, et al
A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical Markers.
J Invest Surg. 2022;35:1186-1194.
Abstract Related articles

PATEL SH, Wang S, Metcalf MR, Gupta N, et al
Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced Stage.
Clin Genitourin Cancer. 2022;20:60-68.
Abstract Related articles

ITO Y, Yamamoto T, Miyai K, Take J, et al
Ascorbic acid-2 glucoside mitigates intestinal damage during pelvic radiotherapy in a rat bladder tumor model.
Int J Radiat Biol. 2022;98:942-957.
Abstract Related articles

LYOU Y, Rosenberg JE, Hoffman-Censits J, Quinn DI, et al
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:35-42.
Abstract Related articles

MORI K, Katayama S, Laukhtina E, Schuettfort VM, et al
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:95.
Abstract Related articles

LAUKHTINA E, Mori K, Mostafaei H, Merseburger AS, et al
Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials.
Semin Oncol. 2021;48:181-192.
Abstract Related articles

CURRAN C, Adib E, Kazakova V, Grivas P, et al
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
Clin Genitourin Cancer. 2022;20:11-16.
Abstract Related articles

LEITE KRM, Borges LL, Filho LR, Chade D, et al
Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant Chemotherapy.
Clin Genitourin Cancer. 2022;20:e1-e6.
Abstract Related articles

ALHALABI O, Hahn AW, Msaouel P, Meric-Bernstam F, et al
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
Clin Genitourin Cancer. 2022;20:e16-e24.
Abstract Related articles

THYAVIHALLY YB, Dev P, Waigankar S, Pednekar A, et al
Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer-analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I).
Asian J Urol. 2022;9:157-164.
Abstract Related articles

CHEN J, Liao Y, Li R, Luo M, et al
Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
Technol Cancer Res Treat. 2022;21:15330338221090093.
Abstract Related articles

HAMADE A, Li D, Tyryshkin K, Xu M, et al
Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer.
Biol Sex Differ. 2022;13:19.
Abstract Related articles

BRICIO TGM, Gouvea GL, Barros RV, Chahud F, et al
What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis.
Cancer Imaging. 2022;22:20.
Abstract Related articles

LU Q, Yin H, Deng Y, Chen W, et al
circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5.
Cell Death Discov. 2022;8:243.
Abstract Related articles

YANG HJ, Liu T, Xiong Y
Anti-cancer effect of LINC00478 in bladder cancer correlates with KDM1A-dependent MMP9 demethylation.
Cell Death Discov. 2022;8:242.
Abstract Related articles

SPEK A
[Intravesical gemcitabine for non-muscle invasive bladder cancer].
Urologe A. 2022 May 4. pii: 10.1007/s00120-022-01840.
Abstract Related articles

MOLLER CT, Fossa SD, Tafjord G, Babigumira R, et al
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment.
Scand J Urol. 2022 May 4:1-7. doi: 10.1080/21681805.2022.2056633.
Abstract Related articles

MARTINEZ MAICAS H, Torregrosa Andres A
Granulomatous renal affectation post-BCG treatment of bladder tumor.
Radiologia (Engl Ed). 2022;64:179-181.
Abstract Related articles

ROUANNE M, Adam J, Radulescu C, Letourneur D, et al
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.
J Clin Invest. 2022 May 3. pii: 145666. doi: 10.1172/JCI145666.
Abstract Related articles

LIU J, Chou Z, Li C, Huang K, et al
ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.
Cancer Cell Int. 2022;22:179.
Abstract Related articles

OBAIDULISLAM M, Bacchetti T, Berrougui H, AbdelouahedKhalil, et al
Effect of glycated HDL on oxidative stress and cholesterol homeostasis in a human bladder cancer cell line, J82.
Exp Mol Pathol. 2022 Apr 29:104777. doi: 10.1016/j.yexmp.2022.104777.
Abstract Related articles

TAN Z, Fu S, Feng R, Huang Y, et al
Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis.
J Oncol. 2022;2022:1802706.
Abstract Related articles

LI T, Xu Q, Wei Y, Lin R, et al
Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma via Inhibition of KLF9.
Comput Math Methods Med. 2022;2022:8911343.
Abstract Related articles

TEOH JY, Castellani D
Editorial: Recent Advances in Bladder Cancer Diagnosis and Treatment.
Front Surg. 2022;9:890172.
Abstract Related articles

GORDON NS, Humayun-Zakaria N, Goel A, Abbotts B, et al
STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes.
Eur Urol Open Sci. 2022;38:88-95.
Abstract Related articles

WU J, Xie RY, Cao CZ, Shang BQ, et al
Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature.
Front Oncol. 2022;12:816444.
Abstract Related articles

KUNIMITSU Y, Morio K, Hirata S, Yamamoto K, et al
Effects of Proton Pump Inhibitors on Survival Outcomes in Patients with Metastatic or Unresectable Urothelial Carcinoma Treated with Pembrolizumab.
Biol Pharm Bull. 2022;45:590-595.
Abstract Related articles

TAIEB A, Berkovic G, Haifler M, Cheshnovsky O, et al
Classification of tissue biopsies by Raman spectroscopy guided by quantitative phase imaging and its application to bladder cancer.
J Biophotonics. 2022 Apr 30:e202200009. doi: 10.1002/jbio.202200009.
Abstract Related articles

VAN HATTUM JW, Scutigliani EM, Helderman RFCPA, Zweije R, et al
A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.
Sci Rep. 2022;12:7017.
Abstract Related articles

HOU J, Lu Z, Liu X, Luo B, et al
Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.
Sci Rep. 2022;12:7003.
Abstract Related articles

AMER S, Ibrahim H, Elkordy M
The Immunohistochemical Expression of SOX-10 in Urothelial Carcinoma and the Non Neoplastic Urothelium; and a Correlation with the Tumor Features.
Asian Pac J Cancer Prev. 2022;23:1425-1432.
Abstract Related articles

CHUNG YH, Cheng YT, Kao YH, Tsai WC, et al
MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/beta-catenin signaling.
Sci Rep. 2022;12:6955.
Abstract Related articles

ALNAJAR H, Ravichandran H, Figueiredo Rendeiro A, Ohara K, et al
Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
Cold Spring Harb Mol Case Stud. 2022;8.
Abstract Related articles

ULLDEMOLINS AZNAR P, Munoz Vicente E, Rosello-Sastre E
[How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre].
Rev Esp Patol. 2022;55:125-134.
Abstract Related articles

CHOU CT, Yu SW, Lin TC
Systematic Review and Meta-Analysis of Inguinal Versus Classic Obturator Nerve Block.
Asian J Anesthesiol. 2022;60:1-10.
Abstract Related articles

MAMMONE RM, Havis B, Royal A, Donnelly LL, et al
Urothelial carcinoma with tonsillar metastasis in a dog.
J Vet Diagn Invest. 2022;34:564-567.
Abstract Related articles

JESSEN NH, Jensen H, Falborg AZ, Glerup H, et al
Contacts to general practice in the 12 months preceding a diagnosis of an abdominal cancer: a national register-based cohort study.
Scand J Prim Health Care. 2022;40:148-156.
Abstract Related articles

LI Z, Feng N, Pu H, Dong Q, et al
PIxel-Level Segmentation of Bladder Tumors on MR Images Using a Random Forest Classifier.
Technol Cancer Res Treat. 2022;21:15330338221086395.
Abstract Related articles

TUNA R, Karaman S, Oktar T, Anak S, et al
Bladder granulocytic sarcoma in a child: case report and literature review.
Turk J Pediatr. 2022;64:152-159.
Abstract Related articles

IZAWA N, Shiokawa H, Onuki R, Hamaji K, et al
The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.
ESMO Open. 2022;7:100415.
Abstract Related articles

SUNG HH, Kim H, Kim R, Kim CK, et al
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
Investig Clin Urol. 2022;63:168-174.
Abstract Related articles

KELSEY K
Epigenetics, environment and epidemiology: an interview with Karl Kelsey.
Epigenomics. 2022;14:323-326.
Abstract Related articles

GUIMARAES-TEIXEIRA C, Lobo J, Miranda-Goncalves V, Barros-Silva D, et al
Downregulation of m(6) A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.
Mol Oncol. 2022;16:1841-1856.
Abstract Related articles

GROBET-JEANDIN E, Pinar U, Roupret M
Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening.
Eur Urol Oncol. 2022;5:42-43.
Abstract Related articles

CHECCUCCI E, Manfredi M, Sica M, Amparore D, et al
Robot-assisted-radical-cystectomy with total intracorporeal Y neobladder: Analysis of postoperative complications and functional outcomes with urodynamics findings.
Eur J Surg Oncol. 2022;48:694-702.
Abstract Related articles

KUMAR S, Kaundal P, Parmar K, Akif S, et al
Bilateral obstructive megaureter with right lower ureteric urothelial carcinoma: a very rare coalition.
Ann R Coll Surg Engl. 2022;104:e153-e155.
Abstract Related articles

LONATI C, Necchi A, Gomez Rivas J, Afferi L, et al
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.
Eur Urol Oncol. 2022;5:30-41.
Abstract Related articles

SAMEH R, Mostafa N, Ramadan M, AbdelRaouf S, et al
Prognostic significance of EZH2 and ARID1A expression in urothelial carcinoma: an immunohistochemical study.
J Histotechnol. 2022;45:21-28.
Abstract Related articles

PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
Abstract Related articles

LIU Y, Wei T
Micturition-triggered severe headache associated with bladder paraganglioma: A case report.
Cephalalgia. 2022;42:166-169.
Abstract Related articles

ABDELZAHER AHMED E, Abdel Bary Abdel-Latif A, Fahmy AM, Elzarrouk Mania I, et al
Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
J Histotechnol. 2021;44:196-205.
Abstract Related articles

ZHONG M, Jiang F, Song L, Nie M, et al
MiR-133b regulates the proliferation, colony formation, and invasion of bladder cancer cells via inhibiting SOX4.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47:407-415.
Abstract Related articles

WOOD LS, Conway D, Lapuente M, Salvador G, et al
Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses.
J Infus Nurs. 2022;45:142-153.
Abstract Related articles

BEANE FREEMAN LE, Kogevinas M, Cantor KP, Villanueva CM, et al
Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies.
Environ Health Perspect. 2022;130:57006.
Abstract Related articles

LV M, Zhong Z, Huang M, Tian Q, et al
Corrigendum to "lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA" [Biochim. Biophys. Acta Mol. Cell Res. 1864 (2017) 1887-1899/BBAMCR-17-151R2].
Biochim Biophys Acta Mol Cell Res. 2022;1869:119281.
Abstract Related articles

GRUBA N, Stachurski L, Lesner A
Chemical tools to monitor bladder cancer progression.
Biomarkers. 2022 May 9:1-41. doi: 10.1080/1354750X.2022.2076153.
Abstract Related articles

SCHULZ A, Loloi J, Pina Martina L, Sankin A, et al
The Development of Non-Invasive Diagnostic Tools in Bladder Cancer.
Onco Targets Ther. 2022;15:497-507.
Abstract Related articles

DE RUITER BM, van de Kamp MW, van Steenbergen JPZ, Franckena M, et al
A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice.
Eur Urol Open Sci. 2022;39:7-13.
Abstract Related articles

GROSSMANN NC, Rajwa P, Quhal F, Konig F, et al
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study.
Eur Urol Open Sci. 2022;39:14-21.
Abstract Related articles

YAMAMOTO Y, Takahara T, Ohashi A, Taniguchi N, et al
Cytokeratin 5/6 expression in pT1 bladder cancer predicts intravesical recurrence in patients treated with bacillus Calmette-Guerin instillation.
Pathology. 2022 May 5. pii: S0031-3025(22)00124.
Abstract Related articles

REN W, Ren J, Zhang N, Liu X, et al
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.
Biochem Biophys Res Commun. 2022;613:12-18.
Abstract Related articles

YONEYAMA MS, Yoneyama T, Tobisawa Y, Yamamoto H, et al
TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
Biochem Biophys Res Commun. 2022;613:1-6.
Abstract Related articles

YAN S, Zeng H, Jin K, Shao F, et al
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer.
J Immunother Cancer. 2022;10.
Abstract Related articles

YANG J, Qi F, Tan B, Dai G, et al
circSPECC1 promotes bladder cancer progression via regulating miR-136-5p/GNAS axis.
Pathol Res Pract. 2022;234:153914.
Abstract Related articles

WANG G, Zhang M, Zhang Y, Xie Y, et al
NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
Clin Transl Med. 2022;12:e738.
Abstract Related articles

INCE O, Yildiz H, Kisbet T, Erturk SM, et al
Classification of retinoblastoma-1 gene mutation with machine learning-based models in bladder cancer.
Heliyon. 2022;8:e09311.
Abstract Related articles

CHO H, Tong F, You S, Jung S, et al
Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology.
IEEE Open J Eng Med Biol. 2022;3:47-57.
Abstract Related articles

KRISTOFFERSEN HL, Roge R, Nielsen S
Comparison of Antibodies to Detect Uroplakin in Urothelial Carcinomas.
Appl Immunohistochem Mol Morphol. 2022;30:326-332.
Abstract Related articles

JAVIER-DESLOGES J, Nelson TJ, Murphy JD, McKay RR, et al
An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials.
Urol Oncol. 2022;40:199.
Abstract Related articles

SCHNEIDEWIND L, Kiss B
[Extended vs. standard lymphadenectomy for the treatment of urothelial carcinoma of the bladder in patients undergoing radical cystectomy].
Urologe A. 2022;61:530-533.
Abstract Related articles

RAVI P, Ravi A, Riaz IB, Freeman D, et al
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.
Oncologist. 2022;27:e406-e409.
Abstract Related articles

SHARMA G, Krishna M, Pareek T, Bora GS, et al
Current practice patterns in the perioperative management of patients undergoing radical cystectomy: Results from a global survey.
Urol Oncol. 2022;40:196.
Abstract Related articles

MOULAVASILIS N, Stravodimos K, Meletis E, Levis P, et al
The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
Diagn Cytopathol. 2022;50:289-294.
Abstract Related articles

SONG Y, Du Y, Qin C, Xu T, et al
Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".
World J Urol. 2022;40:1251-1252.
Abstract Related articles

MCINTIRE PJ, Aragao A, Burns BL, Pambuccian SE, et al
Digital image analysis of high-grade urothelial carcinoma in urine cytology confirms chromasia heterogeneity and reveals a subset with hypochromatic nuclei and another with extremely dark or "India ink" nuclei.
Cancer Cytopathol. 2022;130:363-369.
Abstract Related articles

O'SULLIVAN S, Janssen M, Holzinger A, Nevejans N, et al
Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.
World J Urol. 2022;40:1125-1134.
Abstract Related articles

LI H, Ni M, Xue C, Li L, et al
Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma: Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis.
Clin Immunol. 2022;236:108927.
Abstract Related articles

GEYNISMAN DM, Broughton E, Hao Y, Zhang Y, et al
Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States.
Urol Oncol. 2022;40:195.
Abstract Related articles

YAMAMOTO S, Kato M, Takeyama Y, Yukimatsu N, et al
A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma.
Urol Oncol. 2022;40:194.
Abstract Related articles

BADIANI S, MacDermid E, Rutland T, Turner C, et al
Metastatic urothelial carcinoma to the colon presenting with pelvic abscess tracking to the right hip joint.
ANZ J Surg. 2022;92:1229-1231.
Abstract Related articles

XIA QD, Hu J, Liu Z, Li C, et al
Can artificial intelligence help reduce unnecessary bladder biopsies? Comment on "Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary".
World J Urol. 2022;40:1241-1242.
Abstract Related articles

SHAH HD, Saranath D, Murthy V
A molecular dynamics and docking study to screen anti-cancer compounds targeting mutated p53.
J Biomol Struct Dyn. 2022;40:2407-2416.
Abstract Related articles

KONALA VM, Adapa S, Aronow WS
Immunotherapy in Bladder Cancer.
Am J Ther. 2022;29:e334-e337.
Abstract Related articles

FAVORITO LA
Vesical imaging reporting and data system (VI-RADS) in bladder cancer diagnosis in review in this number of International Brazilian Journal of Urology.
Int Braz J Urol. 2022;48:607-608.
Abstract Related articles

SINGH R, Singh UP, Agrawal V, Garg M, et al
Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
Mol Biol Rep. 2022 May 20. pii: 10.1007/s11033-022-07563.
Abstract Related articles

SUDOL D, Widz D, Mitura P, Plaza P, et al
Neutrophil-to-lymphocyte ratio as a predictor of overall survival and cancer advancement in patients undergoing radical cystectomy for bladder cancer.
Cent European J Urol. 2022;75:41-46.
Abstract Related articles

JEONG SH, Ku JH
Urinary Markers for Bladder Cancer Diagnosis and Monitoring.
Front Cell Dev Biol. 2022;10:892067.
Abstract Related articles

HAGIMOTO H, Sano T, Kashima S, Yoshino T, et al
Rapidly Progressive Bladder Cancer Diagnosed because of Spontaneous Bladder Rupture.
Case Rep Urol. 2022;2022:4586199.
Abstract Related articles

LUO Z, Jiao B, Huang T, Zhao H, et al
What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Technol Cancer Res Treat. 2022;21:15330338221095667.
Abstract Related articles

SARIER M
Association between human papillomavirus and urothelial carcinoma of the bladder.
Rev Assoc Med Bras (1992). 2022;68:551-552.
Abstract Related articles

LIU J, Song W, Li Y, Wang Y, et al
Burden of Coronary Heart Disease and Cancer from Dietary Exposure to Inorganic Arsenic in Adults in China, 2016.
Ann Glob Health. 2022;88:28.
Abstract Related articles

RAJENDRAN G, Taylor JA 3rd, Woolbright BL
Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer.
Cancer Drug Resist. 2021;4:69-84.
Abstract Related articles

FUU T, Iijima K, Kusama Y, Otsuki T, et al
Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report.
J Med Case Rep. 2022;16:193.
Abstract Related articles

CHI M, Liu J, Mei C, Shi Y, et al
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
J Exp Clin Cancer Res. 2022;41:175.
Abstract Related articles

SHAFI S, Aung TN, Xirou V, Gavrielatou N, et al
Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.
Lab Invest. 2022 May 17. pii: 10.1038/s41374-022-00796.
Abstract Related articles

HENSLEY PJ, Panebianco V, Pietzak E, Kutikov A, et al
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations.
Eur Urol Oncol. 2022 May 14. pii: S2588-9311(22)00066.
Abstract Related articles

RANTI D, Bieber C, Wang YS, Sfakianos JP, et al
Natural killer cells: unlocking new treatments for bladder cancer.
Trends Cancer. 2022 May 14. pii: S2405-8033(22)00073.
Abstract Related articles

GARAS SN, McAlpine K, Ross J, Carrier M, et al
Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
Urol Oncol. 2022 May 14. pii: S1078-1439(22)00116.
Abstract Related articles

HIETALA A, Joutsen J, Vaarala S, Saily M, et al
A rare and complete response to combination therapy with radiation and nivolumab in a patient with metastatic urothelial cancer.
BMJ Case Rep. 2022;15.
Abstract Related articles

LI Y, Youssef SF, Buanz AB
Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions.
Eur J Pharmacol. 2022 May 14:175024. doi: 10.1016/j.ejphar.2022.175024.
Abstract Related articles

MARKOVITZ GH
Two cases of Bacillus Calmette-Guerin cystitis treated with hyperbaric oxygen.
Undersea Hyperb Med. 2022;49:191-195.
Abstract Related articles

LONGJUN C, Jianjun Z, Kun P, Lin H, et al
NF-kappaB-Activated lncRNACASC9 Promotes Bladder Cancer Progression by Regulating the TK1 Expression.
J Oncol. 2022;2022:9905776.
Abstract Related articles

TONRY CL, Evans RM, Ruddock MW, Duggan B, et al
Clinical features and predictive biomarkers for bladder cancer in patients with Type 2 Diabetes presenting with haematuria.
Diabetes Metab Res Rev. 2022 May 16:e3546. doi: 10.1002/dmrr.3546.
Abstract Related articles

BEIJERT IJ, Hentschel AE, Brundl J, Comperat EM, et al
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Eur Urol Focus. 2022 May 13. pii: S2405-4569(22)00110.
Abstract Related articles

GOMEZ-ROCA C, Cassier P, Zamarin D, Machiels JP, et al
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naive or experienced for immune checkpoint blockade.
J Immunother Cancer. 2022;10.
Abstract Related articles

WANG EYH, Pihlstrom N, Malmstrom PU, Gardmark T, et al
Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study.
Scand J Urol. 2022 May 16:1-6. doi: 10.1080/21681805.2022.2062046.
Abstract Related articles

LI J, Cao D, Huang Y, Xiong Q, et al
The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer.
Front Immunol. 2022;13:865643.
Abstract Related articles

KONIG F, Pradere B, Grossmann NC, Quhal F, et al
Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.
Transl Cancer Res. 2022;11:908-917.
Abstract Related articles

MITCHELL A, Ingle M, Smith G, Chick J, et al
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac.
Clin Transl Radiat Oncol. 2022;35:27-32.
Abstract Related articles

GAO X, Cai J
Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.
Front Genet. 2022;13:865204.
Abstract Related articles

XIE Q, Zheng H, Chen Y, Peng X, et al
Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma.
Front Public Health. 2022;10:837854.
Abstract Related articles

VILARES AT, Nunes Silva C, Correia da Silva M, Sousa J, et al
Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer.
Radiol Case Rep. 2022;17:2383-2387.
Abstract Related articles

CATTO JWF, Khetrapal P, Ricciardi F, Ambler G, et al
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.
JAMA. 2022 May 15. pii: 2792543. doi: 10.1001/jama.2022.7393.
Abstract Related articles

MAGANTY A, Herrel LA, Hollenbeck BK
Robotic Surgery for Bladder Cancer.
JAMA. 2022 May 15. pii: 2792544. doi: 10.1001/jama.2022.6417.
Abstract Related articles

FENG D, Lv J, Li K, Cao Q, et al
CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
Cell Biol Toxicol. 2022 May 14. pii: 10.1007/s10565-022-09715.
Abstract Related articles

MEDLE B, Sjodahl G, Eriksson P, Liedberg F, et al
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review.
Cancers (Basel). 2022;14.
Abstract Related articles

KOLAT D, Kaluzinska Z, Bednarek AK, Pluciennik E, et al
Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2alpha and AP-2gamma Transcription Factors in Bladder Cancer.
Cells. 2022;11.
Abstract Related articles

LAI CR, Wang HH, Chang HH, Tsai YL, et al
Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers.
Int J Mol Sci. 2022;23.
Abstract Related articles

SHIGETA K, Matsumoto K, Tanaka N, Mikami S, et al
Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma.
Int J Mol Sci. 2022;23.
Abstract Related articles

HARLAND N, Maurer FB, Abruzzese T, Bock C, et al
Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.
Int J Mol Sci. 2022;23.
Abstract Related articles

MICHAELI JC, Boch T, Albers S, Michaeli T, et al
Socio-economic burden of disease: Survivorship costs for bladder cancer.
J Cancer Policy. 2022;32:100326.
Abstract Related articles

WU J, Li T, Ji H, Chen Z, et al
VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo.
Front Pharmacol. 2022;13:874235.
Abstract Related articles

YAN Y, Cao X, Wang Z, Huang Z, et al
Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer.
Front Mol Biosci. 2022;9:815290.
Abstract Related articles

ZENG S, Zhang Z, Xu C
Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population.
Transl Androl Urol. 2022;11:573-574.
Abstract Related articles

ZHANG W, Zhang J, Hu Z, Sun W, et al
LncRNA ARAP1-AS1 Promotes Bladder Cancer Development by Regulating the miR-3918/KIF20A Axis.
Mol Biotechnol. 2022 May 13. pii: 10.1007/s12033-022-00489.
Abstract Related articles

LU K, Chiu KY, Cheng CL
Immunotherapy in Genitourinary Malignancy: Evolution in Revolution or Revolution in Evolution.
Cancer Treat Res. 2022;183:201-223.
Abstract Related articles

LAFORGUE L, Fertin A, Usson Y, Verdier C, et al
Efficient deformation mechanisms enable invasive cancer cells to migrate faster in 3D collagen networks.
Sci Rep. 2022;12:7867.
Abstract Related articles

JONES TD, Cheng L
Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
Urol Oncol. 2021;39:286-290.
Abstract Related articles

KOGUCHI D, Matsumoto K, Ikeda M, Taoka Y, et al
Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study.
BMC Urol. 2022;22:75.
Abstract Related articles

GAITEIRO C, Soares J, Relvas-Santos M, Peixoto A, et al
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Theranostics. 2022;12:3150-3177.
Abstract Related articles

WANG C, Liu S, Zhang X, Wang Y, et al
SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer.
Hereditas. 2022;159:20.
Abstract Related articles

TAKATA M, Kumagai M, Tsubata Y, Okanemasa Y, et al
A surgical case of high-grade urothelial carcinoma of the renal pelvis complicated with giant hydronephrosis, giving rise to diagnostic difficulties on a cytological examination.
Diagn Pathol. 2022;17:47.
Abstract Related articles

QU YY, Sun Z, Han W, Zou Q, et al
Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 study.
J Immunother Cancer. 2022;10.
Abstract Related articles

RAZDAN S, Eilender B, Pfail JP, Garcia M, et al
Higher preoperative eGFR is a predictor of worse renal function decline after robotic assisted radical cystectomy: Implications for postoperative management.
Urol Oncol. 2022;40:275.
Abstract Related articles

MAR N, Uchio E, Kalebasty AR
Use of immunotherapy in clinical management of genitourinary cancers - a review.
Cancer Treat Res Commun. 2022;31:100564.
Abstract Related articles

GHORBANI H, Soltani S, Zakavi SR, Masoudifard A, et al
Bone scan with technetium 99m-methyl diphosphonate, the missing link in the initial staging of muscle-invasive bladder carcinoma.
Nucl Med Commun. 2022 Apr 12. pii: 00006231-990000000-00007.
Abstract Related articles

MING J, Wang Y, Su Z, Wang C, et al
Annular-shaped stenosis in the ureter: Caution should be taken.
Urol Oncol. 2022;40:274.
Abstract Related articles

MOHAMMADINEJAD P, Khandelwal A, Inoue A, Takahashi H, et al
Utility of an automatic adaptive iterative metal artifact reduction AiMAR algorithm in improving CT imaging of patients with hip prostheses evaluated for suspected bladder malignancy.
Abdom Radiol (NY). 2022;47:2158-2167.
Abstract Related articles

BHARADWAJ M, Kaul S, Fleishman A, Korets R, et al
Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder.
Urol Oncol. 2022;40:274.
Abstract Related articles

HSU HT, Lee HL, Cheng HH, Chang CH, et al
Relationships of multiple metals exposure, global DNA methylation, and urothelial carcinoma in central Taiwan.
Arch Toxicol. 2022;96:1893-1903.
Abstract Related articles

FISCHER-VALUCK BW, Patel SA, Brenneman RJ, Christodouleas J, et al
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
Eur Urol Oncol. 2022;5:246-250.
Abstract Related articles

STANGL-KREMSER J, Muto G, Grosso AA, Briganti A, et al
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.
Urol Oncol. 2022;40:243-261.
Abstract Related articles

TANG X, Xiao X, Sun H, Zheng S, et al
96DRA-Urine: A high throughput sample preparation method for urinary proteome analysis.
J Proteomics. 2022;257:104529.
Abstract Related articles

STENMAN J, Wickart-Johansson G, Sundquist F, Nilsson J, et al
Five-Year Follow-up After Multimodal Treatment Incorporating HDR Brachytherapy for Bladder Prostate Rhabdomyosarcoma in Children.
Int J Radiat Oncol Biol Phys. 2022;113:355-359.
Abstract Related articles

PIAZZA P, Bravi CA, Puliatti S, Cacciamani GE, et al
Assessing pentafecta achievement after robot-assisted radical cystectomy and its association with surgical experience: Results from a high-volume institution.
Urol Oncol. 2022;40:272.
Abstract Related articles

SOFTNESS K, Kaul S, Fleishman A, Efstathiou J, et al
Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder.
Urol Oncol. 2022;40:272.
Abstract Related articles

SHBAIR AT, Yasin AI, Topcu A, Coban G, et al
Metastatic Breast Carcinoma Mimicking Urothelial Carcinoma.
Int J Surg Pathol. 2022;30:466-469.
Abstract Related articles

MERMIER M, Baron P, Roumiguie M, Bajeot AS, et al
Predictive Factors of Early Postoperative Complications After Robot-Assisted Radical Cystectomy for Urothelial Bladder Carcinoma.
J Endourol. 2022;36:634-640.
Abstract Related articles

GEDON J, Kehl A, Aupperle-Lellbach H, von Bomhard W, et al
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006-2019).
Vet Comp Oncol. 2022;20:449-457.
Abstract Related articles

GOMEZ-VEIGA F, Alcaraz-Asensio A, Burgos-Revilla JM, Cozar-Olmo FJ, et al
Advances in urologic oncology "OncoUrology Forum Special Edition": The best of 2020.
Actas Urol Esp (Engl Ed). 2022;46:214-222.
Abstract Related articles

M SERAG EL-DIEN M, Fathy Mahmoud S, Alhanafy AM, Mohamed Zanaty F, et al
Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma.
J Immunoassay Immunochem. 2022;43:308-332.
Abstract Related articles

PINARD CJ, Stegelmeier AA, Bridle BW, Mutsaers AJ, et al
Evaluation of lymphocyte-specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
Vet Comp Oncol. 2022;20:427-436.
Abstract Related articles

YU CC, Chen CH, Hong JH, Ke HL, et al
Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration Group.
Surg Endosc. 2022;36:4342-4348.
Abstract Related articles

LIMKIN EJ, Guerin F, Espenel S, Terlizzi M, et al
Use of an intravaginal spacer in young girls treated with brachytherapy for bladder neck rhabdomyosarcoma: Dosimetric impact for organs at risk sparing and acute tolerance.
Cancer Radiother. 2022;26:486-490.
Abstract Related articles

THIRUNAVUKKARASU B, Singh S, Sharma AP, Bal A, et al
Atrophic Kidney-Like Lesion - Case Report of A Provisional Entity with Brief Review of Literature.
Turk Patoloji Derg. 2022;38:148-152.
Abstract Related articles

GU Y, Zeng J, Zou Y, Liu C, et al
Folate Intake and Risk of Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Epidemiological Studies.
Nutr Cancer. 2022;74:1593-1605.
Abstract Related articles

JIAO B, Liu K, Gong H, Ding Z, et al
Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles.
J Control Release. 2022 May 23. pii: S0168-3659(22)00302.
Abstract Related articles

LIAO MY, Huang TC, Chin YC, Cheng TY, et al
Surfactant-Free Green Synthesis of Au@Chlorophyll Nanorods for NIR PDT-Elicited CDT in Bladder Cancer Therapy.
ACS Appl Bio Mater. 2022 May 26. doi: 10.1021/acsabm.2c00228.
Abstract Related articles

WANG F, Liu P, An H, Zhang Y, et al
[Corrigendum] Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT1.
Int J Mol Med. 2022;50.
Abstract Related articles

LIANG S, Fang K, Li S, Liu D, et al
Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts.
Front Genet. 2022;13:872441.
Abstract Related articles

XIAO D, Hu X, Peng M, Deng J, et al
Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy.
Cell Death Dis. 2022;13:499.
Abstract Related articles

JIAN Y, Zhang N, Liu T, Zhu Y, et al
Artificially Intelligent Olfaction for Fast and Noninvasive Diagnosis of Bladder Cancer from Urine.
ACS Sens. 2022 May 25. doi: 10.1021/acssensors.2c00467.
Abstract Related articles

IGAMI K, Uchiumi T, Shiota M, Ueda S, et al
Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients.
Cancer Sci. 2022 May 24. doi: 10.1111/cas.15438.
Abstract Related articles

SHEN Z, Xue D, Wang K, Zhang F, et al
Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
BMC Urol. 2022;22:79.
Abstract Related articles

ZHOU Z, Xiong L, Wu Z, Jiang L, et al
Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1.
Cell Death Dis. 2022;13:492.
Abstract Related articles

APOLO AB, Msaouel P, Niglio S, Simon N, et al
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers.
Am Soc Clin Oncol Educ Book. 2022;42:1-16.
Abstract Related articles

KAO KW, Cheng W, Chang YC
Chondroma of the urinary bladder: A case report.
Medicine (Baltimore). 2022;101:e29229.
Abstract Related articles

CIMADAMORE A, Teoh JY, DI Trapani E, Krajewski W, et al
A gender-related dichotomy in bladder cancer.
Minerva Urol Nephrol. 2022;74:376-378.
Abstract Related articles

TARATKIN M, Morozov A, Checcucci E, Gomez Rivas J, et al
Comment on: "Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder".
Minerva Urol Nephrol. 2022;74:363-364.
Abstract Related articles

QIU J, Zhang H, Xu D, Li L, et al
Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis.
J Oncol. 2022;2022:7306198.
Abstract Related articles

TOOHEY TP, Wallace S, Toohey MG, Francis IC, et al
Papillitis and uveitis complicating Bacillus Calmette-Guerin immunotherapy.
BMJ Case Rep. 2022;15.
Abstract Related articles

BAI X, Lin J, Wu X, Lin Y, et al
Label-free detection of bladder cancer and kidney cancer plasma based on SERS and multivariate statistical algorithm.
Spectrochim Acta A Mol Biomol Spectrosc. 2022;279:121336.
Abstract Related articles

HOLMANG S, Hedelin H
Standardized care pathway for bladder cancer in Sweden. So far lots of pain but little gain.
Scand J Urol. 2022 May 23:1-2. doi: 10.1080/21681805.2022.2078876.
Abstract Related articles

LIN LS, Hu SC, Lin YS, Li DC, et al
A new approach to generating virtual samples to enhance classification accuracy with small data-a case of bladder cancer.
Math Biosci Eng. 2022;19:6204-6233.
Abstract Related articles

LIU C, He D, Zhang S, Chen H, et al
Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting Tumor-Associated Macrophages Toward M1 Through NF-kappaB/NLRP3 Signaling.
Front Immunol. 2022;13:839460.
Abstract Related articles

ZHENG P, Zhang J, Zhu Y, Guan X, et al
Comparative Analysis of the Efficacy of Transurethral Bipolar Plasma Needle Electrode and Ring Electrode in the Treatment of Non-Muscle-Invasive Bladder Cancer.
Comput Intell Neurosci. 2022;2022:6044676.
Abstract Related articles

CHEN K, Zhu S, Yu W, Xia Y, et al
Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
Front Oncol. 2022;12:908832.
Abstract Related articles

NGUYEN C, Ghodoussipour S, Winter M, Cacciamani G, et al
Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patients.
Urol Oncol. 2022 May 19. pii: S1078-1439(22)00121.
Abstract Related articles

CAO X, Yu S, Wang W, Sun R, et al
Lamprey immunity protein enables detection for bladder cancer through recognizing N-hydroxyacetylneuraminic acid (Neu5Gc)-modified as a diagnostic marker and exploration of its production mechanism.
Biochem Biophys Res Commun. 2022;614:153-160.
Abstract Related articles

TSUKAHARA S, Shiota M, Takamatsu D, Nagakawa S, et al
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
Sci Rep. 2022;12:8535.
Abstract Related articles

BARONI RH
A brief review of the VI-RADS classification for bladder tumors on MRI (and a call for increased interface, consistent communication and more joined studies by the radiological and urological communities).
Int Braz J Urol. 2022;48:623-624.
Abstract Related articles

LI M, Xu DM, Lin SB, Yang ZL, et al
Transcriptional expressions of hsa-mir-183 predicted target genes as independent indicators for prognosis in bladder urothelial carcinoma.
Aging (Albany NY). 2022;14:3782-3800.
Abstract Related articles

BELLMUNT J, Valderrama BP, Puente J, Grande E, et al
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management.
Crit Rev Oncol Hematol. 2022;174:103683.
Abstract Related articles

AUDISIO M, Tucci M, Di Stefano RF, Parlagreco E, et al
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?
Crit Rev Oncol Hematol. 2022;174:103682.
Abstract Related articles

POWLES T, Park SH, Voog E, Caserta C, et al
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol. 2022;18:2361-2371.
Abstract Related articles

FRANZA A, Pirovano M, Giannatempo P, Cosmai L, et al
Erdafitinib in locally advanced/metastatic urothelial carcinoma with certain FGFR genetic alterations.
Future Oncol. 2022;18:2455-2464.
Abstract Related articles

NAKANO K, Koh Y, Yamamichi G, Yumiba S, et al
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
Cancer Sci. 2022;113:1830-1842.
Abstract Related articles

VAN DER WEYDEN L, Tibbs C, Knott C, Dobromylskyj M, et al
Metastatic urothelial carcinoma of the urinary bladder in a Sumatran tiger (Panthera tigris sondaica).
Vet Med Sci. 2022;8:1288-1293.
Abstract Related articles

NICOLA R, Pecoraro M, Lucciola S, Dos Reis RB, et al
VI-RADS score system - A primer for urologists.
Int Braz J Urol. 2022;48:609-622.
Abstract Related articles

KRISHNAMURTHY K, Rosen S, Ye H, Sun Y, et al
Yolk sac differentiation in urothelial carcinoma - A rare variant originating from aberrant differentiation of sarcomatoid components.
Ann Diagn Pathol. 2022;58:151923.
Abstract Related articles

DALLA VOLTA A, Petrelli F, Luciani A, Caramella I, et al
Is adjuvant immunotherapy effective in patients with urothelial cancer?
Minerva Urol Nephrol. 2022;74:252-254.
Abstract Related articles

SIEFKER-RADTKE AO, Loriot Y
Erdafitinib for locally advanced or metastatic urothelial carcinoma.
Am J Health Syst Pharm. 2022;79:824-825.
Abstract Related articles

WAKUI S, Takahashi H, Muto T
In Utero Exposure to 3,3',4,4', 5-Pentachlorobiphenyl Dose-Dependently Induces N-butyl-4-(hydroxybutyl) Nitrosamine in Rats With Urinary Bladder Carcinoma.
Toxicol Pathol. 2022;50:366-380.
Abstract Related articles

ZHANG J, Li J, Zhai L, Lin L, et al
Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in a patient with ureteral epithelial cancer.
Neuro Endocrinol Lett. 2021;42:383-386.
Abstract Related articles

FICARRA V, Giannarini G, Alario G, Tulone G, et al
Urethral fixation technique improves urinary continence recovery in men undergoing open radical cystectomy and ileal orthotopic neobladder.
Minerva Urol Nephrol. 2022;74:313-320.
Abstract Related articles

SCHUETTFORT VM, Gust K, D'Andrea D, Quhal F, et al
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Minerva Urol Nephrol. 2022;74:302-312.
Abstract Related articles

PASTORE AL, Fuschi A, DE Nunzio C, Balzarro M, et al
Possible role of 5-alpha reductase inhibitors in non-invasive bladder urothelial neoplasm: multicenter study.
Minerva Urol Nephrol. 2022;74:337-343.
Abstract Related articles

OUSATI ASHTIANI Z, Abbasi S, Pourmand G, Ghafouri-Fard S, et al
Overexpression of long intergenic noncoding RNAs in bladder cancer: A new insight to cancer diagnosis.
Pathol Res Pract. 2022;235:153961.
Abstract Related articles

ABD EL-SALAM MA, Smith CEP, Pan CX
Insights on recent innovations in bladder cancer immunotherapy.
Cancer Cytopathol. 2022 Jun 2. doi: 10.1002/cncy.22603.
Abstract Related articles

KIM H, Roh Y, Yong Park S, Lee C, et al
In vitro and in vivo anti-tumor efficacy of krill oil against bladder cancer: Involvement of tumor-associated angiogenic vasculature.
Food Res Int. 2022;156:111144.
Abstract Related articles

HUANG C, Ai X, Hu L, Ren D, et al
The Role of NMP22 and CSTB Levels in Predicting Postoperative Recurrence of Bladder Cancer.
J Immunol Res. 2022;2022:6735310.
Abstract Related articles

JIANG Y, Zeng Z, Xiong S, Jiang M, et al
New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer.
Front Cell Dev Biol. 2022;10:775417.
Abstract Related articles

ZHANG X, Wang Y, Zhang J, Zhang L, et al
Development of a MRI-Based Radiomics Nomogram for Prediction of Response of Patients With Muscle-Invasive Bladder Cancer to Neoadjuvant Chemotherapy.
Front Oncol. 2022;12:878499.
Abstract Related articles

XIONG Y, Pang M, Du Y, Yu X, et al
The LINC01929/miR-6875-5p/ADAMTS12 Axis in the ceRNA Network Regulates the Development of Advanced Bladder Cancer.
Front Oncol. 2022;12:856560.
Abstract Related articles

ZHONG X, Lin T, Shen Y, Zhang P, et al
Non-muscle-invasive bladder cancer with metastasis to cervical lymph nodes without local recurrence or progression: A case report.
Asian J Surg. 2022 May 26. pii: S1015-9584(22)00622.
Abstract Related articles

CHENG X, Wang Y, Li Y, Liu W, et al
Quantification of ferroptosis pattern in bladder carcinoma and its significance on immunotherapy.
Sci Rep. 2022;12:9066.
Abstract Related articles

HWANG TI, Chen PC, Tsai TF, Lin JF, et al
Correction: Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion.
Cell Death Dis. 2022;13:514.
Abstract Related articles

KOU B, Gao Y, Du C, Shi Q, et al
Corrigendum to 'miR-145 inhibits invasion of bladder cancer cells by targeting PAK1'.
Urol Oncol. 2022 May 28. pii: S1078-1439(22)00179.
Abstract Related articles

SEVERGINA LO, Kislyakov DA, Korovin IA, Sorokin NI, et al
[Interpretation of biopsy material after transuretral and laser en bloc resection of non-muscle-invasive bladder cancer].
Arkh Patol. 2022;84:32-39.
Abstract Related articles

AHMADINEZHAD M, Arshadi M, Hesari E, Sharafoddin M, et al
Relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis in cohort studies.
Epidemiol Health. 2022 May 30:e2022050. doi: 10.4178/epih.e2022050.
Abstract Related articles

FANG Z, Yang X, Wei X, Yang Y, et al
EDARADD silencing suppresses the proliferation and migration of bladder cancer cells.
Urol Oncol. 2022 May 27. pii: S1078-1439(22)00148.
Abstract Related articles

VALENZA C, Antonarelli G, Giugliano F, Aurilio G, et al
Emerging treatment landscape of non-muscle invasive bladder cancer.
Expert Opin Biol Ther. 2022 May 31:1-18. doi: 10.1080/14712598.2022.2082869.
Abstract Related articles

YOUSSIEF AA, Gamal DA, El-Naggar MS, Zarzor MA, et al
Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
Asian Pac J Cancer Prev. 2022;23:1733-1740.
Abstract Related articles

FARSHID S, Alijanpour A, Barahman M, Dastgheib SA, et al
Associations of MTHFR rs1801133 (677C>T) and rs180113 (1298A>C) Polymorphisms with Susceptibility to Bladder Cancer: A Systematic Review and Meta-Analysis.
Asian Pac J Cancer Prev. 2022;23:1465-1482.
Abstract Related articles

ARSLAN AI, Karabag S, Akgul M
Histiocytic Sarcoma with Invasive Urothelial Carcinoma of Urinary Bladder.
J Coll Physicians Surg Pak. 2022;32:S79-S81.
Abstract Related articles

KALKAN G, Ahsen H, Yalcin B
Cutaneous Metastasis from Transitional Cell Carcinoma of Urinary Bladder.
J Coll Physicians Surg Pak. 2022;32:S58-S60.
Abstract Related articles

STARMANS MPA, Ho LS, Smits F, Beije N, et al
Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography.
J Pers Med. 2022;12.
Abstract Related articles

ECKE TH, Le Calvez-Kelm F, Otto T
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision.
Int J Mol Sci. 2022;23.
Abstract Related articles

GENG R, Harland N, Montes-Mojarro IA, Fend F, et al
CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
Int J Mol Sci. 2022;23.
Abstract Related articles

KOTOLLOSHI R, Gajda M, Grimm MO, Steinbach D, et al
Wnt/beta-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells.
Int J Mol Sci. 2022;23.
Abstract Related articles

AUDISIO M, Buttigliero C, Turco F, Delcuratolo MD, et al
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
Cells. 2022;11.
Abstract Related articles

KOIMTZIS G, Alexandrou V, Chalklin CG, Carrington-Windo E, et al
The Role of Adjuvant Single Postoperative Instillation of Gemcitabine for Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Diagnostics (Basel). 2022;12.
Abstract Related articles

LEE CU, Song W, Koo MJ, Boo Y, et al
Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.
Diagnostics (Basel). 2022;12.
Abstract Related articles

BARONE B, Calogero A, Scafuri L, Ferro M, et al
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review.
Cancers (Basel). 2022;14.
Abstract Related articles

STROGGILOS R, Frantzi M, Zoidakis J, Mokou M, et al
Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature.
Cancers (Basel). 2022;14.
Abstract Related articles

HIRANO S, Matsumoto K, Tanaka K, Amano N, et al
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

MADEJ A, Forma E, Golberg M, Kaminski R, et al
(13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

JAGUVA VASUDEVAN AA, Hoffmann MJ, Poschmann G, Petzsch P, et al
Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression.
Sci Data. 2022;9:240.
Abstract Related articles

BLACK PC, Alimohamed N, Kassouf W, Gore JL, et al
Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.
Can Urol Assoc J. 2022;16:E307-E314.
Abstract Related articles

MOLLICA V, Massari F, Rizzo A, Ferrara R, et al
Genomics and Immunomics in the Treatment of Urothelial Carcinoma.
Curr Oncol. 2022;29:3499-3518.
Abstract Related articles

AMENYOGBE A, Lemire F, Yachnin D, Carrier M, et al
A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancer.
Can Urol Assoc J. 2022 May 20. pii: cuaj.7865. doi: 10.5489/cuaj.7865.
Abstract Related articles

YOU S, Kim M, Widen S, Yu A, et al
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients.
Urol Oncol. 2022 May 23. pii: S1078-1439(22)00141.
Abstract Related articles

SUKEZAKI A, Kato S, Makise N, Watadani T, et al
Pseudotumoral cystitis mimicking malignancy in a child.
Pediatr Int. 2022;64:e15160.
Abstract Related articles

MASUDA H, Kato M, Yoshiuchi H, Yukimatsu N, et al
[A Case of Metastatic Urothelial Carcinoma with Pseudoprogression of Liver Metastasis during the Treatment with Pembrolizumab].
Hinyokika Kiyo. 2022;68:117-121.
Abstract Related articles

DI SCIASCIO L, Ambrosi F, Franceschini T, Giunchi F, et al
Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?
Pathol Res Pract. 2022;234:153937.
Abstract Related articles

HOSKOPPAL D, Ren Q, Huang H, Park K, et al
Malignant lymphoma of the lower urinary tract: A single institutional experience.
Pathol Res Pract. 2022;234:153932.
Abstract Related articles

SINGH J, Farooq S, Joshi S, Osunkoya AO, et al
Histopathologic findings in patients who have undergone blue light cystoscopy and bladder biopsy or transurethral resection: A contemporary clinicopathologic analysis of 100 cases.
Pathol Res Pract. 2022;234:153916.
Abstract Related articles

MANTIA CM, Sonpavde G
Enfortumab vedotin-ejfv for the treatment of advanced urothelial carcinoma.
Expert Rev Anticancer Ther. 2022;22:449-455.
Abstract Related articles

WANG T, Niu X, Zhong B
Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classification.
Jpn J Clin Oncol. 2022;52:642-649.
Abstract Related articles

PARK JH, Park I, Kim IH, Hur JY, et al
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure.
Curr Probl Cancer. 2022;46:100848.
Abstract Related articles

CELTIK K, Lim K, Dursun F, Xu J, et al
Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database.
Clin Genitourin Cancer. 2022;20:244-251.
Abstract Related articles

GROSSMANN NC, Pradere B, D'Andrea D, Schuettfort VM, et al
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.
Clin Genitourin Cancer. 2022;20:227-236.
Abstract Related articles

COLOMER GALLARDO A, Candela L, Buisan Rueda O, Freixa Sala R, et al
The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance.
Clin Genitourin Cancer. 2022;20:199-209.
Abstract Related articles

AWADALLA A, Zahran MH, Abol-Enein H, Zekri AN, et al
Identification of Different miRNAs and Their Relevant miRNA Targeted Genes Involved in Sister Chromatid Cohesion and Segregation (SCCS)/chromatin Remodeling Pathway on T1G3 Urothelial Carcinoma (UC) Response to BCG Immunotherapy.
Clin Genitourin Cancer. 2022;20:e181-e189.
Abstract Related articles

KRAFFT U, Mahmoud O, Hess J, Radtke JP, et al
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture.
Langenbecks Arch Surg. 2022;407:1233-1240.
Abstract Related articles

GETZ K, Mamtani R, Hubbard RA
Integrating real world data and clinical trial results using survival data reconstruction and marginal moment-balancing weights.
J Biopharm Stat. 2022;32:191-203.
Abstract Related articles

TSUJI S, Reil K, Nelson K, Proclivo VH, et al
Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer.
Cancer Immunol Res. 2022 Jun 9. pii: 704817. doi: 10.1158/2326-6066.CIR-21-0879.
Abstract Related articles

FAN B, Teng Q, Sun M, Wang Y, et al
Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma.
J Oncol. 2022;2022:1755368.
Abstract Related articles

WANG Z, Li X, Wang X, Liu J, et al
Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy.
J Immunol Res. 2022;2022:6737241.
Abstract Related articles

WANG Z, He S, Jiang M, Li X, et al
Mechanism Study on Radiosensitization Effect of Curcumin in Bladder Cancer Cells Regulated by Filamin A.
Dose Response. 2022;20:15593258221100997.
Abstract Related articles

GLOSSER LD, Zakeri BS, Lombardi CV, Ekwenna OO, et al
Conservative Management of Muscle Invasive Bladder Cancer in Kidney-Pancreas Transplant Patient.
Case Rep Transplant. 2022;2022:5373414.
Abstract Related articles

CHAE HK, Nam W, Kim HG, Lim S, et al
Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen.
Front Immunol. 2022;13:903297.
Abstract Related articles

LIU Y, Xu X, Wang H, Liu Y, et al
The Additional Value Evaluation of Tri-parametric MRI in Identifying Muscle-invasive Status in Bladder Cancer.
Acad Radiol. 2022 Jun 5. pii: S1076-6332(22)00261.
Abstract Related articles

FERRO M, Barone B, Crocetto F, Lucarelli G, et al
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer.
Urol Oncol. 2022 Jun 5. pii: S1078-1439(22)00186.
Abstract Related articles

CAUSA ANDRIEU PI, Tzeng M
Inguinal hernia plugs mimicking abdominal wall invasion of bladder cancer - A potential imaging pitfall.
Radiologia (Engl Ed). 2022;64:274-276.
Abstract Related articles

KOBAYASHI K, Matsumoto H, Misumi T, Ito H, et al
The efficacy of trimodal chemoradiotherapy with gemcitabine and cisplatin as a bladder-preserving strategy for the treatment of muscle-invasive bladder cancer: a single-arm phase II study.
Jpn J Clin Oncol. 2022 Jun 9. pii: 6604440. doi: 10.1093.
Abstract Related articles

HASAN S, Lazarev S, Garg M, Mehta K, et al
Racial inequity and other social disparities in the diagnosis and management of bladder cancer.
Cancer Med. 2022 Jun 8. doi: 10.1002/cam4.4917.
Abstract Related articles

SHI R, Wang X, Wu Y, Xu B, et al
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
Theranostics. 2022;12:4181-4199.
Abstract Related articles

XIONG Y, Song X, Kudusi, Zu X, et al
Oncogenic GBX2 promotes the malignant behaviors of bladder cancer cells by binding to the ITGA5 promoter and activating its transcription.
Funct Integr Genomics. 2022 Jun 8. pii: 10.1007/s10142-022-00870.
Abstract Related articles

Aktuelle Urol. 2022;53:217-218.
Abstract Related articles

Aktuelle Urol. 2022;53:217.
Abstract Related articles

KIM JH, Chang IH
A novel strategy for treatment of bladder cancer: Antibody-drug conjugates.
Investig Clin Urol. 2022 May 30. pii: 63.e49. doi: 10.4111/icu.20220061.
Abstract Related articles

LI H, Chen S, Mi H
A Multiomics Profiling Based on Online Database Revealed Prognostic Biomarkers of BLCA.
Biomed Res Int. 2022;2022:2449449.
Abstract Related articles

WEI Z, Xu J, Li W, Ou L, et al
SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer.
Front Mol Biosci. 2022;9:902220.
Abstract Related articles

LOU K, Feng S, Zhang G, Zou J, et al
Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer.
Front Oncol. 2022;12:879391.
Abstract Related articles

BAEK SW, Mun JY, Jang IH, Yang GE, et al
YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer.
EBioMedicine. 2022;81:104092.
Abstract Related articles

PARK J, Choi YD, Lee K, Seo M, et al
Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis.
Asia Pac J Oncol Nurs. 2022;9:100063.
Abstract Related articles

XIAO S, Zuo Y, Li Y, Huang Y, et al
Long Noncoding RNA HAGLROS Promotes the Malignant Progression of Bladder Cancer by Regulating the miR-330-5p/SPRR1B Axis.
Front Oncol. 2022;12:876090.
Abstract Related articles

CONTIERI R, Lughezzani G, Buffi NM, Taverna G, et al
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.
Front Oncol. 2022;12:879399.
Abstract Related articles

ROBELDO T, Ribeiro LS, Manrique L, Kubo AM, et al
Modified Titanium Dioxide as a Potential Visible-Light-Activated Photosensitizer for Bladder Cancer Treatment.
ACS Omega. 2022;7:17563-17574.
Abstract Related articles

CHI B, Sun Y, Zhao J, Guo Y, et al
Deoxyschizandrin Inhibits the Proliferation, Migration, and Invasion of Bladder Cancer Cells through ALOX5 Regulating PI3K-AKT Signaling Pathway.
J Immunol Res. 2022;2022:3079823.
Abstract Related articles

YU L, Hu R, Peng G, Ding Q, et al
Prognostic Significance of Lineage Diversity in Bladder Cancer Revealed by Single-Cell Sequencing.
Front Genet. 2022;13:862634.
Abstract Related articles

PARK C, Choi EO, Hwangbo H, Lee H, et al
Induction of apoptotic cell death in human bladder cancer cells by ethanol extract of Zanthoxylum schinifolium leaf, through ROS-dependent inactivation of the PI3K/Akt signaling pathway.
Nutr Res Pract. 2022;16:330-343.
Abstract Related articles

HOEH B, Flammia RS, Hohenhorst L, Sorce G, et al
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients.
J Surg Oncol. 2022 Jun 4. doi: 10.1002/jso.26973.
Abstract Related articles

SORIA F, Lucca I, Moschini M, Mathieu R, et al
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362.
Urol Oncol. 2022 Jun 1. pii: S1078-1439(22)00176.
Abstract Related articles

XU N, Yao Z, Shang G, Ye D, et al
Integrated proteogenomic characterization of urothelial carcinoma of the bladder.
J Hematol Oncol. 2022;15:76.
Abstract Related articles

GOEL A, Ward DG, Noyvert B, Yu M, et al
Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes.
Genome Med. 2022;14:59.
Abstract Related articles

BESTARI MG, Oktarina A L, Karim MI, Aryanti, et al
Giant bladder stone resulting in renal failure and concurrent bladder cancer: A case report.
Int J Surg Case Rep. 2022;94:107170.
Abstract Related articles

ZHANG C, Han B, Guo Y, Guan H, et al
MAP9 Exhibits Protumor Activities and Immune Escape toward Bladder Cancer by Mediating TGF-beta1 Pathway.
J Oncol. 2022;2022:3778623.
Abstract Related articles

HE Y, Wu Y, Liu Z, Li B, et al
Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer.
Front Genet. 2022;13:880633.
Abstract Related articles

WANG H, Shao Z, Xu Z, Ye B, et al
Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells.
Iran J Basic Med Sci. 2022;25:536-542.
Abstract Related articles

LIU C, Li Z, Ni L
Analysis of the Significance of miR-141 and CD147 Expression in Bladder Cancer Cells and Its Relationship with Tumor Grade.
Contrast Media Mol Imaging. 2022;2022:1335441.
Abstract Related articles

ZHANG W, Loring M
Incidental Bladder Cancer at the Time of Routine Cystoscopy following Laparoscopic Hysterectomy.
JSLS. 2022;26.
Abstract Related articles

SYMEONIDIS EN, Lo KL, Chui KL, Vakalopoulos I, et al
En bloc resection of bladder tumors: challenges and unmet needs in 2022.
Future Oncol. 2022;18:2545-2558.
Abstract Related articles

ELBADAWY M, Fujisaka K, Yamamoto H, Tsunedomi R, et al
Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method.
Biomed Pharmacother. 2022;151:113105.
Abstract Related articles

PANZA E, Bello I, Smimmo M, Brancaleone V, et al
Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines.
Biomed Pharmacother. 2022;151:113137.
Abstract Related articles

SHEN CH, Wu JY, Wang SC, Wang CH, et al
The suppressive role of phytochemical-induced glutathione S-transferase Mu 2 in human urothelial carcinoma cells.
Biomed Pharmacother. 2022;151:113102.
Abstract Related articles

AHMADI H, Daneshmand S
Association between use of ERAS protocols and complications after radical cystectomy.
World J Urol. 2022;40:1311-1316.
Abstract Related articles

WANG J, Feng Q, Wu Y, Wang H, et al
Involvement of blood lncRNA UCA1 in sepsis development and prognosis, and its correlation with multiple inflammatory cytokines.
J Clin Lab Anal. 2022;36:e24392.
Abstract Related articles

DUM D, Menz A, Volkel C, De Wispelaere N, et al
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Exp Mol Pathol. 2022;126:104762.
Abstract Related articles

LI H, Huang G, Lai Y, Ni L, et al
A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma.
Oncol Res Treat. 2022;45:344-352.
Abstract Related articles

SORCE G, Flammia RS, Hoeh B, Chierigo F, et al
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients.
World J Urol. 2022;40:1481-1488.
Abstract Related articles

ARAGAKI AK, Jing Y, Hoffman-Censits J, Choi W, et al
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Eur Urol Oncol. 2022;5:338-346.
Abstract Related articles

HENSLEY PJ, Bree KK, Brooks N, Matulay J, et al
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guerin Therapy Outcomes.
Eur Urol Oncol. 2022;5:347-356.
Abstract Related articles

SORIA F, D'Andrea D, Gontero P, Shariat SF, et al
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results fro
Eur Urol Focus. 2022;8:633-634.
Abstract Related articles

MONTORSI F, Bandini M, Necchi A
Re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9
Eur Urol Focus. 2022;8:631-632.
Abstract Related articles

MARCQ G, Foerster B, Abufaraj M, Matin SF, et al
Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
Eur Urol Focus. 2022;8:491-497.
Abstract Related articles

VAN DER KWAST T, Liedberg F, Black PC, Kamat A, et al
International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma.
Eur Urol Focus. 2022;8:438-446.
Abstract Related articles

JOSHI M, Holder SL, Zhu J, Zheng H, et al
Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study.
Eur Urol Focus. 2022;8:483-490.
Abstract Related articles

ROSEN G, Anwar T, Syed J, Weinstein D, et al
Initial Experience with Apixaban for Extended Venous Thromboembolism Prophylaxis After Radical Cystectomy.
Eur Urol Focus. 2022;8:480-482.
Abstract Related articles

COLLA RUVOLO C, Nocera L, Stolzenbach LF, Wenzel M, et al
Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy.
Eur Urol Focus. 2022;8:498-505.
Abstract Related articles

MASTROIANNI R, Tuderti G, Anceschi U, Bove AM, et al
Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomised Controlled Trial.
Eur Urol Focus. 2022;8:465-471.
Abstract Related articles

TSANG YP, Lau CW
Outcomes of Partial or Total Cystectomy in Advanced Colon Cancer with Suspected Bladder Invasion-Our 8-Year Experience and Literature Review.
J Gastrointest Cancer. 2022;53:394-402.
Abstract Related articles

MINNELLA EM, Carli F, Kassouf W
Role of prehabilitation following major uro-oncologic surgery: a narrative review.
World J Urol. 2022;40:1289-1298.
Abstract Related articles

HEINZMANN J, Schneider A, Riener MO
[Development of a squamous cell carcinoma of the urinary bladder after intravesical condylomas].
Aktuelle Urol. 2022;53:275-278.
Abstract Related articles

WANG SS, Zhai GQ, Chen G, Huang ZG, et al
Metadherin Promotes the Development of Bladder Cancer by Enhancing Cell Division.
Cancer Biother Radiopharm. 2022 Jun 14. doi: 10.1089/cbr.2021.0392.
Abstract Related articles

MOUSSA M, Chakra MA, Duquesne I
Intravesical MgSO4 for the treatment of BCG refractory T1 G3 bladder cancer: Preliminary results on efficacy and safety.
Intractable Rare Dis Res. 2022;11:81-83.
Abstract Related articles

SONG P, Lu N, Zhang J, Gao X, et al
Cause of death of patients with non-muscular invasive, non-metastatic muscular invasive and metastatic bladder cancer after diagnosis.
Am J Transl Res. 2022;14:3494-3515.
Abstract Related articles

TANG H, Li X, Jiang L, Liu Z, et al
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ.
Cancer Sci. 2022 Jun 14. doi: 10.1111/cas.15459.
Abstract Related articles

CHENG L, Zhang S, Wang M, Lopez-Beltran A, et al
Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management.
Hum Pathol. 2022 Jun 11. pii: S0046-8177(22)00150.
Abstract Related articles

YAO J, Qian K, Chen C, Liu X, et al
Correction for: ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer.
Aging (Albany NY). 2022;undefined.
Abstract Related articles

FREUDENBURG E, Bagheri I, Srinivas S, Martinez A, et al
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review.
Cancer Causes Control. 2022 Jun 14. pii: 10.1007/s10552-022-01593.
Abstract Related articles

CHEN R, Hu B, Jiang M, Deng W, et al
Bioinformatic Analysis of the Expression and Clinical Significance of the DNA Replication Regulator MCM Complex in Bladder Cancer.
Int J Gen Med. 2022;15:5465-5485.
Abstract Related articles

LU B, Wei J, Zhou H, Chen J, et al
Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3.
Cell Death Dis. 2022;13:547.
Abstract Related articles

IBRAHIM A, Khalid R, Mohager S, Fadl-Elmula I, et al
Clinical Characteristics of Urinary Bladder Cancer in the Sudan; Evidence of Pathoetiology Changes.
Gulf J Oncolog. 2022;1:16-20.
Abstract Related articles

DENG L, Jin K, Zhou X, Zhang Z, et al
Blockade of integrin signaling reduces chemotherapy-induced premature senescence in collagen cultured bladder cancer cells.
Precis Clin Med. 2022;5:pbac007.
Abstract Related articles

TU J, Bao W, Ye X, Wu J, et al
Laparoscopic radical cystectomy could be used in the clinical surgical treatment of bladder cancer patients.
Transl Androl Urol. 2022;11:731-732.
Abstract Related articles

ZHU J, Lu Z, Chen W, Ke M, et al
Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer: reply letter.
Transl Androl Urol. 2022;11:733-734.
Abstract Related articles

ZHONG W, Qu H, Yao B, Wang D, et al
Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer.
Cureus. 2022;14:e24818.
Abstract Related articles

PARK J, Kamerer RL, Marjanovic M, Sorrells JE, et al
Label-free optical redox ratio from urinary extracellular vesicles as a screening biomarker for bladder cancer.
Am J Cancer Res. 2022;12:2068-2083.
Abstract Related articles

CHEN MC, Annseles Rajula S, Bharath Kumar V, Hsu CH, et al
Tannic acid attenuate AKT phosphorylation to inhibit UMUC3 bladder cancer cell proliferation.
Mol Cell Biochem. 2022 Jun 13. pii: 10.1007/s11010-022-04454.
Abstract Related articles

PALMIER M, Monnot A, Teniere T, Cohen Q, et al
Mycotic arterial aneurysm secondary to BCG intravesical instillation: A review.
J Med Vasc. 2022;47:94-105.
Abstract Related articles

VERGHOTE F, Sargos P, Christodouleas JP, Murthy V, et al
International Consensus Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy: Update From an IBIS Workgroup.
Pract Radiat Oncol. 2022 Jun 9. pii: S1879-8500(22)00190.
Abstract Related articles

CHIANG Y, Tsai YC, Wang CC, Hsueh FJ, et al
Tumor-derived C-C motif ligand 2 (CCL2) induces the recruitment and polarization of tumor-associated macrophages and increases the metastatic potential of bladder cancer cells in the postirradiated microenvironment.
Int J Radiat Oncol Biol Phys. 2022 Jun 9. pii: S0360-3016(22)00598.
Abstract Related articles

PRUNTY M, Bukavina L, Mahran A, Mishra K, et al
Risk factors for postoperative Clostridium difficile infection after radical cystectomy for bladder cancer: a NSQIP database analysis.
Can J Urol. 2022;29:11170-11174.
Abstract Related articles

ZHENG Y, Ye Y, Chen J, Wei Z, et al
Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.
Int J Surg. 2022;103:106693.
Abstract Related articles

ANSARI DJAFARI A, Javanmard B, Razzaghi M, Hojjati SA, et al
Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Randomized Controlled Trial.
Urol J. 2022 Jun 11. pii: 7194. doi: 10.22037/uj.v19i.7194.
Abstract Related articles

ZHAO W, Sun F, Zhang L, Ouyang J, et al
NEAT1 variant 1 weakens the genome-wide effect of miR-3122 on blocking H3K79me3 in bladder cancer.
Aging (Albany NY). 2022;14.
Abstract Related articles

SENEL C, Asfuroglu A, Aykanat IC, Balci M, et al
Impact of Urinary pH on the Efficacy of a Postoperative Single Instillation of Mitomycin-C.
J Coll Physicians Surg Pak. 2022;32:768-772.
Abstract Related articles

YANG Y, Yu J, Xiong Y, Xiao J, et al
Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer.
Pathol Oncol Res. 2022;28:1610267.
Abstract Related articles

ARIAFAR A, Zeighami S, Salehipour M, Ahmed F, et al
An Investigation of the Pathology Report of Bladder Cancer Patients with Radical Cystectomy in Southern Iran, 2013-2018: A Cross-Sectional Study.
Med J Islam Repub Iran. 2021;35.
Abstract Related articles

WEI Y, Amend B, Todenhofer T, Lipke N, et al
Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems.
Int J Mol Sci. 2022;23.
Abstract Related articles

LOKESHWAR SD, Lopez M, Sarcan S, Aguilar K, et al
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.
Cancers (Basel). 2022;14.
Abstract Related articles

STAKHOVSKYI O, Kobyliak N, Voylenko O, Stakhovskyi E, et al
Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis.
Cells. 2022;11.
Abstract Related articles

MATSUZAWA N, Nishikawa T, Ohno R, Inoue M, et al
Paraganglioma of the urinary bladder initially diagnosed as gastrointestinal stromal tumor requiring combined resection of the rectum: a case report.
World J Surg Oncol. 2022;20:185.
Abstract Related articles

ELAWADY T, Khedr A, El-Enany N, Belal F, et al
Utility of Kolliphor RH 40 in micellar sensitized fluorescence of the novel tyrosine kinase inhibitor "Erdafitinib": Application to human plasma.
Spectrochim Acta A Mol Biomol Spectrosc. 2022;278:121327.
Abstract Related articles

JUN T, Hahn NM, Sonpavde G, Albany C, et al
Phase II Clinical and Translational Study of Everolimus +/- Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
Oncologist. 2022;27:432-e452.
Abstract Related articles

PARK J, Nam A, Lee HB, Jeong SM, et al
Leiomyosarcoma of urinary bladder in a Shih Tzu dog.
J Vet Med Sci. 2022;84:799-803.
Abstract Related articles

KAJTEZOVIC S, Walker AR, Hjalmarsson B, Bell SG, et al
Management of secondary Paget's disease of the vulva associated with transitional cell carcinoma.
J Cancer Res Clin Oncol. 2022;148:1697-1702.
Abstract Related articles

SANGUEDOLCE F, Meneghetti I, Bevilacqua G, Montano B, et al
Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?
Urol Oncol. 2022;40:344.
Abstract Related articles

WILLIAMS SB, Shan Y, Fero KE, Movva G, et al
Comparing costs of renal preservation versus radical nephroureterectomy management among patients with non-metastatic upper tract urothelial carcinoma.
Urol Oncol. 2022;40:345.
Abstract Related articles

DAS JP, Woo S, Ghafoor S, Andrieu PIC, et al
Value of MRI in evaluating urachal carcinoma: A single center retrospective study.
Urol Oncol. 2022;40:345.
Abstract Related articles

UCHIMOTO T, Nakamura K, Komura K, Fukuokaya W, et al
Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma.
Urol Oncol. 2022;40:344.
Abstract Related articles

FUKUOKAYA W, Kimura T, Komura K, Uchimoto T, et al
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors.
Urol Oncol. 2022;40:346.
Abstract Related articles

WU D, Lee CT, Zynger DL
Reclassifying pT3 renal pelvic urothelial carcinoma with renal parenchyma invasion to pT2 improves correlation with overall survival.
Hum Pathol. 2022;125:79-86.
Abstract Related articles

SHANMUGAM BK, Rangaraj S, Subramani K, Srinivasan S, et al
Biomimetic development of chitosan and sodium alginate-based nanocomposites contains zirconia for tissue engineering applications.
J Biomed Mater Res B Appl Biomater. 2022;110:1942-1955.
Abstract Related articles

PATHAK RA, Hemal AK
Editorial Comment on: "Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)" by Veccia et al.
J Endourol. 2022;36:760-761.
Abstract Related articles

MOROZOV A, Babaevskaya D, Taratkin M, Inoyatov J, et al
Systematic Review: The Learning Curve for Robot-Assisted Radical Cystectomy-What Do We Know?
J Endourol. 2022;36:770-784.
Abstract Related articles

ALBISINNI S, Diamand R, Mjaess G, Aoun F, et al
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index.
J Endourol. 2022;36:785-792.
Abstract Related articles

DE WIT R, Powles T, Castellano D, Necchi A, et al
Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.
Br J Clin Pharmacol. 2022;88:3182-3192.
Abstract Related articles

VECCIA A, Carbonara U, Djaladat H, Mehazin R, et al
Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group).
J Endourol. 2022;36:752-759.
Abstract Related articles

MUTAGUCHI J, Morooka K, Kobayashi S, Umehara A, et al
Artificial Intelligence for Segmentation of Bladder Tumor Cystoscopic Images Performed by U-Net with Dilated Convolution.
J Endourol. 2022;36:827-834.
Abstract Related articles

KADONO Y, Kawaguchi S, Nohara T, Shigehara K, et al
Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECIST.
Urol J. 2021;19:202-208.
Abstract Related articles

PENG L, Meng C, Li J, You C, et al
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis.
Eur J Clin Nutr. 2021 Nov 23. pii: 10.1038/s41430-021-01014.
Abstract Related articles

ELSHARNOBY O, Fraser N, Williams A, Scriven S, et al
Bladder urothelial cell carcinoma as a rare cause of haematuria in children: Our experience and review of current literature.
J Pediatr Surg. 2022;57:1409-1413.
Abstract Related articles

WELLIVER C, Feinstein L, Ward JB, Kirkali Z, et al
Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Prostate Cancer Prostatic Dis. 2022;25:269-273.
Abstract Related articles

BAYAT AA, Sadeghi N, Salimi A, Fazli G, et al
The Association of Cell Surface Fibromodulin Expression and Bladder Carcinoma.
Urol J. 2021;19:189-195.
Abstract Related articles

DA COSTA JB, Gibb EA, Nykopp TK, Mannas M, et al
Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy.
Urol Oncol. 2022;40:287-294.
Abstract Related articles

HURST CD, Knowles MA
Mutational landscape of non-muscle-invasive bladder cancer.
Urol Oncol. 2022;40:295-303.
Abstract Related articles

CONDE M, Frew IJ
Therapeutic significance of ARID1A mutation in bladder cancer.
Neoplasia. 2022;31:100814.
Abstract Related articles

LIU H, Gu J, Huang Z, Han Z, et al
Fine particulate matter induces METTL3-mediated m(6)A modification of BIRC5 mRNA in bladder cancer.
J Hazard Mater. 2022;437:129310.
Abstract Related articles

JI N, Long M, Garcia-Vilanova A, Ault R, et al
Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer.
Cancer Immunol Immunother. 2022 Jun 24. pii: 10.1007/s00262-022-03236.
Abstract Related articles

WANG S, Xu D, Gao B, Yan S, et al
Heterogeneity Analysis of Bladder Cancer Based on DNA Methylation Molecular Profiling.
Front Oncol. 2022;12:915542.
Abstract Related articles

BONDARUK J, Jaksik R, Wang Z, Cogdell D, et al
The origin of bladder cancer from mucosal field effects.
iScience. 2022;25:104551.
Abstract Related articles

DONG Y, Ding D, Gu J, Chen M, et al
Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-beta signalling pathway.
Bioengineered. 2022;13:14282-14298.
Abstract Related articles

TOHI Y, Taoka R, Zhang X, Matsuoka Y, et al
Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
Int J Mol Sci. 2022;23.
Abstract Related articles

MAESAKA F, Kuwada M, Horii S, Kishi S, et al
Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer.
Int J Mol Sci. 2022;23.
Abstract Related articles

HU S, Gu S, Wang S, Qi C, et al
Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm.
Genes (Basel). 2022;13.
Abstract Related articles

BIERI U, Buser L, Wettstein MS, Eberli D, et al
Modified Immunoscore Improves Prediction of Survival Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer-A Retrospective Digital Pathology Study.
Diagnostics (Basel). 2022;12.
Abstract Related articles

MORIWAKI M, Le TT, Sung SY, Jotatsu Y, et al
Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy.
Biomolecules. 2022;12.
Abstract Related articles

CHUGHTAI AA, Pannhausen J, Dinger P, Wirtz J, et al
Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR.
Biomedicines. 2022;10.
Abstract Related articles

NISHIMURA K, Ishihara H, Kondo T, Toguchi M, et al
Assessment of Feasibility of Robot-assisted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy.
In Vivo. 2022;36:1801-1806.
Abstract Related articles

ZHUANG J, Yang X, Zheng Q, Li K, et al
Metabolic Profiling of Bladder Cancer Patients' Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy.
Metabolites. 2022;12.
Abstract Related articles

KAMI REDDY KR, Piyarathna DWB, Kamal AHM, Putluri V, et al
Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer.
Metabolites. 2022;12.
Abstract Related articles

TOMIYAMA E, Fujita K, Nakano K, Kuwahara K, et al
Trop-2 in Upper Tract Urothelial Carcinoma.
Curr Oncol. 2022;29:3911-3921.
Abstract Related articles

YAN Y, Li J, Ye M, Li Z, et al
Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer.
Dis Markers. 2022;2022:6936262.
Abstract Related articles

KAVCIC N, Peric I, Zagorac A, Kokalj Vokac N, et al
Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test.
Front Genet. 2022;13:839598.
Abstract Related articles

LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].
Onco Targets Ther. 2022;15:681-682.
Abstract Related articles

RIGIROLI F, Zhang D, Molinger J, Wang Y, et al
Automated versus manual analysis of body composition measures on computed tomography in patients with bladder cancer.
Eur J Radiol. 2022;154:110413.
Abstract Related articles

ALMASSI N, Whiting K, Toubaji A, Lenis AT, et al
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.
JCO Precis Oncol. 2022;6:e2100392.
Abstract Related articles

FACHARZTMAGAZINE R

MMW Fortschr Med. 2022;164:65.
Abstract Related articles

EBNER B, Eismann L, Volz Y, Bischoff R, et al
[Surgical and systemic therapy of bladder cancer].
MMW Fortschr Med. 2022;164:40-42.
Abstract Related articles

EISMANN L, Ebner B, Volz Y, Bischoff R, et al
[Initial symptoms and diagnostics of bladder cancer].
MMW Fortschr Med. 2022;164:36-39.
Abstract Related articles

STIEF CG

MMW Fortschr Med. 2022;164:5.
Abstract Related articles

IYENGAR PV, Marvin DL, Lama D, Tan TZ, et al
TRAF4 inhibits bladder cancer progression by promoting BMP/SMAD signalling.
Mol Cancer Res. 2022 Jun 22. pii: 705055. doi: 10.1158/1541-7786.MCR-20-1029.
Abstract Related articles

SMITH TAD, Lane B, More E, Valentine H, et al
Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature.
Mol Med Rep. 2022;26.
Abstract Related articles

HEO J, Lee J, Nam YJ, Kim Y, et al
The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.
Exp Mol Med. 2022 Jun 21. pii: 10.1038/s12276-022-00786.
Abstract Related articles

CULPAN M, Kazan O, Acar HC, Iplikci A, et al
The probability of residual tumor detection in the second transurethral resection of pT1 urothelial bladder cancer according to the risk factors.
Actas Urol Esp (Engl Ed). 2022 Jun 17. pii: S2173-5786(22)00045.
Abstract Related articles

LU D, Wu Y, Liao S, Xie X, et al
Delayed ileal neobladder fistula caused by bladder stones: a case report.
BMC Urol. 2022;22:87.
Abstract Related articles

ALKANLI N, Ay A, Aydin PK, Cevik G, et al
Investigation of the relationship between MTRR A66G, MTR A2756G gene variations and cell anomalies in early diagnosis and progression of bladder cancer.
Mol Biol Rep. 2022 Jun 17. pii: 10.1007/s11033-022-07597.
Abstract Related articles

NAKATA M, Shimbo T, Kihara A, Sato C, et al
Optimisation of Radiation Therapy in Bladder Preservation Therapy for Patients With Clinical Stage T2N0M0 Bladder Cancer.
Clin Oncol (R Coll Radiol). 2022 Jun 14. pii: S0936-6555(22)00266.
Abstract Related articles

AFFERI L, Lonati C, Montorsi F, Briganti A, et al
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer.
Eur Urol Oncol. 2022 Jun 14. pii: S2588-9311(22)00062.
Abstract Related articles

HOUEDE N, Flahault C, Gross-Goupil M, Le Clanche S, et al
[Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France].
Bull Cancer. 2022 Jun 17. pii: S0007-4551(22)00187.
Abstract Related articles

KIRYAKOZA LC, Diaz JD, Priluck J, Davis J, et al
A Case of Bilateral Diffuse Uveal Melanocytic Proliferation in the Setting of Urothelial Carcinoma of the Ureter: A Failed Response to Plasmapheresis.
Ophthalmic Surg Lasers Imaging Retina. 2022;53:350-353.
Abstract Related articles

AWIWI MO, Vikram R
Radiologic Diagnosis and Staging of Bladder Cancer: An Update.
J Comput Assist Tomogr. 2022 Jun 18. pii: 00004728-990000000-00056.
Abstract Related articles

MATSUE T, Gi M, Shiota M, Tachibana H, et al
The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of beta-catenin signaling.
Cancer Sci. 2022 Jun 20. doi: 10.1111/cas.15467.
Abstract Related articles

NASROLLAHI H, Ahmed F, Eslahi A, Pilehroud MG, et al
Sarcomatoid variant of urothelial carcinoma in the renal pelvis with brain metastasis: a case report.
Pan Afr Med J. 2022;41:233.
Abstract Related articles

CHABAUD S, Pellerin E, Caneparo C, Ringuette-Goulet C, et al
Bladder cancer cell lines adapt their aggressiveness profile to oxygen tension.
Oncol Lett. 2022;24:220.
Abstract Related articles

LU Y, Wang S, Wang Y, Li M, et al
Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy.
Front Oncol. 2022;12:879828.
Abstract Related articles

QIAN J, Yang L, Hu S, Gu S, et al
Feasibility Study on Predicting Recurrence Risk of Bladder Cancer Based on Radiomics Features of Multiphase CT Images.
Front Oncol. 2022;12:899897.
Abstract Related articles

DING L, Xia B, Zhang Y, Liu Z, et al
Web-Based Prediction Models for Overall Survival and Cancer-Specific Survival of Patients With Primary Urachal Carcinoma: A Study Based on SEER Database.
Front Public Health. 2022;10:870920.
Abstract Related articles

SUN X, Xu H, Liu G, Chen J, et al
A Robust Immuno-Prognostic Model of Non-Muscle-Invasive Bladder Cancer Indicates Dynamic Interaction in Tumor Immune Microenvironment Contributes to Cancer Progression.
Front Genet. 2022;13:833989.
Abstract Related articles

ZHANG Y, Hua S, Jiang Q, Xie Z, et al
Identification of Feature Genes of a Novel Neural Network Model for Bladder Cancer.
Front Genet. 2022;13:912171.
Abstract Related articles

TAN WS, Steinberg G, Witjes JA, Li R, et al
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
Eur Urol Oncol. 2022 Jun 16. pii: S2588-9311(22)00088.
Abstract Related articles

TONG S, Hu X, Li Y
Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle-invasive bladder cancer.
Urol Oncol. 2022 Jun 16. pii: S1078-1439(22)00189.
Abstract Related articles

ALATI A, Fabiano E, Geiss R, Mareau A, et al
Bladder preservation in older adults with muscle-invasive bladder cancer: A retrospective study with concurrent chemotherapy and twice-daily hypofractionated radiotherapy schedule.
J Geriatr Oncol. 2022 Jun 15. pii: S1879-4068(22)00135.
Abstract Related articles

NUMAKURA K, Kobayashi M, Ishida T, Okane K, et al
Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study.
Eur Urol Focus. 2022 Jun 15. pii: S2405-4569(22)00130.
Abstract Related articles

TAYLOR AS, Acosta AM, Al-Ahmadie HA, Mehra R, et al
Precursors of Urinary Bladder Cancer: Molecular Alterations and Biomarkers.
Hum Pathol. 2022 Jun 15. pii: S0046-8177(22)00151.
Abstract Related articles

QIU T, Chen Y, Meng L, Xu T, et al
Identification of a metabolism-related gene signature predicting overall survival for bladder cancer.
Genomics. 2022;114:110402.
Abstract Related articles

HUO F, Zhang Y, Li Y, Bu H, et al
Mannose-targeting concanavalin A-epirubicin conjugate for targeted intravesical chemotherapy of bladder cancer.
Chem Asian J. 2022 Jun 17. doi: 10.1002/asia.202200342.
Abstract Related articles

RIETBERGEN DDD, van Gennep EJ, KleinJan GH, Donswijk M, et al
Evaluation of the Hybrid Tracer Indocyanine Green-99mTc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer-A Prospective Pilot Study.
Clin Nucl Med. 2022 Jun 18. pii: 00003072-990000000-00181.
Abstract Related articles

CARRASCO R, Ingelmo-Torres M, Gomez A, Roldan FL, et al
Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer.
World J Urol. 2022 Jun 17. pii: 10.1007/s00345-022-04061.
Abstract Related articles

SILVA DJ, Mesquita A
Complete and long-lasting response to immunotherapy: A case report of urothelial cancer.
Medicine (Baltimore). 2022;101:e28940.
Abstract Related articles

LIU Z, Xing L, Zhu Y, Shi P, et al
Association between TOP2A, RRM1, HER2, ERCC1 expression and response to chemotherapy in patients with non-muscle invasive bladder cancer.
Heliyon. 2022;8:e09643.
Abstract Related articles

XIAYU K, GuoGang C, CanXuan L, WeiBin X, et al
Comprehensive Characterization of Necroptosis-Related lncRNAs in Bladder Cancer Identifies a Novel Signature for Prognosis Prediction.
Dis Markers. 2022;2022:2360299.
Abstract Related articles

MEHMOOD S, Alothman KI, Al Rumayyan M, Altaweel WM, et al
Clinical behavior and survival outcome of urothelial bladder cancer in young adults.
Urol Ann. 2022;14:162-166.
Abstract Related articles

STONE L
Biomarkers for bladder cancer diagnosis, prognosis, monitoring and treatment.
Nat Rev Urol. 2022 Jun 16. pii: 10.1038/s41585-022-00620.
Abstract Related articles

VLAAR JM, Borgman A, Kalkhoven E, Westland D, et al
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer.
Sci Rep. 2022;12:10081.
Abstract Related articles

XUE MQ, Wang YL, Wang JC, Wang XD, et al
Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer.
Sci Rep. 2022;12:10082.
Abstract Related articles

PATHAK A, Kumar M, Singh SK, Singh U, et al
Bayesian inference: Weibull Poisson model for censored data using the expectation-maximization algorithm and its application to bladder cancer data.
J Appl Stat. 2020;49:926-948.
Abstract Related articles

HAN L, Li P, Fu X, Huang Z, et al
Aesculetin inhibits proliferation and induces mitochondrial apoptosis in bladder cancer cells by suppressing the MEK/ERK signaling pathway.
Anticancer Agents Med Chem. 2022 Jun 15. pii: ACAMC-EPUB-124491.
Abstract Related articles

LI R, Xia Y, Chen X, Li X, et al
Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Transl Cancer Res. 2022;11:1005-1016.
Abstract Related articles

ZHENG W, Zhao Y, Wang T, Zhao X, et al
Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Transl Cancer Res. 2022;11:1330-1343.
Abstract Related articles

SOLEK J, Kalwas M, Sobczak M, Debska-Szmich S, et al
Urothelial carcinoma of the prostate with raised beta-hCG levels: a case report.
J Med Case Rep. 2022;16:238.
Abstract Related articles

PAL SK, Somford DM, Grivas P, Sridhar SS, et al
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial.
Future Oncol. 2022;18:2599-2614.
Abstract Related articles

BHANVADIA RR, Lotan Y
Progress in the development of tissue-based biomarkers for urothelial cancer.
Expert Rev Anticancer Ther. 2022;22:605-619.
Abstract Related articles

LETICA-KRIEGEL AS, Tin AL, Nash GM, Benfante NE, et al
Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomy.
Eur J Surg Oncol. 2022;48:1427-1432.
Abstract Related articles

QI Y, Toyooka T, Horiguchi H, Koda S, et al
2-mercaptobenzothiazole generates gamma-H2AX via CYP2E1-dependent production of reactive oxygen species in urothelial cells.
J Biochem Mol Toxicol. 2022;36:e23043.
Abstract Related articles

AL QA'QA' S, Tiwari R, van der Kwast T
Penile extramammary Paget disease associated with urothelial carcinoma in situ: Case report and literature review.
J Cutan Pathol. 2022;49:663-668.
Abstract Related articles

KBIROU A, Hagguir H, Moataz A, Dakir M, et al
Acute renal failure and bladder tumors, about 106 cases.
Nephrol Ther. 2022;18:202-206.
Abstract Related articles

XUE W, Hu X, Zhang Y
The Association of Controlling Nutritional Status (CONUT) Score with Survival in Patients with Surgically Treated Renal Cell Carcinoma and Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Nutr Cancer. 2022;74:1907-1916.
Abstract Related articles

WANG B, Hu L, Chen Y, Zhu B, et al
Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Burns. 2022;48:872-879.
Abstract Related articles

VAN WILPE S, Sultan S, Gorris MAJ, Somford DM, et al
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
Cancer Immunol Immunother. 2022 Jun 30. pii: 10.1007/s00262-022-03234.
Abstract Related articles

YAO J, Liu Y, Yang J, Li M, et al
Single-Cell Sequencing Reveals that DBI is the Key Gene and Potential Therapeutic Target in Quiescent Bladder Cancer Stem Cells.
Front Genet. 2022;13:904536.
Abstract Related articles

YE F, Liang Y, Cheng Z, Liu Y, et al
Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer.
Front Immunol. 2022;13:911902.
Abstract Related articles

Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/beta-Catenin Axis [Retraction].
Cancer Manag Res. 2022;14:2105-2106.
Abstract Related articles

XIAO Y, He L, Dong Y, Huang Y, et al
Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through SAPK/JNK Signaling Pathway.
Cancer Biother Radiopharm. 2022 Jun 29. doi: 10.1089/cbr.2022.0005.
Abstract Related articles

Erratum notice for: "Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation" [Braz J Med Biol Res 2021;54(3):e10222].
Braz J Med Biol Res. 2022;55:e10222erratum.
Abstract Related articles

SAEEDIAN A, Safaei AM, Azimi A, Kolahdouzan K, et al
Implications for pelvic lymph node irradiation in definitive chemoradiotherapy of node negative muscle invasive bladder cancer based on predictive factors of clinicopathologic discrepancy.
J Cancer Res Clin Oncol. 2022 Jun 28. pii: 10.1007/s00432-022-04153.
Abstract Related articles

MARTIN-WAY D, Puche-Sanz I, Cozar JM, Zafra-Gomez A, et al
Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer.
Sci Total Environ. 2022 Jun 25:156965. doi: 10.1016/j.scitotenv.2022.156965.
Abstract Related articles

KHALIL H, Hammam OA, Kamel A
Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma.
Asian Pac J Cancer Prev. 2022;23:2079-2087.
Abstract Related articles

BICCHETTI M, Simone G, Giannarini G, Girometti R, et al
A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
Radiol Med. 2022 Jun 28. pii: 10.1007/s11547-022-01513.
Abstract Related articles

WANG HJ, Cai Q, Huang YP, Li MQ, et al
Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer.
Radiology. 2022 Jun 28:211804. doi: 10.1148/radiol.211804.
Abstract Related articles

LI Y, Jiang L, Wang Z, Wang Y, et al
Profiling of Urine Carbonyl Metabolic Fingerprints in Bladder Cancer Based on Ambient Ionization Mass Spectrometry.
Anal Chem. 2022 Jun 28. doi: 10.1021/acs.analchem.2c01890.
Abstract Related articles

NODA Y, Naiki T, Sugiyama Y, Nagai T, et al
Survival outcome after reduced-port laparoscopic radical cystectomy for bladder cancer: long-term follow-up analysis.
Oncology. 2022 Jun 27. pii: 000525554. doi: 10.1159/000525554.
Abstract Related articles

LEEMING RC, Koutros S, Karagas MR, Baris D, et al
Diet quality, common genetic polymorphisms, and bladder cancer risk in a New England population-based study.
Eur J Nutr. 2022 Jun 27. pii: 10.1007/s00394-022-02932.
Abstract Related articles

JAKIMOW K, Sznajder K
VESICAL IMAGING-REPORTING AND DATA SYSTEM - A NEW APPROACH TO BLADDER CANCER STAGING.
Wiad Lek. 2022;75.
Abstract Related articles

SUN X, Xin S, Jin L, Zhang Y, et al
Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
Bioengineered. 2022;13:13986-13999.
Abstract Related articles

DE NUNZIO C, Lombardo R, Cicione A
Early or Delayed Radical Cystectomy for High-risk Non-muscle-invasive Bladder Cancer: A Hard Dilemma to Solve.
Eur Urol Open Sci. 2022;42:17-18.
Abstract Related articles

BAI Y, Wang H, Wu X, Weng M, et al
Study on Molecular Information Intelligent Diagnosis and Treatment of Bladder Cancer on Pathological Tissue Image.
Front Med (Lausanne). 2022;9:838182.
Abstract Related articles

BARBUR E, Doganca T, Obek C
Safe use of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer during breastfeeding: a case report.
Immunotherapy. 2022 Jun 27. doi: 10.2217/imt-2021-0203.
Abstract Related articles

LIN L, Guo X, Ma Y, Zhu J, et al
Does repeat transurethral resection of bladder tumor influence the diagnosis and prognosis of T1 bladder cancer? A systematic review and meta-analysis.
Eur J Surg Oncol. 2022 Jun 13. pii: S0748-7983(22)00489.
Abstract Related articles

WU X, Wei Y, Lin R, Chen P, et al
Multi-responsive mesoporous polydopamine composite nanorods cooperate with nano-enzyme and photosensitizer for intensive immunotherapy of bladder cancer.
Immunology. 2022 Jun 25. doi: 10.1111/imm.13534.
Abstract Related articles

MAHMOUD AM, Frank I, Orme JJ, Lavoie RR, et al
Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer.
BMC Urol. 2022;22:90.
Abstract Related articles

POHAR KS, Patel S, Lotan Y, Trabulsi E, et al
Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study.
Urol Oncol. 2022 Jun 21. pii: S1078-1439(22)00144.
Abstract Related articles

YAMAGUCHI R, Shimizu Y, Nakayasu R, Utsunomiya N, et al
[A Case of Bladder Plasmacytoma Diagnosed during Treatment of Multiple Myeloma].
Hinyokika Kiyo. 2022;68:149-153.
Abstract Related articles

TAKAHASHI R, Kinase S, Yanagihashi R, Ishitsuka R, et al
[A Case of Reactive Arthritis after BCG Intravesical Infusion Therapy Successfully Treated with Salazosulfapyridine].
Hinyokika Kiyo. 2022;68:145-148.
Abstract Related articles

AKKARY R, Guerin F, Chargari C, Jochault L, et al
Long-term urological complications after conservative local treatment (surgery and brachytherapy) in children with bladder-prostate rhabdomyosarcoma: A single-team experience.
Pediatr Blood Cancer. 2022;69:e29532.
Abstract Related articles

KIJIMA T, Kubo T, Nishihara D, Nukui A, et al
Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients.
Sci Rep. 2022;12:10617.
Abstract Related articles

KIM Y, Choi WJ, Oh J, Kim JK, et al
Compact Smartphone-Based Laser Speckle Contrast Imaging Endoscope Device for Point-of-Care Blood Flow Monitoring.
Biosensors (Basel). 2022;12.
Abstract Related articles

MENDREK M, Witt JH, Sarychev S, Liakos N, et al
Reporting and grading of complications for intracorporeal robot-assisted radical cystectomy: an in-depth short-term morbidity assessment using the novel Comprehensive Complication Index((R)).
World J Urol. 2022;40:1679-1688.
Abstract Related articles

LAUKHTINA E, Boehm A, Peyronnet B, Bravi CA, et al
Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study.
World J Urol. 2022;40:1689-1696.
Abstract Related articles

VEJLGAARD M, Maibom SL, Joensen UN, Thind PO, et al
Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy: a double-blinded, randomised feasibility trial.
World J Urol. 2022;40:1669-1677.
Abstract Related articles

ARORA A, Zugail AS, Pugliesi F, Cathelineau X, et al
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy.
World J Urol. 2022;40:1697-1705.
Abstract Related articles

PUZYRENKO A, Nomani L, Iczkowski K, Giorgadze T, et al
Small cell carcinoma of the urinary bladder: Distinctive cytological characteristics and Cyto-histologic correlation.
Ann Diagn Pathol. 2022;59:151947.
Abstract Related articles

DEL GIUDICE F, Flammia RS, Pecoraro M, Moschini M, et al
The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations.
World J Urol. 2022;40:1617-1628.
Abstract Related articles

HO KKF, Lal V, Hagley D, Bingley J, et al
Systematic Review of Case Reports of Bacillus Calmette-Guerin Vascular Infections.
Ann Vasc Surg. 2022;83:369-377.
Abstract Related articles

LOBO S, Gaze MN, Slater O, Hoskin P, et al
Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
Pediatr Blood Cancer. 2022;69:e29574.
Abstract Related articles

FANG T, Tang C, Yin J, Wang H, et al
Magnetic multi-enzyme cascade combined with liquid chromatography tandem mass spectrometry for fast DNA digestion and quantitative analysis of 5-hydroxymethylcytosine in genome of human bladder cancer T24 cells induced by tetrachlorobenzoquinone.
J Chromatogr A. 2022;1676:463279.
Abstract Related articles

PHE V
Bladder Cancer in Neurogenic Patients.
World J Urol. 2022 Jul 8. pii: 10.1007/s00345-022-04089.
Abstract Related articles

ZHANG Y, Wang Y, Wang J, Zhang K, et al
The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis.
Front Genet. 2022;13:852708.
Abstract Related articles

RUIZ DE PORRAS V
Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
Cancer Drug Resist. 2022;5:339-343.
Abstract Related articles

KE H, Qiu D, Cong Z
Prognosis Analysis and Perioperative Research of Elderly Patients with Non-Muscle-Invasive Bladder Cancer under Computed Tomography Image of Three-Dimensional Reconstruction Algorithm.
Contrast Media Mol Imaging. 2022;2022:6168528.
Abstract Related articles

HU K, Zhu J, Li P, Ying L, et al
Multiorientation Simultaneous Computation of Back-Projection CT Image Reconstruction Algorithm in Staging Diagnosis of Bladder Cancer.
Comput Math Methods Med. 2022;2022:6731491.
Abstract Related articles

MARTIN A, Woolbright BL, Umar S, Ingersoll MA, et al
Bladder cancer, inflammageing and microbiomes.
Nat Rev Urol. 2022 Jul 7. pii: 10.1038/s41585-022-00611.
Abstract Related articles

LIU X, He Y, Tong Y, Huang Q, et al
PODNL1 promotes cell migration and regulates the epithelial/mesenchymal transition process in bladder cancer.
Biochem Biophys Res Commun. 2022;620:165-172.
Abstract Related articles

LEE HW, Seo HK
Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder.
Investig Clin Urol. 2022;63:369-372.
Abstract Related articles

GOTO Y, Tanaka S, Maruo M, Sugawara S, et al
Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis.
IJU Case Rep. 2022;5:304-307.
Abstract Related articles

SONG Q, Yu H, Cheng Y, Han J, et al
Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment.
J Transl Med. 2022;20:308.
Abstract Related articles

XU T, Gu W, Wang X, Xia L, et al
Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature.
World J Surg Oncol. 2022;20:226.
Abstract Related articles

HEMENWAY G, Lewis B, Ghatalia P, Anari F, et al
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and Efficacy.
Eur Urol Oncol. 2022 Jul 2. pii: S2588-9311(22)00107.
Abstract Related articles

KEMP-CASEY A, Mintzes B, Morrow RL, Dormuth CR, et al
Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: an interrupted time series study.
Pharmacoepidemiol Drug Saf. 2022 Jul 5. doi: 10.1002/pds.5508.
Abstract Related articles

HU QG, Yang Z, Chen JW, Kazobinka G, et al
MiR-183-5p-PNPT1 Axis Enhances Cisplatin-induced Apoptosis in Bladder Cancer Cells.
Curr Med Sci. 2022 Jul 5. pii: 10.1007/s11596-022-2580.
Abstract Related articles

GUPTA S, Erickson LA
Postirradiation Angiosarcoma of the Urinary Bladder.
Mayo Clin Proc. 2022;97:1406-1408.
Abstract Related articles

TAN W, Yuan Y, Huang H, Ma J, et al
Comprehensive analysis of autophagy related long non-coding RNAs in prognosis, immunity, and treatment of muscular invasive bladder cancer.
Sci Rep. 2022;12:11242.
Abstract Related articles

ZHENG X, Xu H, Lin T, Tan P, et al
CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer.
Comput Biol Med. 2022;147:105727.
Abstract Related articles

WANG C, Wan H, Zhang H, Yang B, et al
Characterization of Ligand-Receptor Pair in Bladder Cancer Develops a Validated Scoring Model for Prognosis and Treatment Response.
Front Cell Dev Biol. 2022;10:915798.
Abstract Related articles

KOLL FJ, Schwarz A, Kollermann J, Banek S, et al
CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative Cases.
Front Med (Lausanne). 2022;9:875142.
Abstract Related articles

SHANG X, Na X, Wang L, Yang Z, et al
Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells.
Evid Based Complement Alternat Med. 2022;2022:8110796.
Abstract Related articles

CHI BJ, Sun Y, Quan LL, Zhao JT, et al
Metformin Can Enhance the Inhibitory Effect of Olaparib in Bladder Cancer Cells.
Dis Markers. 2022;2022:5709259.
Abstract Related articles

KUMAR P, Sharma S, Sundriyal D, Navria SC, et al
An Institution-Based Demographic Study of Urinary Bladder Cancer from North India.
Indian J Surg Oncol. 2022;13:432-434.
Abstract Related articles

GUO Y, Zheng Z, Zhang W, Mao S, et al
Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer.
Ther Adv Med Oncol. 2022;14:17588359221108690.
Abstract Related articles

MOREO E, Uranga S, Pico A, Gomez AB, et al
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors.
J Immunother Cancer. 2022;10.
Abstract Related articles

WENG M, Bai Y, Xu L, Chang C, et al
Comparison of PD-L1 detection methods, platforms and reagents in bladder cancer.
Ann Diagn Pathol. 2022;60:151986.
Abstract Related articles

YANG Y, Hu H, Chen L, Zhang H, et al
A new survival model based on ferroptosis-related genes (FRGS) for prognostic prediction in bladder cancer.
Actas Urol Esp (Engl Ed). 2022 Jun 29. pii: S2173-5786(22)00046.
Abstract Related articles

HUANG W, Zhang C, Xiong S, Zhou X, et al
miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.
Discov Oncol. 2022;13:57.
Abstract Related articles

RICHTERS A, Leliveld AM, Goossens-Laan CA, Aben KKH, et al
Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry.
World J Urol. 2022 Jul 1. pii: 10.1007/s00345-022-04080.
Abstract Related articles

LIU S, Chen X, Lin T
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives.
J Adv Res. 2022;39:187-202.
Abstract Related articles

CHEN H, Wang Z, Yang N, Zhang J, et al
Decorin inhibits proliferation and metastasis in human bladder cancer cells by upregulating P21.
Medicine (Baltimore). 2022;101:e29760.
Abstract Related articles

ZENG W, Swee DS
Severe and refractory hypocalcaemia secondary to osteoblastic bone metastases in bladder signet ring carcinoma: A case report and literature review.
Medicine (Baltimore). 2022;101:e29731.
Abstract Related articles

ZHANG L, Ding D, Liu J, Liu J, et al
Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer.
Medicine (Baltimore). 2022;101:e29759.
Abstract Related articles

ZHAO X, Li D, Zhao ST, Zhang Y, et al
MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
Eur Rev Med Pharmacol Sci. 2022;26:4158.
Abstract Related articles

JI J, Li H, Chen J, Wang W, et al
Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycleassociated protein 3.
Int J Mol Med. 2022;50.
Abstract Related articles

MEHRNOUSH V, De Lima SG, Kotb A, Hyndman ME, et al
The association of bladder cancer and Cannabis: A systematic review.
Arch Ital Urol Androl. 2022;94:248-251.
Abstract Related articles

ARIAFAR A, Salehipour M, Zeyghami S, Rezaei M, et al
The effect of retroperitonealization of ureteroileal anastomosis on perioperative complications of radical cystectomy with ileal conduit urinary diversion.
Arch Ital Urol Androl. 2022;94:150-154.
Abstract Related articles

MALINARIC R, Mantica G, Balzarini F, Terrone C, et al
Extraperitoneal cystectomy with ureterocutaneostomy derivation in fragile patients - should it be performed more often?
Arch Ital Urol Androl. 2022;94:144-149.
Abstract Related articles

PEREIRA JN, Reis JD, Braga I, Freitas R, et al
Variant histologies of urothelial carcinoma: Does it change the survival outcomes in patients managed with radical cystectomy?
Arch Ital Urol Androl. 2022;94:138-143.
Abstract Related articles

LEONARDI R, Calarco A, Falcone L, Grasso V, et al
Endoscopic laser en bloc removal of bladder tumor. Surgical radicality and improvement of the pathological diagnostic accuracy.
Arch Ital Urol Androl. 2022;94:134-137.
Abstract Related articles

PANG K, Dong Y, Hao L, Shi ZD, et al
ERH Interacts With EIF2alpha and Regulates the EIF2alpha/ATF4/CHOP Pathway in Bladder Cancer Cells.
Front Oncol. 2022;12:871687.
Abstract Related articles

STANGL-KREMSER J, Lambertini L, Di Maida F, Martinez-Fundichely A, et al
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines.
Eur Urol Focus. 2022 Jun 27. pii: S2405-4569(22)00133.
Abstract Related articles

LIU Z, Liu X, Liu F, Zhao H, et al
The comprehensive and systematic identification of BLCA-specific SF-regulated, survival-related AS events.
Gene. 2022;835:146657.
Abstract Related articles

YUAN L, Gero M, Zia S, Aryal SC, et al
Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
Diagn Cytopathol. 2022;50:404-410.
Abstract Related articles

GIM G, Kim Y, Park Y, Kim MJ, et al
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
Oncologist. 2022;27:525-531.
Abstract Related articles

ZHOU Q, Wu WW, Yu CL, Wang P, et al
Saikosaponin A Inhibits Growth of Human Bladder Carcinoma T24 and 5637 Cells Both in Vitro and in Vivo.
Biol Pharm Bull. 2022;45:863-871.
Abstract Related articles

YANG X, Wang Y, Jiao W, Li J, et al
Application of 5G technology to conduct tele-surgical robot-assisted laparoscopic radical cystectomy.
Int J Med Robot. 2022;18:e2412.
Abstract Related articles

MORI K, Schuettfort VM, Egawa S, Comperat E, et al
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Ann Surg Oncol. 2022;29:5317-5318.
Abstract Related articles

BITCON C, Whalen S, Coleman J, Rendon R, et al
Utility of Postoperative Serial Renal Function Monitoring in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma.
Ann Surg Oncol. 2022;29:5333-5337.
Abstract Related articles

MORI K, Schuettfort VM, Katayama S, Laukhtina E, et al
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Ann Surg Oncol. 2022;29:5307-5316.
Abstract Related articles

CHARGARI C, Haie-Meder C, Espenel S, Garcia MA, et al
Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments.
Int J Radiat Oncol Biol Phys. 2022;113:602-613.
Abstract Related articles

YILDIRIM R, Cansu DU, Korkmaz C
A Case of Scleromyxedema Development Following Intravesical Bacillus Calmette-Guerin Administration.
J Rheumatol. 2022;49:858-859.
Abstract Related articles

MORIZANE S, Honda M, Yumioka T, Iwamoto H, et al
Technique of en bloc resection of the membranous urethra and bladder during robot-assisted radical cystectomy in patients without simultaneous urethrectomy.
Asian J Endosc Surg. 2022;15:683-687.
Abstract Related articles

PENNY CL, Quow K, Rundle CW, Al-Rohil RN, et al
Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin.
Br J Dermatol. 2022 Jan 19. doi: 10.1111/bjd.21022.
Abstract Related articles

TAKADA-OWADA A, Fuchizawa H, Kijima T, Ishikawa M, et al
Cryptococcal Prostatitis Forming Caseous and Suppurative Granulomas Diagnosed by Needle Biopsy: A Case Report.
Int J Surg Pathol. 2022;30:586-589.
Abstract Related articles

LI Z, Ren D, Chen C, Sun L, et al
OSU-T315 and doxorubicin synergistically induce apoptosis via mitochondrial pathway in bladder cancer cells.
Cell Biol Int. 2022 Jul 13. doi: 10.1002/cbin.11855.
Abstract Related articles

XIANG Y, Lv D, Song T, Niu C, et al
Tumor suppressive role of microRNA-139-5p in bone marrow mesenchymal stem cells-derived extracellular vesicles in bladder cancer through regulation of the KIF3A/p21 axis.
Cell Death Dis. 2022;13:599.
Abstract Related articles

AZHATI B, Wu G, Zhan H, Liang W, et al
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.
World J Surg Oncol. 2022;20:231.
Abstract Related articles

CHEN C, Na X, Wang L, Yu R, et al
High-throughput screening identifies stevioside as a potent agent to induce apoptosis in bladder cancer cells.
Biochem Pharmacol. 2022 Jul 9:115166. doi: 10.1016/j.bcp.2022.115166.
Abstract Related articles

GUI CP, Li JY, Fu LM, Luo CG, et al
Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer.
J Big Data. 2022;9:88.
Abstract Related articles

HU SP, Zhang Z, Xiao F, Huang JN, et al
Paraganglioma of the Urinary Bladder in a Dog.
J Comp Pathol. 2022;195:1-6.
Abstract Related articles

WANG G, Gao Y, Chen Y, Wang K, et al
Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development.
Front Oncol. 2022;12:921711.
Abstract Related articles

ZHOU Q, Chen S, Lu M, Luo Y, et al
Erratum: EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human bladder cancer: Erratum.
Int J Biol Sci. 2022;18:3798-3799.
Abstract Related articles

WANG L, Wu D, Wu S, Liu Y, et al
The Effect of Narrative Nursing Intervention on Shame in Elderly Patients with Bladder Cancer after Ileal Bladder Replacement: A Cohort Study.
Comput Math Methods Med. 2022;2022:4299919.
Abstract Related articles

D'ANDREA D, Shariat SF, Soria F, Mari A, et al
The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy.
Eur Urol Open Sci. 2022;41:74-80.
Abstract Related articles

KULKARNI GS, Lilge L, Nesbitt M, Dumoulin-White RJ, et al
A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer.
Eur Urol Open Sci. 2022;41:105-111.
Abstract Related articles

YI X, Zheng X, Xu H, Li J, et al
IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer.
Front Immunol. 2022;13:898493.
Abstract Related articles

BONDARUK J, Jaksik R, Wang Z, Cogdell D, et al
Erratum: The origin of bladder cancer from mucosal field effects.
iScience. 2022;25:104715.
Abstract Related articles

AYDIN AM, Cheriyan SK, Reich R, Hajiran A, et al
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer.
Urol Oncol. 2022 Jul 7. pii: S1078-1439(22)00192.
Abstract Related articles

CHU C, Pietzak E
Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non-muscle invasive bladder cancer: Invited review for special issue "Seminar: Treatment Advances and Molecular Biology Insights in Urothelial Carcinoma".
Urol Oncol. 2022 Jul 7. pii: S1078-1439(22)00185.
Abstract Related articles

GRUBA N, Musielak M, Rejmak W, Lesner A, et al
Detection of ADAM15 in urine from patients with bladder cancer.
Anal Biochem. 2022 Jul 7:114805. doi: 10.1016/j.ab.2022.114805.
Abstract Related articles

PAN W, Han J, Wei N, Wu H, et al
LINC00702-mediated DUSP1 transcription in the prevention of bladder cancer progression: Implications in cancer cell proliferation and tumor inflammatory microenvironment.
Genomics. 2022 Jul 6:110428. doi: 10.1016/j.ygeno.2022.110428.
Abstract Related articles

VADER DT, Parikh RB, Li H, Imai K, et al
Impact of label restriction on checkpoint-inhibitor use in bladder cancer and changes in mortality.
JNCI Cancer Spectr. 2022 Jul 9. pii: 6637519. doi: 10.1093.
Abstract Related articles

PENA KB, Riu F, Hernandez A, Guilarte C, et al
Usefulness of the Urine Methylation Test (Bladder EpiCheck((R))) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells-An Institutional Study.
J Clin Med. 2022;11.
Abstract Related articles

WOLLNY T, Wnorowska U, Piktel E, Suprewicz L, et al
Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells.
Int J Mol Sci. 2022;23.
Abstract Related articles

PILISZEK R, Brozyna AA, Rudnicki WR
Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients.
Int J Mol Sci. 2022;23.
Abstract Related articles

BECKER L, Fischer F, Fleck JL, Harland N, et al
Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids.
Int J Mol Sci. 2022;23.
Abstract Related articles

DE CARLO C, Valeri M, Rudini N, Zucali PA, et al
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

HU X, Li G, Wu S
Advances in Diagnosis and Therapy for Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

AMANTINI C, Maggi F, Rossi de Vermandois JA, Gubbiotti M, et al
The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

JIANG S, Redelman-Sidi G
BCG in Bladder Cancer Immunotherapy.
Cancers (Basel). 2022;14.
Abstract Related articles

ZHAO X, Zhang L, Bai L, Zhao Y, et al
Epidemiological analysis of second primary malignant neoplasms in cancer survivors aged 85 years and older: a SEER data analysis (1975-2016).
Sci Rep. 2022;12:11688.
Abstract Related articles

OMORPHOS NP, Ghose A, Hayes JDB, Kandala A, et al
The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer.
Urol Oncol. 2022 Jul 5. pii: S1078-1439(22)00187.
Abstract Related articles

GRANTZAU T, Toft BG, Melchior LC, Elversang J, et al
PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study.
APMIS. 2022;130:498-506.
Abstract Related articles

YHIM HY, Jeon SY, Lee CH, Lee NR, et al
Bilateral pleural effusion associated with atezolizumab in a patient with Lynch syndrome-related urothelial carcinoma: a case report.
Ann Palliat Med. 2022;11:2162-2169.
Abstract Related articles

TAN Z, Jiang Y, Liang L, Wu J, et al
Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.
J Exp Clin Cancer Res. 2022;41:228.
Abstract Related articles

Erratum: Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
Front Immunol. 2022;13:975797.
Abstract Related articles

LIU D, Xu S, Chang T, Ma S, et al
Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Front Immunol. 2022;13:916800.
Abstract Related articles

TENG H, Li Q, Gou M, Liu G, et al
Lamprey immunity protein enables early detection and recurrence monitoring for bladder cancer through recognizing Neu5Gc-modified uromodulin glycoprotein in urine.
Biochim Biophys Acta Mol Basis Dis. 2022;1868:166493.
Abstract Related articles

OEY O, Viswambaram P, Moe A, Swarbick N, et al
Anterior pelvic exenteration and synchronous bilateral nephroureterectomy for BK polyoma virus induced urothelial carcinoma of the bladder: A case report.
Folia Med (Plovdiv). 2022;64:521-526.
Abstract Related articles

WU Q, Cai L, Yuan B, Cao Q, et al
The application value of multi-parameter cystoscope in improving the accuracy of preoperative bladder cancer grading.
BMC Urol. 2022;22:111.
Abstract Related articles

PALACKA P, Janega P, Polakova H, Slopovsky J, et al
Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab.
BMC Urol. 2022;22:108.
Abstract Related articles

YAMASHITA Y, Miura T, Kawamura S, Sumii K, et al
[Treatment of Parastomal Hernia Following Robot-Assisted Radical Cystectomy and Cutaneous Ureterostomy : A Case Report].
Hinyokika Kiyo. 2022;68:197-199.
Abstract Related articles

LI Z, Zhou Z, Cui Y, Zhang Y, et al
Systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection vs. conventional transurethral resection for non-muscle-invasive bladder cancer.
Int J Surg. 2022;104:106777.
Abstract Related articles

LIU S, Shi J, Wang L, Huang Y, et al
Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling.
Free Radic Biol Med. 2022;189:42-57.
Abstract Related articles

WANG L, Shi J, Liu S, Huang Y, et al
RAC3 Inhibition Induces Autophagy to Impair Metastasis in Bladder Cancer Cells via the PI3K/AKT/mTOR Pathway.
Front Oncol. 2022;12:915240.
Abstract Related articles

MOKKAPATI S, Narayan VM, Manyam GC, Lim AH, et al
Lentiviral interferon: A novel method for gene therapy in bladder cancer.
Mol Ther Oncolytics. 2022;26:141-157.
Abstract Related articles

SUN X, Xin S, Li W, Zhang Y, et al
Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer.
Front Genet. 2022;13:928778.
Abstract Related articles

ZHANG X, Liang H, Tang Q, Chen H, et al
Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer.
Front Genet. 2022;13:801665.
Abstract Related articles

WARE AP, Kabekkodu SP, Chawla A, Paul B, et al
Diagnostic and prognostic potential clustered miRNAs in bladder cancer.
3 Biotech. 2022;12:173.
Abstract Related articles

CABALLERO JM, Perez-Marquez M, Gili JM, Pereira JC, et al
Environmental Factors Involved in the High Incidence of Bladder Cancer in an Industrialized Area in North-Eastern Spain.
J Environ Public Health. 2022;2022:1051046.
Abstract Related articles

LI J, Liang Y, Fan J, Xu C, et al
DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinoma.
BMC Med. 2022;20:222.
Abstract Related articles

AHMED ME, Todenhofer T, Karnes RJ, Seiler R, et al
Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Eur Urol Focus. 2022 Jul 14. pii: S2405-4569(22)00138.
Abstract Related articles

TANG F, Yu H, Wang X, Shi J, et al
NCAPG promotes tumorigenesis of bladder cancer through NF-kappaB signaling pathway.
Biochem Biophys Res Commun. 2022;622:101-107.
Abstract Related articles

SINHA A, Patterson B
Persistently elevated beta-human chorionic gonadotropin level after vacuum-assisted uterine aspiration: a case report.
J Med Case Rep. 2022;16:279.
Abstract Related articles

FURUYA H, Sasaki Y, Chen R, Peres R, et al
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.
Sci Rep. 2022;12:12186.
Abstract Related articles

XU H, Cao X, Zhang W, Li Q, et al
Co-existence of two ciprofloxacin-resistant Salmonella enterica serovar Kentucky strains in the urine of a bladder cancer patient.
J Glob Antimicrob Resist. 2022 Jul 13. pii: S2213-7165(22)00177.
Abstract Related articles

CONCONI D, Jemma A, Giambra M, Redaelli S, et al
Analysis of copy number alterations in bladder cancer stem cells revealed a prognostic role of LRP1B.
World J Urol. 2022 Jul 16. pii: 10.1007/s00345-022-04093.
Abstract Related articles

BARAU C, Maille P, Sirab N, Ghaleh B, et al
Automated DNA, RNA, and Protein Extraction from Urine for Biobanking.
J Biomol Tech. 2022;33.
Abstract Related articles

LUO H, Xu C, Ge B, Wang T, et al
CASC1 Expression in Bladder Cancer Is Regulated by Exosomal miRNA-150: A Comprehensive Pan-Cancer and Bioinformatics Study.
Comput Math Methods Med. 2022;2022:8100325.
Abstract Related articles

ZHANG W, He X, Yin H, Cao W, et al
Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis.
J Hematol Oncol. 2022;15:93.
Abstract Related articles

HUANG Z, Yan Y, Wang T, Wang Z, et al
Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
J Transl Med. 2022;20:315.
Abstract Related articles

CHEN J, Gu Z, Pan Y, Zhang Y, et al
Effect of Radical Laparoscopic Surgery and Conventional Open Surgery on Surgical Outcomes, Complications, and Prognosis in Elderly Patients with Bladder Cancer.
Evid Based Complement Alternat Med. 2022;2022:1681038.
Abstract Related articles

YONG C, Mott SL, Steinberg RL, Packiam VT, et al
A longitudinal single center analysis of T1HG bladder cancer: An 18 year experience.
Urol Oncol. 2022 Jul 10. pii: S1078-1439(22)00226.
Abstract Related articles

WISHAHI M, Otto T, Golka K
Re: bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis-are they the same tumors?
World J Urol. 2022;40:2139-2140.
Abstract Related articles

BALASUBRAMANYA R, Shanbhogue AK, Ramani NS, Morani AC, et al
Mesenchymal neoplasms of the urinary bladder: a comprehensive review with focus on cross-sectional imaging findings.
Abdom Radiol (NY). 2022;47:2881-2895.
Abstract Related articles

CARVALHO FLF, Wang Y, Dall CP, Nayan M, et al
Preoperative anemia is associated with increased radical cystectomy complications.
Urol Oncol. 2022;40:382.
Abstract Related articles

BURGESS EF, Sanders JA, Livasy C, Symanowski J, et al
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes.
Urol Oncol. 2022;40:383.
Abstract Related articles

FU T, Lin Y, Lin L, Yang Y, et al
Network architecture of non-coding RNAs provides insights into the pathogenesis of upper tract urothelial carcinoma.
Urol Oncol. 2022;40:383.
Abstract Related articles

SONG Y, Han J, Qin C, Du Y, et al
Whether diagnostic ureteroscopic biopsy and ureteroscopy without biopsy have different impacts on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy?
World J Urol. 2022;40:2135-2137.
Abstract Related articles

MATTE P, Campedel L
[Drug approval: Enfortumab vedotin-advanced urothelial carcinoma (which have previously received platinum-containing chemotherapy and immunotherapy)].
Bull Cancer. 2022;109.
Abstract Related articles

IWAMURA H, Mizuno K, Akamatsu S, Hatakeyama S, et al
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Cancer Sci. 2022;113:2434-2445.
Abstract Related articles

DUM D, Taherpour N, Menz A, Hoflmayer D, et al
Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Pathobiology. 2022;89:245-258.
Abstract Related articles

MEDINA LG, Alsyouf M, Ghoreifi A, Sayegh AS, et al
Distal ureter and bladder cuff excision using the "Keyhole Technique" during Robotic Radical Nephroureterectomy.
Int Braz J Urol. 2022;48:876-877.
Abstract Related articles

HOANG TT, Mandleywala K, Viray T, Tan KV, et al
EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors.
Mol Imaging Biol. 2022;24:511-518.
Abstract Related articles

CANCRINI F, Michel F, Cussenot O, Alshehhi H, et al
Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?
World J Urol. 2022;40:1949-1959.
Abstract Related articles

KIM R, Hong JY, Lee J, Kwon GY, et al
Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.
Cancer Res Treat. 2022;54:894-906.
Abstract Related articles

LI Y, Xiao M, Xiao L
Report of a case of paraganglioma of the urinary bladder: a discussion of the surgical approach.
Minerva Surg. 2022;77:416-418.
Abstract Related articles

HWANG I, Park I, Yoon SK, Lee JL, et al
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD-1 or PD-L1 inhibitor.
Asia Pac J Clin Oncol. 2022;18:371-377.
Abstract Related articles

LAYMON M, Mosbah A, Hashem A, Elsawy AA, et al
Predictors and survival benefit of achieving pentafecta in a contemporary series of open radical cystectomy.
Minerva Urol Nephrol. 2022;74:428-436.
Abstract Related articles

ANDERSON JA, Matoso A, Murati Amador BI, Cheng L, et al
Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study.
Pathology. 2021;53:214-219.
Abstract Related articles

PREYRA B, Cury FL, Katib Y, Monsoor M, et al
The rate of prostatic involvement in men treated with radical cystectomy for muscle invasive bladder cancer.
Pract Radiat Oncol. 2022 Jul 25. pii: S1879-8500(22)00193.
Abstract Related articles

ARSLAN AI, Karabag S, Akgul M
Effect of HER2 and Fascin expression on muscle-invasive bladder cancers: Classification by basaloid and luminal phenotypes.
Indian J Pathol Microbiol. 2022;65:604-609.
Abstract Related articles

MEGHANI K, Folgosa Cooley L, Piunti A, Meeks JJ, et al
Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer.
Bladder Cancer. 2022;8:101-112.
Abstract Related articles

XU W, Tang HJ, Anwaier A, Liu W, et al
Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer.
Front Immunol. 2022;13:909324.
Abstract Related articles

SUN JX, Liu CQ, Xu JZ, An Y, et al
A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
Front Immunol. 2022;13:908068.
Abstract Related articles

ZUPANCIC D, Veranic P
Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis.
Int J Mol Sci. 2022;23.
Abstract Related articles

WANG L, Wang Y, Bi J
In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer.
Funct Integr Genomics. 2022 Jul 28. pii: 10.1007/s10142-022-00884.
Abstract Related articles

DING K, Zheng Z, Han Y, Huang X, et al
Prognostic values of the immune microenvironment-related non-coding RNA IGF2BP2-AS1 in bladder cancer.
Cell Cycle. 2022 Jul 27:1-17. doi: 10.1080/15384101.2022.2103898.
Abstract Related articles

WU D, Niu X, Pan H, Zhou Y, et al
[Corrigendum] MicroRNA335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.
Mol Med Rep. 2022;26.
Abstract Related articles

MIN K, Kim HT, Lee EH, Park H, et al
Bacteria for Treatment: Microbiome in Bladder Cancer.
Biomedicines. 2022;10.
Abstract Related articles

CHEN R, Pagano I, Sun Y, Murakami K, et al
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome.
Diagnostics (Basel). 2022;12.
Abstract Related articles

BECATTINI L, Saieva C, Doni L, Roviello G, et al
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy.
Medicina (Kaunas). 2022;58.
Abstract Related articles

LIM EC, Lim SW, Tan KJ, Sathiya M, et al
In-Silico Analysis of Deleterious SNPs of FGF4 Gene and Their Impacts on Protein Structure, Function and Bladder Cancer Prognosis.
Life (Basel). 2022;12.
Abstract Related articles

ECKE TH, Voss PC, Schlomm T, Rabien A, et al
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Int J Mol Sci. 2022;23.
Abstract Related articles

SANGUEDOLCE F, Zanelli M, Palicelli A, Ascani S, et al
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation.
Int J Mol Sci. 2022;23.
Abstract Related articles

SANGUEDOLCE F, Zanelli M, Palicelli A, Ascani S, et al
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression.
Int J Mol Sci. 2022;23.
Abstract Related articles

CHAN KM, Vasilev K, MacGregor M
Effects of Supplemental Drugs on Hexaminolevulinate (HAL)-Induced PpIX Fluorescence in Bladder Cancer Cell Suspensions.
Int J Mol Sci. 2022;23.
Abstract Related articles

MURESU N, Di Lorenzo B, Saderi L, Sechi I, et al
Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review.
Diagnostics (Basel). 2022;12.
Abstract Related articles

MANSOUR B, Monyok A, Gajdacs M, Stercz B, et al
Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels.
Biomedicines. 2022;10.
Abstract Related articles

LIU YL, Wu CT, Hsu YC, Chen MF, et al
Perioperative Complications and Oncologic Outcomes after Radical Cystectomy in End-Stage Renal Disease Patients with Bladder Cancer Obtained Using a Standardized Reporting System.
Cancers (Basel). 2022;14.
Abstract Related articles

SARAFIDIS M, Lambrou GI, Zoumpourlis V, Koutsouris D, et al
An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

UDUMYAN R, Botteri E, Jerlstrom T, Montgomery S, et al
Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.
Acta Oncol. 2022 Jul 26:1-9. doi: 10.1080/0284186X.2022.2101902.
Abstract Related articles

ALKHOULI MA, Bazargan S, Pilon-Thomas S, Poch M, et al
Current State of Cell Therapies for Genitourinary Malignancies.
Cancer J. 2022;28:294-300.
Abstract Related articles

WU L, Yang Z, Dai G, Fan B, et al
SOX5 promotes cell growth and migration through modulating the DNMT1/p21 pathway in bladder cancer.
Acta Biochim Biophys Sin (Shanghai). 2022;54:1-12.
Abstract Related articles

VERSCHOOR N, Heemsbergen WD, Boormans JL, Franckena M, et al
Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study.
Acta Oncol. 2022 Jul 26:1-7. doi: 10.1080/0284186X.2022.2101381.
Abstract Related articles

SONG Y, Tian J, Yang L, Zhang Y, et al
Prognostic value of preoperative platelet-related parameters and plasma fibrinogen in patients with non-muscle invasive bladder cancer after transurethral resection of bladder tumor.
Future Oncol. 2022 Jul 26. doi: 10.2217/fon-2022-0223.
Abstract Related articles

QING L, Li Q, Yang Y, Xu W, et al
A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research.
BMC Urol. 2022;22:114.
Abstract Related articles

RAO X, Cao H, Yu Q, Ou X, et al
NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer.
Front Genet. 2022;13:892535.
Abstract Related articles

RAGONESE M, Gianfrancesco LD, Palermo G, Pierconti F, et al
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2022;20:e271-e275.
Abstract Related articles

TOMKO AM, Whynot EG, Dupre DJ
Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer.
J Cannabis Res. 2022;4:41.
Abstract Related articles

JUBBER I, Rogers Z, Catto JW, Bottomley S, et al
Sexual Activity, Function and Dysfunction After a Diagnosis of Bladder Cancer.
J Sex Med. 2022 Jul 20. pii: S1743-6095(22)01504.
Abstract Related articles

CORSI NJ, Messing EM, Sood A, Keeley J, et al
Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis.
Clin Genitourin Cancer. 2022 Jun 25. pii: S1558-7673(22)00140.
Abstract Related articles

FAN T, Li S, Xiao C, Tian H, et al
CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition.
Int J Biol Sci. 2022;18:4275-4288.
Abstract Related articles

LIM LM, Chung WY, Hwang DY, Yu CC, et al
Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation.
J Transl Med. 2022;20:324.
Abstract Related articles

IKEDA Y, Hamada M, Matsumi Y, Sekimoto M, et al
Use of ileal bypass in the surgical management of two rare cases of ileal-neobladder fistula in patients who underwent radical cystectomy.
Urologia. 2022;89:488-492.
Abstract Related articles

SATKUNASIVAM R, Lim K, Teh BS, Guzman J, et al
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trial.
Future Oncol. 2022;18:2771-2781.
Abstract Related articles

DOMINGUEZ-GUTIERREZ PR, Kwenda EP, Donelan W, Miranda M, et al
Detection of PD-L1-Expressing Myeloid Cell Clusters in the Hyaluronan-Enriched Stroma in Tumor Tissue and Tumor-Draining Lymph Nodes.
J Immunol. 2022;208:2829-2836.
Abstract Related articles

NIMGAONKAR V, Hubbard RA, Carpenter EL, Mamtani R, et al
Biomarker Testing, Treatment Uptake, and Survival Among Patients With Urothelial Cancer Receiving Gene-Targeted Therapy.
JAMA Oncol. 2022;8:1070-1072.
Abstract Related articles

MARTINI A, Lonati C, Necchi A, Galsky MD, et al
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival.
Clin Genitourin Cancer. 2022;20:389.
Abstract Related articles

VOLZ Y, Eismann L, Pfitzinger P, Westhofen T, et al
Long-term Health-related Quality of Life (HRQOL) After Radical Cystectomy and Urinary Diversion - A Propensity Score-matched Analysis.
Clin Genitourin Cancer. 2022;20:e283-e290.
Abstract Related articles

UNTERRAINER LM, Lindner S, Eismann L, Casuscelli J, et al
Feasibility of [(68)Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.
Eur J Nucl Med Mol Imaging. 2022;49:3571-3580.
Abstract Related articles

LIU J, Wu P, Lai S, Song X, et al
Clinicopathological and Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients with Upper Urinary Tract Urothelial Carcinoma.
Nutr Cancer. 2022;74:2964-2974.
Abstract Related articles

ABRATE A, Sessa F, Sessa M, Campi R, et al
Segmental Ureterectomy Versus Radical Nephroureterectomy in Older Patients Treated for Upper Tract Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:381-387.
Abstract Related articles

RICHTERS A, Kiemeney LALM, Mehra N, Westgeest HM, et al
Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:e346-e352.
Abstract Related articles

SATO R, Watanabe K, Matsushita Y, Watanabe H, et al
Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection.
Urologia. 2022;89:354-357.
Abstract Related articles

GELBRICH N, Miebach L, Berner J, Freund E, et al
Non-invasive medical gas plasma augments bladder cancer cell toxicity in preclinical models and patient-derived tumor tissues.
J Adv Res. 2022 Aug 2. pii: S2090-1232(22)00166.
Abstract Related articles

TANG Z, Tang C, Sun C, Ying X, et al
M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine.
Aging (Albany NY). 2022;14.
Abstract Related articles

GOUBET AG, Lordello L, Alves Costa Silva C, Peguillet I, et al
Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer.
Cancer Discov. 2022 Aug 5. pii: 707463. doi: 10.1158/2159-8290.CD-22-0201.
Abstract Related articles

CHEN T, Zhan X, Chen X, Jiang M, et al
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Front Oncol. 2022;12:895413.
Abstract Related articles

TANG D, Li Y, Tang Y, Zheng H, et al
Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model.
Front Genet. 2022;13:918705.
Abstract Related articles

GUO M, Li Y, Wang W, Kang X, et al
Variation of Anxiety and Depression During a 3-Year Period as Well as Their Risk Factors and Prognostic Value in Postoperative Bladder Cancer Patients.
Front Surg. 2022;9:893249.
Abstract Related articles

OKAMOTO T, Yamamoto K, Kanomata N
Correction to: Metastatic Rectal Linitis Plastica From Bladder Cancer.
Am J Gastroenterol. 2022;117:1336.
Abstract Related articles

GUZVIC M, Engelmann S, Burger M, Mayr R, et al
[Disseminated tumour cells in bladder cancer].
Urologie. 2022;61:728-733.
Abstract Related articles

KARASHIMA T, Umemoto S, Kishida T, Osaka K, et al
Clinical evaluation of urine laminin-gamma2 monomer as a potent biomarker for non-muscle invasive bladder cancer.
Cancer Med. 2022 Aug 4. doi: 10.1002/cam4.5087.
Abstract Related articles

MAY M, Wolff I, Brookman-May SD, Burger M, et al
Bladder cancer with secondary muscle invasion - a prognostic dilemma.
Scand J Urol. 2022 Aug 3:1-2. doi: 10.1080/21681805.2022.2107068.
Abstract Related articles

SU Z, Monshaugen I, Klungland A, Ougland R, et al
Characterization of novel small non-coding RNAs and their modifications in bladder cancer using an updated small RNA-seq workflow.
Front Mol Biosci. 2022;9:887686.
Abstract Related articles

XIANG AP, Chen XN, Xu PF, Shao SH, et al
Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma.
BMC Urol. 2022;22:120.
Abstract Related articles

XU Y, Lei Z, Zhu J, Wan L, et al
Mivebresib synergized with PZ703b, a novel Bcl-xl PROTAC degrader, induces apoptosis in bladder cancer cells via the mitochondrial pathway.
Biochem Biophys Res Commun. 2022;623:120-126.
Abstract Related articles

CHOI NR, Choi WG, Kwon MJ, Woo JH, et al
[6]-Gingerol induces Caspase-Dependent Apoptosis in Bladder Cancer cells via MAPK and ROS Signaling.
Int J Med Sci. 2022;19:1093-1102.
Abstract Related articles

LUO H, Liu GL, Jian D, Liang DD, et al
Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade.
J Immunol Res. 2022;2022:9962397.
Abstract Related articles

LIU Q, You B, Meng J, Huang CP, et al
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.
Cancer Gene Ther. 2022 Aug 1. pii: 10.1038/s41417-022-00506.
Abstract Related articles

KIM YS, Hsieh AC, Lam HM
Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
Eur Urol Focus. 2022 Jul 29. pii: S2405-4569(22)00166.
Abstract Related articles

WEISMAN RJ, Heinrich A, Letkiewicz F, Messner M, et al
Estimating National Exposures and Potential Bladder Cancer Cases Associated with Chlorination DBPs in U.S. Drinking Water.
Environ Health Perspect. 2022;130:87002.
Abstract Related articles

HWANG B, Gho Y, Kim H, Lee S, et al
Rosa hybrida Petal Extract Exhibits Antitumor Effects by Abrogating Tumor Progression and Angiogenesis in Bladder Cancer Both In Vivo and In Vitro.
Integr Cancer Ther. 2022;21:15347354221114337.
Abstract Related articles

CHENG X, Lou K, Ding L, Zou X, et al
Clinical potential of the Hippo-YAP pathway in bladder cancer.
Front Oncol. 2022;12:925278.
Abstract Related articles

ZHU Z, Xiao Y, Hu S, Wang Z, et al
Neoadjuvant and Adjuvant Chemotherapy for Variant Histology Bladder Cancers: A Systematic Review and Meta-Analysis.
Front Oncol. 2022;12:907454.
Abstract Related articles

OU SL, Luo J, Wei H, Qin XL, et al
Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews.
Front Immunol. 2022;13:953761.
Abstract Related articles

CHENG Z, Ye F, Xu C, Liang Y, et al
The potential mechanism of Longsheyangquan Decoction on the treatment of bladder cancer: Systemic network pharmacology and molecular docking.
Front Pharmacol. 2022;13:932039.
Abstract Related articles

ZHAO X, Hu J, Li J, Gu L, et al
THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular Subtype, and Prognosis in Bladder Cancer.
Dis Markers. 2022;2022:7147279.
Abstract Related articles

ZHU Q, Zhang L, Deng Y, Tang L, et al
Identification of immune-related and autophagy-related genes for the prediction of survival in bladder cancer.
BMC Genom Data. 2022;23:60.
Abstract Related articles

LEDDEROSE S, Rodler S, Eismann L, Ledderose G, et al
Tumor-infiltrating lymphocytes predict survival in >/= pT2 urothelial bladder cancer.
Pathol Res Pract. 2022;237:154037.
Abstract Related articles

SORIA F, Gontero P
Intermediate-risk Non-muscle-invasive Bladder Cancer: Time To Tidy Up the Mess?
Eur Urol Oncol. 2022 Jul 27. pii: S2588-9311(22)00115.
Abstract Related articles

NAZAR M, Sabatella A, Ficalora G, Troncoso Y, et al
[Rectal metastasis of a resected urothelial bladder cancer].
Medicina (B Aires). 2022;82:609-612.
Abstract Related articles

TSAI TF, Chang AC, Chen PC, Ho CY, et al
Autophagy blockade potentiates cancer-associated immunosuppression through programmed death ligand-1 upregulation in bladder cancer.
J Cell Physiol. 2022 Jul 29. doi: 10.1002/jcp.30817.
Abstract Related articles

LI DX, Wang XM, Feng DC, Zhang FC, et al
Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for Non-Muscle-Invasive Bladder Cancer.
Front Oncol. 2022;12:937638.
Abstract Related articles

ZHANG Z, Li X, Ren S, Zhang W, et al
CNN1 Represses Bladder Cancer Progression and Metabolic Reprogramming by Modulating HIF-1alpha Signaling Pathway.
Front Oncol. 2022;12:859707.
Abstract Related articles

TAN J, Wang Y, Sun L, Xu S, et al
The Origin and Evolution of Bladder Cancer Stem Cells.
Front Cell Dev Biol. 2022;10:950241.
Abstract Related articles

HE L, Yang B, Jian D, Luo H, et al
Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.
Dis Markers. 2022;2022:2147494.
Abstract Related articles

GAO M, Yang Q, Xu H, Chen Z, et al
Preoperative White Blood Cell-Related Indicators Can Predict the Prognosis of Patients with Transurethral Resection of Bladder Cancer.
J Inflamm Res. 2022;15:4139-4147.
Abstract Related articles

RINONCE HT, Ambarwati THD, Syaebani M, Pudjohartono MF, et al
Assessment of association between PD-L1 expression and clinicopathological characteristics of Indonesian patients with high grade bladder urothelial carcinoma.
Med J Malaysia. 2022;77.
Abstract Related articles

MONTES-MOJARRO IA, Hassas S, Staehle S, Sander P, et al
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification.
Int J Mol Sci. 2022;23.
Abstract Related articles

WANG J, Tuo Z, Gao M, Min J, et al
Is it necessary to perform a retrosigmoid transposition of the left ureter in Bricker Ileal Conduit surgery?
BMC Urol. 2022;22:116.
Abstract Related articles

SETTI BOUBAKER N, Gurtner A, Trabelsi N, Manni I, et al
An insight into the diagnostic and prognostic value of HOX A13's expression in non-muscle invasive bladder cancer.
J Clin Lab Anal. 2022 Jul 19:e24606. doi: 10.1002/jcla.24606.
Abstract Related articles

REHMAN H, Chandrashekar DS, Balabhadrapatruni C, Nepal S, et al
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.
JCI Insight. 2022 Jul 19. pii: 155899. doi: 10.1172/jci.insight.155899.
Abstract Related articles

LIU T, Zhang Z, Wang C, Huang H, et al
Correction: BRD4 promotes the migration and invasion of bladder cancer cells through the Sonic hedgehog signaling pathway and enhances cisplatin resistance.
Biochem Cell Biol. 2022;100:274-275.
Abstract Related articles

KRAJEWSKI W, Aumatell J, Subiela JD, Nowak L, et al
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer.
Urol Oncol. 2022 Jul 15. pii: S1078-1439(22)00227.
Abstract Related articles

STENZL A
En Bloc Resection of Bladder Tumours: Ready for Clinical Use?
Eur Urol Oncol. 2022;5:449-450.
Abstract Related articles

MARCHESE PV, Mollica V, De Biase D, Giunchi F, et al
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.
Pathol Res Pract. 2022;236:153983.
Abstract Related articles

QUEIPO FJ, Unamunzaga GM, Negro BF, Fuertes SG, et al
Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice.
Virchows Arch. 2022;481:191-200.
Abstract Related articles

COSCIA C, Gill D, Benitez R, Perez T, et al
Avoiding collider bias in Mendelian randomization when performing stratified analyses.
Eur J Epidemiol. 2022;37:671-682.
Abstract Related articles

GALLIOLI A, Diana P, Fontana M, Territo A, et al
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial.
Eur Urol Oncol. 2022;5:440-448.
Abstract Related articles

KIM D, Burkhardt R, Alperstein SA, Gokozan HN, et al
Evaluating the role of Z-stack to improve the morphologic evaluation of urine cytology whole slide images for high-grade urothelial carcinoma: Results and review of a pilot study.
Cancer Cytopathol. 2022;130:630-639.
Abstract Related articles

WANG BG, Woodward K, Menezes G, Wang ZQ, et al
Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings.
Diagn Cytopathol. 2022;50:E248-E254.
Abstract Related articles

MARTINI A, Lonati C, Nocera L, Fallara G, et al
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
Eur Urol Oncol. 2022;5:451-459.
Abstract Related articles

ZALESKI MP, Chen H, Roy-Chowdhuri S, Patel KP, et al
Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
Am J Clin Pathol. 2022;158:263-269.
Abstract Related articles

FERNANDES MC, Shoushtari A, Leitao MM Jr, Chui MH, et al
Metastatic melanoma concurrent to the urinary bladder and endometrium: Case report.
J Med Imaging Radiat Oncol. 2022;66:643-646.
Abstract Related articles

LENFANT L, Breda A, Xylinas E, Babjuk M, et al
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma.
Eur Urol Oncol. 2022;5:464-471.
Abstract Related articles

BEYHAN E, Baykal Koca S, Yucetas U, Cermik TF, et al
18F-FDG PET/CT in Urethral Metastases From Bladder Cancer.
Clin Nucl Med. 2022 Aug 4. pii: 00003072-990000000-00227.
Abstract Related articles

WARD K, Kitchen MO, Mathias SJ, Khanim FL, et al
Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning.
Front Surg. 2022;9:912438.
Abstract Related articles

JIN K, He M, Chen B, Zhou X, et al
A single-sample mRNA molecular classification of bladder cancer predicting prognosis and response to immunotherapy.
Transl Androl Urol. 2022;11:943-958.
Abstract Related articles

XU T, Xu W, Zheng Y, Li X, et al
Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.
Front Immunol. 2022;13:931906.
Abstract Related articles

ZHANG Z, Yu Y, Li P, Wang M, et al
Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.
Front Immunol. 2022;13:954616.
Abstract Related articles

LI R, Chen X, Li X, Huang G, et al
A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.
Am J Transl Res. 2022;14:4606-4616.
Abstract Related articles

CAI W, Wei M, Su Z
MITF-Mediated lncRNA CCDC183-As1 Promotes the Tumorigenic Properties and Aerobic Glycolysis of Bladder Cancer via Upregulating TCF7L2.
J Oncol. 2022;2022:6785956.
Abstract Related articles

LIGOR T, Adamczyk P, Kowalkowski T, Ratiu IA, et al
Analysis of VOCs in Urine Samples Directed towards of Bladder Cancer Detection.
Molecules. 2022;27.
Abstract Related articles

SILINA L, Dufour F, Rapinat A, Reyes C, et al
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation.
Int J Mol Sci. 2022;23.
Abstract Related articles

MATUSZCZAK M, Kiljanczyk A, Salagierski M
A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers.
Int J Mol Sci. 2022;23.
Abstract Related articles

MALINARIC R, Mantica G, Lo Monaco L, Mariano F, et al
The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know?
Int J Environ Res Public Health. 2022;19.
Abstract Related articles

DIAMANT E, Roumiguie M, Ingels A, Parra J, et al
Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

WANG D, Zhang P, Liu Z, Xing' Y, et al
NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2.
Cancers (Basel). 2022;14.
Abstract Related articles

GU L, Chen Y, Li X, Mei Y, et al
Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

LAZEBNIK T
Cell-Level Spatio-Temporal Model for a Bacillus Calmette-Guerin-Based Immunotherapy Treatment Protocol of Superficial Bladder Cancer.
Cells. 2022;11.
Abstract Related articles

CHIN YC, Yang LX, Hsu FT, Hsu CW, et al
Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
J Nanobiotechnology. 2022;20:373.
Abstract Related articles

MEHBOOB R, Kurdi M, Baeesa S, Fawzy Halawa T, et al
Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma.
Folia Neuropathol. 2022;60:165-176.
Abstract Related articles

WANG F, Qin CP, DU YQ, Liu SJ, et al
[Optimal surveillance intensity of cystoscopy in intermediate-risk non-muscle invasive bladder cancer].
Beijing Da Xue Xue Bao Yi Xue Ban. 2022;54:669-673.
Abstract Related articles

YING YC, Tang Q, Yang KW, Mi Y, et al
[Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
Beijing Da Xue Xue Bao Yi Xue Ban. 2022;54:644-651.
Abstract Related articles

LI ZH, Xu CR, Liu Y, Guan H, et al
[Correlation between daily fluid intake behavioral habits and pathological characteristics of upper tract urothelial carcinoma].
Beijing Da Xue Xue Bao Yi Xue Ban. 2022;54:621-627.
Abstract Related articles

DAI X, Wang F, DU YQ, Song YX, et al
[Correlation between adipokine and clinicopathological features and prognosis in upper tract urothelial carcinoma].
Beijing Da Xue Xue Bao Yi Xue Ban. 2022;54:605-614.
Abstract Related articles

WANG Y, Shao W, Feng Y, Tang J, et al
Prognostic value and potential biological functions of ferroptosis-related gene signature in bladder cancer.
Oncol Lett. 2022;24:301.
Abstract Related articles

HAJJAR M, Rezazadeh A, Naja F, Kardoust Parizi M, et al
Association of Dietary Approaches to Stop Hypertension diet and risk of bladder cancer: A case-control study.
Eur J Cancer Care (Engl). 2022 Aug 10:e13664. doi: 10.1111/ecc.13664.
Abstract Related articles

SOLTANZADEH S, Saeedian A, Ghalehtaki R, Ayati M, et al
Assessment of Tolerability, Response and Complications of Concurrent Chemoradiation With Capecitabine and Cisplatin in Muscle-Invasive Bladder Cancer; A Single Arm Study.
Clin Genitourin Cancer. 2022 Jul 19. pii: S1558-7673(22)00159.
Abstract Related articles

ANDERSON CB, Chen L, Chang SS, McKiernan JM, et al
Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG.
Clin Genitourin Cancer. 2022 Jul 11. pii: S1558-7673(22)00153.
Abstract Related articles

Aktuelle Urol. 2022;53:314-315.
Abstract Related articles

FLAIG TW, Spiess PE, Abern M, Agarwal N, et al
NCCN Guidelines(R) Insights: Bladder Cancer, Version 2.2022.
J Natl Compr Canc Netw. 2022;20:866-878.
Abstract Related articles

DIAN X, Kun L, Xin W, SongBai Y, et al
Successful treatment of advanced muscle-invasive bladder cancer with the combined therapy of toripalimab and chemotherapy: a case report.
Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00034.
Abstract Related articles

MOHAMEDALI R, Adhya AK, Mandal S, Mitra S, et al
Expression of mismatch repair proteins in urothelial carcinoma of the urinary bladder.
Indian J Cancer. 2022;59:279-281.
Abstract Related articles

RUSSELL B, Spencer-Bowdage S, Rigby J, O'Kelly J, et al
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic.
BJUI Compass. 2022;3:324-326.
Abstract Related articles

LIU JP, Fang YT, Jiang YF, Lin H, et al
HYAL3 as a potential novel marker of BLCA patient prognosis.
BMC Genom Data. 2022;23:63.
Abstract Related articles

WANG L, Wu S, He H, Ai K, et al
CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.
Lab Invest. 2022 Aug 9. pii: 10.1038/s41374-022-00826.
Abstract Related articles

XIAO K, Zhang N, Li F, Hou D, et al
Pro-oxidant response and accelerated ferroptosis caused by synergetic Au(I) release in hypercarbon-centered gold(I) cluster prodrugs.
Nat Commun. 2022;13:4669.
Abstract Related articles

SCHERNUK J, Gonzalez MI, Vecchio F, Alfieri AG, et al
Clinical and histopathological features of bladder cancer following radiotherapy for prostate cancer: A comparative study.
Urol Oncol. 2022 Aug 6. pii: S1078-1439(22)00240.
Abstract Related articles

CHEN X, Chen X, Yu X, He X, et al
EUS-guided fine needle aspiration provides an open view for duodenal obstruction caused by urothelial carcinoma: a case report.
BMC Gastroenterol. 2022;22:376.
Abstract Related articles

PARK C, Cha HJ, Lee H, Jeong JW, et al
Induction of apoptosis through inactivation of ROS-dependent PI3K/Akt signaling pathway by platycodin D in human bladder urothelial carcinoma cells.
Gen Physiol Biophys. 2022;41:263-274.
Abstract Related articles

HALD OC, Phan YC, Carter CJ
Urinary bladder paraganglioma with a family history of neurofibromatosis type 1 treated with partial cystectomy.
Br J Hosp Med (Lond). 2022;83:1-3.
Abstract Related articles

ROVIELLO G, Catalano M, Santi R, Santoni M, et al
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments.
Front Oncol. 2022;12:912699.
Abstract Related articles

HAN Z, Tian Y, Liu Q, Zhao Y, et al
LncRNA PTAR activates the progression of bladder cancer by modulating miR-299-3p/CD164 axis.
Pathol Res Pract. 2022;237:153994.
Abstract Related articles

HEBERT KJ, Matta R, Myers JB
Patient Selection and Outcomes of Urinary Diversion.
Urol Clin North Am. 2022;49:533-551.
Abstract Related articles

XU AJ, Mishra K, Lee YS, Zhao LC, et al
Robotic-Assisted Lower Genitourinary Tract Reconstruction.
Urol Clin North Am. 2022;49:507-518.
Abstract Related articles

ZHANG L, Geng Z, Hao B, Geng Q, et al
Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody.
Cancer Control. 2022;29:10732748221111296.
Abstract Related articles

MELZER MK, Zehe V, Zengerling F, Wezel F, et al
[Organoids as a milestone on the way to personalized treatment of urothelial carcinoma: a systematic review].
Urologie. 2022;61:745-752.
Abstract Related articles

ECKSTEIN M
[Immunological biomarker research in uro-oncology-using the example of urothelial cancer].
Urologie. 2022;61:734-738.
Abstract Related articles

HUANG Y, Wei L, Huang Y, Wen S, et al
Identification of distinct genomic features reveals frequent somatic AHNAK and PTEN mutations predominantly in primary malignant melanoma presenting in the ureter.
Jpn J Clin Oncol. 2022;52:922-935.
Abstract Related articles

REISWICH V, Akdeniz G, Lennartz M, Menz A, et al
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology.
Hum Pathol. 2022;126:108-120.
Abstract Related articles

EVARISTO G, Khadang B, Kool R, Marcq G, et al
Morphologic alterations post trimodal therapy in muscle-invasive urothelial carcinoma: understanding the impact of post-treatment changes on the pathological interpretation and their potential clinical correlates.
Hum Pathol. 2022;126:2-8.
Abstract Related articles

KOTHER AK, Budenbender B, Grune B, Holbach S, et al
Different patients, different preferences: A multicenter assessment of patients' personality traits and anxiety in shared decision making.
Cancer Med. 2022;11:2999-3008.
Abstract Related articles

OSWALD D, Pallauf P, Deininger S, Herrmann TRW, et al
[Safety and efficacy of en bloc vs. conventional transurethral resection of bladder tumors: a meta-analysis and systematic review].
Urologie. 2022;61:644-652.
Abstract Related articles

BURGER R, Jarczyk J, Westhoff N, Worst TS, et al
[Immunotherapy in urologic oncology : Response and treatment interruptions due to adverse events in a bicentric real-world analysis].
Urologie. 2022;61:759-766.
Abstract Related articles

LAW ZW, Anbudurai M, Lee CSN, Lee LS, et al
Vulvar urothelial carcinoma recurrence in an intact bladder free of disease.
ANZ J Surg. 2022;92.
Abstract Related articles

DONEGAN B, Kingston L
Quality of life following formation of an ileal conduit due to urinary bladder neoplasm: A systematic review.
Int J Nurs Pract. 2022;28:e12988.
Abstract Related articles

MA L, Wei HL, Wang KJ, Meng XY, et al
Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression.
Aging (Albany NY). 2022;14.
Abstract Related articles

NAPOLITANO L, Barone B, Reccia P, De Luca L, et al
Preoperative monocyte-to-lymphocyte ratio as a potential predictor of bladder cancer.
J Basic Clin Physiol Pharmacol. 2022 Aug 22. pii: jbcpp-2022-0179.
Abstract Related articles

CHEN H, Wu X, Wen Z, Zhu Y, et al
The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer.
Arch Esp Urol. 2022;75:467-471.
Abstract Related articles

REN L, Jiang M, Xue D, Wang H, et al
Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.
Int J Biol Sci. 2022;18:5207-5220.
Abstract Related articles

XUE R, Zhao C, Chen D, Wang P, et al
Potential influence of anaesthesia techniques on the recurrence and progression after resection of non-muscle-invasive bladder cancer: a propensity score-matched analysis.
BMC Anesthesiol. 2022;22:263.
Abstract Related articles

GAKIS G, Weckermann D
[Gender-associated differences in bladder cancer].
Urologie. 2022 Aug 18. pii: 10.1007/s00120-022-01914.
Abstract Related articles

BAO P, Li P, Zhou X, Zhang H, et al
SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/beta-catenin signaling pathway.
Cell Cycle. 2022 Aug 18:1-13. doi: 10.1080/15384101.2022.2112006.
Abstract Related articles

MAO J, Yang C, Xin S, Cui K, et al
Case report: Bladder preserving after maximal transurethral resection of the bladder tumor combined with chemotherapy and immunotherapy in recurrent muscle-invasive bladder cancer patients: A report of two cases.
Front Med (Lausanne). 2022;9:949567.
Abstract Related articles

JIN YH, Zeng XT, Liu TZ, Bai ZM, et al
Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).
Mil Med Res. 2022;9:44.
Abstract Related articles

GRAF RP, Fisher V, Huang RSP, Hamdani O, et al
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma.
JCO Precis Oncol. 2022;6:e2200121.
Abstract Related articles

LIN EP, Hsu CY, Berry L, Bunn P, et al
Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
JAMA Netw Open. 2022;5:e2227211.
Abstract Related articles

Retraction notice for: "Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation" [Braz J Med Biol Res 2021;54(3): e10222].
Braz J Med Biol Res. 2022;55:e10222retraction.
Abstract Related articles

HAO X, Fan H, Yang J, Tang J, et al
Network Pharmacology Research and Dual-omic Analyses Reveal the Molecular Mechanism of Natural Product Nodosin Inhibiting Muscle-Invasive Bladder Cancer in Vitro and in Vivo.
J Nat Prod. 2022 Aug 17. doi: 10.1021/acs.jnatprod.2c00400.
Abstract Related articles

RUSSO GI, Musso N, Lo Giudice A, Asmundo MG, et al
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer.
J Cancer Res Clin Oncol. 2022 Aug 16. pii: 10.1007/s00432-022-04262.
Abstract Related articles

GONZALEZ-PADILLA DA, Subiela JD, Gonzalez-Diaz A, Hernandez-Arroyo M, et al
Corrigendum to <'Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center'> <[Volume 40, Issue 7, July 2022, Pages 345.e19-345.e23]>.
Urol Oncol. 2022 Aug 12. pii: S1078-1439(22)00237.
Abstract Related articles

KHALIFA J, Roumiguie M, Pouessel D, Sargos P, et al
[Bladder-sparing trimodal therapy for muscle invasive bladder cancer].
Cancer Radiother. 2022 Aug 12. pii: S1278-3218(22)00106.
Abstract Related articles

XIAO Y, Ju L, Qian K, Jin W, et al
Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.
Clin Transl Med. 2022;12:e1008.
Abstract Related articles

HE W, Zhong G, Jiang N, Wang B, et al
Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis.
J Clin Invest. 2022;132.
Abstract Related articles

FENG Y, Yang Z, Xu X
c-Met: A Promising Therapeutic Target in Bladder Cancer.
Cancer Manag Res. 2022;14:2379-2388.
Abstract Related articles

MUNARI E, Querzoli G, Brunelli M, Marconi M, et al
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection.
Front Immunol. 2022;13:954910.
Abstract Related articles

KOLAT D, Kciuk M, Klosinski K, Kaluzinska Z, et al
Pyroptosis-related signatures in bladder cancer prognosis and treatment-are we there yet?
Transl Cancer Res. 2022;11:1861-1864.
Abstract Related articles

ZHAO J, Wu C, Wang Y, Li M, et al
Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer.
Transl Cancer Res. 2022;11:1865-1879.
Abstract Related articles

TANG W
A Commentary on "Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study" [Int. J. Surg. (2022) 103 106693].
Int J Surg. 2022 Aug 12:106802. doi: 10.1016/j.ijsu.2022.106802.
Abstract Related articles

TILLIB SV, Goryainova OS, Sachko AM, Ivanova TI, et al
[Single-Domain Antibodies Used to Pretreat the Human Urinary Proteome in Cancer Biomarker Testing].
Mol Biol (Mosk). 2022;56:671-684.
Abstract Related articles

BOGUSH TA, Basharina AA, Safarov ZM, Mizaeva IE, et al
[Molecular Diagnostics of the Involvement of Visually Normal Mucosa in the Malignancy Process in Urothelial Bladder Cancer].
Mol Biol (Mosk). 2022;56:642-651.
Abstract Related articles

TANG F, Zhang J, Lu Z, Liao H, et al
A novel molecular subtypes and risk model based on inflammatory response-related lncrnas for bladder cancer.
Hereditas. 2022;159:32.
Abstract Related articles

FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.
Sci Rep. 2022;12:13786.
Abstract Related articles

WANG Z, Cheng Y, Song Z, Zhao R, et al
Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.
Dis Markers. 2022;2022:5946110.
Abstract Related articles

DELTOURBE L, Lacerda Mariano L, Hreha TN, Hunstad DA, et al
The impact of biological sex on diseases of the urinary tract.
Mucosal Immunol. 2022;15:857-866.
Abstract Related articles

SHAH VI, Bergin L, Rowlands GL, McCluggage WG, et al
Unusual Manifestations of Vulval Paget Disease.
Int J Gynecol Pathol. 2022;41:476-483.
Abstract Related articles

WANG C, Jiang H
Long Non-Coding RNA PCAT19 Regulates the Malignant Progression of Bladder Cancer through the miR-335-5p/IER2 Axis.
Crit Rev Eukaryot Gene Expr. 2022;32:81-94.
Abstract Related articles

XIE R, Chen X, Zhou J, Huang L, et al
LncRNA CCHE1 Participates in the Postoperative Distant Recurrence of Urothelial Bladder Cancer Possibly by Regulating ROCK1 Expression.
Crit Rev Eukaryot Gene Expr. 2022;32:23-31.
Abstract Related articles

DUAN X, Wang L, Wang Z, Wei W, et al
LncRNA PGM5-AS1 Inhibits the Progression of Bladder Cancer by Regulating miR-587/SLIT3 Axis.
Crit Rev Eukaryot Gene Expr. 2022;32:9-22.
Abstract Related articles

WEI X, Wang J, Liu H, Fan W, et al
Preoperative Nutritional Risk Assessment for Predicting Complications after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
Emerg Med Int. 2022;2022:2901189.
Abstract Related articles

WANG X, Chen B, Cao Y, He Y, et al
Identification of MAN1B1 as a Novel Marker for Bladder Cancer and Its Relationship with Immune Cell Infiltration.
J Oncol. 2022;2022:3387671.
Abstract Related articles

RYDELL H, Huge Y, Eriksson V, Johansson M, et al
Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.
Life (Basel). 2022;12.
Abstract Related articles

KOGUCHI D, Matsumoto K, Shiba I, Harano T, et al
Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review.
Int J Mol Sci. 2022;23.
Abstract Related articles

HU Z, Ma S, Sun Y, Long G, et al
Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer.
Genes (Basel). 2022;13.
Abstract Related articles

CAINI S, Del Riccio M, Vettori V, Francolini G, et al
Prognostic Impact of Post-Diagnosis Smoking Cessation among Bladder Cancer Patients: A Systematic Literature Review and Meta-Analysis.
Cancers (Basel). 2022;14.
Abstract Related articles

PELLERIN E, Pellerin FA, Chabaud S, Pouliot F, et al
Bisphenols A and S Alter the Bioenergetics and Behaviours of Normal Urothelial and Bladder Cancer Cells.
Cancers (Basel). 2022;14.
Abstract Related articles

GARRIDO SILES M, Lopez-Beltran A, Pelechano P, Garcia Vicente AM, et al
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
Cancers (Basel). 2022;14.
Abstract Related articles

KAMAL M, Navai N, Bree KK, Williams LA, et al
Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.
Cancers (Basel). 2022;14.
Abstract Related articles

ZHENG W, Lin T, Chen Z, Cao D, et al
The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis.
Diagnostics (Basel). 2022;12.
Abstract Related articles

SUN B, Mullapudi SS, Zhang Y, Neoh KG, et al
Glycosylated phospholipid-coated upconversion nanoparticles for bioimaging of non-muscle invasive bladder cancers.
Mikrochim Acta. 2022;189:349.
Abstract Related articles

WANG S, Ge C, Zhang J
Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study.
J Cardiovasc Dev Dis. 2022;9.
Abstract Related articles

YU EY, Zhang H, Fu Y, Chen YT, et al
Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study.
Curr Oncol. 2022;29:5442-5456.
Abstract Related articles

LEE S, Oh J, Cho M, Kim JK, et al
Fluorescence-Based Microendoscopic Sensing System for Minimally Invasive In Vivo Bladder Cancer Diagnosis.
Biosensors (Basel). 2022;12.
Abstract Related articles

FENG S, Qian X, Feng D, Zhang X, et al
Downregulation of BLM RecQ helicase inhibits proliferation, promotes the apoptosis and enhances the sensitivity of bladder cancer cells to cisplatin.
Mol Med Rep. 2022;26.
Abstract Related articles

FJELSTRUP S, Dupont DM, Bus C, Enghild JJ, et al
Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer.
NAR Cancer. 2022;4:zcac025.
Abstract Related articles

PENG M
Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
Front Immunol. 2022;13:970885.
Abstract Related articles

MO X, Hu D, Li Y, Nai A, et al
A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer.
Front Genet. 2022;13:936305.
Abstract Related articles

NGUYEN S, Chevalier MF, Benmerzoug S, Cesson V, et al
Vdelta2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
J Immunother Cancer. 2022;10.
Abstract Related articles

LIU SC, Cao YH, Chen LB, Kang R, et al
BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
Cancer Biol Ther. 2022;23:1-13.
Abstract Related articles

OGUZ U, Bekci T, Ogreden E, Aslan S, et al
Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: Accuracy and the factors affecting the results.
Diagn Interv Radiol. 2022 Aug 23. doi: 10.5152/dir.2022.201108.
Abstract Related articles

ANDERSON S, Rigney K, Hayes L, Ryan PC, et al
A retrospective cohort study of bladder cancer following the COVID-19 pandemic: Are patients presenting with more aggressive disease?
Ann Med Surg (Lond). 2022 Aug 18:104430. doi: 10.1016/j.amsu.2022.104430.
Abstract Related articles

GROBET-JEANDIN E, Benamran D, Pinar U, Beirnaert J, et al
Urodynamic assessment and quality of life outcomes of robot-assisted totally intracorporeal radical cystectomy and orthotopic neobladder for bladder cancer: a preliminary study.
World J Urol. 2022 Aug 22. pii: 10.1007/s00345-022-04126.
Abstract Related articles

MI Y, Wang X
Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.
J Environ Pathol Toxicol Oncol. 2022;41:1-12.
Abstract Related articles

RIESTERER O, Ademaj A, Puric E, Eberle B, et al
Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB study.
Int J Hyperthermia. 2022;39:1078-1087.
Abstract Related articles

YANG T, Li Y, Wang G, Guo L, et al
lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
Biomed Res Int. 2022;2022:3858249.
Abstract Related articles

WU Z, Wang Y, Yan M, Liang Q, et al
Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer.
Front Oncol. 2022;12:951631.
Abstract Related articles

DE CARLO C, Valeri M, Corbitt DN, Cieri M, et al
Non-muscle invasive bladder cancer biomarkers beyond morphology.
Front Oncol. 2022;12:947446.
Abstract Related articles

SHAHIDI M, Abazari O, Dayati P, Bakhshi A, et al
Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy.
Front Bioeng Biotechnol. 2022;10:949704.
Abstract Related articles

ZENG S, Feng X, Xing S, Xu Z, et al
Advanced Peptide Nanomedicines for Bladder Cancer Theranostics.
Front Chem. 2022;10:946865.
Abstract Related articles

JIANG J, Zhan Y, Li J
The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer.
J Immunol Res. 2022;2022:7952706.
Abstract Related articles

SONG Q, Zhou R, Shu F, Fu W, et al
Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer.
Front Immunol. 2022;13:958368.
Abstract Related articles

AMINZADEH Z, Ziamajidi N, Abbasalipourkabir R, Daei S, et al
Antitumor Activities of Aqueous Cinnamon Extract on 5637 Cell Line of Bladder Cancer through Glycolytic Pathway.
Int J Inflam. 2022;2022:3855368.
Abstract Related articles

WANG F, Xu Y, Xiang Y, Wu P, et al
The feasibility of amide proton transfer imaging at 3 T for bladder cancer: a preliminary study.
Clin Radiol. 2022 Aug 16. pii: S0009-9260(22)00334.
Abstract Related articles

RUIZ DE PORRAS V, Pardo JC, Etxaniz O, Font A, et al
Neoadjuvant therapy for muscle-invasive bladder cancer: Current clinical scenario, future perspectives, and unsolved questions.
Crit Rev Oncol Hematol. 2022;178:103795.
Abstract Related articles

ZHANG L, Zhan Y, Li L, Deng H, et al
CircOMA1 promotes tumour growth and metastasis of bladder cancer by modulating IGF-IR/MAPK/EMT pathway.
Clin Transl Med. 2022;12:e983.
Abstract Related articles

REN X, Tian Y, Wang Z, Wang J, et al
Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study.
BMC Urol. 2022;22:128.
Abstract Related articles

TSAI YS, Wu TY, Ou CH, Cheng HL, et al
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors.
BMC Urol. 2022;22:126.
Abstract Related articles

PAN Z, Chen Y, Pang H, Wang X, et al
Design, synthesis, and biological evaluation of novel dual inhibitors of heat shock protein 90/mammalian target of rapamycin (Hsp90/mTOR) against bladder cancer cells.
Eur J Med Chem. 2022;242:114674.
Abstract Related articles

MIYAKE M, Miyamoto T, Shimizu T, Ohnishi S, et al
Tumor expression of Nectin-1-4 and its clinical implication in muscle invasive bladder cancer: An intra-patient variability of Nectin-4 expression.
Pathol Res Pract. 2022;237:154072.
Abstract Related articles

TATUM JL, Kalen JD, Jacobs PM, Riffle LA, et al
3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor.
J Transl Med. 2022;20:375.
Abstract Related articles

PENG J, Sridhar S, Siefker-Radtke AO, Selvarajah S, et al
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.
Curr Treat Options Oncol. 2022;23:1269-1287.
Abstract Related articles

D'ANGELO A, Chapman R, Sirico M, Sobhani N, et al
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.
Cancer Chemother Pharmacol. 2022;90:191-205.
Abstract Related articles

HALDAR B, Hwang J, Narimatsu Y, Clausen H, et al
The incorrect use of CD75 as a synonym for ST6GAL1 has fostered the expansion of commercial "ST6GAL1" antibodies that do not recognize ST6GAL1.
Glycobiology. 2022;32:736-742.
Abstract Related articles

MAYNARD JP, Sfanos KS
P2 purinergic receptor dysregulation in urologic disease.
Purinergic Signal. 2022;18:267-287.
Abstract Related articles

CAI Q, Ling J, Kong L, Huang Y, et al
Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
Radiology. 2022 Jun 7:220028. doi: 10.1148/radiol.220028.
Abstract Related articles

DI MAIDA F, Grosso AA, Tasso G, Gemma L, et al
Robot assisted radical cystectomy with Florence Robotic Intracorporeal Neobladder (FloRIN): Functional and urodynamic features compared with a contemporary series of open Vescica Ileale Padovana (VIP).
Eur J Surg Oncol. 2022;48:1854-1861.
Abstract Related articles

SINGH P, Singh A, Gupta N, Raja KD, et al
Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder.
Mol Cell Biochem. 2022;477:2173-2182.
Abstract Related articles

SHIRAISHI Y, Maehama T, Nishio M, Otani J, et al
N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1/TAZ.
Genes Cells. 2022 Aug 10. doi: 10.1111/gtc.12979.
Abstract Related articles

CHEN L, Liu Z, Tang H, Zhou Z, et al
Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.
Cell Prolif. 2022 Aug 26:e13325. doi: 10.1111/cpr.13325.
Abstract Related articles

LI X, Liu J, Li A, Liu X, et al
Analysis of the Relationship between Bladder Cancer Gene Mutation and Clinical Prognosis by High-Throughput Sequencing.
Lab Med. 2022 Sep 2. pii: 6687571. doi: 10.1093.
Abstract Related articles

GOLDBERG IP, Lichtbroun B, Singer EA, Ghodoussipour S, et al
Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments.
Arch Pharmacol Ther. 2022;4:13-22.
Abstract Related articles

SCHROECK FR, Ould Ismail AA, Haggstrom DA, Sanchez SL, et al
Data-driven approach to implementation mapping for the selection of implementation strategies: a case example for risk-aligned bladder cancer surveillance.
Implement Sci. 2022;17:58.
Abstract Related articles

VILLAGRAN-GARCIA M, Muniz-Castrillo S, Ciano-Petersen NL, Vogrig A, et al
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.
J Neurol. 2022 Sep 1. pii: 10.1007/s00415-022-11356.
Abstract Related articles

LI X, Chen W, Li R, Chen X, et al
Bladder cancer diagnosis with a four-miRNA panel in serum.
Future Oncol. 2022 Sep 1. doi: 10.2217/fon-2022-0448.
Abstract Related articles

ZHANG Z, Mao W, Wang L, Liu M, et al
Erratum: Depletion of CDC5L inhibits bladder cancer tumorigenesis: Erratum.
J Cancer. 2022;13:3138-3139.
Abstract Related articles

DAEI S, Abbasalipourkabir R, Khanaki K, Bahreini F, et al
Effects of gold nanoparticles on oxidative stress status in bladder cancer 5637 cells.
Folia Med (Plovdiv). 2022;64:641-648.
Abstract Related articles

HUA X, Xiang D, Guo M, Qian X, et al
Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion.
Cell Death Dis. 2022;13:753.
Abstract Related articles

LI X, Peng X, Zhang C, Bai X, et al
Bladder Cancer-Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP-Related Metabolic Reprogramming and SerRS O-GlcNAcylation in Endothelial Cells.
Adv Sci (Weinh). 2022 Aug 31:e2202993. doi: 10.1002/advs.202202993.
Abstract Related articles

PRUDHOMME T, Andras I, Boissier R, Campi R, et al
Endovesical Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?
Exp Clin Transplant. 2022;20:789-791.
Abstract Related articles

ROSLI N, Mahasin M, Mohd Saleh MF, Abd Shukor N, et al
The prognostic significance of HER2 expression in urothelial carcinoma.
Malays J Pathol. 2022;44:245-252.
Abstract Related articles

WU J, Xie RY, Wei LH, Cao CZ, et al
Dynamic alteration and prognostic significance of tumor-associated CD68(+) and CD68(+) PD-L1(-) macrophages in muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
Cancer Med. 2022 Aug 31. doi: 10.1002/cam4.5191.
Abstract Related articles

YANG X, Toh Q, Huang HH, Sng LH, et al
Intravesical Bacillus Calmette-Guerin and its complications: 12 years of learning experience in a single local institution.
Singapore Med J. 2022;63:325-329.
Abstract Related articles

HALASEH SA, Halaseh S, Alali Y, Ashour ME, et al
A Review of the Etiology and Epidemiology of Bladder Cancer: All You Need To Know.
Cureus. 2022;14:e27330.
Abstract Related articles

DONG L, Xiaoli F, Ya L, Dan W, et al
Bayesian network analysis of long-term oncologic outcomes of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer.
Medicine (Baltimore). 2022;101:e30291.
Abstract Related articles

LEE YL, Chien TW, Wang JC
Using Sankey diagrams to explore the trend of article citations in the field of bladder cancer: Research achievements in China higher than those in the United States.
Medicine (Baltimore). 2022;101:e30217.
Abstract Related articles

ARIAFAR A, Sanati A, Ahmadvand S, Shekarkhar G, et al
Prognostic significance of immunoscore related markers in bladder cancer.
BMC Urol. 2022;22:133.
Abstract Related articles

DRACHAM CB, Kumar N, Kumar S, Elangovan A, et al
A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer.
Asian J Urol. 2022;9:318-328.
Abstract Related articles

TANG Y, Wu K, Li X
Contemporary use trends and effect on survival of pelvic lymph node dissection for non-muscle-invasive bladder cancer.
Front Surg. 2022;9:961430.
Abstract Related articles

WU R, Li D, Zhang F, Bai Y, et al
Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor.
Front Surg. 2022;9:907485.
Abstract Related articles

MONREAL-TRIGO J, Alcaniz M, Martinez-Bisbal MC, Loras A, et al
New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine.
iScience. 2022;25:104829.
Abstract Related articles

BADHEEB A, Alkhanbashi O, Rakrouki S, Mahmood T, et al
Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report.
Pan Afr Med J. 2022;42:98.
Abstract Related articles

RAZZAGHDOUST A, Muhammadnejad S, Parvin M, Bahram B, et al
Combination of T-DM1 and platinum-based chemotherapy in patient-derived xenograft models of muscle-invasive bladder cancer.
Iran J Basic Med Sci. 2022;25:816-821.
Abstract Related articles

BELLOS TC, Tzelves LI, Manolitsis IS, Katsimperis SN, et al
Sarcopenia in Urinary Bladder Cancer: Definition, Prevalence and Prognostic Value in Survival.
Maedica (Bucur). 2022;17:427-435.
Abstract Related articles

ZHU R, Jiang Y, Zhou Z, Zhu S, et al
Prediction of the postoperative prognosis in patients with non-muscle-invasive bladder cancer based on preoperative serum surface-enhanced Raman spectroscopy.
Biomed Opt Express. 2022;13:4204-4221.
Abstract Related articles

PENG JM, Chiu CF, Cheng JH, Liu HY, et al
Evasion of NK cell immune surveillance via the vimentin-mediated cytoskeleton remodeling.
Front Immunol. 2022;13:883178.
Abstract Related articles

EL-MORSHEDY M, Ahmad Z, Tag-Eldin E, Almaspoor Z, et al
A new statistical approach for modeling the bladder cancer and leukemia patients data sets: Case studies in the medical sector.
Math Biosci Eng. 2022;19:10474-10492.
Abstract Related articles

ZHOU X, Yue X, Xu Z, Denoeux T, et al
PENet: Prior Evidence Deep Neural Network for Bladder Cancer Staging.
Methods. 2022 Aug 25. pii: S1046-2023(22)00193.
Abstract Related articles

VALDEZ-FLORES C, Erraguntla N, Budinsky R, Cagen S, et al
An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene.
Chem Biol Interact. 2022 Aug 24:110077. doi: 10.1016/j.cbi.2022.110077.
Abstract Related articles

NISHIMURA N, Miyake M, Shimizu T, Matsubara T, et al
First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.
Int J Clin Oncol. 2022 Aug 27. pii: 10.1007/s10147-022-02230.
Abstract Related articles

DARRAJ M
Urinary Bladder Schistosomiasis Mimicking Neoplasm: A Case Report.
Medicina (Kaunas). 2022;58.
Abstract Related articles

GALSKY MD, Grewal S, Liu Y, Fuldeore R, et al
Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controls.
Urol Oncol. 2022;40:411.
Abstract Related articles

COLLA RUVOLO C, Deuker M, Wenzel M, Nocera L, et al
Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma.
Urol Oncol. 2022;40:411.
Abstract Related articles

WANG J, Wang H, Fu S
A Commentary on "Perioperative outcomes of intracorporeal robot-assisted radical cystectomy versus open radical cystectomy: A systematic review and meta-analysis of comparative studies" (Int. J. Surg. (2021) 94 106137).
Int J Surg. 2022;104:106770.
Abstract Related articles

DONG Q, Huang D, Xu X, Li Z, et al
Content and shape attention network for bladder wall and cancer segmentation in MRIs.
Comput Biol Med. 2022;148:105809.
Abstract Related articles

YAMADA T, Toyoda T, Matsushita K, Akane H, et al
Persistent gamma-H2AX Formation and Expression of Stem Cell Markers in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Bladder Carcinogenesis in Rats.
Toxicol Sci. 2022;189:51-61.
Abstract Related articles

STAERK K, Hjelmager JS, Alm M, Thomsen P, et al
A new catheter-integrated drug-delivery system for controlled intravesical mitomycin C release.
Urol Oncol. 2022;40:409.
Abstract Related articles

PIONTKOWSKI AJ, Corsi N, Morisetty S, Majdalany S, et al
Benefit of lymph node dissection in cN+ patients in the treatment of upper tract urothelial carcinoma: Analysis of NCDB registry.
Urol Oncol. 2022;40:409.
Abstract Related articles

KITA Y, Ito K, Kanda S, Joraku A, et al
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction.
Urol Oncol. 2022;40:410.
Abstract Related articles

SONG Y, Qin C, Du Y, Xu T, et al
Radical cystectomy and chemotherapy on plasmacytoid variant bladder urothelial carcinoma.
World J Urol. 2022;40:2353-2354.
Abstract Related articles

LI X, Li H, Gao XS, Fang D, et al
Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma.
Urol Oncol. 2022;40:410.
Abstract Related articles

SANGOI AR, Chan E, Abdulfatah E, Stohr BA, et al
p53 null phenotype is a "positive result" in urothelial carcinoma in situ.
Mod Pathol. 2022;35:1287-1292.
Abstract Related articles

KATAYAMA S, Mori K, Schuettfort VM, Pradere B, et al
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
Eur Urol Focus. 2022;8:761-768.
Abstract Related articles

MONTIRONI R, Scarpelli M, Cimadamore A, Mikuz G, et al
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Persona
Eur Urol Focus. 2022;8:882-884.
Abstract Related articles

VAN DER KWAST T, Van Rhijn B, Kamat A, Cheng L, et al
Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Uroth
Eur Urol Focus. 2022;8:885-886.
Abstract Related articles

GRUNE B, Kriegmair MC, Lenhart M, Michel MS, et al
Decision Aids for Shared Decision-making in Uro-oncology: A Systematic Review.
Eur Urol Focus. 2022;8:851-869.
Abstract Related articles

GUAN X, Peng Q, Liu Y, Wang J, et al
Effects of Propofol Intravenous Anesthesia on Serum NGF, S100B Protein, and Immune Function in Patients with Bladder Cancer after Resection.
Comput Math Methods Med. 2022;2022:5409323.
Abstract Related articles

ZHOU R, Peng N, Li W
Identification of ISCA1 as novel immunological and prognostic biomarker for bladder cancer.
Front Immunol. 2022;13:975503.
Abstract Related articles

LIU J, Cui J, Zhao S, Wu M, et al
Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer.
Oxid Med Cell Longev. 2022;2022:9316847.
Abstract Related articles

WANG Y, Zhou T, Chen H, Wen S, et al
Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence.
Med Oncol. 2022;39:185.
Abstract Related articles

NIZIOL J, Ossolinski K, Plaza-Altamer A, Kolodziej A, et al
Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer.
Sci Rep. 2022;12:15156.
Abstract Related articles

LIU W, He Q, Su X
Laparoscopic partial cystectomy through extraperitoneal space for primary bladder schwannoma.
Eur J Med Res. 2022;27:170.
Abstract Related articles

LI H, Yu G, Shi R, Lang B, et al
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.
Mol Cancer. 2022;21:155.
Abstract Related articles

LU P, Jiang Y, Xia Z
Hsa_circ_0003221 facilitates the malignant development of bladder cancer cells via resulting in the upregulation of DHCR24 by targeting miR-892b.
Investig Clin Urol. 2022;63:577-588.
Abstract Related articles

AHN HK, Kim K, Park J, Kim KH, et al
Urinary microbiome profile in men with genitourinary malignancies.
Investig Clin Urol. 2022;63:569-576.
Abstract Related articles

LEE HY, Jung SI, Lim DG, Chung HS, et al
Role of oral pentosan polysulfate in Bacillus Calmette-Guerin therapy in patients with non-muscle-invasive bladder cancer.
Investig Clin Urol. 2022;63:539-545.
Abstract Related articles

KIM JY, Lee DB, Song WH, Lee SS, et al
External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer.
Investig Clin Urol. 2022;63:531-538.
Abstract Related articles

ZHU G, Zhang Z, Zhao K, Yin X, et al
Laparoscopic radical cystectomy with pelvic lymph node dissection and ileal orthotopic neobladder by a total extraperitoneal approach: Our initial technique and short-term outcomes.
Investig Clin Urol. 2022;63:523-530.
Abstract Related articles

SZYMANIAK J, Porten SP
Which Biomarkers are Useful in the Management of Muscle-invasive Bladder Cancer in 2022?
Eur Urol Focus. 2022 Sep 1. pii: S2405-4569(22)00178.
Abstract Related articles

OTO J, Fernandez-Pardo A, Roca M, Plana E, et al
LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
World J Urol. 2022 Sep 4. pii: 10.1007/s00345-022-04136.
Abstract Related articles

PROIETTI F, Licari LC, Flammia RS, Bologna E, et al
Pregnancy after sexuality preserving cystectomy with urinary diversion for bladder cancer: case report and review of the literature.
BMC Urol. 2022;22:143.
Abstract Related articles

MULLAPUDI SS, Rahmat JN, Mahendran R, Lim YK, et al
Tumor-targeting albumin nanoparticles as an efficacious drug delivery system and potential diagnostic tool in non-muscle-invasive bladder cancer therapy.
Nanomedicine. 2022 Sep 2:102600. doi: 10.1016/j.nano.2022.102600.
Abstract Related articles

MONTERO-HIDALGO AJ, Perez-Gomez JM, Martinez-Fuentes AJ, Gomez-Gomez E, et al
Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment.
Wiley Interdiscip Rev RNA. 2022 Sep 5:e1760. doi: 10.1002/wrna.1760.
Abstract Related articles

PRABHARANI D, Pramod SV
Single dose Tadalafil 5 mg in Muscle Invasive Bladder Cancer (MIBC) patient induce priapism: A case report and literature review.
Urol Case Rep. 2022;45:102200.
Abstract Related articles

YU P, Yu L, Lu Y
Dietary consumption of cruciferous vegetables and bladder cancer risk: A systematic review and meta-analysis.
Front Nutr. 2022;9:944451.
Abstract Related articles

HUANG X, Wang HF, Huang S
Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients.
Front Genet. 2022;13:906880.
Abstract Related articles

PERVAIZ A, Ather MH, Bashir A, Aziz W, et al
Urdu Translation and Linguistic Validation of the Bladder Cancer Index Questionnaire.
Cureus. 2022;14:e27487.
Abstract Related articles

SU H, Xue X, Wang Y, Lu Y, et al
Competitive Risk Model for Specific Mortality Prediction in Patients with Bladder Cancer: A Population-Based Cohort Study with Machine Learning.
J Oncol. 2022;2022:9577904.
Abstract Related articles

SONG T, He K, Ning J, Li W, et al
Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment.
Front Oncol. 2022;12:930038.
Abstract Related articles

HUANG X, Wang X, Lan X, Deng J, et al
The role of radiomics with machine learning in the prediction of muscle-invasive bladder cancer: A mini review.
Front Oncol. 2022;12:990176.
Abstract Related articles

CHEN H, Yang W, Xue X, Li Y, et al
Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer.
Front Immunol. 2022;13:986359.
Abstract Related articles

CAI J, Xie Z, Yan Y, Huang Z, et al
Establishment of an optimized orthotopic bladder cancer model in mice.
BMC Urol. 2022;22:142.
Abstract Related articles

LOTAN P, Bercovich S, Keidar D, Malshy K, et al
Fascial dehiscence after radical cystectomy: Is abdominal exploration mandatory?
BMC Urol. 2022;22:138.
Abstract Related articles

ALBARAKATI N, Al-Shareeda A, Ramadan M, Al-Sowayan B, et al
Interaction between HER2 and ATM predicts poor survival in bladder cancer patients.
J Cell Mol Med. 2022 Sep 3. doi: 10.1111/jcmm.17512.
Abstract Related articles

CHORNIAK E, Liu Y, Odion R, Etienne W, et al
Intravital optical imaging for immune cell tracking after photoimmunotherapy with plasmonic gold nanostars.
Nanotechnology. 2022;33.
Abstract Related articles

JOSEPH A, Lafarge A, Mabrouki A, Abdel-Nabey M, et al
Severe infections in recipients of cancer immunotherapy: what intensivists need to know.
Curr Opin Crit Care. 2022;28:540-550.
Abstract Related articles

LI WM, Ke HL, Kuo YH, Lai HY, et al
High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
Oncology. 2022;100:485-497.
Abstract Related articles

LEE YC, Lam HM, Rosser C, Theodorescu D, et al
The dynamic roles of the bladder tumour microenvironment.
Nat Rev Urol. 2022;19:515-533.
Abstract Related articles

WANG M, Stendahl K, Cai G, Adeniran A, et al
Evaluation of TRPS1 Expression in Pleural Effusion Cytology Specimens With Metastatic Breast Carcinoma.
Am J Clin Pathol. 2022;158:416-425.
Abstract Related articles

GUPTA P, Jindal A, Ahuja G, Jayadeva, et al
A new deep learning technique reveals the exclusive functional contributions of individual cancer mutations.
J Biol Chem. 2022;298:102177.
Abstract Related articles

QIU T, Luo G, Jiang J, Ding P, et al
Genomic, Metabolic, and Immunological Characterization of GMP-Grade Mycobacterium phlei.
Microbiol Spectr. 2022;10:e0007022.
Abstract Related articles

ZHOU Z, Shi HJ, Jin L, Liu X, et al
Prognostic significance of age, sex, race, and socioeconomic status in patients with stage III-IV upper tract urothelial carcinoma.
Actas Urol Esp (Engl Ed). 2022;46:413-422.
Abstract Related articles

KOYUNCUER A, Sayar S, Zemheri IE, Ozdil K, et al
An exceptionally rare case of metastatic high-grade urothelial carcinoma of the renal pelvis to the pancreas diagnosed on endoscopic ultrasound-guided fine-needle aspiration: A diagnostic challenge.
Diagn Cytopathol. 2022;50:E295-E300.
Abstract Related articles

SAUNDERS KE, Cody Craig J, Hoerres DL, Maygarden SJ, et al
Less Is More.
Am J Clin Pathol. 2022;158:383-388.
Abstract Related articles

GREENLAND NY, Peng Y, Vohra P, Tabatabai ZL, et al
Cytologic features of micropapillary variant urothelial carcinoma in urinary tract cytology: Case series and review of literature.
Diagn Cytopathol. 2022;50:E280-E284.
Abstract Related articles

ZHAO B, Dong A, Zuo C
Prostate-Specific Membrane Antigen-Avid Bone Metastases From Urothelial Carcinoma of the Bladder.
Clin Nucl Med. 2022;47:892-894.
Abstract Related articles

QIN J, Liang Q, Wang G, Hao L, et al
Targeted delivery of nuclear targeting probe for bladder cancer using cyclic pentapeptide c(RGDfK) and acridine orange.
Clin Transl Oncol. 2022 Sep 13. pii: 10.1007/s12094-022-02938.
Abstract Related articles

SUNG CJ, Wang HH, Sun KH, Hsieh CC, et al
Fucoidan from Sargassum hemiphyllum inhibits the stemness of cancer stem cells and epithelial-mesenchymal transitions in bladder cancer cells.
Int J Biol Macromol. 2022 Sep 10. pii: S0141-8130(22)01968.
Abstract Related articles

OGAWA S
Targeting lineage plasticity overcomes chemoresistance.
Cancer Cell. 2022;40:905-907.
Abstract Related articles

WANG M, Chen X, Tan P, Wang Y, et al
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer.
Cancer Cell. 2022;40:1044-1059.
Abstract Related articles

SALOME B, Sfakianos JP, Ranti D, Daza J, et al
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Cancer Cell. 2022;40:1027-1043.
Abstract Related articles

NAKAGAWA R, Iwamoto H, Makino T, Kadomoto S, et al
Squamous or Glandular Differentiation Predicts Poor Prognosis in pT1 Urothelial Carcinoma.
In Vivo. 2022;36:2365-2370.
Abstract Related articles

MEGURO S, Kataoka M, Endo YU, Yaginuma K, et al
Low Risk of Venous Thromboembolism After Robot-assisted Radical Prostatectomy Through Systemic Image Assessment: A Prospective Study.
In Vivo. 2022;36:2384-2391.
Abstract Related articles

WAWERU JW, Mwangi KW, Barker VR, Gozlan EC, et al
Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer.
J Cancer Res Clin Oncol. 2022 Sep 13. pii: 10.1007/s00432-022-04339.
Abstract Related articles

ABDULLIN II, Grigoriev NA, Gaydamaka NV, Drozdova YY, et al
[Primary melanoma of renal pelvis].
Urologiia. 2022;:56-59.
Abstract Related articles

MARTOV AG, Dutov SV, Andronov AS, Mishugin SV, et al
[X-ray endoscopic treatment in patients with ureteral anastomotic obliteration after orthotopic neobladder formation].
Urologiia. 2022;:44-51.
Abstract Related articles

XU XH, Sun JM, Chen XF, Zeng XY, et al
MicroRNA-494-3p facilitates the progression of bladder cancer by mediating the KLF9/RGS2 axis.
Kaohsiung J Med Sci. 2022 Sep 13. doi: 10.1002/kjm2.12588.
Abstract Related articles

LI DX, Wang XM, Feng DC, Han P, et al
Neutrophil-to-lymphocyte ratio (NLR) during induction is a better predictor than preoperative NLR in non-muscle-invasive bladder cancer receiving Bacillus Calmette-GuERin.
Asian J Surg. 2022 Sep 9. pii: S1015-9584(22)01223.
Abstract Related articles

MENG X, Li W, Yuan H, Dong W, et al
KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion.
Biol Proced Online. 2022;24:12.
Abstract Related articles

EL-HADDAD NW, El Kawak M, El Asmar K, Jabbour ME, et al
AhRR methylation contributes to disease progression in urothelial bladder cancer.
Cancer Biomark. 2022 Sep 2. pii: CBM220002. doi: 10.3233/CBM-220002.
Abstract Related articles

LIMA APB, Melo AS, Ferreira GM, da Silva GN, et al
Chrysin inhibits the cell viability, induces apoptosis and modulates expression of genes related to epigenetic events in bladder cancer cells.
Nat Prod Res. 2022 Sep 10:1-5. doi: 10.1080/14786419.2022.2121825.
Abstract Related articles

WANG SD, Ge CG, Zhang JY
Incidence, prognostic factors and survival in bladder cancer patients: a population-based study.
Transl Cancer Res. 2022;11:2742-2756.
Abstract Related articles

HU Q, Hu J, Chen C, Wang Y, et al
Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1.
Transl Androl Urol. 2022;11:1083-1095.
Abstract Related articles

ERIKSSON V, Holmlund J, Wiberg E, Johansson M, et al
Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer-a Swedish retrospective multicentre study of a clinical database.
Transl Androl Urol. 2022;11:1105-1115.
Abstract Related articles

HUANG X, Huang W, Wu K, Lin Q, et al
PRRX1/FOXM1 reduces gemcitabin-induced cytotoxicity by regulating autophagy in bladder cancer.
Transl Androl Urol. 2022;11:1116-1129.
Abstract Related articles

VIVEIROS N, Flores BC, Lobo J, Martins-Lima C, et al
Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies.
Clin Transl Immunology. 2022;11:e1402.
Abstract Related articles

LEE EH, Kim HT, Chun SY, Chung JW, et al
Role of the JNK Pathway in Bladder Cancer.
Onco Targets Ther. 2022;15:963-971.
Abstract Related articles

LI S, Wei R, Yu G, Liu H, et al
Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer.
Front Oncol. 2022;12:982792.
Abstract Related articles

HAN JH, Jeong SH, Yuk HD, Jeong CW, et al
Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy.
Front Oncol. 2022;12:964571.
Abstract Related articles

XIAO Y, Dong Y, Yu T, Wang R, et al
Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy.
Front Immunol. 2022;13:941189.
Abstract Related articles

DENG D, Liu F, Liu Z, Wu Z, et al
Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma.
Front Immunol. 2022;13:965469.
Abstract Related articles

YE JJ, Ren SQ, Bao YG
Comment on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: Results of the GETUG-AFU V05 VESPER trial.
Asian J Surg. 2022 Sep 7. pii: S1015-9584(22)01139.
Abstract Related articles

MIN J, Ma J, Wang Q, Yu D, et al
Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
Clinics (Sao Paulo). 2022;77:100081.
Abstract Related articles

ZHANG J, Cui S, Shen L, Gao Y, et al
Promotion of Bladder Cancer Cell Metastasis by 2-Mercaptobenzothiazole via Its Activation of Aryl Hydrocarbon Receptor Transcription: Molecular Dynamics Simulations, Cell-Based Assays, and Machine Learning-Driven Prediction.
Environ Sci Technol. 2022 Sep 10. doi: 10.1021/acs.est.2c05178.
Abstract Related articles

CAO W, Shao Y, Zou S, Wang N, et al
Prognostic significance of systemic immune-inflammation index in patients with bladder cancer: A systematic review and meta-analysis.
Medicine (Baltimore). 2022;101:e30380.
Abstract Related articles

THIRUMAL S, Jamzad A, Cotechini T, Siemens DR, et al
Automated Cell Phenotyping for Imaging Mass Cytometry.
Annu Int Conf IEEE Eng Med Biol Soc. 2022;2022:426-429.
Abstract Related articles

HOU T, Dan W, Liu T, Liu B, et al
Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression.
Cell Death Dis. 2022;13:778.
Abstract Related articles

XU H, Liu Z, Weng S, Dang Q, et al
Artificial-intelligence-driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi-center integration analysis.
Mol Oncol. 2022 Sep 9. doi: 10.1002/1878-0261.13313.
Abstract Related articles

WARD GRADOS DF, Ahmadi H, Griffith TS, Warlick CA, et al
Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials.
Immunol Invest. 2022 Sep 9:1-26. doi: 10.1080/08820139.2022.2118606.
Abstract Related articles

HU H, Zhou M, Yang B, Zhou S, et al
A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer.
J Clin Med. 2022;11.
Abstract Related articles

YUEN JW, Wu RW, Ching SS, Ng CF, et al
Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review.
Int J Environ Res Public Health. 2022;19.
Abstract Related articles

XU J, Yang R, Li J, Wang L, et al
DNMT3A/miR-129-2-5p/Rac1 Is an Effector Pathway for SNHG1 to Drive Stem-Cell-like and Invasive Behaviors of Advanced Bladder Cancer Cells.
Cancers (Basel). 2022;14.
Abstract Related articles

LIU Q, Xie R, Li Y
Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival.
Int J Mol Sci. 2022;23.
Abstract Related articles

SANDULESCU AS, Stepan AE, Margaritescu C, Enachescu V, et al
The role of cell adhesion molecules in the progression of bladder urothelial carcinomas.
Rom J Morphol Embryol. 2022;63:145-151.
Abstract Related articles

DAI JD, He B, Liu ZH, Shi M, et al
Primary melanoma of the bladder: case report and review of the literature.
World J Surg Oncol. 2022;20:287.
Abstract Related articles

COMPERAT E, Amin MB, Berney DM, Cree I, et al
What's new in WHO fifth edition - urinary tract.
Histopathology. 2022;81:439-446.
Abstract Related articles

ZHOU D, Gao J, Liao Y, Da, et al
The CUSUM curve combined with comprehensive complication index for assessing short-term complications of radical cystectomy.
J Clin Lab Anal. 2022;36:e24616.
Abstract Related articles

YANG Y, Wang J, Huang W, Wan G, et al
Integrated Urinalysis Devices Based on Interface-Engineered Field-Effect Transistor Biosensors Incorporated With Electronic Circuits.
Adv Mater. 2022;34:e2203224.
Abstract Related articles

MARZOUKA NA, Eriksson P, Bernardo C, Hurst CD, et al
The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma.
J Mol Diagn. 2022;24:992-1008.
Abstract Related articles

SARRIO-SANZ P, Martinez-Cayuelas L, Lumbreras B, Sanchez-Caballero L, et al
Mortality prediction models after radical cystectomy for bladder tumour: A systematic review and critical appraisal.
Eur J Clin Invest. 2022;52:e13822.
Abstract Related articles

CHEN X, Chen Y, Lei Y, Huang F, et al
Exophytic Renal Urothelial Carcinoma Versus Renal Clear-cell Carcinoma: Clinical Data and Computed Tomography Findings.
Curr Med Imaging. 2022 May 13. pii: CMIR-EPUB-123530.
Abstract Related articles

MERRIEL SWD, Ball S, Bright CJ, Mak V, et al
A prospective evaluation of the fourth national Be Clear on Cancer 'Blood in Pee' campaign in England.
Eur J Cancer Care (Engl). 2022;31:e13606.
Abstract Related articles

SCARCELLA S, Castellani D, Piazza P, Giulioni C, et al
Concomitant robot-assisted laparoscopic surgeries for upper and lower urinary tract malignancies: a comprehensive literature review.
J Robot Surg. 2022;16:991-1005.
Abstract Related articles

YAO Z, Zhang H, Zhang X, Zhang Z, et al
Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer.
Front Genet. 2022;13:923768.
Abstract Related articles

SHEN L, Zhang J, Zheng Z, Yang F, et al
PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer.
Int J Biol Sci. 2022;18:5459-5474.
Abstract Related articles

POUREBRAHIMI E, Moradi Tabriz H, Miratashi Yazdi SA, Nazar E, et al
The value of BCL2 and CK20 expression in predicting behavioral patterns of bladder cancer, a cross sectional study.
Ann Med Surg (Lond). 2022;81:104372.
Abstract Related articles

AGARWAL N, Zhou Q, Arya D, Rinaldetti S, et al
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.
Int J Mol Sci. 2022;23.
Abstract Related articles

RINALDETTI S, Zhou Q, Abbott JM, de Jong FC, et al
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.
Int J Mol Sci. 2022;23.
Abstract Related articles

BISWAS PK, Kwak Y, Kim A, Seok J, et al
TTYH3 Modulates Bladder Cancer Proliferation and Metastasis via FGFR1/H-Ras/A-Raf/MEK/ERK Pathway.
Int J Mol Sci. 2022;23.
Abstract Related articles

AWADALLA A, Abol-Enein H, Hamam ET, Ahmed AE, et al
Identification of Epigenetic Interactions between miRNA and Gene Expression as Potential Prognostic Markers in Bladder Cancer.
Genes (Basel). 2022;13.
Abstract Related articles

FRIEDRICH V, Choi HW
The Urinary Microbiome: Role in Bladder Cancer and Treatment.
Diagnostics (Basel). 2022;12.
Abstract Related articles

WOZNICKI P, Laqua FC, Messmer K, Kunz WG, et al
Radiomics for the Prediction of Overall Survival in Patients with Bladder Cancer Prior to Radical Cystectomy.
Cancers (Basel). 2022;14.
Abstract Related articles

RODLER S, Eismann L, Schlenker B, Casuscelli J, et al
Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value-Need for Biomarker Testing in High-Risk Patients?
Cancers (Basel). 2022;14.
Abstract Related articles

LAI CR, Tsai YL, Tsai WC, Chen TM, et al
Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition.
Cancers (Basel). 2022;14.
Abstract Related articles

RAHMAN KMM, Giram P, Foster BA, You Y, et al
Photodynamic Therapy for Bladder Cancers, A Focused Review.
Photochem Photobiol. 2022 Sep 22. doi: 10.1111/php.13726.
Abstract Related articles

GAO S, Shan L, Zhang M, Wang Y, et al
Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation.
Cell Oncol (Dordr). 2022 Sep 22. pii: 10.1007/s13402-022-00710.
Abstract Related articles

DE LIMA CSA, Varca JPRO, Alves VM, Nogueira KM, et al
Mucoadhesive Polymers and Their Applications in Drug Delivery Systems for the Treatment of Bladder Cancer.
Gels. 2022;8.
Abstract Related articles

YADOLLAHVANDMIANDOAB R, Jalalizadeh M, Buosi K, Garcia-Perdomo HA, et al
Immunogenic Cell Death Role in Urothelial Cancer Therapy.
Curr Oncol. 2022;29:6700-6713.
Abstract Related articles

LI T, Liu T, Zhao Z, Pan Y, et al
Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer.
Front Immunol. 2022;13:911325.
Abstract Related articles

YANG YY, Hong SY, Xun Y, Liu CQ, et al
Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy.
J Oncol. 2022;2022:7679652.
Abstract Related articles

FAN T, Xue L, Dong B, He H, et al
CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration.
BMC Urol. 2022;22:156.
Abstract Related articles

RASHIDIAN H, Haghdoost AA, Daroudi R, Raadabadi M, et al
Estimating the Prevalence of Bladder Cancer by Stage in Iran as a Developing Country.
Med J Islam Repub Iran. 2022;36:37.
Abstract Related articles

MOSSANEN M, Nassar AH, Stokes SM, Martinez-Chanza N, et al
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
Clin Genitourin Cancer. 2022 Aug 29. pii: S1558-7673(22)00177.
Abstract Related articles

RENNER S, Loussikian P, Foulquie P, Arnould B, et al
Perceived Unmet Needs in Patients Living With Advanced Bladder Cancer and Their Caregivers: Infodemiology Study Using Data From Social Media in the United States.
JMIR Cancer. 2022;8:e37518.
Abstract Related articles

DI MAIDA F, Grosso AA, Tellini R, Lambertini L, et al
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guerin immunotherapy in patients with urothelial non-muscle invasive bladder cancer.
Minerva Urol Nephrol. 2022;74:642-646.
Abstract Related articles

WU P, Guo Y
Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population.
Biomed Res Int. 2022;2022:2988159.
Abstract Related articles

GROEN L, Schalken J
Liquid Biopsy for Prostate and Bladder Cancer: Progress and Pitfalls.
Eur Urol Focus. 2022 Sep 16. pii: S2405-4569(22)00202.
Abstract Related articles

KOELKER M, Alkhatib K, Briggs L, Labban M, et al
Impact of exercise on physical health status in bladder cancer patients.
Can Urol Assoc J. 2022 Aug 30. pii: cuaj.8008. doi: 10.5489/cuaj.8008.
Abstract Related articles

TU Y, Ding X, Mao Z
Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer.
Front Cell Dev Biol. 2022;10:912008.
Abstract Related articles

EL-GAMAL R, Abdelrahim M, El-Sherbiny M, Enan ET, et al
Gasdermin D: A potential mediator and prognostic marker of bladder cancer.
Front Mol Biosci. 2022;9:972087.
Abstract Related articles

CHOI YH, Park YM, Hur KJ, Ha US, et al
Duration of diabetes mellitus and risk of kidney and bladder cancer: a longitudinal nationwide cohort study.
Am J Cancer Res. 2022;12:4050-4061.
Abstract Related articles

STAMATAKOS PV, Moschotzopoulos D, Glykas I, Fragkoulis C, et al
Outcomes of radical cystectomy in pT4 bladder cancer frail patients: Alpha high-volume single center study.
J Frailty Sarcopenia Falls. 2022;7:147-150.
Abstract Related articles

BIAN B, Li L, Ke X, Chen H, et al
Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing.
Front Oncol. 2022;12:976329.
Abstract Related articles

LI F, Zhang H, Wang Y, Yao Z, et al
FGFBP1 as a potential biomarker predicting bacillus Calmette-Guerin response in bladder cancer.
Front Immunol. 2022;13:954836.
Abstract Related articles

MAALOUF N, Gur C, Yutkin V, Scaiewicz V, et al
High mannose level in bladder cancer enhances type 1 fimbria-mediated attachment of uropathogenic E. coli.
Front Cell Infect Microbiol. 2022;12:968739.
Abstract Related articles

EL-ADAWY MS, Ibrahim H, Zanaty F, Kotb S, et al
Factors related to upstaging of clinical stage T2 organ-confined bladder cancer following radical cystectomy: A multicenter study.
Urol Ann. 2022;14:232-235.
Abstract Related articles

PHARO HD, Jeanmougin M, Ager-Wick E, Vedeld HM, et al
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients.
Clin Epigenetics. 2022;14:115.
Abstract Related articles

GRESSER E, Woznicki P, Messmer K, Schreier A, et al
Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
Eur Urol Focus. 2022 Sep 14. pii: S2405-4569(22)00204.
Abstract Related articles

MORTON G
Bladder Cancer: New Insights Into Dose, Volume and Prognostic Biomarkers.
Clin Oncol (R Coll Radiol). 2022;34:622-624.
Abstract Related articles

JAZAYERI SB, Dehghanbanadaki H, Hosseini M, Taghipour P, et al
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis.
Abdom Radiol (NY). 2022 Sep 16. pii: 10.1007/s00261-022-03669.
Abstract Related articles

MO L, Su B, Xu L, Hu Z, et al
MCM7 supports the stemness of bladder cancer stem-like cells by enhancing autophagic flux.
iScience. 2022;25:105029.
Abstract Related articles

CRETTENAND F, M'Baya O, Grilo N, Valerio M, et al
ERAS(R) protocol improves survival after radical cystectomy: A single-center cohort study.
Medicine (Baltimore). 2022;101:e30258.
Abstract Related articles

WANG J, Luo J, Wu X, Li Z, et al
ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression.
Hum Cell. 2022 Sep 15. pii: 10.1007/s13577-022-00789.
Abstract Related articles

FONT A, Domenech M, Buisan O, Lopez H, et al
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
World J Urol. 2022 Sep 15. pii: 10.1007/s00345-022-04147.
Abstract Related articles

LIU L, Wang Q, Yuan H
Clinicopathological Characteristics and Prognostic Factors of Primary Bladder Signet Ring Cell Carcinoma.
J Healthc Eng. 2022;2022:3224616.
Abstract Related articles

WANG X, Yang G, Chai Y, Li Z, et al
Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients.
Dis Markers. 2022;2022:6575605.
Abstract Related articles

CHEN J, Wang K, Ye S, Meng X, et al
Tyrosine kinase receptor RON activates MAPK/RSK/CREB signal pathway to enhance CXCR4 expression and promote cell migration and invasion in bladder cancer.
Aging (Albany NY). 2022;14:7093-7108.
Abstract Related articles

AAYUSH A, Darji S, Dhawan D, Enstrom A, et al
Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma.
Oncotarget. 2022;13:1004-1016.
Abstract Related articles

BANGS R, Quale DZ, Reed T
Checklist for Improving Patient Communication on Bladder Preservation Options: The Patient Advocate Perspective.
Clin Oncol (R Coll Radiol). 2022;34:625-629.
Abstract Related articles

AFTRETH OP, Tenggardjaja CF, Reyblat P
Cystectomy for Benign Indications.
Curr Urol Rep. 2022;23:195-201.
Abstract Related articles

DEL BIONDO D, Napodano G, Di Giacomo F, Di Domenico DD, et al
A New Technique for Continent Urinary Diversion: Initial Experience and Description of the Technique.
Urol J. 2022;19:300-306.
Abstract Related articles

PEREZ JORGE G, Modolo DG, Jaimes-Florez YP, Favaro WJ, et al
p53 gene delivery via a recombinant Salmonella enterica Typhimurium leads to human bladder carcinoma cell death in vitro.
Lett Appl Microbiol. 2022;75:1010-1020.
Abstract Related articles

ABDEL-ATY H, Warren-Oseni K, Bagherzadeh-Akbari S, Hansen VN, et al
Mapping Local Failure Following Bladder Radiotherapy According to Dose.
Clin Oncol (R Coll Radiol). 2022;34:e421-e429.
Abstract Related articles

PRYMA C, Villamil C, Gibb EA, Oo HZ, et al
Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma.
Virchows Arch. 2022;481:397-403.
Abstract Related articles

HAFEEZ S, Koh M, Jones K, El Ghzal A, et al
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis.
Clin Oncol (R Coll Radiol). 2022;34:630-641.
Abstract Related articles

WU Z, Li M, Wang L, Paul A, et al
Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis.
Minerva Urol Nephrol. 2022;74:518-527.
Abstract Related articles

WESSELS F, Kuntz S, Krieghoff-Henning E, Schmitt M, et al
Artificial intelligence to predict oncological outcome directly from hematoxylin and eosin-stained slides in urology.
Minerva Urol Nephrol. 2022;74:538-550.
Abstract Related articles

ETO M, Lee JL, Chang YH, Gao S, et al
Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region.
Asia Pac J Clin Oncol. 2022;18:e191-e203.
Abstract Related articles

JOUMA ALHEJAZI T, Bdeiwi H, Sukkari MW, Ibrahim M, et al
Femoral metastasis in previously treated bladder cancer patient: A case report.
Clin Case Rep. 2022;10:e6357.
Abstract Related articles

LEE J, Park HS, Han SR, Kang YH, et al
Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles.
Front Oncol. 2022;12:976407.
Abstract Related articles

NASCIMBEN M, Rimondini L, Cora D, Venturin M, et al
Polygenic risk modeling of tumor stage and survival in bladder cancer.
BioData Min. 2022;15:23.
Abstract Related articles

CICIONE A, Simone G, Lombardo R, Franco A, et al
Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram.
Clin Genitourin Cancer. 2022 Sep 6. pii: S1558-7673(22)00179.
Abstract Related articles

CHANG Q, Chen P, Yin J, Liang G, et al
Discovery and validation of bladder cancer related excreted nucleosides biomarkers by dilution approach in cell culture supernatant and urine using UHPLC-MS/MS.
J Proteomics. 2022 Sep 26:104737. doi: 10.1016/j.jprot.2022.104737.
Abstract Related articles

COMPERAT E, Amin MB, Cathomas R, Choudhury A, et al
Current best practice for bladder cancer: a narrative review of diagnostics and treatments.
Lancet. 2022 Sep 26. pii: S0140-6736(22)01188.
Abstract Related articles

AL SAIDI I, Mohamedabugroon A, Sawalha A, Sultan I, et al
Epidemiology of Bladder Cancer in the Arab World: 2019 Global Burden of Disease Data.
Asian Pac J Cancer Prev. 2022;23:2907-2919.
Abstract Related articles

ZHANG P, Zhang H, Zheng B, Wang H, et al
Combined Self-Assembled Hendeca-Arginine Nanocarriers for Effective Targeted Gene Delivery to Bladder Cancer.
Int J Nanomedicine. 2022;17:4433-4448.
Abstract Related articles

ABRAHAMI D, Tesfaye H, Yin H, Vine S, et al
Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.
Diabetes Care. 2022 Sep 28. pii: 147692. doi: 10.2337/dc22-1174.
Abstract Related articles

SHI X, Pang S, Zhou J, Yan G, et al
Feedback loop between fatty acid transport protein 2 and receptor interacting protein 3 pathways promotes polymorphonuclear neutrophil myeloid-derived suppressor cells-potentiated suppressive immunity in bladder cancer.
Mol Biol Rep. 2022 Sep 28. pii: 10.1007/s11033-022-07924.
Abstract Related articles

EINERHAND SMH, Black AJ, Zargar H, Fairey AS, et al
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol. 2022 Sep 28. pii: 10.1007/s00345-022-04160.
Abstract Related articles

LIU P, Fan B, Othmane B, Hu J, et al
m(6)A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.
Theranostics. 2022;12:6291-6307.
Abstract Related articles

Retraction: Bladder cancer-associated transcript 2 contributes to nephroblastoma progression.
J Gene Med. 2022 Sep 27:e3448. doi: 10.1002/jgm.3448.
Abstract Related articles

YANJUN Z, Jin S, Qiuyue L, Tao L, et al
Risk factors and nomogram model establishment for incision infection in patients with bladder cancer after radical resection.
Asian J Surg. 2022 Sep 24. pii: S1015-9584(22)01276.
Abstract Related articles

SIVARAJAN G, Akhter M
Effect of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer.
JAMA. 2022;328:1257-1258.
Abstract Related articles

CATTO JWF, Khetrapal P, Ambler G
Effect of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer-Reply.
JAMA. 2022;328:1258-1259.
Abstract Related articles

DE ROSE AF, Vecco F, Ambrosini F, Malinaric R, et al
How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice.
Arch Ital Urol Androl. 2022;94:369-370.
Abstract Related articles

MEHRNOUSH V, Brennan L, Ismail A, Zakaria A, et al
Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology.
Arch Ital Urol Androl. 2022;94:291-294.
Abstract Related articles

QIU T, Xue M, Li X, Li F, et al
Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Mol Omics. 2022 Sep 27. doi: 10.1039/d2mo00107.
Abstract Related articles

XIE YF, Liu YL, Guo XG
Response to comment on "Pooled analysis of Xpert bladder cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma".
World J Surg Oncol. 2022;20:306.
Abstract Related articles

WU S, Cui Y, Zhao H, Xiao X, et al
Trophoblast Exosomal UCA1 Induces Endothelial Injury through the PFN1-RhoA/ROCK Pathway in Preeclampsia: A Human-Specific Adaptive Pathogenic Mechanism.
Oxid Med Cell Longev. 2022;2022:2198923.
Abstract Related articles

PAN S, Li S, Zhan Y, Chen X, et al
Immune status for monitoring and treatment of bladder cancer.
Front Immunol. 2022;13:963877.
Abstract Related articles

HAMAAMIN KS, Marouf BH
Chemopreventive Efficacy of Thymoquinone in Chemically Induced Urinary Bladder Carcinogenesis in Rat.
Biomed Res Int. 2022;2022:6276768.
Abstract Related articles

LI N, Wang L, Liang H, Lin C, et al
Detecting and monitoring bladder cancer with exfoliated cells in urine.
Front Oncol. 2022;12:986692.
Abstract Related articles

CUI Y, Feng H, Liu J, Wu J, et al
Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer.
Front Mol Biosci. 2022;9:1009168.
Abstract Related articles

ROJAS PA, Bravo JC, Gallegos H, Zuniga A, et al
[Prognostic factors in patients with upper urinary tract urothelial carcinoma undergoing nephro-ureterectomy].
Rev Med Chil. 2022;150:172-177.
Abstract Related articles

IKARASHI D, Kitano S, Nakatsura T, Obara W, et al
[The Analysis of Tumor Immune Microenvironment in Muscle-Invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy].
Gan To Kagaku Ryoho. 2022;49:917-921.
Abstract Related articles

ABD EL-AZEEM MA, Ali MA, El-Shorbagy SH
Expression of GLUT4 and FAP in urothelial bladder carcinoma: correlation with angiogenesis and clinicopathological characteristics.
J Egypt Natl Canc Inst. 2022;34:40.
Abstract Related articles

LAVALLEE E, Sfakianos J, Mehrazin R, Wiklund P, et al
Detailed Description of the Karolinska Technique for Intracorporeal Studer Neobladder Reconstruction.
J Endourol. 2022;36.
Abstract Related articles

WANG HJ, Cai Q, Huang YP, Li MQ, et al
Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer.
Radiology. 2022;305:E59.
Abstract Related articles

CHEN YK, Huang EY, Chang YH, Kuo JY, et al
The comparison of different BCG strains in the intravesical treatment of non-muscle invasive urothelial carcinoma of urinary bladder-A real-world practice.
J Chin Med Assoc. 2022;85:928-934.
Abstract Related articles

HUANG J, Su R, Chen Z, Jiang S, et al
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy.
Oncoimmunology. 2022;11:2124691.
Abstract Related articles

MADUREIRA AC
Programmed Cell Death-Ligand-1 expression in Bladder Schistosomal Squamous Cell Carcinoma - There's room for Immune Checkpoint Blockage?
Front Immunol. 2022;13:955000.
Abstract Related articles

TULONE G, Pavan N, Abrate A, Dalmasso E, et al
Preliminary Results of ERAS Protocol in a Single Surgeon Prospective Case Series.
Medicina (Kaunas). 2022;58.
Abstract Related articles

KOHLER SA, Brandl L, Strissel PL, Glossner L, et al
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and Subtyping.
Int J Mol Sci. 2022;23.
Abstract Related articles

KOSTAKOPOULOS N, Athanasiadis G, Omar MI, Abraham J, et al
The impact of low-pressure pneumoperitoneum on robotic-assisted radical cystectomy and intracorporeal ileal conduit urinary diversion: a case-control study.
World J Urol. 2022;40:2467-2472.
Abstract Related articles

SHENG IY, Gupta S, Reddy CA, Angelini D, et al
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors.
Target Oncol. 2022;17:563-569.
Abstract Related articles

PADUA TC, Moschini M, Martini A, Pederzoli F, et al
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review.
Urol Oncol. 2022;40:413-423.
Abstract Related articles

LABBATE CV, Hensley PJ, Miest TS, Qiao W, et al
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.
Urol Oncol. 2022;40:454.
Abstract Related articles

LONE Z, Zhang A, Benidir T, Corrigan D, et al
The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy.
Urol Oncol. 2022;40:453.
Abstract Related articles

KENIGSBERG AP, Carpinito G, Gold SA, Meng X, et al
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy.
Urol Oncol. 2022;40:452.
Abstract Related articles

YU K, Ebbehoj AL, Obeid H, Vaidya A, et al
Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results From a Multicenter Study.
J Clin Endocrinol Metab. 2022;107:2811-2821.
Abstract Related articles

ZHOU X, Luo G
Is radiotherapy helpful for the prognosis of upper urinary tract urothelial carcinoma? A meta-analysis.
Urol Oncol. 2022;40:424-433.
Abstract Related articles

RIZZO A, Mollica V, Santoni M, Massari F, et al
Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis.
Clin Genitourin Cancer. 2022;20:482-487.
Abstract Related articles

AALAMI AH, Aalami F
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.
Int J Clin Oncol. 2022;27:1605-1615.
Abstract Related articles

KIM MY, Aerin J, Traslavina RP, Yoon HY, et al
Orthotopic ureterocele with concurrent ureteral urothelial carcinoma in a dog.
Vet Med Sci. 2022;8:1881-1886.
Abstract Related articles

MIRON B, Handorf E, Zarrabi K, Zibelman MR, et al
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.
Urol Oncol. 2022;40:454.
Abstract Related articles

MAKRAKIS D, Talukder R, Lin GI, Diamantopoulos LN, et al
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:e440-e452.
Abstract Related articles

MILOT L
Amide Proton Transfer-weighted MRI: Insight into Cancer Cell Biology.
Radiology. 2022 Jun 28:221376. doi: 10.1148/radiol.221376.
Abstract Related articles

ZHAO CC, Bjurlin MA, Wysock JS, Taneja SS, et al
Machine learning decision support model for radical cystectomy discharge planning.
Urol Oncol. 2022;40:453.
Abstract Related articles

GOTTE M, Bahlburg H, Butea-Bocu MC, von Landenberg N, et al
Complications in the Early Recovery Period After Radical Cystectomy-Real Data From Impartial Inpatient Rehabilitation.
Clin Genitourin Cancer. 2022;20:e424-e431.
Abstract Related articles

TEO MY, Guercio BJ, Arora A, Hao X, et al
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.
Clin Genitourin Cancer. 2022;20:431-441.
Abstract Related articles

MINATO A, Furubayashi N, Harada M, Negishi T, et al
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer. 2022;20:499.
Abstract Related articles

GAKIS G, Schmid MA, Hassan F, Stenzl A, et al
The Accuracy of Sequential Urethral Frozen Section and its Impact on Urethral Recurrence After Radical Cystectomy.
Clin Genitourin Cancer. 2022;20:e390-e395.
Abstract Related articles

CASTEL-AJGAL Z, Goulvestre C, Zaibet S, Arrondeau J, et al
Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab.
Clin Genitourin Cancer. 2022;20:e362-e368.
Abstract Related articles

PANER GP, Smith SC, Hartmann A, Agarwal PK, et al
Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice.
Mod Pathol. 2022;35:1296-1305.
Abstract Related articles

YOSHIDA T, Ohe C, Ito K, Takada H, et al
Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis.
Cancer Immunol Immunother. 2022;71:2815-2828.
Abstract Related articles

BHATTACHARYYA N, Mukherjee D, Singh S, Ghosh R, et al
"Seeing" invisible volatile organic compound (VOC) marker of urinary bladder cancer: A development from bench to bedside prototype spectroscopic device.
Biosens Bioelectron. 2022;218:114764.
Abstract Related articles

LIU N, Wu T, Ma Y, Cheng H, et al
Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer.
Anticancer Drugs. 2022 Oct 6. pii: 00001813-990000000-00069.
Abstract Related articles

OLAH C, Reis H, Hoffmann MJ, Mairinger F, et al
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer.
Cancer Med. 2022 Oct 7. doi: 10.1002/cam4.5324.
Abstract Related articles

YUAN X, Chen M, Yang J, Ye Y, et al
Complete transurethral resection of bladder tumor before radical cystectomy is not a risk factor for organ-confined bladder cancer: A case-control study.
Curr Urol. 2022;16:142-146.
Abstract Related articles

SANGUEDOLCE F, Troiano F, Musci G, Zanelii M, et al
Collision nodal metastasis of bladder cancer and melanoma: The first reported case and literature review.
Curr Urol. 2022;16:168-171.
Abstract Related articles

BROUGHTON EI, Chun DS, Gooden KM, Mycock KL, et al
Treatment and disease management patterns for bacillus Calmette-Guerin unresponsive nonmuscle invasive bladder cancer in North America, Europe and Asia: A real-world data analysis.
Curr Urol. 2022;16:147-153.
Abstract Related articles

WU ZS, Wu S
The era of personalized treatments: Updates on immunotherapy within urothelial of bladder cancer.
Curr Urol. 2022;16:117-120.
Abstract Related articles

SHALABY EA, Mohamed AR, Elkammash TH, Abouelkheir RT, et al
Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer.
Curr Urol. 2022;16:127-135.
Abstract Related articles

CAHILL EM, Chua K, Doppalapudi SK, Ghodoussipour S, et al
The use of blue-light cystoscopy in the detection and surveillance of nonmuscle invasive bladder cancer.
Curr Urol. 2022;16:121-126.
Abstract Related articles

DI GIANFRANCESCO L, Ragonese M, Palermo G, Sacco E, et al
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer.
Curr Urol. 2022;16:172-174.
Abstract Related articles

LEE N, Canagasingham A, Bajaj M, Shanmugasundaram R, et al
Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance.
Front Oncol. 2022;12:1019391.
Abstract Related articles

HASHEMI M, Arani HZ, Orouei S, Rostamnejad E, et al
Crosstalk of miRNAs With Signaling Networks in Bladder Cancer Progression: Therapeutic, Diagnostic and Prognostic Functions.
Pharmacol Res. 2022 Oct 3:106475. doi: 10.1016/j.phrs.2022.106475.
Abstract Related articles

DARYANTO B, Purnomo AF, Seputra KP, Budaya TN, et al
Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis.
Med Arch. 2022;76:198-201.
Abstract Related articles

DONG L, Ying X, Tao S, Guang-Peng Z, et al
Diabetes Is a Risk Factor for the Prognosis of Patients with Bladder Cancer: A Meta-Analysis.
J Oncol. 2022;2022:1997507.
Abstract Related articles

GAO Z, Fang L, Yin P, Deng Y, et al
Effects of Nursing Care for the Treatment of Patients with Bladder Cancer: A Systematic Review and Meta-analysis.
Comput Math Methods Med. 2022;2022:9554223.
Abstract Related articles

ZHOU RS, Zhao JZ, Guo LM, Guo JL, et al
The novel antitumor compound clinopodiside A induces cytotoxicity via autophagy mediated by the signaling of BLK and RasGRP2 in T24 bladder cancer cells.
Front Pharmacol. 2022;13:982860.
Abstract Related articles

QIN JX, Liu X, Wang XL, Wang GY, et al
Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker.
Front Genet. 2022;13:984279.
Abstract Related articles

LIU S, Liu Z, Piao C, Zhang Z, et al
Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
J Exp Clin Cancer Res. 2022;41:293.
Abstract Related articles

LV J, Song Q, Bai K, Han J, et al
N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer.
Cancer Cell Int. 2022;22:301.
Abstract Related articles

HAYASHI Y, Fujita K, Sakai K, Adomi S, et al
Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer.
Sci Rep. 2022;12:16642.
Abstract Related articles

ROCCO B, Eissa A, Gaia G, Assumma S, et al
Pelvic lymph node dissection in prostate and bladder cancers: a narrative review.
Minerva Urol Nephrol. 2022 Oct 5. pii: S2724-6051.22.04904.
Abstract Related articles

SONG Y, Ren P, Wu Y, Zhang B, et al
Efficacy of long-term extended nursing services combined with atezolizumab in patients with bladder cancer after endoscopic bladder resection.
Medicine (Baltimore). 2022;101:e30690.
Abstract Related articles

HU X, Zhang YS, Liu YC, Wang N, et al
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges.
J Nanobiotechnology. 2022;20:437.
Abstract Related articles

DESAI G, Bhardwaj A, Lokhande K, Wagle PK, et al
Synchronous Multifocal Gall Bladder Cancer and Extrahepatic Cholangiocarcinoma.
J Gastrointest Cancer. 2022 Oct 4. pii: 10.1007/s12029-022-00869.
Abstract Related articles

HE F, Zhang F, Liao Y, Tang MS, et al
Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer.
Cancer Lett. 2022;550:215924.
Abstract Related articles

QIAO H, Zhang W, Liu P, Zhu R, et al
Ropivacaine inhibits proliferation and invasion and promotes apoptosis and autophagy in bladder cancer cells via inhibiting PI3K/AKT pathway.
J Biochem Mol Toxicol. 2022 Oct 3:e23233. doi: 10.1002/jbt.23233.
Abstract Related articles

ZHAO K, Gao M, Lin M
KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma.
Dis Markers. 2022;2022:3373851.
Abstract Related articles

WARRICK JI, Knowles MA, Hurst CD, Shuman L, et al
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.
Sci Rep. 2022;12:16538.
Abstract Related articles

TAPPERO S, Panunzio A, Hohenhorst L, Cano Garcia C, et al
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer.
Eur J Surg Oncol. 2022 Sep 24. pii: S0748-7983(22)00683.
Abstract Related articles

ZHENG B, Liu Z, Wang H, Sun L, et al
R11 modified tumor cell membrane nanovesicle-camouflaged nanoparticles with enhanced targeting and mucus-penetrating efficiency for intravesical chemotherapy for bladder cancer.
J Control Release. 2022 Sep 30. pii: S0168-3659(22)00650.
Abstract Related articles

EMINAGA O, Ge TJ, Shkolyar E, Laurie MA, et al
An Efficient Framework for Video Documentation of Bladder Lesions for Cystoscopy: A Proof-of-Concept Study.
J Med Syst. 2022;46:73.
Abstract Related articles

Retraction to: Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
Cancer Biomark. 2022 Sep 23. pii: CBM229006. doi: 10.3233/CBM-229006.
Abstract Related articles

XU J, Xu Z, Yin H, Zang J, et al
Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis.
Front Surg. 2022;9:849929.
Abstract Related articles

CASTELLANO E, Samba C, Esteso G, Simpson L, et al
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.
Front Immunol. 2022;13:970931.
Abstract Related articles

KONG J, Lu S, Zhang L, Yao Y, et al
m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent.
Front Immunol. 2022;13:1014861.
Abstract Related articles

NAHHAT F, Doyya M, Ksiri H
Complete response to intravesical gemcitabine in non-muscle invasive bladder cancer patient after BCG failure: A case report and literature review.
Clin Case Rep. 2022;10:e6373.
Abstract Related articles

BHIRUD DP, Mittal A, Kumar S, Narain TA, et al
When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center.
Indian J Surg Oncol. 2022;13:604-611.
Abstract Related articles

XU Z, Xu C, Wang Q, Ma S, et al
An enhancer RNA-based risk model for prediction of bladder cancer prognosis.
Front Med (Lausanne). 2022;9:979542.
Abstract Related articles

ZHANG Y, Li X, Li X, Zhao Y, et al
Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer.
Front Genet. 2022;13:990326.
Abstract Related articles

SU Q, Tan Q, Liu X, Wu L, et al
Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model.
Front Genet. 2022;13:1001608.
Abstract Related articles

LV Y, Liu Z, Jia H, Xiu Y, et al
Properties of flavonoids in the treatment of bladder cancer (Review).
Exp Ther Med. 2022;24:676.
Abstract Related articles

TUNG CL, Chao WY, Li YZ, Shen CH, et al
Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells.
Int J Med Sci. 2022;19:1567-1575.
Abstract Related articles

SHIZUYA T, Miyazaki S
Comparison of New Drug Indications Approved in the United States, Europe, and Japan from 2001 to 2020.
Biol Pharm Bull. 2022;45:1495-1502.
Abstract Related articles

ZHANG B, He Y, Ma G, Zhang L, et al
Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA.
Mol Cell Probes. 2022 Sep 29:101867. doi: 10.1016/j.mcp.2022.101867.
Abstract Related articles

MAKRAKIS D, Holt SK, Bernick C, Grivas P, et al
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset.
Alzheimer Dis Assoc Disord. 2022 Sep 30. pii: 00002093-990000000-00029.
Abstract Related articles

WANG J, Wu M, Zhu Y, Wang Z, et al
A multilayer nanofibrous mat for the topical chemotherapy of the positive margin in bladder cancer.
Tissue Eng Part A. 2022 Oct 1. doi: 10.1089/ten.TEA.2022.0096.
Abstract Related articles

YANG H, Yan J
A systematic review of prognosis of ABO blood group and rhesus factor on outcomes in patients with bladder cancer.
Medicine (Baltimore). 2022;101:e30893.
Abstract Related articles

LIU B, Meng LB, Su JZ, Fan B, et al
PLK1 as one novel target for the poor prognosis of bladder cancer: An observational study.
Medicine (Baltimore). 2022;101:e30723.
Abstract Related articles

FAN L, Yang J, Shen C, Wu Z, et al
Corrigendum to "Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis" [Acta Histochem. 123(5) (2021) 151745].
Acta Histochem. 2022 Sep 27:151956. doi: 10.1016/j.acthis.2022.151956.
Abstract Related articles

MAO T, Zhang H, Cui J, Zhao Z, et al
The 980 nm diode laser treatment for non-muscle-invasive bladder tumor with en bloc technique: single-center experience.
World J Surg Oncol. 2022;20:324.
Abstract Related articles

SCHNEIDER T, Zhao L, Zhu Z, Gabrielyan G, et al
The past, present, and future of immunotherapy for bladder tumors.
Med Oncol. 2022;39:236.
Abstract Related articles

LIN CT, Su PJ, Huang SY, Wu CC, et al
First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis.
J Immunother. 2022;45:407-414.
Abstract Related articles

TURKERI L, Karsiyakali N, Aslan G, Akgul M, et al
Immediate post-operative intravesical instillation of a single dose chemotherapy is not superior to continuous saline irrigation.
Actas Urol Esp (Engl Ed). 2022;46:464-472.
Abstract Related articles

REDELMAN-SIDI G, Binyamin A, Antonelli AC, Catalano W, et al
BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.
Cancer Immunol Res. 2022;10:1241-1253.
Abstract Related articles

RODRIGUEZ KM, Kates M
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything.
Nat Rev Urol. 2022;19:579-580.
Abstract Related articles

URABE F, Matsuzaki J, Takeshita F, Kishida T, et al
Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma.
Cancer Sci. 2022;113:3510-3517.
Abstract Related articles

LIEDBERG F, Abrahamsson J, Bobjer J, Gudjonsson S, et al
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma-feasibility and complications: a single center experience.
Scand J Urol. 2022;56:301-307.
Abstract Related articles

XIONG B, Xu C, Zhang X
A rare case of primary malignant paraganglioma of the urinary bladder.
Asian J Surg. 2022;45:2496-2497.
Abstract Related articles

MA Q, Yang W, Zhang K
Parastomal hernia following radical cystectomy with urinary diversion: An unusual case report.
Asian J Surg. 2022;45:2280-2281.
Abstract Related articles

HERIK RODRIGO AG, Tomonobu N, Yoneda H, Kinoshita R, et al
Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.
Biochem Biophys Res Commun. 2022;634:83-91.
Abstract Related articles

ZHANG Y, Nosseir M, Dyer J
Analysing cause of death during follow-up for non-muscle-invasive bladder cancer: is there a role for watchful waiting?
Ann R Coll Surg Engl. 2022 Oct 14. doi: 10.1308/rcsann.2022.0099.
Abstract Related articles

TRIPATHI K, Maurya N, Goel A, Singhai A, et al
Immunohistochemical expressions of EMT markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
Mol Cell Biochem. 2022 Oct 14. pii: 10.1007/s11010-022-04579.
Abstract Related articles

KIM N, Moon SK, You MW, Lim JW, et al
Recurrence of Subepithelial Non-Muscle Invasive Bladder Cancer Following Transurethral Resection: A Case Report.
Taehan Yongsang Uihakhoe Chi. 2021;82:715-720.
Abstract Related articles

YOON IN, Cha ES, Kim JH, Lee JE, et al
Bladder Cancer Metastasis to the Breast in a Male Patient: Imaging Findings on Mammography and Ultrasonography.
Taehan Yongsang Uihakhoe Chi. 2022;83:687-692.
Abstract Related articles

WANG P, Wang Z, Zhu L, Sun Y, et al
A pyroptosis-related lncRNA signature in bladder cancer.
Cancer Med. 2022 Oct 13. doi: 10.1002/cam4.5344.
Abstract Related articles

QIAN K, Wang G, Cao R, Liu T, et al
Correction: Qian et al. Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways. Molecules 2016, 21, 1406.
Molecules. 2022;27.
Abstract Related articles

CARRASCO R, Ingelmo-Torres M, Gomez A, Trullas R, et al
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.
Int J Mol Sci. 2022;23.
Abstract Related articles

RUTZ J, Maxeiner S, Grein T, Sonnenburg M, et al
Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines.
Int J Mol Sci. 2022;23.
Abstract Related articles

FU G, Wu Y, Zhao G, Chen X, et al
Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin.
Cells. 2022;11.
Abstract Related articles

OLKHOV-MITSEL E, Yu Y, Lajkosz K, Liu SK, et al
Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification.
Cancers (Basel). 2022;14.
Abstract Related articles

ZHENG Z, Guo Y, Huang X, Liu J, et al
CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

XING J, Chen W, Chen K, Zhu S, et al
TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-kappaB.
Cancers (Basel). 2022;14.
Abstract Related articles

AVETA A, Cacciapuoti C, Barone B, Di Zazzo E, et al
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
Cancers (Basel). 2022;14.
Abstract Related articles

CAI H, Xu H, Lu H, Xu W, et al
LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARgamma Ubiquitination in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

XIE H, Rutz J, Maxeiner S, Grein T, et al
Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro.
Cancers (Basel). 2022;14.
Abstract Related articles

JO YY, Yea JW, Park J, Oh SA, et al
Optimized Adaptive Radiotherapy with Individualized Plan Library for Muscle-Invasive Bladder Cancer Using Internal Target Volume Generation.
Cancers (Basel). 2022;14.
Abstract Related articles

KUMAR RA, Asanad K, Miranda G, Cai J, et al
Population-Based Assessment of Determining Predictors for Discharge Disposition in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Cancers (Basel). 2022;14.
Abstract Related articles

GUAN T, Su M, Luo Z, Peng W, et al
Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

KOCSMAR I, Kocsmar E, Pajor G, Kulka J, et al
Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

CHEN S, Shu G, Wang G, Ye J, et al
HOXA1 promotes proliferation and metastasis of bladder cancer by enhancing SMAD3 transcription.
Pathol Res Pract. 2022;239:154141.
Abstract Related articles

LI Z, Liu J, Fu H, Li Y, et al
SENP3 affects the expression of PYCR1 to promote bladder cancer proliferation and EMT transformation by deSUMOylation of STAT3.
Aging (Albany NY). 2022;14.
Abstract Related articles

SUN JX, Xu JZ, Liu CQ, An Y, et al
The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two-sample mendelian randomization.
J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28208.
Abstract Related articles

LIU P, Chen S, Gao X, Liang H, et al
Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer.
Front Immunol. 2022;13:1032907.
Abstract Related articles

CHEN Q, Yin G, He X, Jiang T, et al
Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.
Evid Based Complement Alternat Med. 2022;2022:4351005.
Abstract Related articles

STONE L
The composition and influence of the gut mycobiome in bladder cancer.
Nat Rev Urol. 2022 Oct 12. pii: 10.1038/s41585-022-00668.
Abstract Related articles

GAO F, Li H, Mao Z, Xiao Y, et al
An integrative approach for identification of smoking-related genes involving bladder cancer.
Arch Toxicol. 2022 Oct 12. pii: 10.1007/s00204-022-03380.
Abstract Related articles

MAAS M, Black PC
Radical Transurethral Resection of Bladder Tumor in Seemingly Organ-confined Muscle-invasive Bladder Cancer: Con.
Eur Urol Focus. 2022 Oct 8. pii: S2405-4569(22)00221.
Abstract Related articles

KRANZ J, Hoffmann M
[Narrow Band Imaging versus white light cystoscopy alone in transurethral resection of non-muscle invasive bladder cancer : Study commentary].
Urologie. 2022 Oct 11. pii: 10.1007/s00120-022-01952.
Abstract Related articles

CT and clinical features for distinguishing endophytic clear cell renal cell carcinoma from urothelial carcinoma.
Diagn Interv Radiol. 2022;28:410-417.
Abstract Related articles

ELSALEM L, Alfaqih MA, Al Bashir S, Halalsheh O, et al
Genetic variation in the ADIPOQ gene and serum adiponectin increase the risk of bladder cancer.
J Appl Biomed. 2022;20:106-113.
Abstract Related articles

ZHAO G, Yang F, Yang Q, Yang Y, et al
Efficacy of compound aluminum sulfate injection as a monotherapeutic regimen in non-muscle invasive bladder cancer patients: a retrospective single-arm cohort study.
Transl Androl Urol. 2022;11:1292-1303.
Abstract Related articles

SUN S, Jiang K, Zeng J
Differential expression of DNA damage repair genes after chemoradiotherapy and inhibition rate in different bladder cancer cells.
Transl Androl Urol. 2022;11:1336-1344.
Abstract Related articles

JOBST M, Kiss E, Gerner C, Marko D, et al
Activation of autophagy triggers mitochondrial loss and changes acetylation profile relevant for mechanotransduction in bladder cancer cells.
Arch Toxicol. 2022 Oct 10. pii: 10.1007/s00204-022-03375.
Abstract Related articles

WOOLBRIGHT BL, Rajendran G, Abbott E, Martin A, et al
Role of MIF1/MIF2/CD74 interactions in bladder cancer.
J Pathol. 2022 Oct 10. doi: 10.1002/path.6018.
Abstract Related articles

YE K, Xiao M, Li Z, He K, et al
Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non-muscle-invasive bladder cancer.
Cancer Med. 2022 Oct 10. doi: 10.1002/cam4.5284.
Abstract Related articles

LOPEZ-FONTANA R, Lopez-Fontana G, Guglielmi JM, Lopez-Laur JD, et al
Cistytis Glandularis: An Infrequent and Little-Known Tumor. Two Cases Report and Current Evidence.
Arch Esp Urol. 2022;75:663-666.
Abstract Related articles

DE LA ENCARNACION CASTELLANO C, Canos Nebot A, Vargas Andreu P, Garcia Carbajosa N, et al
Incidence of Bladder Cancer in Patients Undergoing Radiotherapy for Prostate Cancer.
Arch Esp Urol. 2022;75:655-662.
Abstract Related articles

LUCCA I, Derre L, Cesson V, Bohner P, et al
Intravesical Ty21a Treatment of Non-muscle-invasive Bladder Cancer Shows a Good Safety Profile.
Eur Urol Open Sci. 2022;45:55-58.
Abstract Related articles

BIERI U, Enderlin D, Buser L, Wettstein MS, et al
Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.
Front Oncol. 2022;12:964672.
Abstract Related articles

DUGGAN B, O'Rourke D, Anderson N, Reid CN, et al
Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific.
Front Oncol. 2022;12:1009014.
Abstract Related articles

QU G, Xu Y, Lu Z, Nie H, et al
Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
Oxid Med Cell Longev. 2022;2022:4754935.
Abstract Related articles

HOU J, Wen X, Lu Z, Wu G, et al
A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer.
Front Immunol. 2022;13:970949.
Abstract Related articles

XIAO Z, Cai Z, Deng D, Tong S, et al
An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer.
Front Immunol. 2022;13:1000321.
Abstract Related articles

LI H, Zu X, Hu J, Xiao Z, et al
Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.
Front Immunol. 2022;13:964393.
Abstract Related articles

HE Z, Gu J, Luan T, Li H, et al
Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA.
Front Immunol. 2022;13:973974.
Abstract Related articles

YAMASAKI H, Uematsu Y, Hayashi Y, Yamashita M, et al
Coincidence of v-raf murine sarcoma viral oncogene homolog B mutation (V595E) with phosphorylated v-raf murine sarcoma viral oncogene homolog B in urothelial carcinoma in dogs.
Can J Vet Res. 2022;86:286-293.
Abstract Related articles

ZOU Z, Cheng Q, Li Z, Gao W, et al
[microRNA let-7g-3p regulates proliferation, migration, invasion and apoptosis of bladder cancer cells by targeting HMGB2].
Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1335-1343.
Abstract Related articles

EDIZ C, Terzi NK, Akan S, Yilmaz O, et al
Association between Serum Carcino-embryonic Antigen Levels and Micropapillary Bladder Cancer Metastasis in an Elderly Male.
J Coll Physicians Surg Pak. 2022;32:S186-S188.
Abstract Related articles

DING M, Lin J, Qin C, Wei P, et al
Application of synthetic biology in bladder cancer.
Chin Med J (Engl). 2022 Oct 10. pii: 00029330-990000000-00183.
Abstract Related articles

XIE J, Ni J, Shi H, Wang K, et al
LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer.
Cancer Med. 2022 Oct 8. doi: 10.1002/cam4.5316.
Abstract Related articles

ZHONG X, Pan Y, Xiong Y, Zhang P, et al
Preoperative hydronephrosis represents an unfavorable prognostic factor in muscle-invasive bladder cancer patients undergoing radical cystectomy from a single high-volume center.
Asian J Surg. 2022 Oct 4. pii: S1015-9584(22)01369.
Abstract Related articles

KARAKOSE A, Akdeniz E
Papillary Urothelial Carcinoma Arising from Ureterocele: Is it a Rare Occurrence?
J Coll Physicians Surg Pak. 2022;32:1360-1362.
Abstract Related articles

KUROKAWA M, Shimizu K, Kitabayashi R, Ogawa K, et al
[Re-Administration of Pembrolizumab for Urothelial Carcinoma after immune-Related Myasthenia Gravis : A Case Report].
Hinyokika Kiyo. 2022;68:295-300.
Abstract Related articles

PIUNTI A, Meghani K, Yu Y, Robertson AG, et al
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
Sci Adv. 2022;8:eabo8043.
Abstract Related articles

PAN C, Qin H, Jin H, Chen W, et al
Environmental exposure to microcystin-LR increases the risks of urinary bladder proliferation and carcinogenesis: Evidence from case control, animal, and in vitro studies.
Toxicology. 2022;480:153326.
Abstract Related articles

WONG RL, Yu EY
Enfortumab vedotin in the treatment of urothelial cancers and beyond.
Future Oncol. 2022;18:3067-3084.
Abstract Related articles

PIATON E, Prat JJ, Nennig C, Hutin K, et al
ThinPrep(R) imaging system-assisted vs manual screening of urinary cytology slides in the detection of the "suspicious for high-grade urothelial carcinoma" category.
Cytopathology. 2022;33:716-724.
Abstract Related articles

BELLIO H, Benderra MA
[New drug approval: Nivolumab for adjuvant treatment of patients with PD-L1-positive (>/=1%), muscle invasive urothelial carcinoma who are at high risk of recurrence after radical resection].
Bull Cancer. 2022;109:992-993.
Abstract Related articles

ZEUSCHNER P, Junker K
Optimal Selection of Patients with Genitourinary Cancers for Anti-PD1/PD-L1 Treatment with a Focus on Urothelial and Renal Cell Carcinoma.
Eur Urol Focus. 2022;8:907-909.
Abstract Related articles

HEMIDA AS, Aiad HAES, Hassan NA, Al Sharaky DR, et al
Fibroblast activation protein (FAP) expression in CK5/6 expressed (Basal subtype) & CK20 expressed (Luminal subtype) urothelial bladder carcinoma: an immunohistochemical study.
J Immunoassay Immunochem. 2022;43:618-633.
Abstract Related articles

JIN G, Zheng J, Zhang Y, Yang Z, et al
LncRNA UCA1 epigenetically suppresses APAF1 expression to mediate the protective effect of sevoflurane against myocardial ischemia-reperfusion injury.
Funct Integr Genomics. 2022;22:965-975.
Abstract Related articles

WITJES JA, Galsky MD, Gschwend JE, Broughton E, et al
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial.
Eur Urol Oncol. 2022;5:553-563.
Abstract Related articles

RICHTERS A, Boormans JL, van der Heijden MS, van der Heijden AG, et al
Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study.
Eur Urol Focus. 2022;8:995-1002.
Abstract Related articles

MORI K, Schuettfort VM, Katayama S, Laukhtina E, et al
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
Eur Urol Focus. 2022;8:972-979.
Abstract Related articles

GUSZCZ T, Sankiewicz A, Gorodkiewicz E
Application of surface plasmon resonance imaging biosensors for determination of fibronectin, laminin-5 and type IV collagen in serum of transitional bladder cancer patients.
J Pharm Biomed Anal. 2022;222:115103.
Abstract Related articles

HOU Y, Chen Y, Lai S, Seery S, et al
Decision regret related to urinary diversion choices after cystectomy among Chinese bladder cancer patients.
Cancer Med. 2022 Oct 21. doi: 10.1002/cam4.5281.
Abstract Related articles

MALHOTRA B, Hiteshi P, Khalkho P, Malik R, et al
Bladder cancer with pioglitazone: A case-control study.
Diabetes Metab Syndr. 2022;16:102637.
Abstract Related articles

WAGNER J, Simon R, Buchler JW, Kirchhoff F, et al
Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer.
World J Urol. 2022 Oct 21. pii: 10.1007/s00345-022-04187.
Abstract Related articles

FENG L, Yang K, Kuang Q, Peng M, et al
A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer.
J Oncol. 2022;2022:8408328.
Abstract Related articles

BARRIOS W, Abdollahi B, Goyal M, Song Q, et al
Bladder cancer prognosis using deep neural networks and histopathology images.
J Pathol Inform. 2022;13:100135.
Abstract Related articles

XU H, Clemenceau JR, Park S, Choi J, et al
Spatial heterogeneity and organization of tumor mutation burden with immune infiltrates within tumors based on whole slide images correlated with patient survival in bladder cancer.
J Pathol Inform. 2022;13:100105.
Abstract Related articles

TU H, Liu H, Zhang L, Tan Z, et al
A novel prognostic model based on three integrin subunit genes-related signature for bladder cancer.
Front Oncol. 2022;12:970576.
Abstract Related articles

ELEY SJ, Fatima S, Barlev D, Rohr BR, et al
Discrete red-brown crusted papules with a bladder cancer history.
JAAD Case Rep. 2022;29:161-163.
Abstract Related articles

ZOU Y, Yuan G, Tan X, Luo S, et al
Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients.
Front Genet. 2022;13:1011390.
Abstract Related articles

REIKE MJ, Ingersoll MA, Muller DC, Zuiverloon TCM, et al
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.
Urol Oncol. 2022 Oct 17. pii: S1078-1439(22)00340.
Abstract Related articles

YE Y, Zheng Y, Yu K, Zhang X, et al
Response to "A commentary on "Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study" [Int. J. Surg. (2022) 103 106693]" (Int J Surg 202
Int J Surg. 2022 Oct 17:106894. doi: 10.1016/j.ijsu.2022.106894.
Abstract Related articles

HU J, Chen J, Ou Z, Chen H, et al
Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study.
Cell Rep Med. 2022 Oct 12:100785. doi: 10.1016/j.xcrm.2022.100785.
Abstract Related articles

ZHANG S, Yu S, Duan H, Xia W, et al
Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.
Front Genet. 2022;13:997573.
Abstract Related articles

FANG S, Liu Y, Dai H, Gao T, et al
Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study.
Front Oncol. 2022;12:996440.
Abstract Related articles

WU S, Qiu S, Chen W, Ding L, et al
Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer.
Dis Markers. 2022;2022:5081413.
Abstract Related articles

XIAO Y, Wang T, Cheng X, Liu F, et al
LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress.
Oxid Med Cell Longev. 2022;2022:2435114.
Abstract Related articles

SAKAMOTO T, Fujimoto N, Nakashima M
[ONE COURSE OF PEMBROLIZUMAB AFTER RADIATION THERAPY WAS VERY EFFECTIVE AGAINST METASTATIC BLADDER CANCER AND CR WAS CONFIRMED: A CASE REPORT].
Nihon Hinyokika Gakkai Zasshi. 2021;112:220-223.
Abstract Related articles

LI L, Wang D, Xin S, Ren X, et al
Sphingosine Kinase 1 Acts as a Hypoxia-Upregulated Oncogene to Regulate Cell Invasion and Resistance to NK Cell Killing in Bladder Carcinoma Cells.
Ann Clin Lab Sci. 2022;52:763-771.
Abstract Related articles

HINTERMEIER S, Schwentner C
[The 90-day mortality and morbidity after open vs. robot-assisted radical cystectomy with intracorporeal urinary diversion for nonmetastatic bladder cancer : Summary of the iROC study].
Urologie. 2022 Oct 19. pii: 10.1007/s00120-022-01961.
Abstract Related articles

YOUNG PA, Rangel J, Keller LC
Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report.
Dermatol Online J. 2022;28.
Abstract Related articles

KOURIE HR, Succar B, Chouery E, Mehawej C, et al
Genetic susceptibility of bladder cancer in the Lebanese population.
BMC Med Genomics. 2022;15:217.
Abstract Related articles

GNANACHANDRAN K, Kedracka-Krok S, Pabijan J, Lekka M, et al
Discriminating bladder cancer cells through rheological mechanomarkers at cell and spheroid levels.
J Biomech. 2022;144:111346.
Abstract Related articles

GUO Y, Zheng Z, Mao S, Yang F, et al
Metabolic-associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer.
Mol Carcinog. 2022 Oct 17. doi: 10.1002/mc.23475.
Abstract Related articles

HUANG R, Li Z, Weng S, Wu S, et al
Simultaneous triple primary malignancies, including bladder cancer, lymphoma, and lung cancer, in an elderly male: A case report.
Open Life Sci. 2022;17:1263-1268.
Abstract Related articles

ZHANG J, Song L, Zhu H, Liu Q, et al
Prognostic value of programmed cell death ligand-1 expression in patients with bladder urothelial carcinoma undergoing radical cystectomy: A meta-analysis.
Front Immunol. 2022;13:986911.
Abstract Related articles

QU W, Zhang F, Cheng Y, Li J, et al
The impact of genetic variants in the CYP2C8 gene on bladder cancer susceptibility.
Front Endocrinol (Lausanne). 2022;13:989030.
Abstract Related articles

BESANCON M, Gris T, Joncas FH, Picard V, et al
Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment.
Eur Urol Open Sci. 2022;43:35-44.
Abstract Related articles

ZHAO Z, Jiang N, Zhang Y, Bai Y, et al
Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
Front Genet. 2022;13:919829.
Abstract Related articles

DENG Y, Wu T, Luo G, Chen L, et al
Exploring the casual association between coffee intake and bladder cancer risk using Mendelian Randomization.
Front Genet. 2022;13:992599.
Abstract Related articles

JIANG Y, Huang S, Zhu X, Cheng L, et al
Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer.
J Oncol. 2022;2022:8213321.
Abstract Related articles

GUI Z, Ying X, Liu C
NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer.
J Oncol. 2022;2022:4271409.
Abstract Related articles

LI D, Zuo M, Hu X
Global Trends in Research of Treatment on Bladder Cancer with Chinese Medicine Monomer from 2000 to 2021: A Bibliometric Analysis.
J Oncol. 2022;2022:3382360.
Abstract Related articles

DAEI S, Ziamajidi N, Abbasalipourkabir R, Aminzadeh Z, et al
Silver Nanoparticles Exert Apoptotic Activity in Bladder Cancer 5637 Cells Through Alteration of Bax/Bcl-2 Genes Expression.
Chonnam Med J. 2022;58:102-109.
Abstract Related articles

GAO Z, Chen C, Gu P, Chen J, et al
The tumor microenvironment and prognostic role of autophagy- and immune-related genes in bladder cancer.
Cancer Biomark. 2022 Sep 30. pii: CBM220058. doi: 10.3233/CBM-220058.
Abstract Related articles

ALSYOUF M, Maldonado J, Denham L, Rohweller B, et al
Detailed cadaveric analysis of perivesical lymph nodes in cystectomy specimens.
Can J Urol. 2022;29:11312-11317.
Abstract Related articles

HEINLEN JE
Re: "The Effect of prior prostate cancer treatment on perioperative and pathological outcomes after cystectomy".
Can J Urol. 2022;29:11291.
Abstract Related articles

FARAJ KS, Bunn WD, Edmonds VS, Tyson MD, et al
The effect of prior prostate cancer treatment on perioperative and pathological outcomes after cystectomy.
Can J Urol. 2022;29:11284-11290.
Abstract Related articles

KUWADA H, Ihara K, Imaishi H
Development of a new assay system for bladder cancer using interactions between cytochromes P450 and serum.
Drug Metab Pharmacokinet. 2022;47:100472.
Abstract Related articles

DENG R, Li Y, Zhang Z, Liang C, et al
The "Hand as Foot" teaching method in the TNM stage of bladder cancer.
Asian J Surg. 2022 Oct 12. pii: S1015-9584(22)01339.
Abstract Related articles

KIM K, Youm JY, Lee EH, Gulenko O, et al
Tapered catheter-based transurethral photoacoustic and ultrasonic endoscopy of the urinary system.
Opt Express. 2022;30:26169-26181.
Abstract Related articles

RESTA J, Santin Y, Roumiguie M, Riant E, et al
Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells.
Int J Mol Sci. 2022;23.
Abstract Related articles

MERLER S, Pafumi S, Zampiva I, Zacchi F, et al
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report.
Anticancer Drugs. 2022;33:1171-1174.
Abstract Related articles

FAN B, Huang Y, Zhang H, Chen T, et al
Analysis of genetic profiling, pathomics signature, and prognostic features of primary lymphoepithelioma-like carcinoma of the renal pelvis.
Mol Oncol. 2022;16:3666-3688.
Abstract Related articles

GRAHAM J, Vogel A, Cheng AL, Bjarnason GA, et al
Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review.
Cancer Treat Rev. 2022;110:102453.
Abstract Related articles

PAL L, Jenei T, McKee M, Kovacs N, et al
Health and economic gain attributable to the introduction of the World Health Organization's drinking water standard on arsenic level in Hungary: A nationwide retrospective study on cancer occurrence and ischemic heart disease mortality.
Sci Total Environ. 2022;851.
Abstract Related articles

WANG H, Shen Z, Tan Z, Zhang Z, et al
Fast Lasso-type safe screening for Fine-Gray competing risks model with ultrahigh dimensional covariates.
Stat Med. 2022;41:4941-4960.
Abstract Related articles

BELLAMRI M, Walmsley SJ, Brown C, Brandt K, et al
DNA Damage and Oxidative Stress of Tobacco Smoke Condensate in Human Bladder Epithelial Cells.
Chem Res Toxicol. 2022;35:1863-1880.
Abstract Related articles

VIKTORSSON K, Haag P, Shah CH, Franzen B, et al
Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.
Mol Oncol. 2022;16:3620-3641.
Abstract Related articles

HO JCS, Mir SA, Cavalera M, Esmaeili P, et al
Lipid bilayer composition as a determinant of cancer cell sensitivity to tumoricidal protein-lipid complexes.
Biofactors. 2022;48:1145-1159.
Abstract Related articles

CHIEN TM, Li CC, Lu YM, Chang HW, et al
Prognostic value of renal function for upper tract urothelial carcinoma who underwent radical nephroureterectomy: Sex differences.
J Formos Med Assoc. 2022;121:2182-2190.
Abstract Related articles

OLKHOV-MITSEL E, Hodgson A, Liu SK, Vesprini D, et al
Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression.
J Clin Pathol. 2022;75:766-771.
Abstract Related articles

LONG X, Chen L, Yang J, Dong T, et al
Network-based pharmacology and in vitro validation reveal that galangin induces apoptosis in bladder cancer cells by promoting the p53 signaling pathway.
Anticancer Agents Med Chem. 2022 Oct 26. pii: ACAMC-EPUB-127207.
Abstract Related articles

FANG P, Jiang Q, Liu S, Gu J, et al
Circ_0002099 is a novel molecular therapeutic target for bladder cancer.
Drug Dev Res. 2022 Oct 27. doi: 10.1002/ddr.22005.
Abstract Related articles

HEER R, Lewis R, Duncan A, Penegar S, et al
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
Health Technol Assess. 2022;26:1-144.
Abstract Related articles

ZHANG L, Li X, Yang L, Tang Y, et al
Multi-Sequence and Multi-Regional MRI-Based Radiomics Nomogram for the Preoperative Assessment of Muscle Invasion in Bladder Cancer.
J Magn Reson Imaging. 2022 Oct 27. doi: 10.1002/jmri.28498.
Abstract Related articles

DE CELIS ALONSO B
Editorial for "Multi-Sequence and Multi-Regional MRI-Based Radiomics Nomogram for the Preoperative Prediction of Muscle Invasion in Bladder Cancer".
J Magn Reson Imaging. 2022 Oct 27. doi: 10.1002/jmri.28497.
Abstract Related articles

FENG L, Yang J, Zhang W, Wang X, et al
Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer.
Front Oncol. 2022;12:994703.
Abstract Related articles

SHEN C, Li Z, Zhang Y, Zhang Z, et al
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.
Front Oncol. 2022;12:1018285.
Abstract Related articles

JEONG HJ, Kim K, Kim HW, Park Y, et al
Classification between Normal and Cancerous Human Urothelial Cells by Using Micro-Dimensional Electrochemical Impedance Spectroscopy Combined with Machine Learning.
Sensors (Basel). 2022;22.
Abstract Related articles

ROSLAN A, Sulaiman N, Mohd Ghani KA, Nurdin A, et al
Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer.
Pharmaceutics. 2022;14.
Abstract Related articles

HAO L, Shi Z, Dong Y, Chen J, et al
Efficient Delivery of P3H4 siRNA and Chlorin e6 by cRGDfK-Installed Polyarginine Nanoparticles for Tumor-Targeting Therapy of Bladder Cancer.
Pharmaceutics. 2022;14.
Abstract Related articles

WALKER JM, O'Malley P, He M
Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer.
Pharmaceutics. 2022;14.
Abstract Related articles

BARONE B, Napolitano L, Reccia P, De Luca L, et al
Preoperative Fibrinogen-to-Albumin Ratio as Potential Predictor of Bladder Cancer: A Monocentric Retrospective Study.
Medicina (Kaunas). 2022;58.
Abstract Related articles

FENG C, Zhou Z, Huang Q, Meng X, et al
Radiomics Nomogram Based on High-b-Value Diffusion-Weighted Imaging for Distinguishing the Grade of Bladder Cancer.
Life (Basel). 2022;12.
Abstract Related articles

BILIM V, Kuroki H, Shirono Y, Murata M, et al
Advanced Bladder Cancer: Changing the Treatment Landscape.
J Pers Med. 2022;12.
Abstract Related articles

KING B, Singh D, Rathore A, Flenner R, et al
Case Report with Systematic Literature Review on Vascular Complications of BCG Intravesical Therapy for Bladder Cancer.
J Clin Med. 2022;11.
Abstract Related articles

ALBARRAN V, Rosero DI, Chamorro J, Pozas J, et al
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.
Int J Mol Sci. 2022;23.
Abstract Related articles

XIE Q, Hua X, Huang C, Liao X, et al
SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation.
Int J Mol Sci. 2022;23.
Abstract Related articles

HOLICKOVA A, Roska J, Orasova E, Bruderova V, et al
Response of the Urothelial Carcinoma Cell Lines to Cisplatin.
Int J Mol Sci. 2022;23.
Abstract Related articles

MEHUS AA, Bergum N, Knutson P, Shrestha S, et al
Chronic Arsenic Exposure Upregulates the Expression of Basal Transcriptional Factors and Increases Invasiveness of the Non-Muscle Invasive Papillary Bladder Cancer Line RT4.
Int J Mol Sci. 2022;23.
Abstract Related articles

SHALATA AT, Shehata M, Van Bogaert E, Ali KM, et al
Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends.
Cancers (Basel). 2022;14.
Abstract Related articles

WANG Y, Wang X
A Pan-Cancer Analysis of Heat-Shock Protein 90 Beta1(HSP90B1) in Human Tumours.
Biomolecules. 2022;12.
Abstract Related articles

KONG C, Zhang S, Lei Q, Wu S, et al
State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer.
Biosensors (Basel). 2022;12.
Abstract Related articles

ALIMOHAMED N, Grewal S, Wirtz HS, Hepp Z, et al
Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada.
Curr Oncol. 2022;29:7587-7597.
Abstract Related articles

YANG J, Huang H, Li W, Ran S, et al
A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy.
Curr Oncol. 2022;29:6834-6846.
Abstract Related articles

LI S, Karagas MR, Jackson BP, Passarelli MN, et al
Adaptive-mixture-categorization (AMC)-based g-computation and its application to trace element mixtures and bladder cancer risk.
Sci Rep. 2022;12:17841.
Abstract Related articles

KHANSARY S, Tavilani H, Ghasemi H
Gender, bladder cancer healthcare and burden of COVID-19.
Cancer Invest. 2022 Oct 25:1-15. doi: 10.1080/07357907.2022.2140351.
Abstract Related articles

PANG L, Ding Z, Li F, Chai H, et al
HPV-16 Expression and Loss of Cell Differentiation in Primary Bladder Tumors.
Biomed Res Int. 2022;2022:6565620.
Abstract Related articles

BONFILL X, Martinez-Zapata MJ, Barrionuevo-Rosas L, Vernooij RW, et al
Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study.
Medicine (Baltimore). 2022;101:e31175.
Abstract Related articles

LAM CM, Li Z, Theodorescu D, Li X, et al
Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors.
Bladder Cancer. 2022;8:241-254.
Abstract Related articles

ZHANG P, Wang X
Erratum: [Corrigendum] Suppression of SIPA1 expression may reduce bladder cancer invasion and metastasis via the downregulation of Ecadherin and ZO1.
Exp Ther Med. 2022;24:686.
Abstract Related articles

WU D, Ding J, Wang L, Pan H, et al
microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.
Oncol Lett. 2022;24:389.
Abstract Related articles

OMLAND LH, Ammitzboll G, Lund CM, Lindberg H, et al
Muscle mass and physical function in patients with bladder cancer-Data from a prematurely terminated prospective cohort study.
Front Rehabil Sci. 2022;3:942475.
Abstract Related articles

LU F, Wu J, Zou H, Yang X, et al
The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis.
Oxid Med Cell Longev. 2022;2022:3355365.
Abstract Related articles

JIANG Y, Qu X, Zhang M, Zhang L, et al
Identification of a six-gene prognostic signature for bladder cancer associated macrophage.
Front Immunol. 2022;13:930352.
Abstract Related articles

ATHANS S, Krishnan N, Ramakrishnan S, Cortes Gomez E, et al
STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer.
Cancer Res Commun. 2022;2:1129-1143.
Abstract Related articles

LIU G, Li B, Xu Z, Wang J, et al
Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status.
Discov Med. 2022;33:85-92.
Abstract Related articles

CLAPS F, Mir MC, van Rhijn BWG, Mazzon G, et al
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy.
Urol Oncol. 2022 Oct 20. pii: S1078-1439(22)00343.
Abstract Related articles

FADEL J, Simonyan D, Fradet V, Lodde M, et al
Analysis of sex-based differences to Bacillus Calmette-Guerin for non-muscle invasive bladder cancer.
Urol Oncol. 2022 Oct 19. pii: S1078-1439(22)00352.
Abstract Related articles

YOO JW, Koo KC, Chung BH, Baek SY, et al
Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method.
Sci Rep. 2022;12:17699.
Abstract Related articles

SANDERS C, Lau JF, Dietrich D, Strieth S, et al
Nectin-4 is widely expressed in head and neck squamous cell carcinoma.
Oncotarget. 2022;13:1166-1173.
Abstract Related articles

BENJAMIN DJ, Shrestha A, Fellman D, Cress RD, et al
Association of Sociodemographic Characteristics With Survival Among Patients With Urachal Cancer in California From 1988 to 2019.
JAMA Oncol. 2022;8:1505-1507.
Abstract Related articles

MOHANAD M, Yousef HF, Bahnassy AA
Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients.
Mol Genet Genomics. 2022;297:1671-1687.
Abstract Related articles

LEVY JJ, Liu X, Marotti JD, Kerr DA, et al
Large-scale longitudinal comparison of urine cytological classification systems reveals potential early adoption of The Paris System criteria.
J Am Soc Cytopathol. 2022;11:394-402.
Abstract Related articles

DOLASHKI A, Antonova O, Velkova L, Kaynarov D, et al
Selective Cytotoxicity and Changes in Protein Expression of T24 Bladder Carcinoma Permanent Cell Line after Treatment with Hemocyanins.
Curr Med Chem. 2022;29:6479-6498.
Abstract Related articles

TRIPATHI N, Jo Y, Tripathi A, Sayegh N, et al
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
Urol Oncol. 2022;40:493.
Abstract Related articles

MAETA N, Kutara K, Saeki K, Hoshi F, et al
Modified Toyoda technique for total cystectomy and cutaneous ureterostomy in a cat.
Vet Surg. 2022;51:1280-1286.
Abstract Related articles

REISWICH V, Konemann S, Lennartz M, Hoflmayer D, et al
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
Pathol Res Pract. 2022;237:154028.
Abstract Related articles

CAPUTO A, Califano A, Addesso M, Caleo A, et al
Non-urothelial lesions of the urinary bladder A 14.5-year, single-institution review.
Pathol Res Pract. 2022;237:153998.
Abstract Related articles

BAXI V, Lee G, Duan C, Pandya D, et al
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab +/- ipilimumab.
Mod Pathol. 2022;35:1529-1539.
Abstract Related articles

JINGUSHI K, Kawashima A, Saito T, Kanazawa T, et al
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
Cancer Immunol Immunother. 2022;71:2999-3011.
Abstract Related articles

HOLZBEIERLEIN JM
Perioperative optimization of the genitourinary oncology patient.
Urol Oncol. 2022;40:487-488.
Abstract Related articles

PING Z, Zhan X, Chen T, Zheng Y, et al
Survival Outcome of Partial Cystectomy versus Transurethral Bladder Tumor Resection in T1 High-Grade Bladder Cancer Patients: A Propensity Score Matching Study.
J Oncol. 2022;2022:3016725.
Abstract Related articles

LYU Q, Nie Y, Yuan J, Wang D, et al
Causes of death in female patients with bladder cancer after local tumor excision and radical cystectomy: a contemporary, US population-based analysis.
Eur J Med Res. 2022;27:230.
Abstract Related articles

MELGAREJO-SEGURA MT, Morales-Martinez A, Yanez-Castillo Y, Arrabal-Polo MA, et al
A systematic review of the efficacy of intravesical electromotive drug administration therapy for non-muscle invasive bladder cancer.
Urol Oncol. 2022 Oct 31. pii: S1078-1439(22)00351.
Abstract Related articles

HUANG Z, Wang G, Wu Y, Yang T, et al
N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer.
Transl Oncol. 2022;27:101581.
Abstract Related articles

CHEN J, Hao L, Zhang Z, Zhang S, et al
Activation hypoxia inducible factor-1alpha gene affected the tumor microenvironment and induced recurrence and invasion of bladder cancer in vitro.
Cir Cir. 2022;90:588-595.
Abstract Related articles

SUN Z, Zhang W, Ye Z, Yuan L, et al
NIR-II-triggered doxorubicin release for orthotopic bladder cancer chemo-photothermal therapy.
Nanoscale. 2022 Nov 3. doi: 10.1039/d2nr04200.
Abstract Related articles

LIEDBERG F, Bobjer J
Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092.
Eur Urol Open Sci. 2022;46:53-54.
Abstract Related articles

CHANG K, Porten SP
Sex-specific Augmentation of Treatment Responses in Bladder Cancer.
Eur Urol Open Sci. 2022;46:43-44.
Abstract Related articles

PATIL G, Basu A
Emerging perioperative therapeutic approaches in muscle invasive bladder cancer.
Ther Adv Urol. 2022;14:17562872221134389.
Abstract Related articles

WANG Y, Zhang Y, Wang F, Li T, et al
Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.
Sci Rep. 2022;12:18518.
Abstract Related articles

WARRICK JI, Hu W, Yamashita H, Walter V, et al
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Nat Commun. 2022;13:6575.
Abstract Related articles

ZHANG SW, Deng YM, Jiang B, Guo HQ, et al
[Exploration and thinking on functional preservation after orthotopic neobladder construction].
Zhonghua Wai Ke Za Zhi. 2022;60:969-972.
Abstract Related articles

JANG E, Jung S, Sohng W, Choi D, et al
Screening of gall bladder cancer through infrared analysis of bile and examination of varied bile constituent composition by the disease.
Spectrochim Acta A Mol Biomol Spectrosc. 2022;286:122030.
Abstract Related articles

MURPHY N, Shih AJ, Shah P, Yaskiv O, et al
Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer.
Oncotarget. 2022;13:1188-1200.
Abstract Related articles

REIS IB, Tibo LHS, de Souza BR, Duran N, et al
OncoTherad((R)) is an immunomodulator of biological response that downregulate RANK/RANKL signaling pathway and PD-1/PD-L1 immune checkpoint in non-muscle invasive bladder cancer.
J Cancer Res Clin Oncol. 2022 Nov 2. pii: 10.1007/s00432-022-04449.
Abstract Related articles

KARAM AM, Alshrouf MA, Albandi AM, Alhanbali AE, et al
Awareness of Bladder Cancer Symptoms and Risk Factors in Jordan: A Nationwide Study.
Asia Pac J Public Health. 2022 Nov 2:10105395221136181.
Abstract Related articles

PILALA KM, Papadimitriou MA, Panoutsopoulou K, Barbarigos P, et al
Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome.
Mol Ther Nucleic Acids. 2022;30:311-322.
Abstract Related articles

QI J, Chu Y, Zhang G, Li H, et al
Retraction: Down-regulated LncR-MALAT1 suppressed cell proliferation and migration by inactivating autophagy in bladder cancer.
RSC Adv. 2022;12:28009.
Abstract Related articles

AKGUL M, Humble R, Osme A, Yuce S, et al
GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall.
Diagn Pathol. 2022;17:87.
Abstract Related articles

DI Y, Li H, He C, Peng H, et al
En-bloc transurethral resection vs. conventional transurethral resection for primary non-muscle invasive bladder cancer: A meta-analysis.
Actas Urol Esp (Engl Ed). 2022 Aug 6. pii: S2173-5786(22)00087.
Abstract Related articles

CARRION DM, Pradere B, Soria F, Del Giudice F, et al
Editorial commentary on: "Reduced vs full-dose BCG therapy in bladder cancer: A systematic review and meta-analysis".
Actas Urol Esp (Engl Ed). 2022 Oct 6. pii: S2173-5786(22)00101.
Abstract Related articles

DEKALO S, McArthur E, Campbell J, Ordon M, et al
5alpha-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort.
Urol Oncol. 2022 Oct 29. pii: S1078-1439(22)00312.
Abstract Related articles

[Quality control index for standardized diagnosis and treatment of bladder cancer in China (2022 edition)].
Zhonghua Zhong Liu Za Zhi. 2022;44:1003-1010.
Abstract Related articles

KURONYA Z, Danyi T, Balatoni T, Liszkay G, et al
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report.
J Med Case Rep. 2022;16:396.
Abstract Related articles

LI X, Tai Y, Liu S, Gao Y, et al
The targets of aspirin in bladder cancer: bioinformatics analysis.
BMC Urol. 2022;22:168.
Abstract Related articles

XIE F, Huang C, Liu F, Zhang H, et al
Correction: CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.
Mol Cancer. 2022;21:205.
Abstract Related articles

TELEKA S, Orho-Melander M, Liedberg F, Melander O, et al
Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men.
Sci Rep. 2022;12:18336.
Abstract Related articles

DI YC, Zhang ZH, Sun YP, Song J, et al
Vitamin D3 sensitizes resistant human bladder cancer cells to cisplatin by regulating Sirtuin 1 gene expression.
Eur Rev Med Pharmacol Sci. 2022;26:7656-7666.
Abstract Related articles

BURLEY A, Rullan A, Wilkins A
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer.
Front Oncol. 2022;12:1000888.
Abstract Related articles

YANG J, Xu J, Gao Q, Wu F, et al
Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment.
Front Oncol. 2022;12:1025195.
Abstract Related articles

LUO Y, Deng FM, Zhang Y, Xiao Y, et al
Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer.
Front Cell Dev Biol. 2022;10:1014565.
Abstract Related articles

GOMEZ GVB, Longhi LNA, Saito HPA, Lourenco GJ, et al
PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk.
Am J Clin Exp Urol. 2022;10:334-340.
Abstract Related articles

WALTER V, DeGraff DJ, Yamashita H
Characterization of laminin-332 gene expression in molecular subtypes of human bladder cancer.
Am J Clin Exp Urol. 2022;10:311-319.
Abstract Related articles

YANG X, Zhou Y, Huang L, Lin S, et al
Fibroblast Common Serum Response Signature-Related Classification Affects the Tumour Microenvironment and Predicts Prognosis in Bladder Cancer.
Oxid Med Cell Longev. 2022;2022:5645944.
Abstract Related articles

GENG Z, Geng Q
Corrigendum: Risk of urinary bladder cancer in patients with inflammatory bowel diseases: A meta-analysis.
Front Surg. 2022;9:1052518.
Abstract Related articles

MASAOKA H, Matsuo K, Oze I, Kimura T, et al
Cigarette smoking, smoking cessation and bladder cancer risk: A pooled analysis of ten cohort studies in Japan.
J Epidemiol. 2022 Oct 29. doi: 10.2188/jea.JE20220085.
Abstract Related articles

FENG ZH, Liang YP, Cen JJ, Yao HH, et al
m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
J Transl Med. 2022;20:492.
Abstract Related articles

MAKINO T, Ofude M, Kawahara T, Hori T, et al
Poor Prognosis With Intravesical Bacillus Calmette-Guerin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid.
In Vivo. 2022;36:2952-2959.
Abstract Related articles

GUPTA G, Pasricha S, Kamboj M, Sharma A, et al
PD-L1 expression in muscle invasive urothelial carcinoma: Comparison of SP142 and SP263 assay.
Indian J Pathol Microbiol. 2022;65:839-843.
Abstract Related articles

GUPTA G, Gupta R, Pasricha S, Sharma A, et al
Molecular stratification of high-grade urothelial carcinoma by immunohistochemistry with its histomorphological and clinical correlation.
Indian J Pathol Microbiol. 2022;65:832-838.
Abstract Related articles

SHETH H, Limaye S, Kumar P, Shreenivas A, et al
Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review.
J Cancer Res Clin Oncol. 2022 Oct 28. pii: 10.1007/s00432-022-04428.
Abstract Related articles

ZHOU B, Ying X, Chen Y, Cai X, et al
A Comprehensive Pan-Cancer Analysis of the Tumorigenic Effect of Leucine-Zipper-Like Transcription Regulator (LZTR1) in Human Cancer.
Oxid Med Cell Longev. 2022;2022:2663748.
Abstract Related articles

SENSERRICH J, Guallar-Garrido S, Gomez-Mora E, Urrea V, et al
Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition.
Front Immunol. 2022;13:993401.
Abstract Related articles

SHAO T, Jiang X, Bao G, Li C, et al
Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
Dis Markers. 2022;2022:7571066.
Abstract Related articles

CAI T, Lu J, Lin Z, Luo M, et al
Bladder paraganglioma: basic characteristics and new perspectives on perioperative management.
World J Urol. 2022;40:2807-2816.
Abstract Related articles

TAFURI A, Marchioni M, Cerrato C, Mari A, et al
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).
World J Urol. 2022;40:2771-2779.
Abstract Related articles

BAARD J, Shariat SF, Roupret M, Yoshida T, et al
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registry.
World J Urol. 2022;40:2755-2763.
Abstract Related articles

YU H, Sfakianos JP, Wang L, Hu Y, et al
Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfbeta-Dependent Mechanisms.
Mol Cancer Ther. 2022;21:1729-1741.
Abstract Related articles

TEOH JY, Ng CF, Eto M, Chiruvella M, et al
Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities.
World J Urol. 2022;40:2657-2665.
Abstract Related articles

sEphB4-HSA plus Pembrolizumab Improves Overall Survival in Urothelial Carcinoma.
Cancer Discov. 2022;12:2492.
Abstract Related articles

IACOVELLI R, Ciccarese C, Brunelli M, Battelli N, et al
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
Ann Oncol. 2022;33:1179-1185.
Abstract Related articles

LEW M
An Approach to Nonurothelial Malignancies of the Urinary Bladder in Urine Cytology.
Adv Anat Pathol. 2022;29:412-422.
Abstract Related articles

ZULIA Y, Gopireddy D, Virarkar MK, Morani AC, et al
Magnetic resonance imaging of bladder pheochromocytomas: a review.
Abdom Radiol (NY). 2022;47:4032-4041.
Abstract Related articles

ALI A, Leibowitz D, Bhatt N, Doubrovin M, et al
Preliminary efficacy of [(90)Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer.
Eur J Nucl Med Mol Imaging. 2022 Nov 9. pii: 10.1007/s00259-022-06027.
Abstract Related articles

HOU Y, Yang C, Liu C, Gao L, et al
Quantitative detection of urinary bladder cancer antigen via peptide-immobilized magnetic bead-based SERS probe.
Anal Bioanal Chem. 2022 Nov 9. pii: 10.1007/s00216-022-04361.
Abstract Related articles

ZHOU H, Huang G, Chen T, Zhang J, et al
Identification of a New Prediction Model for Bladder Cancer Related to Immune Functions and Chemotherapy Using Gene Sets of Biological Processes.
Biomed Res Int. 2022;2022:4740686.
Abstract Related articles

WANG W, Jiang X, Xia F, Chen X, et al
HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
Mol Biol Rep. 2022 Nov 8. pii: 10.1007/s11033-022-07978.
Abstract Related articles

ALKANLI N, Ay A, Cevik G
Investigation of roles of IL-8 (+ 781 C/T) and MMP-2 (-735 C/T) gene variations in early diagnosis of bladder cancer and progression.
Mol Biol Rep. 2022 Nov 8. pii: 10.1007/s11033-022-07881.
Abstract Related articles

PYRGIDIS N, Sokolakis I, Haltmair G, Hatzichristodoulou G, et al
The effect of urinary diversion on renal function after cystectomy for bladder cancer: comparison between ileal conduit, orthotopic ileal neobladder, and heterotopic ileocecal pouch.
World J Urol. 2022 Nov 8. pii: 10.1007/s00345-022-04211.
Abstract Related articles

CLARK KR
Bladder Cancer: Types, Risk Factors, Diagnosis, and Treatment.
Radiol Technol. 2022;94:46-50.
Abstract Related articles

YANG X, Yuan B, Zhang Y, Zhuang J, et al
Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer.
Eur J Radiol. 2022;157:110587.
Abstract Related articles

KADORIKU F, Sasaki Y, Fukuta K, Atagi Y, et al
A propensity score matching study on robot-assisted radical cystectomy for older patients: comparison of intracorporeal ileal conduit and cutaneous ureterostomy.
BMC Urol. 2022;22:174.
Abstract Related articles

MUN JY, Baek SW, Jeong MS, Jang IH, et al
Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells.
Cell Death Discov. 2022;8:450.
Abstract Related articles

WOOD EL, Djaladat H
Radical Transurethral Resection of Bladder Tumor in Organ-confined Muscle-invasive Bladder Cancer: Yes!
Eur Urol Focus. 2022 Nov 4. pii: S2405-4569(22)00239.
Abstract Related articles

PERECMAN A, Wiggins A, Xu J, Das S, et al
How New Developments Impact Diagnosis in Existing Renal Neoplasms.
Surg Pathol Clin. 2022;15:695-711.
Abstract Related articles

GUO CC, Czerniak B
Molecular Taxonomy and Immune Checkpoint Therapy in Bladder Cancer.
Surg Pathol Clin. 2022;15:681-694.
Abstract Related articles

ARON M, Zhou M
Urothelial Carcinoma: Update on Staging and Reporting, and Pathologic Changes Following Neoadjuvant Chemotherapies.
Surg Pathol Clin. 2022;15:661-679.
Abstract Related articles

GANDHI J, Chen JF, Al-Ahmadie H
Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes.
Surg Pathol Clin. 2022;15:641-659.
Abstract Related articles

COMPERAT E, Oszwald A, Wasinger G, Shariat S, et al
Update on Flat and Papillary Urothelial Lesions: Genitourinary Pathology Society Consensus Recommendations.
Surg Pathol Clin. 2022;15:629-640.
Abstract Related articles

ZOU Y, Cai L, Chen C, Shao Q, et al
Multi-task deep learning based on T2-Weighted Images for predicting Muscular-Invasive Bladder Cancer.
Comput Biol Med. 2022;151.
Abstract Related articles

AGHAMAJIDI A, Ousati Ashtiani Z, Mohsenzadegan M, Tajik N, et al
Molecular Characteristics of Bladder Tumor: Increased Gene Expression of MAGE-A6 and MAGE-A11 with Decreased MicroRNA-34a and MicroRNA-125b.
Iran J Allergy Asthma Immunol. 2022;21:561-573.
Abstract Related articles

LI Y, Zheng F, Xiao X, Xie F, et al
CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 2022;23:e56102.
Abstract Related articles

YANG R, Zhang W, Shang X, Chen H, et al
Neutrophil-related genes predict prognosis and response to immune checkpoint inhibitors in bladder cancer.
Front Pharmacol. 2022;13:1013672.
Abstract Related articles

LYU T, Lin Y, Wu K, Cao Z, et al
Single-cell sequencing technologies in bladder cancer research: Applications and challenges.
Front Genet. 2022;13:1027909.
Abstract Related articles

MA YT, Yang HL, Yan L, Hua F, et al
Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma.
Pathol Oncol Res. 2022;28:1610638.
Abstract Related articles

LI M, Jiang Z, Shen W, Liu H, et al
Deep learning in bladder cancer imaging: A review.
Front Oncol. 2022;12:930917.
Abstract Related articles

CHENG J, Zhang S, Fan A, Li Y, et al
An immune-related gene signature for the prognosis of human bladder cancer based on WGCNA.
Comput Biol Med. 2022;151.
Abstract Related articles

KAMITANI R, Ando T, Hanai K, Tanaka A, et al
Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab.
BMC Urol. 2022;22:170.
Abstract Related articles

DAMRAUER JS, Beckabir W, Klomp J, Zhou M, et al
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.
Nat Commun. 2022;13:6658.
Abstract Related articles

LOBO N, Afferi L, Moschini M, Mostafid H, et al
Epidemiology, Screening, and Prevention of Bladder Cancer.
Eur Urol Oncol. 2022 Nov 1. pii: S2588-9311(22)00173.
Abstract Related articles

MEDINA-GONZALEZ M, Panach-Navarrete J, Mata-Cano D, Martinez Jabaloyas JM, et al
Microbladder due to Granulomatous Cystitis Secondary to BCG Treatment.
Arch Esp Urol. 2022;75:729-730.
Abstract Related articles

YACHIMOTO K, Wada N, Tamaki G, Ishikawa M, et al
[Comparison of Perioperative Outcomes between Open and Robot-Assisted Laparoscopic Radical Cystectomy].
Hinyokika Kiyo. 2022;68:317-322.
Abstract Related articles

FERNANDEZ DE LOS REYES I, Lacarra Fernandez S, Chouza Sanin M, Huarte Perez-Alfaro P, et al
Pleomorphic giant cell carcinoma of the bladder: The diagnostic challenge of an unusual variant of urothelial carcinoma.
Actas Urol Esp (Engl Ed). 2022;46:584-585.
Abstract Related articles

STRACCIA P, Fiorentino V, Martini M, Pierconti F, et al
A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ.
Actas Urol Esp (Engl Ed). 2022;46:521-530.
Abstract Related articles

OTSUKA H, Kita Y, Ito K, Sano T, et al
Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time bias.
Cancer Sci. 2022;113:3912-3921.
Abstract Related articles

SAHINER N, Ayyala RS, Suner SS
Nontoxic Natural Polymeric Particle Vehicles Derived from Hyaluronic Acid and Mannitol as Mitomycin C Carriers for Bladder Cancer Treatment.
ACS Appl Bio Mater. 2022 Nov 18. doi: 10.1021/acsabm.2c00558.
Abstract Related articles

LI L, Zhao L, Li B, Wang T, et al
Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes.
Aging (Albany NY). 2022;14.
Abstract Related articles

KOWALSKI F, Drewa T, Adamowicz J, Wilamowski J, et al
Influence of Antibiotic Administration on the Urinary Bladder Cancer Early Recurrence Rate.
J Oncol. 2022;2022:9495920.
Abstract Related articles

FENG Y, Jia B, Shen Z
Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review.
Medicine (Baltimore). 2022;101:e31635.
Abstract Related articles

XIE H, Wang M, Yu H, Wang H, et al
METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m(7)G-modified miR-760-dependent manner.
Cell Death Discov. 2022;8:458.
Abstract Related articles

HU Y, Deng C, Zhang H, Zhang J, et al
Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/beta-catenin signaling pathway in bladder cancer.
Oncotarget. 2022;13:1258.
Abstract Related articles

CHANG Z, Li R, Zhang J, An L, et al
Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients.
Front Immunol. 2022;13:1008865.
Abstract Related articles

KE C, Liu Z, Zhu J, Zeng X, et al
Fluorescence in situ hybridization (FISH) to predict the efficacy of Bacillus Calmette-Guerin perfusion in bladder cancer.
Transl Cancer Res. 2022;11:3448-3457.
Abstract Related articles

ZHU J, Ye X, Zhou L, He Z, et al
Treatment decisions of bladder cancer in patients older than 85 years: a SEER-based analysis 2011-2015.
Transl Cancer Res. 2022;11:3584-3592.
Abstract Related articles

XIANG Z, Ye Z, Ma J, Lin Y, et al
Temporal Trends and Projections of Bladder Cancer Burden in China from 1990 to 2030: Findings from the Global Burden of Disease Study.
Clin Epidemiol. 2022;14:1305-1315.
Abstract Related articles

BLICHERT-REFSGAARD L, Norgaard M, Bengtsen MB, Jensen JB, et al
Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry.
Clin Epidemiol. 2022;14:1317-1325.
Abstract Related articles

WANG Y, Cheng H, Zeng T, Chen S, et al
A novel 17 apoptosis-related genes signature could predict overall survival for bladder cancer and its associations with immune infiltration.
Heliyon. 2022;8:e11343.
Abstract Related articles

DUAN H, Xia W, Xu D, Chen Y, et al
Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment.
Front Oncol. 2022;12:927410.
Abstract Related articles

FU J, Zhang W, Jiang T
Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer.
Front Genet. 2022;13:1035484.
Abstract Related articles

LIN PT, Hsieh ML, Su SH, Chang YH, et al
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation.
Cancer Manag Res. 2022;14:3121-3130.
Abstract Related articles

ALCHERA E, Monieri M, Maturi M, Locatelli I, et al
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods.
Photoacoustics. 2022;28:100400.
Abstract Related articles

FUKUSHIMA H, Koga F
Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review.
Transl Androl Urol. 2022;11:1433-1441.
Abstract Related articles

MELGAREJO SEGURA MT, Morales Martinez A, Yanez Castillo Y, Arrabal Polo MA, et al
Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer.
Urol Oncol. 2022 Nov 12. pii: S1078-1439(22)00398.
Abstract Related articles

MAGLIOCCO AM, Moughan J, Miyamoto DT, Simko J, et al
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.
JAMA Netw Open. 2022;5:e2242378.
Abstract Related articles

GHANSHYAM K, Nachiket V, Govind S, Shivam P, et al
Validation of Vesical Imaging Reporting and Data System score for the diagnosis of muscle-invasive bladder cancer: A prospective cross-sectional study.
Asian J Urol. 2022;9:467-472.
Abstract Related articles

YANG C, Xiang H, Fu K, Jin L, et al
Lycorine suppresses cell growth and invasion via down-regulation of NEDD4 ligase in bladder cancer.
Am J Cancer Res. 2022;12:4708-4720.
Abstract Related articles

GARCIA-CANO-FERNANDEZ AM, Szczesniewski-Dudzik JJ, Garcia-Tello A, Diego-Garcia V, et al
Quality of bladder cancer information on YouTube.
Cent European J Urol. 2022;75:248-251.
Abstract Related articles

FLAMMIA RS, Chierigo F, Wurnschimmel C, Wenzel M, et al
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer.
Cent European J Urol. 2022;75:240-247.
Abstract Related articles

SHAH PM, Rasool I, Maguire D
Refractory paraneoplastic hypercalcaemia responding to cinacalcet.
BMJ Case Rep. 2022;15.
Abstract Related articles

WANG Y, Li Z, Tian X, Tian J, et al
Nursing experience after radical resection of bladder cancer and orthotopic ileal new bladder.
Asian J Surg. 2022 Nov 11. pii: S1015-9584(22)01557.
Abstract Related articles

LI EH, Xu BH, Wei HB, Bai YC, et al
Molecular mechanism of di-n-butyl phthalate promotion of bladder cancer development.
Toxicol In Vitro. 2022;86:105508.
Abstract Related articles

YANG C, Yang Y, Wang W, Zhou W, et al
CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Cell Oncol (Dordr). 2022 Nov 14. pii: 10.1007/s13402-022-00712.
Abstract Related articles

YE Q, Wang J, Xu D, Liu Y, et al
Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
Expert Rev Anticancer Ther. 2022 Nov 18:1-13. doi: 10.1080/14737140.2022.2147511
Abstract Related articles

LIMA APB, da Silva GN
Long Non-Coding RNA and Chemoresistance in Bladder Cancer - A Mini Review.
Cancer Invest. 2022 Nov 14:1-9. doi: 10.1080/07357907.2022.2146703.
Abstract Related articles

DAWOOD EE, Awadalla A, Hashem A, Shokeir AA, et al
Evaluation of molecular signatures in the urinary bladder and upper tract urothelial carcinomas: a prospective controlled clinical study.
J Egypt Natl Canc Inst. 2022;34:47.
Abstract Related articles

SHOZU K, Kaneko S, Shinkai N, Dozen A, et al
Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer.
Clin Epigenetics. 2022;14:147.
Abstract Related articles

OZGEN O, Ozen Eroglu G, Kucukhuseyin O, Akdeniz N, et al
Vitamin D increases the efficacy of cisplatin on bladder cancer cell lines.
Mol Biol Rep. 2022 Nov 12. pii: 10.1007/s11033-022-08044.
Abstract Related articles

ZHENG CM, Piao XM, Byun YJ, Song SJ, et al
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues.
Cancer Genet. 2022;268-269:137-143.
Abstract Related articles

SIMONET M, Dominguez Gutierrez A, Territo A, Prudhomme T, et al
Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant.
World J Urol. 2022 Nov 11. pii: 10.1007/s00345-022-04188.
Abstract Related articles

O'SULLIVAN N, MacCraith E, Temperley HC, Naughton A, et al
Standard transurethral resection versus transurethral laser surgery for bladder cancer: A systematic review and meta-analysis comparing clinical outcomes and complications.
J Endourol. 2022 Nov 11. doi: 10.1089/end.2022.0328.
Abstract Related articles

GAGLIARDI A, Francescato G, Ferrero G, Birolo G, et al
The 8q24 region hosts miRNAs altered in biospecimens of colorectal and bladder cancer patients.
Cancer Med. 2022 Nov 10. doi: 10.1002/cam4.5375.
Abstract Related articles

LIU CW, Chen PH, Yu TJ, Lin KJ, et al
WWOX Modulates ROS-Dependent Senescence in Bladder Cancer.
Molecules. 2022;27.
Abstract Related articles

CALACE FP, Napolitano L, Arcaniolo D, Stizzo M, et al
Micro-Ultrasound in the Diagnosis and Staging of Prostate and Bladder Cancer: A Comprehensive Review.
Medicina (Kaunas). 2022;58.
Abstract Related articles

SONG F, Kotolloshi R, Gajda M, Holzer M, et al
Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines.
Int J Mol Sci. 2022;23.
Abstract Related articles

LEE EH, Chung JW, Sung E, Yoon BH, et al
Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways.
Int J Mol Sci. 2022;23.
Abstract Related articles

HARSANYI S, Novakova ZV, Bevizova K, Danisovic L, et al
Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs.
Int J Mol Sci. 2022;23.
Abstract Related articles

PALACKA P, Kucharska J, Obertova J, Rejlekova K, et al
Changes in CoQ10/Lipids Ratio, Oxidative Stress, and Coenzyme Q10 during First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma (mUC).
Int J Mol Sci. 2022;23.
Abstract Related articles

PELLERIN E, Pellerin FA, Chabaud S, Pouliot F, et al
Glucuronidated Metabolites of Bisphenols A and S Alter the Properties of Normal Urothelial and Bladder Cancer Cells.
Int J Mol Sci. 2022;23.
Abstract Related articles

QIN C, Chen Z, Cao R, Shi M, et al
Integrated Analysis of the Fecal Metagenome and Metabolome in Bladder Cancer in a Chinese Population.
Genes (Basel). 2022;13.
Abstract Related articles

CHIU LW, Tsai LH, Hsieh PF, Chen WC, et al
Tuberculosis Epididymo-Orchitis Mimicking Malignancy Resulting from Intravesical Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer: A Case Report of a Rare Complication.
Diagnostics (Basel). 2022;12.
Abstract Related articles

GRIMALDI AM, Lapucci C, Salvatore M, Incoronato M, et al
Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review.
Biomedicines. 2022;10.
Abstract Related articles

MASSON-LECOMTE A, Vaillant V, Roumiguie M, Levy S, et al
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee.
Cancers (Basel). 2022;14.
Abstract Related articles

PALIOURAS A, Markopoulos GS, Tsampalas S, Mantziou S, et al
Accurate Characterization of Bladder Cancer Cells with Intraoperative Flow Cytometry.
Cancers (Basel). 2022;14.
Abstract Related articles

LAI G, Zhong X, Liu H, Deng J, et al
A Novel m7G-Related Genes-Based Signature with Prognostic Value and Predictive Ability to Select Patients Responsive to Personalized Treatment Strategies in Bladder Cancer.
Cancers (Basel). 2022;14.
Abstract Related articles

BAKER SC, Mason AS, Slip RG, Eriksson P, et al
The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy.
Cancers (Basel). 2022;14.
Abstract Related articles

MALKIEWICZ B, Gurwin A, Karwacki J, Nagi K, et al
Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+).
Cancers (Basel). 2022;14.
Abstract Related articles

WANG S, Wang H, Zhu S, Li F, et al
Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer.
Front Oncol. 2022;12:1040892.
Abstract Related articles

ELBAKRY AA, Trump T, Ferari C, Mattes MD, et al
Survival outcomes in node-positive non-metastatic bladder cancer: An analysis of the national cancer database.
Arab J Urol. 2022;20:175-181.
Abstract Related articles

BUKAVINA L, Prunty M, Isali I, Calaway A, et al
Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer.
Eur Urol Open Sci. 2022;43:5-13.
Abstract Related articles

MARCQ G, Evaristo G, Kool R, Shinde-Jadhav S, et al
Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy.
Eur Urol Open Sci. 2022;43:14-21.
Abstract Related articles

TAE JH, Ha MS, Chi BH, Chang IH, et al
Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study.
BMC Urol. 2022;22:175.
Abstract Related articles

TAKAGI K, Naruse A, Akita K, Muramatsu-Maekawa Y, et al
CALN1 hypomethylation as a biomarker for high-risk bladder cancer.
BMC Urol. 2022;22:176.
Abstract Related articles

SUGIMOTO K, Taguchi S, Kishitani K, Kawai T, et al
Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma.
BMC Urol. 2022;22:177.
Abstract Related articles

MINGARDO E, Beaman G, Grote P, Nordenskjold A, et al
A genome-wide association study with tissue transcriptomics identifies genetic drivers for classic bladder exstrophy.
Commun Biol. 2022;5:1203.
Abstract Related articles

LIU L, Hou Y, Deng C, Tao Z, et al
Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment.
Nat Commun. 2022;13:6740.
Abstract Related articles

GU JS, Ryu JW, Yu SH, Chung HS, et al
Prognostic value of the endothelial activation and stress index in patients with upper tract urothelial cancer undergoing radical nephroureterectomy.
Investig Clin Urol. 2022;63:623-630.
Abstract Related articles

PARK JS, Yuk HD, Jeong CW, Kwak C, et al
Comparison of functional and oncological outcomes between uterus-sparing radical cystectomy and standard radical cystectomy in females: A retrospective study.
Investig Clin Urol. 2022;63:612-622.
Abstract Related articles

PERECMAN A, Wiggins A, Xu J, Das S, et al
The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series.
Pathol Res Pract. 2022;239:154164.
Abstract Related articles

VAN PEL DM, Pors J, Yuen E, Chan R, et al
Distinct Uroplakin II Staining Pattern in Apocrine Breast Carcinoma.
Appl Immunohistochem Mol Morphol. 2022;30:681-686.
Abstract Related articles

OMLAND LH, Joensen UN, Toft BG, Lund CM, et al
Reasons for lack of treatment in patients with locally advanced, unresectable or metastatic urothelial carcinoma.
Acta Oncol. 2022;61:1036-1042.
Abstract Related articles

GALLICCHIO L, Devasia TP, Tonorezos E, Mollica MA, et al
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States.
J Natl Cancer Inst. 2022;114:1476-1483.
Abstract Related articles

NUTI S, Zhang Y, Zerrouki N, Roach C, et al
High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.
Histopathology. 2022;81:732-741.
Abstract Related articles

WATANABE M, Taguchi S, Machida H, Tambo M, et al
Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field.
Eur Radiol. 2022;32:7513-7521.
Abstract Related articles

DA SILVA MC, Pecoraro M, Pisciotti ML, Dehghanpour A, et al
The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program.
Eur Radiol. 2022;32:7494-7503.
Abstract Related articles

HOU CP, Tsui KH, Chang KS, Sung HC, et al
Caffeic acid phenethyl ester inhibits the growth of bladder carcinoma cells by upregulating growth differentiation factor 15.
Biomed J. 2022;45:763-775.
Abstract Related articles

GHALI A, Bahr T, Sherwani A, Nashawi M, et al
Acute inflammatory presentation of orbital metastasis from urothelial carcinoma: a case report.
Orbit. 2022;41:786-790.
Abstract Related articles

SHAWKY S, Makled S, Awaad A, Boraie N, et al
Quercetin Loaded Cationic Solid Lipid Nanoparticles in a Mucoadhesive In Situ Gel-A Novel Intravesical Therapy Tackling Bladder Cancer.
Pharmaceutics. 2022;14:2527.
Abstract Related articles

PIAO XM, Kim SK, Byun YJ, Zheng CM, et al
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups.
Int J Mol Sci. 2022;23:14481.
Abstract Related articles

SURMAN M, Wilczak M, Przybylo M
Lectin-Based Study Reveals the Presence of Disease-Relevant Glycoepitopes in Bladder Cancer Cells and Ectosomes.
Int J Mol Sci. 2022;23:14368.
Abstract Related articles

PAKMANESH H, Anvari O, Forey N, Weiderpass E, et al
TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.
Int J Mol Sci. 2022;23:14319.
Abstract Related articles

WANG W, Zheng X, Azoitei A, John A, et al
The Role of TKS5 in Chromosome Stability and Bladder Cancer Progression.
Int J Mol Sci. 2022;23:14283.
Abstract Related articles

SAH DK, Khoi PN, Li S, Arjunan A, et al
(-)-Epigallocatechin-3-Gallate Prevents IL-1beta-Induced uPAR Expression and Invasiveness via the Suppression of NF-kappaB and AP-1 in Human Bladder Cancer Cells.
Int J Mol Sci. 2022;23:14008.
Abstract Related articles

SU PW, Chen BS
Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications.
Int J Mol Sci. 2022;23:13869.
Abstract Related articles

KRONSTEDT S, Doppalapudi SK, Boyle J, Chua K, et al
Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review.
Cancers (Basel). 2022;14:5644.
Abstract Related articles

BIERI U, Kranzbuhler B, Seifert B, Helmchen BM, et al
Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?
Cancers (Basel). 2022;14:5586.
Abstract Related articles

CAO Y, Yan X, Bai X, Tang F, et al
UCHL5 Promotes Proliferation and Migration of Bladder Cancer Cells by Activating c-Myc via AKT/mTOR Signaling.
Cancers (Basel). 2022;14:5538.
Abstract Related articles

HUANG EY, Chen YK, Ou CP, Chen YT, et al
Oncogenic Roles of Polycomb Repressive Complex 2 in Bladder Cancer and Upper Tract Urothelial Carcinoma.
Biomedicines. 2022;10:2925.
Abstract Related articles

DOUGLAWI A, Ghoreifi A, Lee R, Ladi-Seyedian SS, et al
Recurrence patterns in bladder cancer patients with no residual disease (pT0N0) at radical cystectomy: A 20-year experience.
Urol Oncol. 2022 Nov 22:S1078-1439(22)00347.
Abstract Related articles

YU Z, Lu B, Gao H, Liang R, et al
A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer.
J Oncol. 2022;2022:5643496.
Abstract Related articles

PATEL A, Orakwue CW, Olek D, Guzman JCA, et al
A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques.
Brachytherapy. 2022 Nov 21:S1538-4721(22)00158.
Abstract Related articles

HUSSEIN AA, Smith G, Guru KA
The Association Between the Urinary Microbiome and Bladder Cancer.
Urol Clin North Am. 2023;50:81-89.
Abstract Related articles

LOTAN Y, Baky FJ
Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-muscle-Invasive Bladder Cancer.
Urol Clin North Am. 2023;50:53-67.
Abstract Related articles

GIRARD A, Dercle L, Vila-Reyes H, Schwartz LH, et al
A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on [(18)F]FDG PET/CT: a pathology-controlled study.
Eur Radiol. 2022 Nov 24. doi: 10.1007/s00330-022-09270.
Abstract Related articles

CHEN Z, Cao R, Wang R, Wang Y, et al
Prognosis Risk Model Based on Necroptosis-Related Signature for Bladder Cancer.
Genes (Basel). 2022;13:2120.
Abstract Related articles

AN Y, Sun JX, Xu MY, Xu JZ, et al
Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
Front Immunol. 2022;13:1049884.
Abstract Related articles

GRAVESTOCK P, Vale L, Heer R
Reply to Fredrik Liedberg and Johannes Bobjer's Letter to the Editor re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.
Eur Urol Open Sci. 2022;46:149-150.
Abstract Related articles

WANG J, Xie Y, Qin D, Zhong S, et al
CXCL12, a potential modulator of tumor immune microenvironment (TIME) of bladder cancer: From a comprehensive analysis of TCGA database.
Front Oncol. 2022;12:1031706.
Abstract Related articles

TENG L, Li C, Wang W, Li D, et al
Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer.
BMC Urol. 2022;22:189.
Abstract Related articles

WANG W, Xu Y, Ren L, Yang XY, et al
[Curative effect of complete transperitoneal laparoscopic nephroureterectomy in post kidney transplantation patients with upper tract urothelial carcinoma].
Zhonghua Yi Xue Za Zhi. 2022;102:3532-3536.
Abstract Related articles

HAO P, Zhang C, Ma H, Wang R, et al
Enhanced tumor inhibiting effect of 131I-BDI-1-based radioimmunotherapy and cytosine deaminase gene therapy modulated by a radio-sensitive promoter in nude mice bearing bladder cancer.
J Radiat Res. 2022 Nov 23:rrac075. doi: 10.1093.
Abstract Related articles

KOMINA S, Petrusevska G, Jovanovic R, Kunovska SK, et al
AHNAK2 Urinary Protein Expression as Potential Biomarker for Bladder Cancer Detection: A Pilot Study.
Turk J Urol. 2022;48:423-430.
Abstract Related articles

Correction to: Blockade of integrin signaling reduces chemotherapy-induced premature senescence in collagen cultured bladder cancer cells.
Precis Clin Med. 2022;5:pbac027.
Abstract Related articles

AGARWAL K, Osama MA, Kavita G, Majumdar AD, et al
Squamous cell carcinoma arising from keratinizing desquamative squamous metaplasia of renal pelvis and double paraneoplastic syndrome: Association of two rare entities.
J Cancer Res Ther. 2022;18:1827-1831.
Abstract Related articles

CHEN YR, Wang SC, Huang SP, Su CC, et al
Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways.
Biomed Pharmacother. 2022;156:113929.
Abstract Related articles

WEINEKOTTER J, Gurtner C, Protschka M, von Bomhard W, et al
Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
BMC Vet Res. 2022;18:412.
Abstract Related articles

TENG C, Zheng S, Wan W, Liu L, et al
Fatty foods and the risk of bladder cancer: A case-control study.
Nutrition. 2022 Oct 17:111868. doi: 10.1016/j.nut.2022.111868.
Abstract Related articles

CHEN K, Feng D, Han P
Identification of prognostic cellular senescence related-lncRNAs in bladder cancer via bioinformatics analysis.
Asian J Surg. 2022 Nov 18:S1015-9584(22)01600.
Abstract Related articles

ZENG F, Lan Y, Wang N, Huang X, et al
Ferroptosis: A new therapeutic target for bladder cancer.
Front Pharmacol. 2022;13:1043283.
Abstract Related articles

LYU X, Qiang Y, Zhang B, Xu W, et al
Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction.
Front Oncol. 2022;12:1016542.
Abstract Related articles

TFAILY MA, Tamim H, El Hajj A, Mukherji D, et al
Muscle invasive bladder cancer and radical cystectomy: a risk predictive model.
Ecancermedicalscience. 2022;16:1456.
Abstract Related articles

YANG XB, Zhang LH, Xue JN, Wang YC, et al
High incidence combination of multiple primary malignant tumors of the digestive system.
World J Gastroenterol. 2022;28:5982-5992.
Abstract Related articles

SLUSARCZYK A, Zapala P, Zapala L, Radziszewski P, et al
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis.
J Cancer Res Clin Oncol. 2022 Nov 21. doi: 10.1007/s00432-022-04464.
Abstract Related articles

HENSLEY PJ, Duan Z, Bree K, Sood A, et al
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship.
Urol Oncol. 2022 Nov 17:S1078-1439(22)00393.
Abstract Related articles

HRBACEK J, Tlaskal V, Cermak P, Hanacek V, et al
Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition.
Urol Oncol. 2022 Nov 16:S1078-1439(22)00344.
Abstract Related articles

GARG H, Wheeler KM, Dursun F, Cooper RE, et al
Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis.
Clin Genitourin Cancer. 2022 Oct 29:S1558-7673(22)00221.
Abstract Related articles

STAHLGREN M, Forsell C, Drott J
Information needs in patients with bladder cancer undergoing radical cystectomy - A qualitative review with thematic synthesis.
Eur J Oncol Nurs. 2022;61:102231.
Abstract Related articles

WU K, Liu X, Wang Y, Wang X, et al
Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
Front Public Health. 2022;10:994351.
Abstract Related articles

DOROUD D, Hozouri H
Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma.
Iran Biomed J. 2022;26:340-9.
Abstract Related articles

TAKEMOTO K, Hayashi T, Hsi RS, Kobatake K, et al
Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
Urol Oncol. 2022;40:539.
Abstract Related articles

CHUNG R, Moran GW, Wang C, McKiernan JM, et al
Partial cystectomy: Review of a single center experience from 2004 to 2019.
Urol Oncol. 2022;40:538.
Abstract Related articles

ABTAHI M, Dobaradaran S, Koolivand A, Jorfi S, et al
Assessment of cause-specific mortality and disability-adjusted life years (DALYs) induced by exposure to inorganic arsenic through drinking water and foodstuffs in Iran.
Sci Total Environ. 2023;856.
Abstract Related articles

STOHR BA, Chan E, Anderson JA, Matoso A, et al
Molecular characterization of adenocarcinomas arising in the urinary bladder following augmentation cystoplasty: a multi-institutional study.
Hum Pathol. 2022;129:98-102.
Abstract Related articles

PAPADOPOULOU K, Koliou GA, Tsimiliotis D, Kotoula V, et al
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens.
Urol Oncol. 2022;40:538.
Abstract Related articles

LAGARDE-LENON MS, Aron M
Female urethral carcinoma: a contemporary review of the clinicopathologic features, with emphasis on the histoanatomic landmarks and potential staging issues.
Hum Pathol. 2022;129:71-80.
Abstract Related articles

HAMADA A, Sano T, Kita Y, Takada H, et al
Limited predictive impact of tumor size dynamics on further tumor shrinkage after 4 cycles of first-line chemotherapy in patients with advanced urothelial carcinoma.
Urol Oncol. 2022;40:540.
Abstract Related articles

MIYAMA Y, Kaneko G, Nishimoto K, Yasuda M, et al
Lower neutrophil-to-lymphocyte ratio and positive programmed cell death ligand-1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma.
Cancer Med. 2022;11:4236-4245.
Abstract Related articles

DURSUN F, Lim K, Svatek RS, Xu J, et al
Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database.
Cancer Med. 2022;11:4273-4282.
Abstract Related articles

CABANILLAS G, Montoya-Cerrillo D, Kryvenko ON, Pal SK, et al
"Collecting duct carcinoma of the kidney: diagnosis and implications for management".
Urol Oncol. 2022;40:525-536.
Abstract Related articles

JIANG P, Xu Z, Wu S, Sun J, et al
RFWD3 acts as a tumor promotor in the development and progression of bladder cancer.
Histol Histopathol. 2022 Dec 2:18558. doi: 10.14670.
Abstract Related articles

AL NABHANI S, Al Harthy A, Al Riyami M, Al Sinawi S, et al
Programmed Death-ligand 1 (PD-L1) Expression in Bladder Cancer and its Correlation with Tumor Grade, Stage, and Outcome.
Oman Med J. 2022;37:e441.
Abstract Related articles

DING L, Deng X, Xia W, Wang K, et al
Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer.
Front Immunol. 2022;13:1070043.
Abstract Related articles

WANG Y, Zhang H, Hu X
Characterization of Epithelial-Mesenchymal Transition Identifies a Gene Signature for Predicting Clinical Outcomes and Therapeutic Responses in Bladder Cancer.
Dis Markers. 2022;2022:9593039.
Abstract Related articles

CHEVURU PT, McElree IM, Mott SL, Steinberg RL, et al
Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer.
Urol Oncol. 2022 Nov 28:S1078-1439(22)00426.
Abstract Related articles

ESTEVEZ A, Kaul S, Fleishman A, Korets R, et al
Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer.
Urol Oncol. 2022 Nov 28:S1078-1439(22)00444.
Abstract Related articles

CHEN J, Guan Y, Li C, Du H, et al
Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer.
Discov Oncol. 2022;13:133.
Abstract Related articles

CHEN L, Zhang G, Xu L, Zhang X, et al
Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer.
Abdom Radiol (NY). 2022 Dec 1. doi: 10.1007/s00261-022-03730.
Abstract Related articles

QIU Q, Deng C, Li H, Qiu J, et al
The global research of bladder cancer immunotherapy from 2012 to 2021: A bibliometric analysis.
Front Oncol. 2022;12:999203.
Abstract Related articles

HAFEEZ S, Koh M, Jones K, Ghzal AE, et al
Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy.
Front Oncol. 2022;12:961393.
Abstract Related articles

LIANG Y, Tan Y, Guan B, Guo B, et al
Single-cell atlases link macrophages and CD8(+) T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma.
Theranostics. 2022;12:7745-7759.
Abstract Related articles

BAI Y, Zhang Q, Liu F, Quan J, et al
A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
Front Immunol. 2022;13:1027449.
Abstract Related articles

YANG Y, Zhang G, Hu C, Luo W, et al
The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
BMC Urol. 2022;22:196.
Abstract Related articles

NOH TI, Shim JS, Kang SG, Sung DJ, et al
Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS.
Sci Rep. 2022;12:20689.
Abstract Related articles

CULPAN M, Iplikci A, Kir G, Cecikoglu GE, et al
The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer.
Rev Assoc Med Bras (1992). 2022;68:1587-1592.
Abstract Related articles

KWAN ML, Haque R, Young-Wolff KC, Lee VS, et al
Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.
JAMA Netw Open. 2022;5:e2244430.
Abstract Related articles

LEWERICH J, Schmid SC, Gschwend JE, Retz M, et al
[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer].
Urologie. 2022 Nov 30. doi: 10.1007/s00120-022-01983.
Abstract Related articles

SARKIS J, Vannier E, Mjaess G, Pochet C, et al
Neoadjuvant immunochemotherapy in the treatment of nonmetastatic muscle-invasive bladder cancer: a systematic review.
Immunotherapy. 2022 Nov 30. doi: 10.2217/imt-2022-0039.
Abstract Related articles

REN R, Wang H, Xie L, Muthupandian S, et al
Identify Potential Urine Biomarkers for Bladder Cancer Prognosis Using NGS Data Analysis and Experimental Validation.
Appl Biochem Biotechnol. 2022 Nov 30. doi: 10.1007/s12010-022-04234.
Abstract Related articles

AYYASH O, Yabes J, Hugar L, Maganty A, et al
New Mental Health Diagnosis as a Prognostic Factor for Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2022 Nov 2:S1558-7673(22)00219.
Abstract Related articles

ZHANG X, Du Y, Xiong W, Shang P, et al
Combined single-cell RNA-seq and bulk RNA-seq to analyze the expression and role of TREM2 in bladder cancer.
Med Oncol. 2022;40:23.
Abstract Related articles

CHEN YC, Chen CI, Chang CY, Huang BM, et al
Clerodane diterpene induces apoptosis/anoikis and suppresses migration and invasion of human bladder cancer cells through the histone deacetylases, integrin-focal adhesion kinase, and matrix metalloproteinase 9 signalling pathways.
Hum Exp Toxicol. 2022;41:9603271221143040.
Abstract Related articles

SAWASDEE A, Tanthanuch M, Bejrananda T
Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer.
Asian Pac J Cancer Prev. 2022;23:3641-3647.
Abstract Related articles

GAYA JM, Territo A, Woldu S, Schwartzmann I, et al
Incidental diagnosis of bladder cancer in a national observational study in spain.
Actas Urol Esp (Engl Ed). 2022 Oct 1:S2173-5786(22)00104.
Abstract Related articles

BASIN MF, Bratslavsky G, Nahhas N, Basnet A, et al
Novel synthetic lethality drug target in urothelial bladder cancer based on MTAP genomic loss.
Urol Oncol. 2022 Nov 25:S1078-1439(22)00358.
Abstract Related articles

BURES J, Kohoutova D, Zavoral M
Gastrointestinal toxicity of systemic oncology immunotherapy.
Klin Onkol. 2022;35:346-357.
Abstract Related articles

YU EM, Belay S, Li W, Aragon-Ching JB, et al
Non-urothelial and urothelial variants of bladder cancer.
Cancer Treat Res Commun. 2022;33:100661.
Abstract Related articles

ZHANG W, Liu Z
MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway.
Pharmacogenet Genomics. 2023;33:1-9.
Abstract Related articles

HUELE EH, Veenboer PW, Wessels FJ, Jonges TN, et al
Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
Urol Oncol. 2023;41:49.
Abstract Related articles

LU X, Wang J, Dong B, Wang L, et al
Exosomal miR-93-5p from cancer-associated fibroblasts confers malignant phenotypes on bladder cancer cells by targeting PAFAH1B1.
Anticancer Drugs. 2022 Nov 21. doi: 10.1097/CAD.0000000000001453.
Abstract Related articles

LONG J, Wang L, Dong N, Bai X, et al
Robotic-assisted versus standard laparoscopic radical cystectomy in bladder cancer: A systematic review and meta-analysis.
Front Oncol. 2022;12:1024739.
Abstract Related articles

CHEN W, Liu N, Yuan Y, Zhu M, et al
ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential.
Front Immunol. 2022;13:1040669.
Abstract Related articles

WANG J, He X, Bai Y, Du G, et al
Identification and validation of novel biomarkers affecting bladder cancer immunotherapy via machine learning and its association with M2 macrophages.
Front Immunol. 2022;13:1051063.
Abstract Related articles

DYRSKJOT L, Vlahou A, Black PC, Droller M, et al
25 years International Bladder Cancer Network (IBCN): The past, the present, and the future.
Urol Oncol. 2022 Nov 24:S1078-1439(22)00430.
Abstract Related articles

CHRISTENSEN E, Wyatt AW, Galsky MD, Grivas P, et al
IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer.
Urol Oncol. 2022 Nov 24:S1078-1439(22)00442.
Abstract Related articles

MENG X, Xiao W, Sun J, Li W, et al
CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer.
Cancer Lett. 2022 Nov 24:216023. doi: 10.1016/j.canlet.2022.216023.
Abstract Related articles

SHEN C, Yue X, Dai L, Wang J, et al
Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer.
J Cancer Res Clin Oncol. 2022 Nov 27. doi: 10.1007/s00432-022-04385.
Abstract Related articles

AZEM S, Raphael R, Raibman-Spector S, Faierstien K, et al
A Rare Manifestation of Neurovasculitis and Hemophagocytic Lymphohistiocytosis as a Late Complication of Bacillus Calmette-Guerin Administration.
Isr Med Assoc J. 2022;24:777-778.
Abstract Related articles

HAJJAR M, Pourkerman M, Rezazadeh A, Yunus F, et al
Adherence to Mediterranean-Style Dietary Pattern and Risk of Bladder Cancer: A Case-Control Study in Iran.
Nutr Cancer. 2022 Nov 27:1-8. doi: 10.1080/01635581.2022.2143536.
Abstract Related articles

ANGULO JC, Alvarez-Ossorio JL, Dominguez JL, Moyano JL, et al
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.
Eur Urol Oncol. 2022 Nov 23:S2588-9311(22)00178.
Abstract Related articles

ZHANG H, Yu S, Fei K, Huang Z, et al
NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo.
BMC Urol. 2022;22:193.
Abstract Related articles

WANG X, Zhang S, Wu L, Feng B, et al
Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study.
BMC Urol. 2022;22:194.
Abstract Related articles

LI J, Cao K, Lin H, Deng L, et al
Predicting muscle invasion in bladder cancer by deep learning analysis of MRI: comparison with vesical imaging-reporting and data system.
Eur Radiol. 2022 Nov 25. doi: 10.1007/s00330-022-09272.
Abstract Related articles

REIKE MJ, Contreras-Sanz A, Black PC
Biological Stratification of Invasive and Advanced Urothelial Carcinoma.
Urol Clin North Am. 2023;50:69-80.
Abstract Related articles

[Not Available].
Aktuelle Urol. 2022;53:502-503.
Abstract Related articles

[Not Available].
Aktuelle Urol. 2022;53:494-496.
Abstract Related articles

[Not Available].
Aktuelle Urol. 2022;53:492-494.
Abstract Related articles

ZHANG J, Huang C, Yang R, Wang X, et al
Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer.
Biomolecules. 2022;12:1670.
Abstract Related articles

VLACHOSTERGIOS PJ, Tamposis IA, Anagnostou M, Papathanassiou M, et al
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features.
Curr Oncol. 2022;29:8638-8649.
Abstract Related articles

TANG YZ, Alabousi A
Incidental findings on staging CT for rectal cancer: Frequency, clinical significance and outcomes.
Clin Imaging. 2023;93:14-22.
Abstract Related articles

KAYYAL-TARABEIA I, Blank M, Zick A, Agay-Shay K, et al
Residence near industrial complex and cancer incidence: A registry-based cohort of 1,022,637 participants with a follow-up of 21 years, Israel.
Environ Res. 2023;216.
Abstract Related articles

IRWIN S, Karr C, Furman C, Tsai J, et al
Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARgamma by inverse agonists.
J Biol Chem. 2022;298:102539.
Abstract Related articles

BAHMAD HF, Lopez O, Moreno JCA, Lopez K, et al
Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome.
Ann Diagn Pathol. 2022;61:152030.
Abstract Related articles

NADAL R, Apolo AB, Girardi DM, Hahn NM, et al
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer.
Urol Oncol. 2023;41:27-34.
Abstract Related articles

GIRARDI DM, Ghatalia P, Singh P, Iyer G, et al
Systemic therapy in bladder preservation.
Urol Oncol. 2023;41:39-47.
Abstract Related articles

ALBARGHOUTH MH, Hamza A
[The impact of using intraoperative photodynamic diagnosis on the prognosis of bladder cancer].
Aktuelle Urol. 2022;53:552-558.
Abstract Related articles

TAN R, Wang L, Xia R, Zheng H, et al
Use of an Application to Increase Self-Care Ability, Improve Quality of Life, and Decrease Stoma Complications in Patients With Ileocystoplasty or Ureterostomy Due to Bladder Cancer.
Wound Manag Prev. 2022;68:26-31.
Abstract Related articles

CARUS A, Holmsten K, Pappot H, Ullen A, et al
The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?
Acta Oncol. 2022 Dec 9:1-2. doi: 10.1080/0284186X.2022.2153620.
Abstract Related articles

GUIMARAES T, Pinheiro H, Pimentel J, Pereira H, et al
An Unexpected and Unpredictable Emergence of Muscle-Invasive Bladder Cancer in a Patient Successfully Treated With Nivolumab for Small-Cell Bladder Cancer.
Cureus. 2022;14:e32244.
Abstract Related articles

DEMIR DO, Doluoglu OG, Yildiz AK, Kacan T, et al
Effect of Re-TUR time on recurrence and progression in high-risk non-muscle-invasive bladder cancer.
Cir Cir. 2022;90.
Abstract Related articles

DING L, Wang X, Deng X, Xia W, et al
Preoperative systemic immune-inflammation index as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis.
Cancer Med. 2022 Dec 7. doi: 10.1002/cam4.5501.
Abstract Related articles

LI S, Wang Y, Hu X
Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Cancer Med. 2022 Dec 7. doi: 10.1002/cam4.5475.
Abstract Related articles

XIAO Y, Yang J, Yang M, Len J, et al
The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia.
Front Oncol. 2022;12:916850.
Abstract Related articles

ZHOU Y, Chen J, Chen P, Tang Y, et al
Super-selective transcatheter vesical arterial chemoembolization with drug-loaded beads for muscle-invasive bladder cancer with hematuria.
Abdom Radiol (NY). 2022 Dec 7. doi: 10.1007/s00261-022-03748.
Abstract Related articles

LIU Z, Xie D, Zhang H
Retraction Note: Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.
Cell Death Dis. 2022;13:1025.
Abstract Related articles

ZHANG X, Liu J, Yang X, Jiao W, et al
High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer.
Cell Cycle. 2022 Dec 6:1-9. doi: 10.1080/15384101.2022.2154551.
Abstract Related articles

LI Y, Zhou Y, Huang M, Wang Z, et al
DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.
Cell Signal. 2022 Dec 3:110553. doi: 10.1016/j.cellsig.2022.110553.
Abstract Related articles

RIVEROS C, Ranganathan S, Nipper C, Lim K, et al
Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer: A pairwise meta-analysis of outcomes and a network meta- analysis of complications by urinary diversion approach.
Can Urol Assoc J. 2022 Oct 25. doi: 10.5489/cuaj.8096.
Abstract Related articles

RIVEROS C, Elshafei A, Chalfant V, Alam U, et al
Complications after neoadjuvant chemotherapy and radical cystectomy for patients with bladder cancer: A propensity score matched analysis.
Can Urol Assoc J. 2022 Oct 25. doi: 10.5489/cuaj.7952.
Abstract Related articles

TAPPERO S, Sorce G, Hoeh B, Hohenhorst L, et al
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy.
Can Urol Assoc J. 2022 Oct 25. doi: 10.5489/cuaj.8056.
Abstract Related articles

JIANG S, Ma J, Wei S, Ren P, et al
Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
Arch Esp Urol. 2022;75:779-790.
Abstract Related articles

XIANG W, Peng Y, Zeng H, Yu C, et al
Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate.
Biomater Res. 2022;26:74.
Abstract Related articles

HU CY, Su BH, Lee YC, Wang CT, et al
Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer.
J Biomed Sci. 2022;29:104.
Abstract Related articles

ZHANG L, Wang Y, Song M, Chang A, et al
Fibronectin 1 as a Key Gene in the Genesis and Progression of Cadmium-Related Bladder Cancer.
Biol Trace Elem Res. 2022 Dec 6. doi: 10.1007/s12011-022-03510.
Abstract Related articles

GUO Y, Dong J, Ji T, Li X, et al
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy.
Aging (Albany NY). 2022;14.
Abstract Related articles

TEMPO J, Yiu TW, Ischia J, Bolton D, et al
Global changes in bladder cancer mortality in the elderly.
Cancer Epidemiol. 2022;82:102294.
Abstract Related articles

ZHANG C, Zhao J, Wang W, Geng H, et al
Current advances in the application of nanomedicine in bladder cancer.
Biomed Pharmacother. 2022;157:114062.
Abstract Related articles

ZHANG L, Gao S, Shi X, Chen Y, et al
NUPR1 imparts oncogenic potential in bladder cancer.
Cancer Med. 2022 Dec 5. doi: 10.1002/cam4.5518.
Abstract Related articles

KAO S, Barger A, Garrett LD
Vaginal swab cytology as a diagnostic tool for neoplasia of the lower urinary tract in 5 dogs.
Can Vet J. 2022;63:1221-1225.
Abstract Related articles

YAN X, Zhang X, Wu HH, Wu SJ, et al
Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma.
Front Immunol. 2022;13:994594.
Abstract Related articles

OTHMANE B, Yi Z, Zhang C, Chen J, et al
Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology.
Front Public Health. 2022;10:1036722.
Abstract Related articles

CHEN G, Chen Y, Xu R, Zhang G, et al
Impact of SOX2 function and regulation on therapy resistance in bladder cancer.
Front Oncol. 2022;12:1020675.
Abstract Related articles

DENG S, Meng F, Wang L, Yang Z, et al
Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis.
Front Oncol. 2022;12:1044830.
Abstract Related articles

CHEN R, Zhan X, Jiang H, Liu Y, et al
Risk and prognosis of secondary malignant neoplasms after radiation therapy for bladder cancer: A large population-based cohort study.
Front Oncol. 2022;12:953615.
Abstract Related articles

HUANG ZM, Wang H, Ji ZG
Bladder cancer tissue-derived exosomes suppress ferroptosis of T24 bladder cancer cells by transporting miR-217.
Environ Mol Mutagen. 2022 Dec 2. doi: 10.1002/em.22520.
Abstract Related articles

HSU KW, Lai JC, Chang JS, Peng PH, et al
METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets.
Genome Biol. 2022;23:249.
Abstract Related articles

ZHANG HW, Tsai ZR, Kok VC, Peng HC, et al
Long-term ambient hydrocarbon exposure and incidence of urinary bladder cancer.
Sci Rep. 2022;12:20799.
Abstract Related articles

MA Z, Li X, Mao Y, Wei C, et al
Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer.
Cancer Cell. 2022 Nov 30:S1535-6108(22)00552-9. doi: 10.1016/j.ccell.2022.
Abstract Related articles

TANG C, Deng Y, Shao S, Guo Y, et al
Long noncoding RNA UCA1 promotes the expression and function of P-glycoprotein by sponging miR-16-5p in human placental BeWo cells.
FASEB J. 2023;37:e22657.
Abstract Related articles

XU Z, Ma J, Chen T, Yang Y, et al
Case report: The remarkable response of pembrolizumab combined with RC48 in the third-line treatment of metastatic urothelial carcinoma.
Front Immunol. 2022;13:978266.
Abstract Related articles

TRIPATHI A, MacDougall K, Sonpavde GP
Therapeutic Landscape Beyond Immunotherapy in Advanced Urothelial Carcinoma: Moving Past the Checkpoint.
Drugs. 2022;82:1649-1662.
Abstract Related articles

SIVA S, Ali M, Correa RJM, Muacevic A, et al
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
Lancet Oncol. 2022;23:1508-1516.
Abstract Related articles

VIEHWEGER F, Azem A, Gorbokon N, Uhlig R, et al
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
Pathol Res Pract. 2022;240:154200.
Abstract Related articles

MASONE MC
Intravesical ICIs to reduce toxicity in NMIBC.
Nat Rev Urol. 2022;19:694.
Abstract Related articles

CHANG SJ, Bin PJ, Luo CW, Chai CY, et al
CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma.
Pathol Res Pract. 2022;240:154173.
Abstract Related articles

BEIRNAERT J, Benarroche D, Pinar U, Roupret M, et al
Robotic versus open cystectomy with ileal conduit for the management of neurogenic bladder: a comparative study.
World J Urol. 2022;40:2963-2970.
Abstract Related articles

TAILBAUT E, Monge M, Compain F, Pacheco A, et al
Muscular pseudotumor revealing a mycobacterial granuloma after bacillus Calmette-Guerin therapy.
Rev Med Interne. 2022;43:743-745.
Abstract Related articles

TALUKDER R, Makrakis D, Lin GI, Diamantopoulos LN, et al
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:558-567.
Abstract Related articles

MORGANS AK, Grewal S, Hepp Z, Fuldeore R, et al
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy.
Clin Genitourin Cancer. 2022;20:543-552.
Abstract Related articles

HASEGAWA T, Oyama N, Kasamatsu H, Chino T, et al
Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.
J Dermatol. 2022;49:e453-e454.
Abstract Related articles

PIERINI A, Criscuolo MC, Bonfanti U, Benvenuti E, et al
Usefulness of squash preparation cytology in the diagnosis of canine urinary bladder carcinomas.
Vet Clin Pathol. 2022;51:498-506.
Abstract Related articles

DURANT AM, Chang YH, Faraj KS, Tyson MD, et al
BCG Administration after Prior Radiation Treatment for Prostate Cancer.
Clin Genitourin Cancer. 2022;20:591-597.
Abstract Related articles

TARIQ A, McCart Reed AE, Morton A, Porten S, et al
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.
Eur Urol Focus. 2022;8:1256-1269.
Abstract Related articles

FERRARIS F, Raman JD, Yaber F
Bladder Chemoprophylaxis Following Ureterorenoscopy in Patients with Upper Tract Urothelial Carcinoma.
Eur Urol Focus. 2022;8:1253-1255.
Abstract Related articles

FUJIWARA M, Yokoyama M, Toide M, Fujiwara R, et al
Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with mus
Jpn J Clin Oncol. 2022 Dec 15:hyac190. doi: 10.1093.
Abstract Related articles

ZHANG S, Du J, Zhong X, Tan P, et al
The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy.
Front Immunol. 2022;13:1072433.
Abstract Related articles

ANWAR I, Pandith AA, Mir H, Manzoor U, et al
Implications of risk conferred by 5p15.33 loci genetic variants; human telomerase reverse transcriptase rs2736098 and rs2736100 in predisposition of bladder cancer.
Rep Pract Oncol Radiother. 2022;27:787-796.
Abstract Related articles

WANG H, Dai Y, Wu X, Hu B, et al
Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy.
Transl Cancer Res. 2022;11:4089-4104.
Abstract Related articles

PATEL SR, Lerner SP
Evolving the surgical approach for bladder cancer - robotic versus open radical cystectomy.
Nat Rev Urol. 2022 Dec 15. doi: 10.1038/s41585-022-00704.
Abstract Related articles

LEE J, Heo JE, Kang SK, Lee KS, et al
Noninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up.
Sci Rep. 2022;12:21677.
Abstract Related articles

LAVIANA AA, Schiftan EG, Mashni JW, Large MC, et al
Biodynamic prediction of neoadjuvant chemotherapy response: Results from a prospective multicenter study of predictive accuracy among muscle-invasive bladder cancer patients.
Urol Oncol. 2022 Dec 13:S1078-1439(22)00477.
Abstract Related articles

FAVARO WJ, Alonso JCC, de Souza BR, Reis IB, et al
New synthetic nano-immunotherapy (OncoTherad(R)) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property.
Tissue Cell. 2022;80:101988.
Abstract Related articles

WEI X, Cai L, Chen H, Shang L, et al
Noninvasive Multiplexed Analysis of Bladder Cancer-Derived Urine Exosomes via Janus Magnetic Microspheres.
Anal Chem. 2022 Dec 14. doi: 10.1021/acs.analchem.2c04408.
Abstract Related articles

SUN L, Liu XP, Yan X, Wu S, et al
Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer.
Front Immunol. 2022;13:1059568.
Abstract Related articles

STONE L
Urine microbiota differ in bladder cancer.
Nat Rev Urol. 2022 Dec 14. doi: 10.1038/s41585-022-00690.
Abstract Related articles

YANAGISAWA T, Quhal F, Kawada T, Mostafaei H, et al
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer.
Eur Urol Focus. 2022 Dec 12:S2405-4569(22)00287.
Abstract Related articles

OTT OJ, Gaipl US, Lamrani A, Fietkau R, et al
The Emerging Evidence Supporting Integration of Deep Regional Hyperthermia With Chemoradiation in Bladder Cancer.
Semin Radiat Oncol. 2023;33:82-90.
Abstract Related articles

KAHN JM, Smits GAHJ, Oosterveld BJ, van der Steen-Banasik EM, et al
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy.
Semin Radiat Oncol. 2023;33:76-81.
Abstract Related articles

MOORE NS, McWilliam A, Aneja S
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence.
Semin Radiat Oncol. 2023;33:70-75.
Abstract Related articles

BROCKLEHURST A, Varughese M, Birtle A
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology.
Semin Radiat Oncol. 2023;33:62-69.
Abstract Related articles

ELUMALAI T, Joseph N, Choudhury A
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer.
Semin Radiat Oncol. 2023;33:56-61.
Abstract Related articles

STECCA C, Mitin T, Sridhar SS
The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer.
Semin Radiat Oncol. 2023;33:51-55.
Abstract Related articles

VENKATESULU B, Liauw SL, Joshi M, Baumann BC, et al
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder Cancer.
Semin Radiat Oncol. 2023;33:35-50.
Abstract Related articles

KAMRAN SC, Efstathiou JA
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America.
Semin Radiat Oncol. 2023;33:26-34.
Abstract Related articles

KOMBATHULA SH, Hoskin P
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer.
Semin Radiat Oncol. 2023;33:21-25.
Abstract Related articles

MESSINA E, Pecoraro M, Pisciotti ML, Giudice FD, et al
Seeing is Believing: State of the Art Imaging of Bladder Cancer.
Semin Radiat Oncol. 2023;33:12-20.
Abstract Related articles

MAU B, Johnson B, Hansel DE, McConkey DJ, et al
The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization.
Semin Radiat Oncol. 2023;33:1-11.
Abstract Related articles

GONZALEZ-ALBO G, Velez J, Bernaschina C, Awasum M, et al
Rare Case of Intramural Urinary Bladder Leiomyoma.
P R Health Sci J. 2022;41:247-249.
Abstract Related articles

BIAN Z, Chen J, Liu C, Ge Q, et al
Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy.
Comput Struct Biotechnol J. 2022;21:74-85.
Abstract Related articles

SHI C, Li Y, Wan E, Zhang E, et al
Construction of an lncRNA model for prognostic prediction of bladder cancer.
BMC Med Genomics. 2022;15:257.
Abstract Related articles

SATO M, Osawa T, Abe T, Honda M, et al
Validation of the Japanese version of the Body Image Scale for bladder cancer patients.
Sci Rep. 2022;12:21544.
Abstract Related articles

KARDOUST PARIZI M, Margulis V, Lotan Y, Aydh A, et al
A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer.
Clin Genitourin Cancer. 2022 Nov 13:S1558-7673(22)00236.
Abstract Related articles

LI H, Yang F, Chang K, Yu X, et al
The synergistic function of long and short forms of beta4GalT1 in p53-mediated drug resistance in bladder cancer cells.
Biochim Biophys Acta Mol Cell Res. 2022 Dec 10:119409.
Abstract Related articles

ROCCO B, Assumma S, Calcagnile T, Sangalli M, et al
Reproducibility of a modified posterior reconstruction during robotic intracorporeal neobladder reconfiguration.
Int Braz J Urol. 2022;49:136-142.
Abstract Related articles

HAO Y, Wang C, Xu D
Identification and validation of a novel prognostic model based on platinum Resistance-related genes in bladder cancer.
Int Braz J Urol. 2023;49:61-88.
Abstract Related articles

WANG R, Gao D, Chen C, Fan G, et al
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
Clin Transl Oncol. 2022 Dec 13. doi: 10.1007/s12094-022-03044.
Abstract Related articles

JIN M, Hu J, Tong L, Zhang BZ, et al
The Epitope Basis of Embryonic Stem Cell-induced Antitumor Immunity against Bladder Cancer.
Adv Healthc Mater. 2022 Dec 12:e2202691. doi: 10.1002/adhm.202202691.
Abstract Related articles

WU T, Li S, Yu C, Wu Y, et al
A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.
Sci Rep. 2022;12:21467.
Abstract Related articles

SHLYAPNIKOV YM, Malakhova EA, Vinarov AZ, Potoldykova NV, et al
Cancer-Retina Antigens in the Urine of Bladder and Prostate Cancer Patients.
Biochemistry (Mosc). 2022;87:1268-1276.
Abstract Related articles

ABUFARAJ M, Li R, Meeks J, Shariat SF, et al
Cytoreductive Surgery in Patients with Urothelial Bladder Cancer.
Eur Urol Focus. 2022 Dec 9:S2405-4569(22)00283-8. doi: 10.1016/j.euf.2022.
Abstract Related articles

PANG L, Ding Z, Chai H, Li F, et al
Causal relationship between smoking status, smoking frequency and bladder cancer: a Mendelian randomization study.
Genes Genomics. 2022 Dec 12. doi: 10.1007/s13258-022-01346.
Abstract Related articles

CHENG C, Wu X, Song W, Li D, et al
A reporting quality evaluation of the clinical practice guidelines for bladder cancer based on the RIGHT checklist.
Transl Androl Urol. 2022;11:1586-1597.
Abstract Related articles

HAN D, Liu Y, Liu C, Jing C, et al
Effect of long noncoding RNA NONHSAT070806 on the apoptosis, proliferation, migration, invasion and tumorigenesis of bladder cancer.
Transl Androl Urol. 2022;11:1544-1554.
Abstract Related articles

LIU Z, Zhu F, Zhang P, Qian B, et al
Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation.
Front Genet. 2022;13:1074981.
Abstract Related articles

LUO L, Li F, Gong B, Xi P, et al
A novel prognostic model based on cellular senescence-related gene signature for bladder cancer.
Front Oncol. 2022;12:937951.
Abstract Related articles

WANG S, Wang H, Zhu S, Wang Z, et al
PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration.
Front Oncol. 2022;12:1058506.
Abstract Related articles

ZHANG YY, Li XW, Li XD, Zhou TT, et al
Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.
Front Immunol. 2022;13:1055304.
Abstract Related articles

ZHANG L, Peng M
Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer.
Front Immunol. 2022;13:1030097.
Abstract Related articles

LIU Y, Pang ZQ, Han YS, Shen LK, et al
The predictive value of pyroptosis for the prognosis and immune escape of bladder cancer.
Am J Transl Res. 2022;14:7744-7757.
Abstract Related articles

DENG-XIONG L, Qing-Xin Y, De-Chao F, Fa-Cai Z, et al
Systemic Immune-inflammation Index (SII) During Induction has Higher Predictive Value Than Preoperative SII in Non-muscle-invasive Bladder Cancer Patients Receiving Intravesical Bacillus Calmette -Guerin.
Clin Genitourin Cancer. 2022 Nov 20:S1558-7673(22)00247.
Abstract Related articles

MARCHESE PV, Mollica V, Tassinari E, De Biase D, et al
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers.
Expert Rev Mol Diagn. 2022;22:997-1008.
Abstract Related articles

HUYAN T, Gao L, Gao N, Wang C, et al
miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction.
Int J Mol Sci. 2022;23:15177.
Abstract Related articles

ROH J, Im M, Chae Y, Kang J, et al
The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer.
Int J Mol Sci. 2022;23:14808.
Abstract Related articles

ZHENG Q, Yang R, Ni X, Yang S, et al
Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer.
J Clin Med. 2022;11:7081.
Abstract Related articles

HU H, Xia Q, Hu J, Wang S, et al
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects.
J Clin Med. 2022;11:6997.
Abstract Related articles

LISINSKI J, Kienitz J, Tousty P, Kaczmarek K, et al
Comparison of Laparoscopic and Open Radical Cystectomy for Muscle-Invasive Bladder Cancer.
Int J Environ Res Public Health. 2022;19:15995.
Abstract Related articles

DIAMANT E, Roumiguie M, Ingels A, Parra J, et al
Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797.
Cancers (Basel). 2022;14:6001.
Abstract Related articles

GAO Y, Nie Z, Cao H, Huang D, et al
Scabertopin Derived from Elephantopus scaber L. Mediates Necroptosis by Inducing Reactive Oxygen Species Production in Bladder Cancer In Vitro.
Cancers (Basel). 2022;14:5976.
Abstract Related articles

ZHENG Q, Yang R, Ni X, Yang S, et al
Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides.
Cancers (Basel). 2022;14:5807.
Abstract Related articles

YU H, Chen L, Wang X, Tang F, et al
STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc.
Cancers (Basel). 2022;14:5777.
Abstract Related articles

NAKAGAWA R, Izumi K, Naito R, Kadomoto S, et al
Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?
Cancers (Basel). 2022;14:5767.
Abstract Related articles

BARLETTA F, Tappero S, Panunzio A, Incesu RB, et al
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype.
Cancers (Basel). 2022;14:5766.
Abstract Related articles

MARCQ G, Afferi L, Neuzillet Y, Nykopp T, et al
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group.
Cancers (Basel). 2022;14:5740.
Abstract Related articles

GUO M, Wang SM
The BRCAness Landscape of Cancer.
Cells. 2022;11:3877.
Abstract Related articles

HUANG G, Huang Y, Zhang C, Jiang Y, et al
Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer.
Sci Rep. 2022;12:21386.
Abstract Related articles

YU B, Huang Y, Yang Y, Hu H, et al
Effect of CTP-mediated PTEN on 5637 bladder cancer cells and the underlying molecular mechanism.
BMC Urol. 2022;22:200.
Abstract Related articles

SHAH YB, Clark CB, Shumaker A, Denisenko AA, et al
Does antithrombotic use enable earlier diagnosis of bladder cancer? A brief institutional assessment.
Can J Urol. 2022;29:11391-11393.
Abstract Related articles

ORTIZ RESTREPO A, Ross JS, Spiess PE, Necchi A, et al
Emerging targets in upper tract urothelial carcinomas: the TERT gene.
Can J Urol. 2022;29:11378-11383.
Abstract Related articles

ZHANG B, Jia P, Wang J, Pei G, et al
Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer.
Mol Oncol. 2022 Dec 10. doi: 10.1002/1878-0261.13360.
Abstract Related articles

CHENG L, Yang F, Zhao Y, Liu Z, et al
Tetrahedron supported CRISPR/Cas13a cleavage for electrochemical detection of circular RNA in bladder cancer.
Biosens Bioelectron. 2022;222:114982.
Abstract Related articles

ZHENG CM, Piao XM, Byun YJ, Song SJ, et al
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143].
Cancer Genet. 2022;270-271:31.
Abstract Related articles

HOEGGER MJ, Strnad BS, Ballard DH, Siegel CL, et al
Urinary Bladder Masses, Rare Subtypes, and Masslike Lesions: Radiologic-Pathologic Correlation.
Radiographics. 2023;43:e220034.
Abstract Related articles

WANG K, Meng J, Wang X, Yan M, et al
Pan-cancer analysis of the prognostic and immunological role of PAQR4.
Sci Rep. 2022;12:21268.
Abstract Related articles

SUN X, Zhang Z, Wang Z, Xie R, et al
The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer.
Front Immunol. 2022;13:1033967.
Abstract Related articles

ANZENGRUBER M, Wimmer L, Szuchar R, Skoll K, et al
LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy.
Eur J Pharm Sci. 2023;180:106330.
Abstract Related articles

SCHMID SC, Lewerich J, Retz M, Rodel C, et al
["Surgery only" is not enough: potential of multimodal therapy in urothelial bladder carcinoma].
Urologie. 2022;61:1332-1340.
Abstract Related articles

YOON P, Murakami K, Athanasiadi I, Rancilio NJ, et al
Palliative radiation therapy as a treatment for feline urinary bladder masses in four cats.
J Feline Med Surg. 2022;24:e655-e660.
Abstract Related articles

DUARTE T, Costa C, Goncalves S, Raposo L, et al
A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agents.
Rev Port Cardiol. 2022;41:1047-1051.
Abstract Related articles

VELEZ TORRES JM, Zhao J, Epstein JI, Kryvenko ON, et al
Condyloma acuminatum of the urinary tract demonstrates atypical squamous cells in urine cytology.
Hum Pathol. 2022;130:110-116.
Abstract Related articles

CONDE-FERREIROS M, Dominguez-de Dios J, Juaneda-Magdalena L, Bellas-Pereira A, et al
Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
Actas Urol Esp (Engl Ed). 2022;46:600-605.
Abstract Related articles

PLAGE H, Samtleben H, Hofbauer S, Kornienko K, et al
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.
Hum Pathol. 2022;130:10-17.
Abstract Related articles

YOKOYAMA T, Toguchi M, Iizuka J, Horita S, et al
5-Aminolevulinic acid-based photodynamic diagnosis for detection of urothelial carcinoma cells in bladder washing sediment suspension: A pilot study.
Photodiagnosis Photodyn Ther. 2022;40:103072.
Abstract Related articles

OHLMANN CH, Kerkmann M, Holtmann L, Gschwend JE, et al
[Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in Germany : An initiative of the Working Groups Urological Oncology (AUO) and Internal Oncology (AIO) in the German Cancer Society (DKG)].
Urologie. 2022;61:1351-1364.
Abstract Related articles

TAKAHASHI S, Narita S, Fujiyama N, Hatakeyama S, et al
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
Cancer Sci. 2022;113:4059-4069.
Abstract Related articles

LOKESHWAR SD, Rahman SN, Press BH, Khan AI, et al
Surveillance and office management of low-grade Ta bladder tumors.
Actas Urol Esp (Engl Ed). 2022;46:613-618.
Abstract Related articles

KHADHOURI S, Gallagher KM, MacKenzie KR, Shah TT, et al
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study.
Eur Urol Focus. 2022;8:1673-1682.
Abstract Related articles

LAUKHTINA E, Hassler MR, Pradere B, Yanagisawa T, et al
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma.
Eur Urol Focus. 2022;8:1683-1686.
Abstract Related articles

LAUKHTINA E, Moschini M, Soria F, Andrea DD, et al
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.
Eur Urol Focus. 2022;8:1635-1642.
Abstract Related articles

MORI K, Schuettfort VM, Yanagisawa T, Katayama S, et al
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis.
Eur Urol Focus. 2022;8:1687-1695.
Abstract Related articles

LAURIDSEN SV, Thomsen T, Jensen JB, Kallemose T, et al
Effect of a Smoking and Alcohol Cessation Intervention Initiated Shortly Before Radical Cystectomy-the STOP-OP Study: A Randomised Clinical Trial.
Eur Urol Focus. 2022;8:1650-1658.
Abstract Related articles

DOLUOGLU OG, Yildiz AK, Kacan T, Bayburtluoglu V, et al
Efficacy of Obturator Nerve Block During Transurethral Resection on Non-muscle invasive Intermediate and High Risk Lateral Wall Bladder Tumours: A Prospective Randomized Controlled Study.
Urol J. 2022;19:445-450.
Abstract Related articles

WAN S, Cao J, Chen S, Yang J, et al
Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds.
J Cancer Res Clin Oncol. 2022 Dec 23. doi: 10.1007/s00432-022-04524.
Abstract Related articles

PSUTKA SP, Veleber S, Siman J, Jannat S, et al
Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: Study protocol for a randomized, controlled pilot and feasibility study.
Contemp Clin Trials Commun. 2022;30:101044.
Abstract Related articles

ZOU HY, Zhang LY, Qin YL, Li P, et al
Influences of Heider Balance on Knowledge, Attitude, Practice, and Quality of Life in Bladder Cancer Patients after Urinary Diversion.
J Healthc Eng. 2022;2022:5635971.
Abstract Related articles

EL-FALOUJI AI, Sabri DM, Lotfi NM, Medany DM, et al
Rapid Detection of Recurrent Non-Muscle Invasive Bladder Cancer in Urine Using ATR-FTIR Technology.
Molecules. 2022;27:8890.
Abstract Related articles

HSIAO SY, Tang CH, Chen PC, Lin TH, et al
Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy.
Molecules. 2022;27:8649.
Abstract Related articles

RYDELL H, Ericson A, Eriksson V, Johansson M, et al
Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Study of Renal Impairment in Relation to Potential Thromboprophylaxis.
J Pers Med. 2022;12:1961.
Abstract Related articles

CHEN H, Yang W, Xue X, Li Y, et al
Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients.
Int J Mol Sci. 2022;23:15970.
Abstract Related articles

BILSKI K, Kozikowski M, Skrzypczyk MA, Dobruch A, et al
Sex Remains Negative Prognostic Factor in Contemporary Cohort of High-Risk Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2022;14:6110.
Abstract Related articles

YANG C, Mou Z, Wu S, Ou Y, et al
Correction to: High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.
Cell Death Dis. 2022;13:1066.
Abstract Related articles

DARYANTO B, Wibowo E, Seputra KP, Yudhanto HS, et al
Effect of Conjugated Linoleic Acid (CLA) Supplementation on Expression of B-Cell Lymphoma-2 (Bcl-2) in the Bladder Epithelium of Wistar (Rattus norvegicus) Rats Exposed to Cigarette Smoke.
Med Arch. 2022;76:343-347.
Abstract Related articles

CHEN W, Gong M, Zhou D, Zhang L, et al
CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer.
Front Oncol. 2022;12:1019749.
Abstract Related articles

LI D, Wu X, Fan X, Cheng C, et al
Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer.
Ann Transl Med. 2022;10:1232.
Abstract Related articles

NAKANE W, Naito Y, Morishita K, Matsuo K, et al
A case of undifferentiated carcinoma of the bladder treated by combination therapy of surgery, local radiation, and immune checkpoint inhibitors.
Nagoya J Med Sci. 2022;84:865-870.
Abstract Related articles

FONTANA MC, Bosch P, Yarza M, Rueda ML, et al
Disseminated Bacillus Calmette-Guerin Infection in a Young Girl Leading to a Diagnosis of Immunodeficiency.
Actas Dermosifiliogr. 2022;113 Suppl 1:S2-S4.
Abstract Related articles

CLINTON TN, Chen Z, Wise H, Lenis AT, et al
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer.
Cell Rep. 2022;41:111859.
Abstract Related articles

ZHANG C, Bai X, Peng X, Shi W, et al
Starvation-induced long non-coding RNAs are significant for prognosis evaluation of bladder cancer.
Aging (Albany NY). 2022;14.
Abstract Related articles

MIRANDA BALEIRAS M, Vasques C, Pinto M, Miranda H, et al
Pembrolizumab-Induced Autoimmune Grade 4 Neutropenia in a Patient With Advanced Bladder Cancer: A Case Report.
Cureus. 2022;14:e31552.
Abstract Related articles

LIEDBERG F, Abrahamsson J, Bernardo C, Blackberg M, et al
UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.
Scand J Urol. 2022 Dec 20:1-8. doi: 10.1080/21681805.2022.2159519.
Abstract Related articles

BERRY MR, Fadl-Alla BA, Samuelson J, Rosol TJ, et al
Investigating PSMA differential expression in canine uroepithelial carcinomas to aid disease-based stratification and guide therapeutic selection.
BMC Vet Res. 2022;18:441.
Abstract Related articles

LU P, Jiang Y, Xia Z
Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
Anticancer Drugs. 2023;34:144-154.
Abstract Related articles

YUAN H, Wei S, Ren Z, Li F, et al
KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-kappaB signaling.
Int Immunopharmacol. 2022;114:109202.
Abstract Related articles

LI Z, Wang Z, Yang S, Shen C, et al
CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway.
Cell Biol Toxicol. 2022 Dec 20. doi: 10.1007/s10565-022-09785.
Abstract Related articles

YU J, Li H, Liu Z, Wang T, et al
Meat Intake and the Risk of Bladder Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
Nutr Cancer. 2022 Dec 20:1-21. doi: 10.1080/01635581.2022.2159043.
Abstract Related articles

JING L, Wenjian C, Meimei Z, Yanfei C, et al
Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy.
Int J Hyperthermia. 2023;40:2129103.
Abstract Related articles

JIANG K, Wu L, Yin X, Tang Q, et al
Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer.
Front Genet. 2022;13:1036098.
Abstract Related articles

CABALLERO JM, Gili JM, Pereira JC, Gomariz A, et al
Systematic review of population-based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences.
Cancer Med. 2022 Dec 18. doi: 10.1002/cam4.5494.
Abstract Related articles

INAL GULTEKIN G, Timirci Kahraman O, Isbilen M, Durmus S, et al
Six potential biomarkers for bladder cancer: key proteins in cell-cycle division and apoptosis pathways.
J Egypt Natl Canc Inst. 2022;34:54.
Abstract Related articles

ZHU LK, Li ZJ, Wang ZB, Chen JT, et al
A rare case of bladder cancer that metastasized to brain, heart, and lung lymph nodes benefited from immunotherapy.
World J Surg Oncol. 2022;20:402.
Abstract Related articles

RAPOPORT E, Bjurlin MA, Furberg H, Donahue TF, et al
Smoking cessation pharmacotherapy use during index hospital admission following cystectomy for bladder cancer: A retrospective cohort study.
Urol Oncol. 2022 Dec 16:S1078-1439(22)00473.
Abstract Related articles

FILIPPOU P, Hugar LA, Louwers R, Pomper A, et al
Palliative care knowledge, attitudes, and experiences amongst patients with bladder cancer and their caregivers.
Urol Oncol. 2022 Dec 16:S1078-1439(22)00394.
Abstract Related articles

JOSHI M, Atlas SJ, Beinfeld M, Chapman RH, et al
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guerin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer.
Value Health. 2022 Dec 15:S1098-3015(22)04779-9. doi: 10.1016/j.jval.2022.
Abstract Related articles

PAN Y, Zhong X, Liu J
The prognostic significance of Geriatric nutritional risk index in elderly patients with bladder cancer after radical cystectomy.
Asian J Surg. 2022 Dec 15:S1015-9584(22)01644.
Abstract Related articles

BROWN JT, Narayan VM, Joshi SS, Harik L, et al
Challenges and opportunities in the management of non-urothelial bladder cancers.
Cancer Treat Res Commun. 2022;34:100663.
Abstract Related articles

MA J, Zhou Q, Xu W, Li C, et al
Urine PD-L1 is a tumor tissue candidate substitute and is associated with poor survival in muscle-invasive bladder cancer patients.
Int Immunopharmacol. 2022;114:109535.
Abstract Related articles

ZHOU R, Zhou J, Muhuitijiang B, Tan W, et al
Construction and experimental validation of a B cell senescence-related gene signature to evaluate prognosis and immunotherapeutic sensitivity in bladder cancer.
Funct Integr Genomics. 2022;23:3.
Abstract Related articles

WANG W, Li W, Wang K, Wu J, et al
Integrating radiomics with the vesical imaging-reporting and data system to predict muscle invasion of bladder cancer.
Urol Oncol. 2022 Dec 14:S1078-1439(22)00424.
Abstract Related articles

LU M, Liu B, Li D, Gao Z, et al
PXDNL activates the motility of urothelial bladder carcinoma cells through the Wnt/beta-catenin pathway and has a prognostic value.
Life Sci. 2023;312:121270.
Abstract Related articles

LI L, Williamson SR, Castillo RP, Delma KS, et al
Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and Morphology.
Am J Surg Pathol. 2023;47:37-46.
Abstract Related articles

NISHIKAWA T, Matsuzaki I, Ryuta I, Musangile FY, et al
Use of Artificial Intelligence for the Interpretable Prediction of the Pathologic Diagnosis and Molecular Abnormalities of Flat Urothelial Lesions.
Am J Pathol. 2023;193:39-50.
Abstract Related articles

KOBAYASHI G, Hayashi T, Sentani K, Takemoto K, et al
Clinicopathological significance of the overexpression of MUC1 in upper tract urothelial carcinoma and possible application as a diagnostic marker.
Pathol Int. 2022;72:606-616.
Abstract Related articles

TANG G, Liu J, Qi L, Li Y, et al
The evolving role of checkpoint inhibitors in the treatment of urothelial carcinoma.
Br J Clin Pharmacol. 2023;89:93-113.
Abstract Related articles

GALIYA R, Stanislav K, Jawdat J, Benjamin H, et al
Pediatric urothelial bladder neoplasm.
J Pediatr Urol. 2022;18:833.
Abstract Related articles

CHOU J, Trepka K, Sjostrom M, Egusa EA, et al
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.
Eur Urol Oncol. 2022;5:714-718.
Abstract Related articles

LABAKI C, Bakouny Z, Sonpavde G, Choueiri TK, et al
Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma.
Eur Urol Oncol. 2022;5:719-721.
Abstract Related articles

CHEN J, Cao D, Peng Z, Song P, et al
The prognostic value of the Controlling Nutritional Status score on patients undergoing nephrectomy for upper tract urothelial carcinoma or renal cell carcinoma: a systematic review and meta-analysis.
Br J Nutr. 2022;128:217-224.
Abstract Related articles

KACZOROWSKI M, Matysiak J, Kielb P, Malkiewicz B, et al
Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers.
Anticancer Res. 2022;42:493-500.
Abstract Related articles

KURASHINA R, Ando K, Inoue M, Izumi K, et al
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma.
Anticancer Res. 2022;42:1131-1136.
Abstract Related articles

TOMISAKI I, Harada M, Minato A, Nagata Y, et al
Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma.
Anticancer Res. 2022;42:1629-1634.
Abstract Related articles

FURUBAYASHI N, Morokuma F, Tomoda T, Hori Y, et al
Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study.
Anticancer Res. 2022;42:1571-1577.
Abstract Related articles

SALKINI MW, Yang X, Hashmi FH, Kandzari SJ, et al
First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report.
Anticancer Res. 2022;42:1339-1344.
Abstract Related articles

INOUE S, Sassa N, Kawanishi H, Yuguchi Y, et al
Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial Cancer.
Anticancer Res. 2022;42:3627-3636.
Abstract Related articles

DENG F, Kong MX, Lai J
Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and Prostate Adenocarcinoma Diagnosed in One Procedure.
Anticancer Res. 2022;42:3601-3605.
Abstract Related articles

WALLACE B, Dekalo S, Kabha M, Mintz I, et al
Can We Predict a Higher Risk of Urothelial Bladder Cancer With a Simple Blood Test?
Anticancer Res. 2022;42:3569-3573.
Abstract Related articles

VASSILIOU V, Katsila T, Sodergren SC, Kardamakis D, et al
Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications.
Anticancer Res. 2022;42:3767-3778.
Abstract Related articles

RADES D, Kopelke S, Schild SE, Kjaer TW, et al
Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy.
Anticancer Res. 2022;42:4511-4515.
Abstract Related articles

ECKE TH, Scislowski M, Hassan N, Saura M, et al
Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat((R)), NMP22((R)) BladderChek((R)) and UBC((R)) Rapid Test).
Anticancer Res. 2022;42:5249-5256.
Abstract Related articles

KOIZUMI M, Sato S, Yoshihara M, Nakamura Y, et al
Chronological Change in EPHA2 Protein Expression Is Associated With Recurrence of Bladder Cancer.
Anticancer Res. 2022;42:5783-5794.
Abstract Related articles

HENSLEY PJ, Bree KK, Brooks N, Matulay J, et al
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guerin induction does not impact therapeutic response.
BJU Int. 2021;128:634-641.
Abstract Related articles

ABOZAID M, Tan WS, Khetrapal P, Baker H, et al
Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
BJU Int. 2022;129:72-79.
Abstract Related articles

VAN HOOGSTRATEN LMC, Witjes JA, Meijer RP, Ripping TM, et al
Non-metastatic muscle-invasive bladder cancer: the role of age in receiving treatment with curative intent.
BJU Int. 2022 Jan 22. doi: 10.1111/bju.15697.
Abstract Related articles

MAISCH P, Koziarz A, Vajgrt J, Narayan V, et al
Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.
BJU Int. 2022 Mar 2. doi: 10.1111/bju.15723.
Abstract Related articles

ALMASSI N, Vertosick EA, Sjoberg DD, Wong NC, et al
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
BJU Int. 2022;129:463-469.
Abstract Related articles

SCHUETTFORT VM, D'Andrea D, Quhal F, Mostafaei H, et al
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
BJU Int. 2022;129:182-193.
Abstract Related articles

LEUNBACH TL, Stilling C, Tabor MB, Bjerggaard Jensen J, et al
Caveats in the diagnosis of suspected non-endemic verrucous carcinoma in the urinary bladder.
BJU Int. 2022;129:457-459.
Abstract Related articles

SUBIELA JD, Rodriguez Faba O, Aumatell J, Calderon J, et al
Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guerin immunotherapy.
BJU Int. 2022;129:542-550.
Abstract Related articles

HASHEM A, Abdellutif MM, Laymon M, Abdullateef M, et al
Clinical efficacy of mebeverine for persistent nocturnal enuresis after orthotopic W-neobladder.
BJU Int. 2022;129:387-393.
Abstract Related articles

LEBRET T, Pignot G, Colombel M, Guy L, et al
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.
BJU Int. 2022;129:356-363.
Abstract Related articles

YANAGISAWA T, Sato S, Hayashida Y, Okada Y, et al
Do we need repeat TUR after en bloc resection for pT1 bladder cancer?
BJU Int. 2022 Apr 29. doi: 10.1111/bju.15760.
Abstract Related articles

Advances in the management of prostate and bladder cancer and recurrent urinary tract infections.
BJU Int. 2022;129:659-660.
Abstract Related articles

CONROY S, Hubbard R, Noon AP, Hussain SA, et al
Case of the month from the University of Sheffield, UK: Expediting definitive treatment in patients with invasive bladder cancer: an MRI-guided pathway.
BJU Int. 2022;129:691-694.
Abstract Related articles

VEERATTERAPILLAY R, Geraghty R, Pandian R, Roy C, et al
Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
BJU Int. 2022;129:744-751.
Abstract Related articles

NURMINEN P, Ettala O, Uusitalo-Seppala R, Nummi A, et al
Incidence of and mortality from Bacille Calmette-Guerin (BCG) infections after BCG instillation therapy.
BJU Int. 2022;129:737-743.
Abstract Related articles

JUBBER I, Mitchell S, Hussain S, Tsoi H, et al
Social deprivation and bladder cancer: cause or affect for disparities in survival for affected women.
BJU Int. 2022 Jun 20. doi: 10.1111/bju.15832.
Abstract Related articles

DADIKHI K, Mueller F, Montani M, Thalmann GN, et al
Case of the Month from the University Hospital of Bern, Switzerland: Urothelial carcinoma in an orthotopic neobladder: reported cases and pathophysiological hypotheses.
BJU Int. 2022;130:38-42.
Abstract Related articles

LOIZZO D, Pandolfo SD, Del Giudice F, Cerrato C, et al
Ureteroscopy and tailored treatment of upper tract urothelial cancer: recent advances and unmet needs.
BJU Int. 2022;130:35-37.
Abstract Related articles

MAIBOM SL, Roder MA, Aasvang EK, Rohrsted M, et al
Open vs robot-assisted radical cystectomy (BORARC): a double-blinded, randomised feasibility study.
BJU Int. 2022;130:102-113.
Abstract Related articles

AHMADI H, Ladi-Seyedian SS, Konety B, Pohar K, et al
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry.
BJU Int. 2022;130:62-67.
Abstract Related articles

GRAHN A, Eisfeldt J, Malm C, Foroughi Asl H, et al
Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma.
BJU Int. 2022;130:92-101.
Abstract Related articles

WALRAVEN JEW, Ripping TM, Oddens JR, van Rhijn BWG, et al
The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.
BJU Int. 2022 Jul 21. doi: 10.1111/bju.15856.
Abstract Related articles

AHMADI H, Reddy S, Nguyen C, Douglawi A, et al
Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder.
BJU Int. 2022;130:200-207.
Abstract Related articles

KOBAYASHI M, Narita S, Matsui Y, Kanda S, et al
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
BJU Int. 2022;130:226-234.
Abstract Related articles

JAMES ND, Liu W, Pirrie S, Kaur B, et al
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.
BJU Int. 2022 Jul 31. doi: 10.1111/bju.15864.
Abstract Related articles

Updates on bladder, kidney and prostate cancers.
BJU Int. 2022;130:275-276.
Abstract Related articles

JOHN JB, Rajaretnam N, McGrath JS, Smart NJ, et al
Re: risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit.
BJU Int. 2022;130:394-395.
Abstract Related articles

VENTIMIGLIA E, Villa L, Salonia A, Traxer O, et al
Fibre optic ureteroscopes for the management of upper tract urothelial carcinoma? No thanks! Re: Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): re
BJU Int. 2022;130:395-396.
Abstract Related articles

LOBO N, Bree KK, Hensley PJ, Nogueras-Gonzalez GM, et al
Reduced-dose bacillus Calmette-Guerin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre.
BJU Int. 2022;130:323-330.
Abstract Related articles

GHOREIFI A, Allgood E, Whang G, Douglawi A, et al
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit.
BJU Int. 2022;130:381-388.
Abstract Related articles

YU EY, Liu YX, Chen YT, Tang QY, et al
The Effects of Genetic Predisposition Interacted with Lifestyle Factors on Bladder Cancer Risk.
BJU Int. 2022 Sep 2. doi: 10.1111/bju.15880.
Abstract Related articles

HERZBERG H, Lifshitz K, Golan S, Baniel J, et al
Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomes.
BJU Int. 2022 Apr 27. doi: 10.1111/bju.15757.
Abstract Related articles

GHOREIFI A, Duddalwar V, Djaladat H
Re: re: risk factors and natural history of parastomal hernia following radical cystectomy and ileal conduit.
BJU Int. 2022;130:700-701.
Abstract Related articles

HENSLEY PJ, Bree KK, Guo CC, Lobo N, et al
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder.
BJU Int. 2022;130:604-610.
Abstract Related articles

MAKRAKIS D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, et al
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int. 2022;130:592-603.
Abstract Related articles

HUANG C, Assel M, Beech BB, Benfante NE, et al
Uretero-enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot-assisted radical cystectomy.
BJU Int. 2022;130:809-814.
Abstract Related articles

BRAIDE K, Kindblom J, Thellenberg Karlsson C, Stattin P, et al
Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study.
BJU Int. 2022;130:799-808.
Abstract Related articles

YANAGISAWA T, Quhal F, Kawada T, Mostafaei H, et al
Oncologic Impact of Cystoscopic Findings in Non-Muscle Invasive Bladder Cancer: A Meta-analysis.
BJU Int. 2022 Dec 7. doi: 10.1111/bju.15944.
Abstract Related articles

NEUZILLET Y, Leon P, Seisen T, Allory Y, et al
A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer.
BJU Int. 2022 Dec 3. doi: 10.1111/bju.15941.
Abstract Related articles

ROBERSON DS, Xia L, Lee DJ, Pierorazio PM, et al
Comparison of iROC Trial Participants to US Bladder Cancer Patients Undergoing Radical Cystectomy.
BJU Int. 2022 Dec 22. doi: 10.1111/bju.15954.
Abstract Related articles

LIU Z, Zeng H, Jin K, Yu Y, et al
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer.
Br J Cancer. 2022 Jan 17. pii: 10.1038/s41416-022-01703.
Abstract Related articles

CHEN J, Rodopoulou S, Strak M, de Hoogh K, et al
Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project.
Br J Cancer. 2022 Feb 16. pii: 10.1038/s41416-022-01735.
Abstract Related articles

JIN K, Yu Y, Zeng H, Liu Z, et al
CD103(+)CD8(+) tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer.
Br J Cancer. 2022 Feb 14. pii: 10.1038/s41416-022-01725.
Abstract Related articles

SHOHDY KS, Villamar DM, Cao Y, Trieu J, et al
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer. 2022;126:430-439.
Abstract Related articles

NARII N, Sobue T, Zha L, Kitamura T, et al
Vegetable and fruit intake and the risk of bladder cancer: Japan Public Health Center-based prospective study.
Br J Cancer. 2022 Mar 3. pii: 10.1038/s41416-022-01739.
Abstract Related articles

LETT L, George M, Slater R, De Lacy Costello B, et al
Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer.
Br J Cancer. 2022 Mar 29. pii: 10.1038/s41416-022-01785.
Abstract Related articles

DE JONG JJ, Valderrama BP, Perera J, Juanpere N, et al
Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis.
Br J Cancer. 2022 Apr 21. pii: 10.1038/s41416-022-01799.
Abstract Related articles

ZHOU Z, Zhang Z, Chen H, Bao W, et al
SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.
Br J Cancer. 2022 Apr 28. pii: 10.1038/s41416-022-01794.
Abstract Related articles

TOMIYAMA E, Fujita K, Matsuzaki K, Narumi R, et al
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.
Br J Cancer. 2022 Jul 6. pii: 10.1038/s41416-022-01860.
Abstract Related articles

LIU C, Liu Z, Jin K, Zeng H, et al
Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients.
Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01943.
Abstract Related articles

MENGUAL L, Frantzi M, Mokou M, Ingelmo-Torres M, et al
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
Br J Cancer. 2022 Oct 3. pii: 10.1038/s41416-022-01992.
Abstract Related articles

REN J, Yu H, Li W, Jin X, et al
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.
Br J Cancer. 2022 Nov 17. pii: 10.1038/s41416-022-02058.
Abstract Related articles

KOSHKIN VS, Henderson N, James M, Natesan D, et al
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer. 2022;128:1194-1205.
Abstract Related articles

MARTINI A, Yu M, Raggi D, Joshi H, et al
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring.
Cancer. 2022;128:2892-2897.
Abstract Related articles

DOERSCH KM, Tabayoyong WB, Bandari J
Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials.
Cancer. 2022 Oct 19. doi: 10.1002/cncr.34508.
Abstract Related articles

JOYCE DD, Wymer KM, Sharma V, Moriarty JP, et al
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data.
Cancer. 2022 Oct 17. doi: 10.1002/cncr.34502.
Abstract Related articles

HO MD, Modi PK
Novel cryotherapy in non-muscle-invasive bladder cancer.
Cancer. 2022 Dec 7. doi: 10.1002/cncr.34560.
Abstract Related articles

XU C, Jiang S, Zou L, Sheng L, et al
Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial.
Cancer. 2022 Dec 7. doi: 10.1002/cncr.34563.
Abstract Related articles

BELLAT V, Michel AO, Thomas C, Stokol T, et al
A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating non-muscle invasive bladder cancer.
Cancer Res. 2022 Jan 17. pii: 0008-5472.CAN-21-2897.
Abstract Related articles

WANG Y, Zhang Y, Li PC, Guo J, et al
Development of novel aptamer-based targeted chemotherapy for bladder cancer.
Cancer Res. 2022 Jan 21. pii: 0008-5472.CAN-21-2691.
Abstract Related articles

AN M, Zheng H, Huang J, Lin Y, et al
Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer.
Cancer Res. 2022 Apr 8. pii: 694333. doi: 10.1158/0008-5472.CAN-21-4349.
Abstract Related articles

NI Z, Sun P, Zheng J, Wu M, et al
JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
Cancer Res. 2022;82:1789-1802.
Abstract Related articles

LIU W, Newhall KP, Khani F, Barlow L, et al
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer.
Cancer Res. 2022 Dec 8:CAN-22-2912. doi: 10.1158/0008-5472.CAN-22-2912.
Abstract Related articles

KUMAR B, Koul S, Petersen J, Khandrika L, et al
Editor's Note: p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity.
Cancer Res. 2022;82:4696.
Abstract Related articles

QIAN J, Huang C, Zhu Z, He Y, et al
NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer.
Carcinogenesis. 2022 Jan 12. pii: 6505217. doi: 10.1093.
Abstract Related articles

ZHANG X, Tang X, Pan L, Li Y, et al
Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in sepsis-induced pneumonia via inhibiting HOXA1.
Carcinogenesis. 2022;43:371-381.
Abstract Related articles

ZHANG Z, Liu T, Cheng C, Wang J, et al
LncRNA GAS5 regulates the Wnt/beta-catenin pathway through the miR-18a-5p/AXIN2/GSK3beta axis to inhibit the proliferation and migration of bladder cancer cells.
Carcinogenesis. 2022 Nov 4. pii: 6798911. doi: 10.1093.
Abstract Related articles

SHENG X, Yan X, Wang L, Shi Y, et al
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
Clin Cancer Res. 2021;27:43-51.
Abstract Related articles

CHANG E, Weinstock C, Zhang L, Charlab R, et al
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.
Clin Cancer Res. 2021;27:922-927.
Abstract Related articles

CRABB SJ, Danson S, Catto JWF, Hussain S, et al
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).
Clin Cancer Res. 2021;27:1882-1892.
Abstract Related articles

SHENG X, Chen H, Hu B, Yao X, et al
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03.
Clin Cancer Res. 2022;28:489-497.
Abstract Related articles

CHU CE, Sjostrom M, Egusa EA, Gibb EA, et al
Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin.
Clin Cancer Res. 2021;27:5123-5130.
Abstract Related articles

KOUTROS S, Rao N, Moore LE, Nickerson ML, et al
Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors.
Clin Cancer Res. 2021;27:3725-3733.
Abstract Related articles

WANG L, Sfakianos JP, Beaumont KG, Akturk G, et al
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing.
Clin Cancer Res. 2021;27:4287-4300.
Abstract Related articles

GIRARDI DM, Niglio SA, Mortazavi A, Nadal R, et al
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res. 2022;28:1353-1362.
Abstract Related articles

BELLMUNT J, de Wit R, Fradet Y, Climent MA, et al
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.
Clin Cancer Res. 2022;28:2050-2060.
Abstract Related articles

PIETZAK EJ, Whiting K, Srinivasan P, Bandlamudi C, et al
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Clin Cancer Res. 2022 Jul 14. pii: 707011. doi: 10.1158/1078-0432.CCR-22-1006.
Abstract Related articles

ZHU Z, Ma AH, Zhang H, Lin TY, et al
Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in bladder cancer.
Clin Cancer Res. 2022 Aug 3. pii: 707432. doi: 10.1158/1078-0432.CCR-22-1362.
Abstract Related articles

KIM TW, Burris HA, de Miguel Luken MJ, Pishvaian MJ, et al
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.
Clin Cancer Res. 2022;28:3452-3463.
Abstract Related articles

SZABADOS B, Ponz-Sarvis M, Machado R, Saldana D, et al
Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI).
Clin Cancer Res. 2022 Jul 25. pii: 707208. doi: 10.1158/1078-0432.CCR-22-0200.
Abstract Related articles

BASILE G, Bandini M, Gibb EA, Ross JS, et al
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial.
Clin Cancer Res. 2022 Oct 3. pii: 709568. doi: 10.1158/1078-0432.CCR-22-2158.
Abstract Related articles

ENIKEEV D, Babjuk M, Shpikina A, Shariat S, et al
En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser.
Curr Opin Urol. 2021 Dec 24. pii: 00042307-900000000-98808.
Abstract Related articles

HUSSEIN AA, Li Q, Guru KA
Robot-assisted radical cystectomy: surgical technique, perioperative and oncologic outcomes.
Curr Opin Urol. 2022;32:116-122.
Abstract Related articles

BERNDL F, Hassler MR
Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations.
Curr Opin Urol. 2022;32:48-53.
Abstract Related articles

LONATI C, Moschini M, Simeone C, Spiess PE, et al
Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.
Curr Opin Urol. 2022;32:40-47.
Abstract Related articles

COMPERAT E, Wasinger G, Oszwald A, Pradere B, et al
Nonmuscle-invasive bladder cancer, old problems, new insights.
Curr Opin Urol. 2022;32:352-357.
Abstract Related articles

VARTOLOMEI MD, Ferro M, Roth B, Teoh JY, et al
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update.
Curr Opin Urol. 2022 Jun 27. pii: 00042307-990000000-00015.
Abstract Related articles

HEESAKKERS JPFA, Witjes F
Editorial: Medical, technical and functional aspect of various types of urinary diversion.
Curr Opin Urol. 2021;31:542-543.
Abstract Related articles

GRAUER R, Wiklund NP
Update on robotic cystectomy.
Curr Opin Urol. 2021;31:537-541.
Abstract Related articles

LIEDBERG F, Bobjer J
Urinary diversions for benign and oncologic indications: what did we learn about short term complications in the last 24 months?
Curr Opin Urol. 2021;31:556-561.
Abstract Related articles

NUIJENS ST, Cobussen-Boekhorst H, Heesakkers JPFA, Witjes JA, et al
Patient-reported outcomes and health-related quality of life after urinary diversions.
Curr Opin Urol. 2021;31:574-579.
Abstract Related articles

VAN 'T HOF MEM, Bruins HM, van Roermund JGH
Management of upper urinary tract problems after radical cystectomy for urothelial carcinoma: tips and tricks.
Curr Opin Urol. 2021;31:570-573.
Abstract Related articles

LONATI C, Simeone C, Suardi N, Briganti A, et al
Micropapillary bladder cancer: an evolving biology.
Curr Opin Urol. 2022 Jul 19. pii: 00042307-990000000-00030.
Abstract Related articles

SCHOBER JP, Plimack E, Geynisman D, Zibelman M, et al
The past, present, and future of pT0 in bladder cancer clinical trials.
Curr Opin Urol. 2022 Jul 19. pii: 00042307-990000000-00026.
Abstract Related articles

SORIA F, Dutto D, Gontero P
Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancer.
Curr Opin Urol. 2022 Jul 15. pii: 00042307-990000000-00019.
Abstract Related articles

VON DEIMLING M, Pallauf M, Bianchi A, Laukhtina E, et al
Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?
Curr Opin Urol. 2022 Jul 25. pii: 00042307-990000000-00032.
Abstract Related articles

ESCOTT M, Avulova S, Bree KK, Westerman ME, et al
Radical cystectomy and women's sexual health - can we do better?
Curr Opin Urol. 2022;32:545-553.
Abstract Related articles

PIJPERS OM, de Jong JJ, Zuiverloon TCM, Boormans JL, et al
RNA-based urinary assays for non-muscle invasive bladder cancer.
Curr Opin Urol. 2022;32:523-530.
Abstract Related articles

COMPERAT E, Oszwald A, Wasinger G, Klager J, et al
Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis.
Curr Opin Urol. 2022;32:451-455.
Abstract Related articles

LAUKHTINA E, Pradere B, Lemberger U, Karakiewicz PI, et al
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder.
Curr Opin Urol. 2022;32:561-566.
Abstract Related articles

SHEYBAEE MOGHADDAM F, Ghoreifi A, Djaladat H
Comparative performance of the different orthotopic urinary diversions.
Curr Opin Urol. 2022;32:554-560.
Abstract Related articles

KIM SH, Lerner SP
Drug instillation in the management of urinary tract urothelial carcinoma.
Curr Opin Urol. 2022;32:531-535.
Abstract Related articles

MARTINI A, Fallara G, Ploussard G, Pradere B, et al
Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metastatic urothelial carcinoma.
Curr Opin Urol. 2022;32:500-503.
Abstract Related articles

COMPERAT E, Wasinger G, Oszwald A, Shariat SF, et al
Brief update of the new WHO classification for urothelial carcinoma.
Curr Opin Urol. 2022;32:511-516.
Abstract Related articles

MESSINA E, Pisciotti ML, Pecoraro M, Borrelli A, et al
The use of MRI in urothelial carcinoma.
Curr Opin Urol. 2022;32:536-544.
Abstract Related articles

CROCEROSSA F, Autorino R, Carbonara U, Cantiello F, et al
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer.
Curr Opin Urol. 2022 Sep 14. pii: 00042307-990000000-00040.
Abstract Related articles

IBILIBOR C, Kennady EH, Greene KL
The role of surgery for locally advanced urothelial cancers.
Curr Opin Urol. 2022;32:614-617.
Abstract Related articles

KAWADA T, Yanagisawa T, Araki M, Pradere B, et al
Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis.
Curr Opin Urol. 2022 Dec 12. doi: 10.1097/MOU.0000000000001065.
Abstract Related articles

SONPAVDE GP, Sternberg CN, Loriot Y, Marabelle A, et al
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma.
Eur J Cancer. 2022;163:55-65.
Abstract Related articles

KLUMPER N, Sikic D, Saal J, Buttner T, et al
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma.
Eur J Cancer. 2022;167:13-22.
Abstract Related articles

LIU Z, Jin K, Zeng H, Shao F, et al
B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer.
Eur J Cancer. 2022;171:133-142.
Abstract Related articles

YOON S, Shin SJ, Kim HC, Kim YS, et al
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure.
Eur J Cancer. 2022;174:81-89.
Abstract Related articles

MEYNARD L, Dinart D, Delaunay B, Flechon A, et al
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
Eur J Cancer. 2022;175:43-53.
Abstract Related articles

ROUMIGUIE M, Kamat AM, Bivalacqua TJ, Lerner SP, et al
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guerin-exposed High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol. 2021 Dec 23. pii: S0302-2838(21)02213.
Abstract Related articles

MOSSANEN M, Carvalho FLF, Muralidhar V, Preston MA, et al
Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.
Eur Urol. 2021 Dec 22. pii: S0302-2838(21)02212.
Abstract Related articles

GROBET-JEANDIN E, Pinar U, Roupret M
Re: Trey Durdin, Alvin Goh, Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol 2021;80:16-7: Transurethral Resection of Bladder Tumor in Diagnosis of Muscle-invasive Bladder Cancer:
Eur Urol. 2022 Jan 11. pii: S0302-2838(21)02282.
Abstract Related articles

SJODAHL G, Abrahamsson J, Holmsten K, Bernardo C, et al
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjodahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. In press. https://do
Eur Urol. 2022 Jan 13. pii: S0302-2838(21)02284.
Abstract Related articles

DE JONG JJ, Gibb EA
Re: Gottfrid Sjodahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.10.035: Neoadjuvant Chemotherapy Resp
Eur Urol. 2022 Jan 13. pii: S0302-2838(21)02281.
Abstract Related articles

RENTSCH CA, Hayoz S, Cathomas RL
Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicenter, Phase 2 Study.
Eur Urol. 2022 Jan 24. pii: S0302-2838(22)00022.
Abstract Related articles

BRAUN A, Abbosh PH
Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy: A Rare Entity with Unique Genomic Features.
Eur Urol. 2022 Jan 30. pii: S0302-2838(22)00067.
Abstract Related articles

BABJUK M
Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer.
Eur Urol. 2022 Jan 29. pii: S0302-2838(22)00023.
Abstract Related articles

GROBET-JEANDIN E, Pinar U, Roupret M
Re: Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.
Eur Urol. 2022 Jan 27. pii: S0302-2838(22)00012.
Abstract Related articles

PARIKH DA, Khaki AR, Williams SB
Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study.
Eur Urol. 2022 Feb 4. pii: S0302-2838(22)00017.
Abstract Related articles

HE P, Zhou X, Chen Z
Reply to Shun-Fa Hung, Shyi-Chun Yii, and Shiu-Dong Chung's Letter to the Editor re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligament
Eur Urol. 2022 Feb 3. pii: S0302-2838(22)00081.
Abstract Related articles

LEOW JJ, Chong YL, Chang SL, Valderrama BP, et al
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Eur Urol. 2021;79:635-654.
Abstract Related articles

HUNG SF, Yii SC, Chung SD
Re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eur
Eur Urol. 2022 Feb 9. pii: S0302-2838(22)00077.
Abstract Related articles

VAN DER HEIJDEN MS, Loriot Y, Duran I, Ravaud A, et al
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial.
Eur Urol. 2021;80:7-11.
Abstract Related articles

LI R, Gilbert SM, Kamat AM
Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guerin.
Eur Urol. 2021;80:1-3.
Abstract Related articles

SATISH P, Kuusk T, Campain N, Abu-Ghanem Y, et al
The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal Tumours.
Eur Urol. 2021;80:265-267.
Abstract Related articles

DELL'OGLIO P, Andras I, Ortega D, Galfano A, et al
Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic Review.
Eur Urol. 2021;80:129-133.
Abstract Related articles

XU P, Chen B, Xu A, Yuan D, et al
Initial Experience with Intracorporeal Laparoscopic Radical Cystectomy and Detaenial Sigmoid Neobladder Reconstruction.
Eur Urol. 2021;79:545-551.
Abstract Related articles

FOERSTER B, Abufaraj M, Matin SF, Azizi M, et al
Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
Eur Urol. 2021;80:507-515.
Abstract Related articles

PIAZZA P, Rosiello G, Chacon VT, Puliatti S, et al
Robot-assisted Cystectomy with Intracorporeal Urinary Diversion After Pelvic Irradiation for Prostate Cancer: Technique and Results from a Single High-volume Center.
Eur Urol. 2021 Apr 7. pii: S0302-2838(21)00229.
Abstract Related articles

WEINSTOCK C, Agrawal S, Chang E
Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer.
Eur Urol. 2022 Mar 15. pii: S0302-2838(22)01655.
Abstract Related articles

MAYR R, Eckstein M, Wirtz RM, Santiago-Walker A, et al
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guerin Immunotherapy.
Eur Urol. 2022 Mar 26. pii: S0302-2838(22)01670.
Abstract Related articles

ALFRED WITJES J
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study.
Eur Urol. 2022 Mar 25. pii: S0302-2838(22)01786.
Abstract Related articles

ERTL IE, Lemberger U, Ilijazi D, Hassler MR, et al
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
Eur Urol. 2022 Apr 4. pii: S0302-2838(22)01678.
Abstract Related articles

MCGREGOR B, O'Donnell PH, Balar A, Petrylak D, et al
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.
Eur Urol. 2022;81:515-522.
Abstract Related articles

GALLIOLI A, Breda A, Palou J
Re: Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
Eur Urol. 2022;81:428-429.
Abstract Related articles

GEAVLETE P, Multescu R, Geavlete B
Re: How to Manage Patients with Suspected Upper Tract Urothelial Carcinoma in the Pandemic of COVID-19?
Eur Urol. 2022;81:543.
Abstract Related articles

NAKAUMA-GONZALEZ JA, Rijnders M, van Riet J, van der Heijden MS, et al
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
Eur Urol. 2022;81:331-336.
Abstract Related articles

HENSLEY PJ, Kamat AM
Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Eur Urol. 2022;81:316-317.
Abstract Related articles

RUTKA JT, Fleshner N, Nathens AB
Re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Euro Urol 2021;80:442-9.
Eur Urol. 2022;81:e51.
Abstract Related articles

SJODAHL G, Abrahamsson J, Holmsten K, Bernardo C, et al
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Eur Urol. 2022;81:523-532.
Abstract Related articles

CARMEN MIR M, Greenwell T, O'Kelly F, Proietti S, et al
Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80
Eur Urol. 2022;81:e26-e27.
Abstract Related articles

CATHOMAS R, Lorch A, Bruins HM, Comperat EM, et al
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma.
Eur Urol. 2022;81:95-103.
Abstract Related articles

SAAD S, Osman NI, Chapple CR
Reply to Sanjay B. Kulkarni, Pankaj M. Joshi, Marco Bandini, et al.'s Letter to the Editor re: Sanad Saad, Nadir I. Osman, Christopher R. Chapple. Female Urethra: Is Ventral the True Dorsal? Eur Urol 2020;78:e218-9.
Eur Urol. 2022;81:e16-e17.
Abstract Related articles

LIEDBERG F, Abrahamsson J, Bobjer J
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/
Eur Urol. 2022;81:e18-e19.
Abstract Related articles

SHIGETA K, Matsumoto K, Oya M
Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial
Eur Urol. 2022;81:e20-e21.
Abstract Related articles

DEV S
Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80
Eur Urol. 2022;81:e25.
Abstract Related articles

CLEMENTS MB, Atkinson TM, Dalbagni GM, Li Y, et al
Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.
Eur Urol. 2022;81:294-304.
Abstract Related articles

LAUKHTINA E, Shariat SF
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer.
Eur Urol. 2022 Apr 30. pii: S0302-2838(22)01816.
Abstract Related articles

CONROY S, Nguyen AHT
Compound to Clinic? A Preclinical High-throughput Screening Pathway To Expedite Drug Discovery in Bladder Cancer.
Eur Urol. 2022 May 5. pii: S0302-2838(22)01811.
Abstract Related articles

HALL E, Hussain SA, Porta N, Lewis R, et al
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial.
Eur Urol. 2022 May 13. pii: S0302-2838(22)02265.
Abstract Related articles

RADZISZEWSKI P, Szablonski W
Re: Bladder Cancer in Patients Younger than 40 Years: Outcomes from the National Cancer Database de la Calle CM, Washington SL 3rd, Lonergan PE, et al World J Urol 2021;39:1911-6.
Eur Urol. 2022 May 19. pii: S0302-2838(22)01812.
Abstract Related articles

SOLANKI AA, Kates MR, Tran PT
Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001.
Eur Urol. 2022 May 28. pii: S0302-2838(22)02343.
Abstract Related articles

HANEY CM, Kriegmair MC, Michel MS, Stolzenburg JU, et al
New Evidence and Innovative Approaches to Blinding in Robot-assisted Radical Cystectomy.
Eur Urol. 2022;81:615-617.
Abstract Related articles

PEEKER R
Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Eur Urol. 2022;81:619-620.
Abstract Related articles

TAKAHASHI T
Re: Ekaterina Laukhtina, Shahrokh F. Shariat. Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.o
Eur Urol. 2022 Jul 1. pii: S0302-2838(22)02466.
Abstract Related articles

ADELEKE S, Tocco B, Kasivisvanathan V
Re: Chemoradiotherapy in Muscle-invasive Bladder Cancer (BC2001): 10-year Follow-up of a Phase 3 Randomised Controlled Trial.
Eur Urol. 2022 Jul 1. pii: S0302-2838(22)02470.
Abstract Related articles

SZABADOS B, Kockx M, Assaf ZJ, van Dam PJ, et al
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
Eur Urol. 2022;82:212-222.
Abstract Related articles

RAI BP, Luis Dominguez Escrig J, Vale L, Kuusk T, et al
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.
Eur Urol. 2022;82:182-192.
Abstract Related articles

CARVALHO FLF, Mossanen M, Van Allen EM, Mouw KW, et al
Reply to Yuxuan Song, Yiqing Du, and Tao Xu's Letter to the Editor re: Matthew Mossanen, Filipe L.F. Carvalho, Vinayak Muralidhar, et al. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. Eur Urol 2022;81:466-73.
Eur Urol. 2022 Aug 6. pii: S0302-2838(22)02534.
Abstract Related articles

CATTO JWF, Khetrapal P, Ambler G, Williams NR, et al
Reply to Andreas Skolarikos's Words of Wisdom re: Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical
Eur Urol. 2022 Aug 6. pii: S0302-2838(22)02535.
Abstract Related articles

SONG Y, Du Y, Xu T
Re: Matthew Mossanena, Filipe L.F. Carvalhoa, Vinayak Muralidhar, et al. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. Eur Urol 2022;81:466-73.
Eur Urol. 2022 Aug 5. pii: S0302-2838(22)02530.
Abstract Related articles

SKOLARIKOS A
Re: Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial.
Eur Urol. 2022 Aug 3. pii: S0302-2838(22)02525.
Abstract Related articles

DE RUITER BM, van Hattum JW, Lipman D, de Reijke TM, et al
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab +/- Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.
Eur Urol. 2022 Aug 3. pii: S0302-2838(22)02522.
Abstract Related articles

GIL-JIMENEZ A, van Dorp J, Contreras-Sanz A, van der Vos K, et al
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
Eur Urol. 2022 Aug 11. pii: S0302-2838(22)02538.
Abstract Related articles

NAKAUMA-GONZALEZ JA, Rijnders M, van de Werken HJG, Lolkema MPJ, et al
Reply to Yuxuan Song, Caipeng Qin, and Tao Xu's Letter to the Editor re: J. Alberto Nakauma-Gonzalez, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Car
Eur Urol. 2022;82:e78-e79.
Abstract Related articles

SONG Y, Qin C, Xu T
Re: J. Alberto Nakauma-Gonzalez, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6: Novel Insights into Evidence of Metas
Eur Urol. 2022;82:e76-e77.
Abstract Related articles

MEGHANI K, Cooley LF, Choy B, Kocherginsky M, et al
First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guerin.
Eur Urol. 2022 Aug 22. pii: S0302-2838(22)02553.
Abstract Related articles

TAN WS, Prendergast A, Ackerman C, Yogeswaran Y, et al
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
Eur Urol. 2022 Aug 20. pii: S0302-2838(22)02552.
Abstract Related articles

GHATALIA P, Plimack ER
Adding a Fourth Modality to Trimodal Therapy for Muscle-invasive Bladder Cancer.
Eur Urol. 2022 Sep 1. pii: S0302-2838(22)02584.
Abstract Related articles

KAVOUSSI M, Nasrallah AA, Williams SB
Re: Sequential Intravesical Gemcitabine and Docetaxel for Bacillus Calmette-Guerin-naive High-risk Nonmuscle-invasive Bladder Cancer.
Eur Urol. 2022 Sep 8. pii: S0302-2838(22)02615.
Abstract Related articles

SUAREZ-CABRERA C, Estudillo L, Ramon-Gil E, Martinez-Fernandez M, et al
BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.
Eur Urol. 2022 Sep 6. pii: S0302-2838(22)02562.
Abstract Related articles

MIRON B, Geynisman DM
Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma.
Eur Urol. 2022;82:374-376.
Abstract Related articles

SIEFKER-RADTKE AO, Cho DC, Diab A, Sznol M, et al
Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02.
Eur Urol. 2022;82:365-373.
Abstract Related articles

CATTO JWF, Khetrapal P, Ambler G, Williams NR, et al
Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy
Eur Urol. 2022 Sep 13. pii: S0302-2838(22)02627.
Abstract Related articles

TAYLOR J, Lotan Y
Is Office-based Management of Intermediate-risk Low-grade Non-muscle-invasive Bladder Cancer Ready For Prime Time?
Eur Urol. 2022 Sep 21. pii: S0302-2838(22)02629.
Abstract Related articles

HAYNE D, Redfern A
The Evolving Role of Locally Delivered Checkpoint Inhibitors in Non-muscle-invasive Bladder Cancer.
Eur Urol. 2022 Sep 21. pii: S0302-2838(22)02623.
Abstract Related articles

SRIDHAR SS, North SA, Blais N
Predictive Biomarkers in Muscle Invasive Bladder Cancer: Are We There Yet?
Eur Urol. 2022 Sep 22. pii: S0302-2838(22)02631.
Abstract Related articles

ROCCO B, Sighinolfi MC
Re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Ran
Eur Urol. 2022 Sep 22. pii: S0302-2838(22)02626.
Abstract Related articles

MERTENS LS, Meijer RP, Alfred Witjes J
Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy.
Eur Urol. 2022 Oct 3. pii: S0302-2838(22)02691.
Abstract Related articles

STRANDGAARD T, Lindskrog SV, Nordentoft I, Christensen E, et al
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guerin Failure in Patients with Non-muscle-invasive Bladder Cancer.
Eur Urol. 2022 Oct 6. pii: S0302-2838(22)02636.
Abstract Related articles

STENZL A
Re. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial.
Eur Urol. 2022 Oct 14. pii: S0302-2838(22)02706.
Abstract Related articles

XU P, Chen C, Chen B, Bi E, et al
Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre.
Eur Urol. 2022;82:543-550.
Abstract Related articles

LONATI C, Suardi N
Re: Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
Eur Urol. 2022;82:574.
Abstract Related articles

MONTIRONI R, Cimadamore A
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity.
Eur Urol. 2022;82:483-486.
Abstract Related articles

TAN WS, Kelly JD
Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-
Eur Urol. 2022 Oct 19. pii: S0302-2838(22)02719.
Abstract Related articles

ZLOTTA AR
Re: Management, Surveillance Patterns, and Costs Associated with Low-grade Papillary Stage Ta Non-muscle-invasive Bladder Cancer Among Older Adults, 2004-2013.
Eur Urol. 2022 Oct 19. pii: S0302-2838(22)02711.
Abstract Related articles

CAMPODONICO F, Mattioli F, Introini C
Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackermann, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Co
Eur Urol. 2022 Nov 10. pii: S0302-2838(22)02778.
Abstract Related articles

ZHAO Z, Guo H, Yang R
Re: Bernadett Szabados, Mark Kockx, Zoe June Assaf, et al. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder. Eur Urol 2022;82:212-22.
Eur Urol. 2022;82:e176.
Abstract Related articles

STEINBERG RL, O'Donnell MA, Packiam VT
Re: Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guerin. Eur Urol. 2022;82:602-10.
Eur Urol. 2022 Nov 17:S0302-2838(22)02781-6. doi: 10.1016/j.eururo.2022.
Abstract Related articles

SAHOO S, Pandey A, Mandal S, Kumar Das M, et al
Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Con
Eur Urol. 2022 Nov 17:S0302-2838(22)02783-X. doi: 10.1016/j.eururo.2022.
Abstract Related articles

TAN WS, Mustard C, Kelly JD
Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Pat
Eur Urol. 2022 Nov 28:S0302-2838(22)02793-2. doi: 10.1016/j.eururo.2022.
Abstract Related articles

GRIFFIN J
TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer.
Eur Urol. 2022 Nov 25:S0302-2838(22)02795-6. doi: 10.1016/j.eururo.2022.
Abstract Related articles

BABJUK M
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study.
Eur Urol. 2022 Nov 30:S0302-2838(22)02830-5. doi: 10.1016/j.eururo.2022.
Abstract Related articles

LIEDBERG F, Tragardh E
Re: Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017.
Eur Urol. 2022 Dec 8:S0302-2838(22)02842-1. doi: 10.1016/j.eururo.2022.
Abstract Related articles

SHI MJ, Fontugne J, Moreno-Vega A, Meng XY, et al
FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.
Eur Urol. 2023;83:70-81.
Abstract Related articles

VIGNANI F, Tambaro R, De Giorgi U, Giannatempo P, et al
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.
Eur Urol. 2023;83:82-89.
Abstract Related articles

EINERHAND SMH, van Dorp J, van der Heijden MS, van Rhijn BWG, et al
Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible Operable High-risk Urothelial Carcinoma.
Eur Urol. 2023;83:91-92.
Abstract Related articles

KARTOLO A, Robinson A, Vera Badillo FE
Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?
Eur Urol. 2023;83:1-2.
Abstract Related articles

DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies.
Int J Cancer. 2022 Feb 19. doi: 10.1002/ijc.33970.
Abstract Related articles

XIONG J, Yang L, Deng YQ, Yan SY, et al
The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study.
Int J Cancer. 2022 Jul 29. doi: 10.1002/ijc.34228.
Abstract Related articles

KIM B, Jung M, Moon KC, Han D, et al
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.
Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34265.
Abstract Related articles

TAKAHASHI T
Comments on "Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
Int J Cancer. 2022;151:1847-1848.
Abstract Related articles

EINERHAND SMH, van Dijk N, van der Heijden MS, van Rhijn BWG, et al
Reply to: Comments on "Neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
Int J Cancer. 2022;151:1849-1850.
Abstract Related articles

EINERHAND SMH, van Dijk N, van Dorp J, de Feijter JM, et al
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
Int J Cancer. 2022;151:2004-2011.
Abstract Related articles

HAYAKAWA N, Kikuchi E
Editorial Comment to Incidence and location of perioperative deep vein thrombosis in patients with bladder cancer undergoing radical cystectomy.
Int J Urol. 2021 Dec 28. doi: 10.1111/iju.14777.
Abstract Related articles

SHINDO T
Editorial Comment from Dr Shindo to Prognostication in Japanese patients with Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Int J Urol. 2022 Jan 4. doi: 10.1111/iju.14783.
Abstract Related articles

GRAVESTOCK P, Coulthard N, Veeratterapillay R, Heer R, et al
Response to Re: Systematic review and meta-analysis of narrow band imaging for non-muscle-invasive bladder cancer.
Int J Urol. 2022 Jan 1. doi: 10.1111/iju.14780.
Abstract Related articles

CHEN CS, Li JR, Yang CK, Cheng CL, et al
Significant predictors of contralateral upper tract recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
Int J Urol. 2022;29:69-75.
Abstract Related articles

KIJIMA T
Editorial Comment to Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
Int J Urol. 2022;29:91.
Abstract Related articles

TOMIYAMA E, Fujita K, Hashimoto M, Miyamoto H, et al
Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
Int J Urol. 2022;29:89-90.
Abstract Related articles

LEOW JJ, Yong DZ, Chia PL
Editorial Comment to Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
Int J Urol. 2022 Feb 10. doi: 10.1111/iju.14818.
Abstract Related articles

YANG T, Liang H, Pei X, Zhang N, et al
Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
Int J Urol. 2022 Feb 5. doi: 10.1111/iju.14808.
Abstract Related articles

TAOKA R, Sugimoto M
Editorial Comment to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
Int J Urol. 2022 Feb 15. doi: 10.1111/iju.14828.
Abstract Related articles

IQBAL U, Houenstein HA, Elsayed AS, Jing Z, et al
Ileal conduit versus neobladder: A propensity score-matched analysis of the effect on renal function.
Int J Urol. 2022;29:158-163.
Abstract Related articles

LIN MY, Niu SW, Li WM, Lee HL, et al
Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010).
Int J Urol. 2022;29:121-127.
Abstract Related articles

IDE H
Editorial Comment from Dr Ide to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
Int J Urol. 2022 Feb 25. doi: 10.1111/iju.14837.
Abstract Related articles

KOBAYASHI K, Matsuyama H, Kawai T, Ikeda A, et al
Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Int J Urol. 2022 Mar 15. doi: 10.1111/iju.14854.
Abstract Related articles

URABE F, Matsuzaki J, Ito K, Takamori H, et al
Serum microRNA as liquid biopsy biomarker for the prediction of oncological outcomes in patients with bladder cancer.
Int J Urol. 2022 Mar 14. doi: 10.1111/iju.14858.
Abstract Related articles

NASELLI A, Pirola GM
Editorial Comment from Dr Naselli and Dr Pirola to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Int J Urol. 2022 Mar 31. doi: 10.1111/iju.14883.
Abstract Related articles

TELLINI R, Mari A, Minervini A
Editorial Comment from Dr Tellini et al. to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Int J Urol. 2022 Apr 5. doi: 10.1111/iju.14895.
Abstract Related articles

HAYAKAWA N, Kikuchi E
Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Int J Urol. 2022 Apr 2. doi: 10.1111/iju.14888.
Abstract Related articles

MIYAKE M
Editorial Comment to Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.
Int J Urol. 2022;29:364-365.
Abstract Related articles

OZAKI K, Hatakeyama S, Hamaya T, Okita K, et al
Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.
Int J Urol. 2022;29:362-364.
Abstract Related articles

KANNO T, Kobori G, Ito K, Nakagawa H, et al
Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy.
Int J Urol. 2022;29:455-461.
Abstract Related articles

FUJITA N, Hatakeyama S, Momota M, Narita T, et al
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guerin therapy.
Int J Urol. 2022 May 16. doi: 10.1111/iju.14926.
Abstract Related articles

WANG Z, So WZ, Loh KY, Lim YK, et al
Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer.
Int J Urol. 2022 May 22. doi: 10.1111/iju.14921.
Abstract Related articles

MIYAKE M, Kikuchi E, Shinozaki K, Piao Y, et al
Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guerin treatment.
Int J Urol. 2022 May 21. doi: 10.1111/iju.14933.
Abstract Related articles

HIRATA Y, Higuchi M, Osawa T, Hinotsu S, et al
Late recurrence in patients with non-muscle-invasive bladder cancer after 5-year cancer-free periods.
Int J Urol. 2022 May 21. doi: 10.1111/iju.14936.
Abstract Related articles

ZENNAMI K, Sumitomo M, Hasegawa K, Kozako M, et al
Risk factors for postoperative ileus after robot-assisted radical cystectomy with intracorporeal urinary diversion.
Int J Urol. 2022;29:553-558.
Abstract Related articles

TAOKA R, Sugimoto M
Editorial Comment from Dr Taoka and Dr Sugimoto to Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guerin treatment.
Int J Urol. 2022 Jun 11. doi: 10.1111/iju.14954.
Abstract Related articles

MATSUMOTO K
Editorial Comment from Dr Matsumoto to Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guerin treatment.
Int J Urol. 2022 Jun 9. doi: 10.1111/iju.14955.
Abstract Related articles

ARAI T, Sazuka T, Sato H, Imamura Y, et al
Efficacy of photodynamic diagnosis-assisted transurethral resection of bladder tumor for T1 bladder cancer: Novel second transurethral resection initiatives utilizing photodynamic diagnosis.
Int J Urol. 2022 Jun 20. doi: 10.1111/iju.14962.
Abstract Related articles

NOHARA T
Editorial Comment to Late recurrence in patients with non-muscle-invasive bladder cancer after 5-year cancer-free periods.
Int J Urol. 2022 Jun 19. doi: 10.1111/iju.14967.
Abstract Related articles

TANAKA T, Shindo T, Hashimoto K, Kobayashi K, et al
Management of hydronephrosis after radical cystectomy and urinary diversion for bladder cancer: A single tertiary center experience.
Int J Urol. 2022 Jun 30. doi: 10.1111/iju.14970.
Abstract Related articles

ISHIYAMA Y
Editorial Comment to Impact of early postoperative creatinine increase on mid-term renal function after cystectomy.
Int J Urol. 2022;29:724.
Abstract Related articles

MASTROIANNI R, Simone G
Editorial Comment to Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy.
Int J Urol. 2022;29:684.
Abstract Related articles

SARI MOTLAGH R, Schuettfort VM, Mori K, Katayama S, et al
Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy.
Int J Urol. 2022;29:676-683.
Abstract Related articles

TOGASHI K, Hatakeyama S, Yoneyama T, Hamaya T, et al
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Int J Urol. 2022;29:733-739.
Abstract Related articles

KITA Y, Ito K, Sano T, Hashimoto K, et al
Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era.
Int J Urol. 2022;29:647-655.
Abstract Related articles

IDE H
Editorial Comment from Dr Ide to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle-invasive bladder cancer.
Int J Urol. 2022 Jul 20. doi: 10.1111/iju.14988.
Abstract Related articles

NASELLI A, Pirola GM
Editorial Comment from Dr Naselli and Dr Pirola to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle-invasive bladder cancer.
Int J Urol. 2022 Jul 20. doi: 10.1111/iju.15000.
Abstract Related articles

TOCHIGI K, Nagayama J, Bando S, Ishiyama A, et al
Relationship between the number of lymph nodes dissected and prognosis in muscle-invasive bladder cancer in the era of neoadjuvant chemotherapy.
Int J Urol. 2022 Jul 20. doi: 10.1111/iju.14974.
Abstract Related articles

MURAKAMI Y, Matsumoto K, Miyake M, Amano N, et al
Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle-invasive bladder cancer.
Int J Urol. 2022 Jul 20. doi: 10.1111/iju.14976.
Abstract Related articles

LEOW JJ, Chen K, Yuen JSP
Editorial Comment to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle invasive bladder cancer.
Int J Urol. 2022 Sep 12. doi: 10.1111/iju.15037.
Abstract Related articles

SHINDO T, Maehana T, Tanaka T, Hashimoto K, et al
Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study.
Int J Urol. 2022 Jun 2. doi: 10.1111/iju.14941.
Abstract Related articles

LEE AY, Allen JC Jr, Teoh JY, Kang SH, et al
Predicting perioperative outcomes of robot-assisted radical cystectomy: Data from the Asian Robot-Assisted Radical Cystectomy Consortium.
Int J Urol. 2022 May 25. doi: 10.1111/iju.14937.
Abstract Related articles

KOGA F
Editorial Comment to Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy: Multicenter KORARC database study.
Int J Urol. 2022 Feb 20. doi: 10.1111/iju.14832.
Abstract Related articles

KIM H, Jeong BC, Lee S, Ku JH, et al
Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy: Multicenter KORARC database study.
Int J Urol. 2022 Feb 8. doi: 10.1111/iju.14815.
Abstract Related articles

YAMAMOTO A, Kawashima A, Uemura T, Yamamichi G, et al
Anticancer maintenance chemotherapy prolonged prognosis of metastatic urothelial carcinoma patients: A single institute retrospective study using propensity score matching.
Int J Urol. 2022;29:1294-1303.
Abstract Related articles

NISHIKAWA R, Miyake M, Morizane S, Shimizu R, et al
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guerin therapy: A Japan Urological Oncology Group study analysis.
Int J Urol. 2022 Nov 30. doi: 10.1111/iju.15106.
Abstract Related articles

TAGUCHI S, Kawai T, Nakagawa T, Miyakawa J, et al
Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).
Int J Urol. 2022;29:1462-1469.
Abstract Related articles

GHOREIFI A, Basin MF, Ghodoussipour S, Bazargani ST, et al
Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol.
Int Urol Nephrol. 2021;53:1827-1833.
Abstract Related articles

PARAJULI P, Luitel BR, Pradhan MM, Chapagain S, et al
Clinicopathological patterns of bladder carcinoma over 1 year: experience from University Hospital of Nepal.
Int Urol Nephrol. 2021;53:2289-2294.
Abstract Related articles

YORULMAZ EM, Yilmaz Y, Kose O, Akin Y, et al
Investigation of the causes of BCG refractory in patients treated with intracavitary BCG as secondary treatment in superficial bladder tumors with transurethral resection.
Int Urol Nephrol. 2022;54:533-540.
Abstract Related articles

REHME C, Fritsch B, Thomas L, Istin S, et al
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
Int Urol Nephrol. 2022;54:71-79.
Abstract Related articles

ZHAO X, Wang Y, Liang C
Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis.
Int Urol Nephrol. 2022 Mar 25. pii: 10.1007/s11255-022-03173.
Abstract Related articles

KAWADA T
Serum irisin concentration in patients with bladder cancer.
Int Urol Nephrol. 2022 Apr 1. pii: 10.1007/s11255-022-03199.
Abstract Related articles

CHIERIGO F, Borghesi M, Wurnschimmel C, Flammia RS, et al
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
Int Urol Nephrol. 2022 May 4. pii: 10.1007/s11255-022-03221.
Abstract Related articles

TAKEN K, Aslan R, Eryilmaz R, Alp HH, et al
Response to Letter to the Editor 'Serum irisin concentration in patients with bladder cancer'.
Int Urol Nephrol. 2022;54:1247-1248.
Abstract Related articles

ZHUANG W, Xie H, Yu S, Li Y, et al
Effects of treatments on gender differences in patients with localized muscle-invasive bladder cancer.
Int Urol Nephrol. 2022 May 24. pii: 10.1007/s11255-022-03200.
Abstract Related articles

HE W, Yang J, Gao M, Liu H, et al
Pelvic reconstruction and lateral prostate capsule sparing techniques improve early continence of robot-assisted radical cystectomy with orthotopic ileal neobladder.
Int Urol Nephrol. 2022;54:1537-1543.
Abstract Related articles

BASOURAKOS SP, Al Hussein Al Awamlh B, Borregales LD, Abrahimi P, et al
A comparative population-based analysis of peritoneal carcinomatosis in patients undergoing robotic-assisted and open radical cystectomy.
Int Urol Nephrol. 2022;54:1513-1519.
Abstract Related articles

ZHU J, Lu Z, Ke M, Cai X, et al
Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
Int Urol Nephrol. 2022;54:1505-1512.
Abstract Related articles

JAFFER A, Lee M, Khalil O, Raslan M, et al
The natural history of low-risk non-muscle-invasive bladder cancer: a collaborative multi-centre study.
Int Urol Nephrol. 2022 Jun 27. pii: 10.1007/s11255-022-03264.
Abstract Related articles

SAINI S, Pathak RA, Hemal AK
Robotic nephroureterectomy in the management of upper tract urothelial cancer: inching toward standard of care?
Int Urol Nephrol. 2022;54:1777-1785.
Abstract Related articles

REIS LO, Salustiano ACC, Capibaribe DM, Kiehl IGA, et al
Castration immunoregulates toll-like receptor-4 in male bladder cancer.
Int Urol Nephrol. 2022 Aug 8. pii: 10.1007/s11255-022-03336.
Abstract Related articles

XIAO S, Zhan X, Chen T, Wu J, et al
Prognostic values of distal ureter involvement and survival outcomes in bladder cancer at T1 and T2 stages: a propensity score matching study.
Int Urol Nephrol. 2022 Aug 13. pii: 10.1007/s11255-022-03260.
Abstract Related articles

CHAKRA MA, Azoulai D, Moussa M, Ismail K, et al
The prognostic role of pre-cystectomy thrombocytosis in invasive bladder cancer.
Int Urol Nephrol. 2022 Aug 25. pii: 10.1007/s11255-022-03346.
Abstract Related articles

VAN GINKEL N, Hermans TJN, Meijer D, Boormans JL, et al
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study.
Int Urol Nephrol. 2022 Aug 23. pii: 10.1007/s11255-022-03339.
Abstract Related articles

CATARINO R, Alves L, Pereira D, Costa G, et al
Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?
Int Urol Nephrol. 2022 Sep 5. pii: 10.1007/s11255-022-03358.
Abstract Related articles

DEVLIN CM, Molokwu CN, Wood B, Yuen KK, et al
Routine urethroscopic surveillance is of limited value after radical cystectomy: a single centre retrospective cohort analysis.
Int Urol Nephrol. 2022;54:3139-3144.
Abstract Related articles

LIU J, Ma C, Li X, Li A, et al
Circulating tumor cells correlating with Ki-67 predicts the prognosis of bladder cancer patients.
Int Urol Nephrol. 2022 Nov 5. pii: 10.1007/s11255-022-03406.
Abstract Related articles

YAZICI G, Gokmen E, Kose MG, Cetin B, et al
The use of natural killer cell activity and PPD test in the prediction of results in intravesical BCG treatment of patients with nonmuscle-invasive bladder cancer.
Int Urol Nephrol. 2022 Nov 22. doi: 10.1007/s11255-022-03414.
Abstract Related articles

FUNT SA, Lattanzi M, Whiting K, Al-Ahmadie H, et al
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
J Clin Oncol. 2022 Jan 28:JCO2101485. doi: 10.1200/JCO.21.01485.
Abstract Related articles

PFISTER C, Gravis G, Flechon A, Chevreau C, et al
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.
J Clin Oncol. 2022 Mar 7:JCO2102051. doi: 10.1200/JCO.21.02051.
Abstract Related articles

SONPAVDE GP, Mouw KW, Mossanen M
Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas.
J Clin Oncol. 2022;40:1275-1280.
Abstract Related articles

OWENS-WALTON J, Williams C, Rompre-Brodeur A, Pinto PA, et al
Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.
J Clin Oncol. 2022;40:1583-1589.
Abstract Related articles

ZENG S, Zhang Z, Xu C
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as the Gold Standard Neoadjuvant Chemotherapy Regimen for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer Remains Controversial.
J Clin Oncol. 2022 Jun 15:JCO2200669. doi: 10.1200/JCO.22.00669.
Abstract Related articles

GRIMM MO, Schmitz-Drager BJ, Zimmermann U, Grun CB, et al
Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma.
J Clin Oncol. 2022;40:2128-2137.
Abstract Related articles

ZHANG S
Neoadjuvant Programmed Cell Death Protein 1 and Chemotherapy in Combination in Muscle-Invasive Urothelial Cancer: Promising, But Not Deserving to Try Further.
J Clin Oncol. 2022;40:2656.
Abstract Related articles

LINDGREN MS, Hansen E, Azawi N, Nielsen AM, et al
DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.
J Clin Oncol. 2022 Oct 12:JCO2200470. doi: 10.1200/JCO.22.00470.
Abstract Related articles

KIM SH, Lerner SP
Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors.
J Clin Oncol. 2022 Nov 30:JCO2202104. doi: 10.1200/JCO.22.02104.
Abstract Related articles

KHALEEL S, Regmi S, Hannah P, Watarai B, et al
Impact of Preoperative Immunonutrition on Perioperative Outcomes Following Cystectomy. Reply.
J Urol. 2021;206:1531-1532.
Abstract Related articles

ALSYOUF M, Djaladat H
Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy. Letter.
J Urol. 2021;206:1530-1531.
Abstract Related articles

MONAGHAN TF, Wagg AS, Rahman SN, Winer AG, et al
Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy. Letter.
J Urol. 2022;207:237-238.
Abstract Related articles

CHESNUT GT, Goh AC
Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy. Reply.
J Urol. 2022;207:238-239.
Abstract Related articles

GOLD SA, Kenigsberg AP, Lotan Y
Diagnostic and Cost Implications of the 2020 AUA Microhematuria Guidelines: Modeling Impact in a Large Public Health Care System.
J Urol. 2022;207:52-60.
Abstract Related articles

RAMAN JD, Kavalieris L, Konety B, Porten S, et al
The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma.
J Urol. 2021;206:1380-1389.
Abstract Related articles

YANKELEVICH GR, Dreher PC, Taylor Z, Kim D, et al
Socio-Environmental Conditions Associated with Geospatial Clusters of Urothelial Carcinoma: A Multi-Institutional Analysis.
J Urol. 2021;206:1390-1402.
Abstract Related articles

FURBERG H, Petruzella S, Whiting K, Stein E, et al
Association of Biochemically Verified Post-diagnosis Smoking and Non-muscle Invasive Bladder Cancer Recurrence Risk.
J Urol. 2022 Jan 27:101097JU0000000000002449. doi: 10.1097/JU.0000000000002449.
Abstract Related articles

MITRA AP, Cai J, Miranda G, Bhanvadia S, et al
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases.
J Urol. 2022;207:302-313.
Abstract Related articles

MIEST T, Khanna A, Sharma V, Hensley PJ, et al
Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.
J Urol. 2022;207:284-292.
Abstract Related articles

SONG Y, Du Y, Qin C, Xu T, et al
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. Letter.
J Urol. 2022;207:937.
Abstract Related articles

GESSNER KH, Siemens DR, Bjurlin MA
Does Smoking Cessation Reduce Bladder Cancer Recurrence?
J Urol. 2022 Mar 15:101097JU0000000000002649. doi: 10.1097/JU.0000000000002649.
Abstract Related articles

YANAGISAWA T, Mori K, Motlagh RS, Kawada T, et al
En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.
J Urol. 2022;207:754-768.
Abstract Related articles

MATIN SF, Pierorazio PM, Kleinmann N, Gore JL, et al
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
J Urol. 2022;207:779-788.
Abstract Related articles

RICHTER LA, Osazuwa-Peters OL, Routh JC, Handa VL, et al
Vaginal Complications after Cystectomy: Results from a Medicare Sample.
J Urol. 2022;207:789-796.
Abstract Related articles

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
J Urol. 2022;207:1166.
Abstract Related articles

MASTROIANNI R, Ferriero M, Tuderti G, Anceschi U, et al
Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial.
J Urol. 2022;207:982-992.
Abstract Related articles

ROSEN GH, Nallani A, Muzzey C, Murray KS, et al
Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience.
J Urol. 2022;207:1302-1311.
Abstract Related articles

KATES M, Mansour AM, Lamm DL, Shore N, et al
Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Non-muscle Invasive Bladder Cancer.
J Urol. 2022 May 16:101097JU0000000000002778. doi: 10.1097/JU.0000000000002778.
Abstract Related articles

HUELSTER HL, Sexton WJ
Real-World Outcomes Driving the Needle toward Simplification of Nonmuscle Invasive Bladder Cancer Risk Stratification.
J Urol. 2022 May 2:101097JU0000000000002731. doi: 10.1097/JU.0000000000002731.
Abstract Related articles

STOVER AM, Basak R, Mueller D, Lipman R, et al
Minimal Patient-Reported Side Effects for a Chemoablative Gel (UGN-102) Used as Frontline Treatment in Adults with Non-Muscle-Invasive Bladder Cancer.
J Urol. 2022 May 31:101097JU0000000000002747. doi: 10.1097/JU.0000000000002747.
Abstract Related articles

SONG Y, Du Y, Qin C, Bai F, et al
Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Letter.
J Urol. 2022;208:222-223.
Abstract Related articles

GESSNER KH, Siemens DR, Bjurlin MA
Re: Does Smoking Cessation Reduce Bladder Cancer Recurrence?
J Urol. 2022 Jun 21:101097JU0000000000002832. doi: 10.1097/JU.0000000000002832.
Abstract Related articles

MCELREE IM, Packiam VT, Steinberg RL, Mott SL, et al
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment OF NON-MUSCLE Invasive Bladder Cancer.
J Urol. 2022 Jul 5:101097JU0000000000002848. doi: 10.1097/JU.0000000000002848.
Abstract Related articles

BREE KK, Hensley PJ, Lobo N, Brooks NA, et al
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guerin Response in High-Grade Ta Tumors.
J Urol. 2022;208:284-291.
Abstract Related articles

HAKIMI K, Carbonara U, Djaladat H, Mehrazin R, et al
Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry.
J Urol. 2022;208:268-276.
Abstract Related articles

MCELREE IM, Steinberg RL, Martin AC, Richards J, et al
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guerin-Naive High-Risk Nonmuscle-Invasive Bladder Cancer.
J Urol. 2022 Jul 27:101097JU0000000000002740. doi: 10.1097/JU.0000000000002740.
Abstract Related articles

MEEKS JJ, Sexton WJ, Clark PE
Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guerin.
J Urol. 2022;208:526-527.
Abstract Related articles

TERRITO A, Gallioli A, Diana P, Boissier R, et al
DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial.
J Urol. 2022;208:570-579.
Abstract Related articles

NAZMIFAR M, Williams C, Naser-Tavakolian A, Heard J, et al
Clinical and Preclinical Therapies for Bladder Cancer Following BCG Failure.
J Urol. 2022 Sep 6:101097JU0000000000002957. doi: 10.1097/JU.0000000000002957.
Abstract Related articles

PARISSE T, Reines K, Basak R, Mueller D, et al
Patient and Provider Perception of Transurethral Resection of Bladder Tumor vs. Chemoablation for Non-Muscle Invasive Bladder Cancer Treatment.
J Urol. 2022 Sep 6:101097JU0000000000002941. doi: 10.1097/JU.0000000000002941.
Abstract Related articles

NOGUEIRA LM, Yip W, Assel MJ, Tracey AT, et al
Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma.
J Urol. 2022;208:813-820.
Abstract Related articles

MATULEWICZ RS, Whiting K, Bochner BH, Ostroff JS, et al
Knowledge of bladder cancer risk factors among patients diagnosed with non-muscle invasive bladder cancer.
J Urol. 2022 Oct 4:101097JU0000000000002978. doi: 10.1097/JU.0000000000002978.
Abstract Related articles

BREE KK, Kokorovic A, Westerman ME, Hensley PJ, et al
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.
J Urol. 2022 Oct 11:101097JU0000000000003015. doi: 10.1097/JU.0000000000003015.
Abstract Related articles

LEE HW, Lee HH, Park EY, Park WS, et al
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately before Transurethral Resection of Bladder Tumor in Patients with Non-muscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
J Urol. 2022 Oct 12:101097JU0000000000003002. doi: 10.1097/JU.0000000000003002.
Abstract Related articles

KOMURA K, Inamoto T, Tsujino T, Matsui Y, et al
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
Oncogene. 2021;40:6210-6222.
Abstract Related articles

BAKER SC, Mason AS, Slip RG, Skinner KT, et al
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02235.
Abstract Related articles

ZHENG X, Liu Z, Zhong J, Zhou L, et al
Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer.
Oncogene. 2022 Jun 6. pii: 10.1038/s41388-022-02371.
Abstract Related articles

LIU F, Zhang H, Xie F, Tao D, et al
Correction: Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.
Oncogene. 2022 Jul 7. pii: 10.1038/s41388-022-02358.
Abstract Related articles

LIU W, Shen D, Ju L, Zhang R, et al
MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.
Oncogene. 2022 Sep 7. pii: 10.1038/s41388-022-02456.
Abstract Related articles

XIAO H, Li H, Yu G, Xiao W, et al
[Corrigendum] MicroRNA10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
Oncol Rep. 2022;48.
Abstract Related articles

NAKAI Y, Tatsumi Y, Hori S, Morizawa Y, et al
5Aminolevurinic acid inhibits the proliferation of bladder cancer cells by activating heme synthesis.
Oncol Rep. 2022;48.
Abstract Related articles

WU D, Niu X, Tao J, Li P, et al
[Corrigendum] MicroRNA3795p plays a tumorsuppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
Oncol Rep. 2022;48.
Abstract Related articles

ZHAO Y, Ren P, Yang Z, Wang L, et al
Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis.
Oncol Rep. 2023;49:16.
Abstract Related articles

MESSAOUD M, Vercherin P, Chaneliere AF, Mottet N, et al
[Geriatric assessment and treatment of nonmetastatic muscle-invasive bladder cancer in patients over 75 years of age. Retrospective and multicentric study of 121 cases].
Prog Urol. 2022 Jan 5. pii: S1166-7087(21)00582.
Abstract Related articles

SOOROJEBALLY Y, Surlemont L, Neuzillet Y, Lebret T, et al
Impact of carcinoma in situ on survival of patients treated by adjuvant chemotherapy after cystectomy.
Prog Urol. 2022;32:53-60.
Abstract Related articles

LEON P, Saint F, Audenet F, Roumiguie M, et al
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
Prog Urol. 2022 Feb 9. pii: S1166-7087(22)00011.
Abstract Related articles

AUDENET F, Sotto A, Roumiguie M, Allory Y, et al
[Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].
Prog Urol. 2022;32:165-176.
Abstract Related articles

ROLLIN P, Xylinas E, Lanz C, Audenet F, et al
[Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
Prog Urol. 2022;32:326-331.
Abstract Related articles

DOBE TR, Belhadj Y, Michel C, Djouadou M, et al
Perioperative results of radical cystectomy after neoadjuvant chemotherapy according to the implementation of ERAS pathway.
Prog Urol. 2022;32:401-409.
Abstract Related articles

EL AZAB A, Hossam E, Abdelrahman I, Aboulkassem H, et al
Variables affecting quality of life after Radical cystectomy and neobladder substitution: Egyptian National Cancer Institute experience.
Prog Urol. 2022;32:410-418.
Abstract Related articles

NEUZILLET Y, Audenet F, Loriot Y, Allory Y, et al
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC).
Prog Urol. 2022;32:1141-1163.
Abstract Related articles

NEUZILLET Y, Pradere B, Xylinas E, Allory Y, et al
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC).
Prog Urol. 2022;32:1102-1140.
Abstract Related articles

WEINHOLD P, Jokisch F, Schulz GB, Buchner A, et al
Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder Cancer: What You See Is Not Always What You Got.
Urol Int. 2022 Feb 3:1-10. doi: 10.1159/000521857.
Abstract Related articles

VOLZ Y, Pfitzinger PL, Eismann L, Ebner B, et al
Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
Urol Int. 2022 Feb 8:1-8. doi: 10.1159/000521829.
Abstract Related articles

KAMECKI H, Debowska M, Nyk L, Przewor A, et al
The Clinical Features of Incidentally Diagnosed Urothelial Bladder Cancer: A Retrospective Data Analysis.
Urol Int. 2022 Feb 11:1-8. doi: 10.1159/000521684.
Abstract Related articles

LANNES F, Walz J, Maubon T, Rybikowski S, et al
Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
Urol Int. 2022;106:171-179.
Abstract Related articles

SHAO G, Xu C, Liu J, Li X, et al
Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
Urol Int. 2022;106:199-208.
Abstract Related articles

LIU Z, Zhang P, Wang H, Zheng B, et al
Raman Spectrum-Based Diagnosis Strategy for Bladder Tumor.
Urol Int. 2022;106:109-115.
Abstract Related articles

CHEN H, Wang M, Weng T, Wei Y, et al
Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
Urol Int. 2022;106:186-194.
Abstract Related articles

ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
Complication Rate after Radical Cystectomy Depends on the Surgical Technique and Patient's Clinical Status.
Urol Int. 2022;106:163-170.
Abstract Related articles

LEE J, Suh J, Jeong CW, Kwak C, et al
Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.
Urol Int. 2022;106:138-146.
Abstract Related articles

GROBET-JEANDIN E, Wirth GJ, Benamran D, Dupont A, et al
Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
Urol Int. 2022;106:130-137.
Abstract Related articles

GRAFFEILLE V, Verhoest G, Gryn A, Kammerer-Jacquet SF, et al
Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
Urol Int. 2022;106:122-129.
Abstract Related articles

PAREEK T, Parmar K, Sharma AP, Kumar S, et al
Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study.
Urol Int. 2022 Jun 2:1-7. doi: 10.1159/000524098.
Abstract Related articles

STOKKEL LE, van de Kamp MW, Schaake EE, Boellaard TN, et al
Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer.
Urol Int. 2022;106:840-847.
Abstract Related articles

NIENTIEDT M, Waldbillig F, Stroop F, Nuhn P, et al
Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section.
Urol Int. 2022;106:816-824.
Abstract Related articles

DREGER NM, Lohbeck A, Roth S, Godde D, et al
Effectiveness and Safety of a Modified Technique of Transvesical Obturator Nerve Block to Avoid Adductor Contractions during Transurethral Resection of Bladder Tumors.
Urol Int. 2022;106:775-783.
Abstract Related articles

SCHNEIDEWIND L, Torabi L, Drager DL, Hakenberg OW, et al
Reduction of Perioperative Antibiotic Prophylaxis in Open Radical Cystectomy with Ileal Conduit Is Feasible: Results of a Prospective Clinical Trial.
Urol Int. 2022;106:825-831.
Abstract Related articles

CILESIZ NC, Ozkan A, Kalkanli A, Gezmis CT, et al
Spinal Anesthesia Provides Longer Administration Time for Postoperative Intravesical Chemotherapy after TUR-B Operation.
Urol Int. 2022;106:768-774.
Abstract Related articles

LEE MS, Shen M, Williams A, Kendrick D, et al
Retroureteral Small Bowel Herniation Resulting in Bowel Obstruction Following Robotic Cystectomy With Extracorporeal Ileal Conduit.
Urology. 2021;147:3-6.
Abstract Related articles

DALIMOV Z, Iqbal U, Jing Z, Wiklund P, et al
Intracorporeal Versus Extracorporeal Neobladder After Robot-assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium.
Urology. 2022;159:127-132.
Abstract Related articles

HINATA N, Hussein AA, Bando Y, Terakawa T, et al
Histologic Investigation of the Female Vesicourethral Junction and Adjacent Tissues for Nerve-sparing Radical Cystectomy.
Urology. 2021;149:161-167.
Abstract Related articles

ELSAYED AS, Ozair S, Iqbal U, Mostowy M, et al
Prevalence and Predictors of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
Urology. 2021;149:146-153.
Abstract Related articles

ALDHAAM NA, Elsayed AS, Hussein AA, Siam A, et al
Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-assisted Radical Cystectomy: A Matched Analysis.
Urology. 2021;147:155-161.
Abstract Related articles

AVULOVA S, Wittmann D
Optimizing Women's Sexual Function and Sexual Experience After Radical Cystectomy.
Urology. 2021;151:138-144.
Abstract Related articles

SMITH AL, Weissbart SJ
Gynecologic Considerations for the Urologic Surgeon.
Urology. 2021;150:116-124.
Abstract Related articles

CRUZ AP, Chelluri R, Ramchandani P, Guzzo TJ, et al
Post-cystectomy Enterocele: A Case Series and Review of the Literature.
Urology. 2021;150:180-187.
Abstract Related articles

KIM AH, Ruel NH, Yamzon J, Zhumkhawala AA, et al
Novel Antibiotic-Irrigating Wound Protector Reduces Infectious Complications in Robot-Assisted Radical Cystectomy with Extracorporeal Urinary Diversion.
Urology. 2022;159:160-166.
Abstract Related articles

STANGL-KREMSER J, Ahmadi H, Derstine B, Wang SC, et al
Psoas Muscle Mass can Predict Postsurgical Outcomes in Patients Who Undergo Radical Cystectomy and Urinary Diversion Reconstruction.
Urology. 2021;158:142-149.
Abstract Related articles

LOH-DOYLE JC, Bhanvadia SK, Han J, Ghodoussipour S, et al
Patient Reported Sexual Function Outcomes in Male Patients Following Open Radical Cystoprostatectomy and Urinary Diversion.
Urology. 2021;157:161-167.
Abstract Related articles

WESTERMAN ME, Bree KK, Kokorovic A, Frank J, et al
What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs.
Urology. 2021;157:181-187.
Abstract Related articles

MURTHY PB, Lone Z, Munoz Lopez C, Ericson JZK, et al
Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion.
Urology. 2021;154:184-190.
Abstract Related articles

KLEIN GT, Ajay D, Volk RJ, Leal V, et al
Living With Urinary Diversions: Patient Insights to Improve the Perioperative Experience.
Urology. 2021;152:190-194.
Abstract Related articles

KERN SQ, Speir RW, Tong Y, Kaimakliotis H, et al
Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder.
Urology. 2021;152:184-189.
Abstract Related articles

KNORR JM, Ericson KJ, Zhang JH, Murthy P, et al
Comparison of Major Complications at 30 and 90 Days Following Radical Cystectomy.
Urology. 2021;148:192-197.
Abstract Related articles

GUL ZG, Liaw CW, Mehrazin R
Gender Differences in Incidence, Diagnosis, Treatments, and Outcomes in Clinically Localized Bladder and Renal Cancer.
Urology. 2021;151:176-181.
Abstract Related articles

YANG H, Zhang Z, Zhao K, Zhang Y, et al
Extraperitoneal Laparoscopic Radical Cystectomy With Preservation of Fertility for the Treatment of Ewing Sarcoma: The First Report of a Reliable Surgical Method.
Urology. 2022;159:241-246.
Abstract Related articles

VASSANTACHART A, Daneshmand S, Cai J, Miranda G, et al
Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation.
Urology. 2021;148:198-202.
Abstract Related articles

GHOREIFI A, Djaladat H
Re: Vejlgaard M, Maibom SL, Stroomberg HV, et al. Long-term Renal Function following Radical Cystectomy for Bladder Cancer. Urology. 2021;S0090-4295(21)01083-9. doi:10.1016/j.urology.2021.11.015.
Urology. 2022 Feb 25. pii: S0090-4295(22)00146.
Abstract Related articles

CROGHAN SM, Daniels AE, Kelly C, Fitzgibbon L, et al
The Pull-through Anastomosis of Ureter to Enteric Conduit (PAUTEC): A Novel Technique for Urinary Diversion.
Urology. 2021;157:263-268.
Abstract Related articles

PACCHETTI A, Pignot G, Le Quellec A, Rybikowski S, et al
Sexual-Sparing Robot Assisted Radical Cystectomy in Female: A Step-By-Step Guide.
Urology. 2021;156:322-323.
Abstract Related articles

CHANDORA A, Lovin JM, Smith EA
Inflammatory Myofibroblastic Tumor Presenting as Gross Hematuria in a Pediatric Patient With VACTERL Syndrome Following Bladder Augmentation.
Urology. 2021;154:268-270.
Abstract Related articles

TRAN THT, Melamed J, Deng FM
Gastric Adenocarcinoma Arising in Gastrocystoplasty.
Urology. 2021;148:270-273.
Abstract Related articles

VEJLGAARD M, Andreas Roder M
Reply to Djaladat H and Ghoreifi A's Letter-to-the-Editor Re: Vejlgaard M, Maibom SL, Stroomberg HV, et al. Long-term Renal Function Following Radical Cystectomy for Bladder Cancer. Urology. 2021;S0090-4295(21)01083-9. doi:10.1016/j.urology.2021.11.01
Urology. 2022 Mar 6. pii: S0090-4295(22)00147.
Abstract Related articles

DOUGLAWI A, Ghoreifi A, Lee R, Yip W, et al
Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective?
Urology. 2022;160:142-146.
Abstract Related articles

KUMARASEGARAM V, Drejer D, Jensen JB
Detection Rate of Carcinoma In Situ During TURBT Following Shift from Photodynamic Diagnosis to Narrow Band Imaging in a Single University Hospital.
Urology. 2022;161:83-86.
Abstract Related articles

IPLIKCI A, Cakici MC, Simsek BC, Yildirim A, et al
Lip Metastasis After Radical Cystectomy.
Urology. 2022;161:17-18.
Abstract Related articles

SCHLOMER BJ, Norris N, Gurram B, Carpinito G, et al
Bladder Necrosis at Time of Presentation with Ulcerative Colitis in an 8-year-old Female: A Case Report.
Urology. 2022;160:195-198.
Abstract Related articles

KNORR JM, Campbell RA, Cockrum J, Dalton JE, et al
Neighborhood Socioeconomic Disadvantage Associated With Increased 90-Day Mortality Following Radical Cystectomy.
Urology. 2022;163:177-184.
Abstract Related articles

INOUE T, Miyake M, Nishimura N, Onozawa M, et al
Association of increased age with decreased response to intravesical instillation of Bacille Calmette-Guerin in patients with high-risk non-muscle invasive bladder cancer: Retrospective multi-institute results from the Japanese Urological Oncology Res
Urology. 2022 Jun 11. pii: S0090-4295(22)00455.
Abstract Related articles

LABBATE CV, Kuchta K, Park S, Agarwal PK, et al
Incidence of Preoperative Antibiotic Use and Its Association with Postoperative Infectious Complications after Radical Cystectomy.
Urology. 2022;164:169-177.
Abstract Related articles

CHEN J, Cai D, Gong K, Zhu S, et al
Collecting Duct Carcinoma of the Kidney: Analysis of 74 Cases From Multiple Centers.
Urology. 2022;164:163-168.
Abstract Related articles

ANDERSON AL, Tollefson MK, Frank I, Peffley ND, et al
Intraoperative Ventilatory Pressures During Robotic Assisted vs Open Radical Cystectomy.
Urology. 2022;164:157-162.
Abstract Related articles

NODIT PG, Bienvenu JM
Rhabdomyosarcoma of the Urinary Bladder Occurring in an Adult.
Urology. 2022;164:306-307.
Abstract Related articles

BENIDIR T, Lone Z, Zhang A, Nowacki AS, et al
Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer when treated by Radical Cystectomy With or Without Neoadjuvant Chemotherapy.
Urology. 2022 Jun 27. pii: S0090-4295(22)00514.
Abstract Related articles

ISCAIFE A, Ribeiro Filho LA, Aparecido Pereira MW, Gallucci FP, et al
Holmium Laser Resection of Large Bladder Tumors: Technique Description, Feasibility, and Histopathological Quality Analysis.
Urology. 2022;165:373.
Abstract Related articles

ALSYOUF M, Daneshmand S
Re: Detection Rate of CIS During TURBT Following Shift From PDD to NBI in a Single University Hospital.
Urology. 2022;165:e47.
Abstract Related articles

RASMUSSEN M, Madsen MG, Therkildsen C
Immunohistochemical Screening of Upper Tract Urothelial Carcinomas for Lynch Syndrome Diagnostics: A Systematic Review.
Urology. 2022;165:44-53.
Abstract Related articles

KHONDAKAR NR, Lee P, McNeil BK
Gross Hematuria in an Adolescent Secondary to a Rare Bladder Tumor: A Case Report and Review of Inflammatory Myofibroblastic Tumors of the Urinary Bladder.
Urology. 2022;165:e39-e45.
Abstract Related articles

TSIVIAN M, Bole R, Packiam VT, Boorjian SA, et al
The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic Outcomes.
Urology. 2022;165:128-133.
Abstract Related articles

ELSAYED AS, Iqbal U, Jing Z, Houenstein HA, et al
Relapses Rates and Patterns for Pathological T0 After Robot-Assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium.
Urology. 2022;166:177-181.
Abstract Related articles

MITCHELL K, Elbakry AA, Naili RE, Al-Omar O, et al
Dysfunctional Voiding- Presentation of a Rare Case of Pediatric Non Muscle Invasive Urothelial Bladder Carcinoma.
Urology. 2022;166:233-235.
Abstract Related articles

SHUMAKER L, Nocera A, Selph P
Enhanced Recovery After Surgery in the Urinary Diversion Population: Are Protocols Applied Differently in the Benign Indication Population?
Urology. 2022;166:50-55.
Abstract Related articles

WEISS K, Matulewicz RS, Morton E, Shoenbill K, et al
History of the Relationship between Smoking and Bladder Cancer: A Public Health Perspective.
Urology. 2022 Aug 14. pii: S0090-4295(22)00705.
Abstract Related articles

HERR H
Neoadjuvant Chemotherapy and Bladder-Sparing Surgery for Muscle-Invasive Bladder Cancer: Ten-year Outcomes.
Urology. 2022 Aug 31. pii: S0090-4295(22)00741.
Abstract Related articles

KATRAGADDA C, Fung C, Yousefi-Nooraie R, Cupertino P, et al
Medicare Accountable Care Organizations: Post-acute Care Use and Post-surgical Outcomes in Urologic Cancer Surgery.
Urology. 2022;167:102-108.
Abstract Related articles

BURNS R, Speir R, Kern SQ, Jarvis H, et al
Early and Midterm Complications of the Continent Catheterizable Indiana Pouch Urinary Diversion: A 7-year Experience.
Urology. 2022;167:229-233.
Abstract Related articles

HWANG J, Baird BA, Taylor T, Borkar S, et al
The Association Between Mood and Anxiety Disorders With Perioperative Outcomes Following Radical Cystectomy.
Urology. 2022;168:143-149.
Abstract Related articles

CHKIR S, Michel F, Akakpo W, Chinier E, et al
Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee
Urology. 2022;168:216-221.
Abstract Related articles

YANG H, Zhang Z, Zhao K, Zhang Y, et al
Initial experience with extraperitoneal laparoscopic radical cystectomy with pelvic organ-preserving and orthotopic neobladder techniques for bladder cancer in female patients.
Urology. 2022 Nov 14. pii: S0090-4295(22)00952.
Abstract Related articles

PHAM MN, Ko OS, Huang R, Vo AX, et al
An Evaluation of Peer-Rated Surgical Skill and its Relationship With Detrusor Muscle Sampling in Transurethral Resection of Bladder Tumor.
Urology. 2022;169:134-140.
Abstract Related articles

LEIBA A, Zino S, Korman AA, Rappaport V, et al
Persistent Asymptomatic Isolated Microscopic Hematuria in Adolescents is not Associated With an Increased Risk for Early Onset Urinary Tract Cancer.
Urology. 2022;169:29-34.
Abstract Related articles

SHUMAKER AD, Harel M, Gitlin J, Friedman SC, et al
Pediatric Bladder Tumors: A Ten-Year Retrospective Analysis.
Urology. 2022;169:185-190.
Abstract Related articles

REZAEE ME, Atwater BL, Bihrle W, Schroeck FR, et al
Ileal Conduit Versus Continent Urinary Diversion in Radical Cystectomy: A Retrospective Cohort Study of 30-day Complications, Readmissions, and Mortality.
Urology. 2022;170:139-145.
Abstract Related articles

ALHAMDANI Z, Ong S, Lawrentschuk N, Woon D, et al
A Unique Urine Isolating Drape Technique for on Table Pyeloscopy Post Radical Cystectomy for a Suspected Upper Tract Lesion With an Obliterated Ureteric Orifice.
Urology. 2022;170:e6-e7.
Abstract Related articles

ZHANG Y, Zhu B, Cai Y, Zhu S, et al
Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.
BMC Cancer. 2022;22:2.
Abstract Related articles

HUANG T, Li J, Wang SM
Core promoter mutation contributes to abnormal gene expression in bladder cancer.
BMC Cancer. 2022;22:68.
Abstract Related articles

WAHLIN S, Boman K, Moran B, Nodin B, et al
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity.
BMC Cancer. 2022;22:131.
Abstract Related articles

KIM KS, Kim SH, Cho HJ, Sur HJ, et al
Holmium laser-assisted laparoscopic partial cystectomy for bladder cancer: a single-institutional pilot study with technical feasibility and short-term oncological outcome.
BMC Cancer. 2022;22:195.
Abstract Related articles

FANG Q, Zhang X, Nie Q, Hu J, et al
Improved urine DNA methylation panel for early bladder cancer detection.
BMC Cancer. 2022;22:237.
Abstract Related articles

WANG R, Kang H, Zhang X, Nie Q, et al
Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
BMC Cancer. 2022;22:214.
Abstract Related articles

GUAN Z, Sun Y, Mu L, Jiang Y, et al
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-kappaB signaling activation.
BMC Cancer. 2022;22:240.
Abstract Related articles

BHATTACHARJEE S, Sullivan MJ, Wynn RR, Demagall A, et al
PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth.
BMC Cancer. 2022;22:312.
Abstract Related articles

SUN M, Liu X, Zhao W, Zhang B, et al
Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p.
BMC Cancer. 2022;22:313.
Abstract Related articles

WU Z, Xia C, Zhang C, Yang D, et al
Prognostic significance of SNCA and its methylation in bladder cancer.
BMC Cancer. 2022;22:330.
Abstract Related articles

FANG C, Huang X, Dai J, He W, et al
The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype.
BMC Cancer. 2022;22:373.
Abstract Related articles

YANG Z, Zhang X, Zhang J, Gao J, et al
Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT
BMC Cancer. 2022;22:462.
Abstract Related articles

WEICKHARDT AJ, Lau DK, Hodgson-Garms M, Lavis A, et al
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.
BMC Cancer. 2022;22:478.
Abstract Related articles

DENG L, Chao H, Deng H, Yu Z, et al
A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer.
BMC Cancer. 2022;22:510.
Abstract Related articles

HAO N, Yang D, Liu T, Liu S, et al
Laminin-integrin a6b4 interaction activates notch signaling to facilitate bladder cancer development.
BMC Cancer. 2022;22:558.
Abstract Related articles

ZHU L, Liu X, Zhang W, Hu H, et al
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
BMC Cancer. 2022;22:556.
Abstract Related articles

JEONG SH, Han JH, Jeong CW, Kim HH, et al
Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor.
BMC Cancer. 2022;22:631.
Abstract Related articles

ZHANG Q, Zhang W, Lin T, Lu W, et al
Mass cytometry reveals immune atlas of urothelial carcinoma.
BMC Cancer. 2022;22:677.
Abstract Related articles

JIANG L, Chen S, Pan Q, Zheng J, et al
The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients.
BMC Cancer. 2022;22:676.
Abstract Related articles

HOU J, Lu Z, Cheng X, Dong R, et al
Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
BMC Cancer. 2022;22:719.
Abstract Related articles

LI JD, Farah AA, Huang ZG, Zhai GQ, et al
Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.
BMC Cancer. 2022;22:713.
Abstract Related articles

KIM GT, Kim EY, Shin SH, Lee H, et al
Improving anticancer effect of aPD-L1 through lowering neutrophil infiltration by PLAG in tumor implanted with MB49 mouse urothelial carcinoma.
BMC Cancer. 2022;22:727.
Abstract Related articles

MIYAI K, Kawamura K, Ito K, Matsukuma S, et al
Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.
BMC Cancer. 2022;22:787.
Abstract Related articles

LIN Q, Pei L, Zhao Z, Zhuang X, et al
Glycoprotein alpha-Subunit of Glucosidase II (GIIalpha) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma.
BMC Cancer. 2022;22:817.
Abstract Related articles

XING P, Jiang Z, Liu Y
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.
BMC Cancer. 2022;22:926.
Abstract Related articles

XIONG M, Li W, Wang L, Chen L, et al
Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer.
BMC Cancer. 2022;22:1026.
Abstract Related articles

GAO L, Ren R, Shen J, Hou J, et al
Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer.
BMC Cancer. 2022;22:1016.
Abstract Related articles

HUANG Q, Zi H, Luo L, Li X, et al
Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030.
BMC Cancer. 2022;22:1164.
Abstract Related articles

HU J, Wang L, Li L, Wang Y, et al
A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database.
BMC Cancer. 2022;22:1158.
Abstract Related articles

OH TJ, Lim E, Bang BR, Lee JJ, et al
Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
BMC Cancer. 2022;22:1195.
Abstract Related articles

COQUAN E, Clarisse B, Lequesne J, Brachet PE, et al
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC Cancer. 2022;22:1213.
Abstract Related articles

MOLLER CT, Stoer NC, Blindheim A, Berge V, et al
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study.
BMC Cancer. 2022;22:1301.
Abstract Related articles

CHEN M, Chan RWY, Cheung PPH, Ni M, et al
Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.
PLoS Genet. 2022;18:e1010262.
Abstract Related articles

HUANG J, Zhou W, Hao C, He Q, et al
The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.
PLoS Genet. 2022;18:e1010366.
Abstract Related articles

ODA S, Fujisawa M, Chunning L, Ito T, et al
Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
PLoS One. 2021;16:e0254289.
Abstract Related articles

AL-EZZI EM, Veitch ZW, Salah SH, Van der Kwast TH, et al
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.
PLoS One. 2021;16:e0259272.
Abstract Related articles

LEMINSKI A, Kaczmarek K, Byrski T, Slojewski M, et al
Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience.
PLoS One. 2021;16:e0259526.
Abstract Related articles

SANGSTER AG, Gooding RJ, Garven A, Ghaedi H, et al
Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer.
PLoS One. 2022;17:e0259992.
Abstract Related articles

HEMMINKI K, Forsti A, Hemminki A, Ljungberg B, et al
Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.
PLoS One. 2022;17:e0261124.
Abstract Related articles

FU Y, Sun S, Bi J, Kong C, et al
An HDAC9-associated immune-related signature predicts bladder cancer prognosis.
PLoS One. 2022;17:e0264527.
Abstract Related articles

ISONO M, Okubo K, Asano T, Sato A, et al
Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances gemcitabine-induced cytotoxic effects in bladder cancer cells.
PLoS One. 2022;17:e0266476.
Abstract Related articles

KANG DH, Cho KS, Moon YJ, Chung DY, et al
Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation.
PLoS One. 2022;17:e0267410.
Abstract Related articles

AGHAMIR SMK, Khatami F, Farrokhpour H, Oliveira Reis L, et al
Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis.
PLoS One. 2022;17:e0267934.
Abstract Related articles

OKORIE CL, Gatsby E, Schroeck FR, Ould Ismail AA, et al
Using electronic health records to streamline provider recruitment for implementation science studies.
PLoS One. 2022;17:e0267915.
Abstract Related articles

Retraction: MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.
PLoS One. 2022;17:e0269903.
Abstract Related articles

ABDELGAWAD A, Hashem A, Mosbah A, Eissa LA, et al
A prospective trial investigating the role of Serum 25-Hydroxyvitamin D in diagnosis and prognosis of bladder cancer.
PLoS One. 2022;17:e0266371.
Abstract Related articles

GULYAS D, Kovacs G, Jankovics I, Meszaros L, et al
Effects of the combination of a monoclonal agonistic mouse anti-OX40 antibody and toll-like receptor agonists: Unmethylated CpG and LPS on an MB49 bladder cancer cell line in a mouse model.
PLoS One. 2022;17:e0270802.
Abstract Related articles

GLEICHENHAGEN J, Arndt C, Casjens S, Topfer C, et al
Exploring solid-phase proximity ligation assay for survivin detection in urine.
PLoS One. 2022;17:e0270535.
Abstract Related articles

JURI H, Higashiyama A, Yamamoto K, Narumi Y, et al
Comparison of reduced field-of-view DWI and full field-of view DWI for the differentiation between non-muscle invasive bladder cancer and muscle invasive bladder cancer using VI-RADS.
PLoS One. 2022;17:e0271470.
Abstract Related articles

DE WISPELAERE N, Rico SD, Bauer M, Luebke AM, et al
High prevalence of p16 staining in malignant tumors.
PLoS One. 2022;17:e0262877.
Abstract Related articles

LUND HAHEIM L, Thelle DS, Ronningen KS, Olsen I, et al
Low level of antibodies to the oral bacterium Tannerella forsythia predicts bladder cancers and Treponema denticola predicts colon and bladder cancers: A prospective cohort study.
PLoS One. 2022;17:e0272148.
Abstract Related articles

GILLEZEAU C, Movva N, van Gerwen M, Rabon-Stith K, et al
Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients.
PLoS One. 2022;17:e0271339.
Abstract Related articles

MOON YJ, Cho KS, Jeong JY, Chung DY, et al
Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.
PLoS One. 2022;17:e0273733.
Abstract Related articles

HOLMBERG L, Hagberg O, Haggstrom C, Gardmark T, et al
Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer.
PLoS One. 2022;17:e0274859.
Abstract Related articles

MACHLEID F, Ho-Wrigley J, Chowdhury A, Paliah A, et al
Cost-utility analysis of robotic-assisted radical cystectomy for bladder cancer compared to open radical cystectomy in the United Kingdom.
PLoS One. 2022;17:e0270368.
Abstract Related articles

AZUMA T, Kano M, Iwata S, Honda S, et al
Utility of periodic medical questionnaires and examinations for immune-related adverse event screening: A prospective observational study.
PLoS One. 2022;17:e0274451.
Abstract Related articles

ZHOU W, Liu J, Mao D, Hu C, et al
The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis.
PLoS One. 2022;17:e0276453.
Abstract Related articles

KARIMI A, Shobeiri P, Azadnajafabad S, Masinaei M, et al
A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: The global burden of disease study 1990-2019.
PLoS One. 2022;17:e0275574.
Abstract Related articles

ZHAO H, Tse RT, Cheng CK, Wong CY, et al
In vitro cytotoxicity of human urine and its potential toxic parameters towards bladder cancer cells.
PLoS One. 2022;17:e0276127.
Abstract Related articles

KIKUCHI H, Osawa T, Abe T, Matsumoto R, et al
Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor.
PLoS One. 2022;17:e0276816.
Abstract Related articles

HSIEH HC, Wang CL, Chen CS, Yang CK, et al
The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
PLoS One. 2022;17:e0278038.
Abstract Related articles

KONG N, Zhang R, Wu G, Sui X, et al
Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer.
Proc Natl Acad Sci U S A. 2022;119.
Abstract Related articles

SUN X, Xie L, Qiu S, Li H, et al
Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder cancer through aptamer-based target discovery.
Proc Natl Acad Sci U S A. 2022;119:e2110500119.
Abstract Related articles

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.

;